In	O
our	O
setting	O
,	O
family	O
planning	O
and	O
care	O
of	O
the	O
newborn	O
are	O
usually	O
discussed	O
in	O
Infant	O
Welfare	O
Clinic	O
.	O

Despite	O
active	O
research	O
and	O
impressive	O
improvements	O
in	O
the	O
understanding	O
of	O
the	O
regulation	O
of	O
energy	O
balance	O
,	O
there	O
are	O
only	O
a	O
very	O
limited	O
number	O
of	O
drugs	O
that	O
can	O
be	O
used	O
for	O
the	O
efficient	O
treatment	O
of	O
obesity	O
and	O
its	O
comorbidities	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

What	O
we	O
can	O
do	O
is	O
modulate	O
children	O
'	O
s	O
flavor	O
preferences	O
by	O
providing	O
early	O
exposure	O
,	O
starting	O
in	O
utero	O
and	O
early	O
infancy	O
,	O
to	O
a	O
variety	O
of	O
healthy	O
flavors	O
.	O

We	O
merged	O
the	O
forward	O
and	O
reverse	O
reads	O
based	O
on	O
sequence	O
overlap	O
[	O
33	O
],	O
removed	O
the	O
primer	O
sequences	O
,	O
and	O
discarded	O
the	O
sequences	O
containing	O
any	O
ambiguous	O
nucleotides	O
.	O

A	O
major	O
issue	O
in	O
sex	O
differences	O
is	O
the	O
need	O
for	O
control	O
the	O
estrous	O
phase	O
on	O
which	O
the	O
evaluations	O
were	O
performed	O
in	O
order	O
to	O
clarify	O
the	O
impact	O
of	O
sex	O
hormones	O
variations	O
in	O
the	O
female	O
.	O

For	O
example	O
,	O
epigenetic	O
mechanisms	O
and	O
markers	O
identified	O
within	O
the	O
47	O
studies	O
highlighted	O
in	O
this	B
review	I
could	O
be	O
further	O
examined	O
and	O
potentially	O
validated	O
in	O
existing	O
regulatory	O
studies	O
.	O

Central	O
neck	O
and	O
upper	O
mediastinum	O
clearance	O
and	O
,	O
in	O
addition	O
,	O
mono	O
or	O
bilateral	O
node	O
dissection	O
(	O
depending	O
on	O
the	O
extent	O
of	O
nodal	O
involvement	O
)	O
is	O
also	O
advisable	O
.	O

The	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
was	O
acceptable	O
for	O
all	O
sections	O
(	O
general	O
recommendations	O
,	O
0	O
.	O
66	O
;	O
sources	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
;	O
the	O
role	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
),	O
except	O
for	O
breastfeeding	O
(	O
0	O
.	O
60	O
),	O
which	O
was	O
therefore	O
eliminated	O
.	O

This	O
mutation	O
occurs	O
within	O
the	O
membrane	O
proximal	O
region	O
of	O
the	O
extracellular	O
domain	O
of	O
the	O
receptor	O
,	O
which	O
is	O
important	O
for	O
ligand	O
binding	O
(	O
Figure	O
3C	O
,	O
upper	O
panel	O
).	O

Their	O
liver	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
,	O
Ppar	O
α	O
,	O
Ppar	O
γ	O
,	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
,	O
the	O
de	O
novo	O
lipogenic	O
enzymes	O
Acaca	O
and	O
Fasn	O
,	O
and	O
the	O
liver	O
-	O
specific	O
cholesterol	O
biosynthesis	O
regulators	O
Insig1	O
and	O
Hmgcr	O
.	O

In	O
humans	O
,	O
a	O
unique	O
patient	O
suffering	O
from	O
extreme	O
diabetes	O
due	O
to	O
a	O
mutation	O
in	O
the	O
insulin	O
receptor	O
gene	O
had	O
to	O
undergo	O
total	O
thyroidectomy	O
because	O
of	O
the	O
presence	O
of	O
a	O
papillary	O
carcinoma	O
.	O

MUSC	O
is	O
a	O
comprehensive	O
,	O
urban	O
medical	O
center	O
treating	O
a	O
large	O
,	O
diverse	O
population	O
of	O
women	O
(~	O
3000	O
deliveries	O
/	O
year	O
).	O

Homocysteine	O
is	O
an	O
amino	O
acid	O
,	O
which	O
plays	O
several	O
important	O
roles	O
in	O
human	O
physiology	O
.	O

These	O
models	O
demonstrate	O
that	O
with	O
a	O
10	O
%	O
increase	O
in	O
LINE	O
-	O
1	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
9	O
.	O
7	O
(	O
95	O
%	O
CI	O
:	O
2	O
.	O
9	O
,	O
16	O
.	O
6	O
),	O
and	O
with	O
a	O
10	O
%	O
increase	O
in	O
AluYb8	O
mean	O
methylation	O
levels	O
,	O
birth	O
weight	O
percentile	O
significantly	O
increased	O
by	O
14	O
.	O
5	O
(	O
95	O
%	O
CI	O
:	O
4	O
.	O
9	O
,	O
24	O
.	O
0	O
)	O
(	O
Table	O
1	O
).	O

The	O
approach	O
to	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
methylation	O
was	O
not	O
designed	O
to	O
assess	O
specific	O
loci	O
or	O
genes	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
but	O
rather	O
to	B
evaluate	I
whether	O
methylation	O
of	O
particular	O
groups	O
of	O
CpG	O
loci	O
with	O
like	O
methylation	O
patterns	O
or	O
similar	O
bioinformatic	O
attributes	O
were	O
coordinately	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
because	O
this	O
could	O
inform	O
on	O
the	O
process	O
responsible	O
for	O
the	O
variation	O
between	O
the	O
two	O
.	O

Primiparous	O
and	O
secundiparous	O
women	O
were	O
predominant	O
(	O
49	O
.	O
5	O
%	O
and	O
32	O
.	O
3	O
%,	O
respectively	O
);	O
10	O
.	O
0	O
%	O
of	O
women	O
declared	O
that	O
the	O
pregnancy	O
was	O
unwanted	O
(	O
Table	O
1	O
).	O

Unfortunately	O
,	O
the	O
tiny	O
10	O
μg	O
(	O
400	O
IU	O
)	O
dose	O
in	O
prenatal	O
vitamins	O
is	O
virtually	O
irrelevant	O
in	O
preventing	O
the	O
current	O
epidemic	O
of	O
gestational	O
vitamin	O
D	O
deficiency	O
(	O
8	O
).	O

The	O
colored	O
dots	O
indicate	O
the	O
degree	O
of	O
average	O
CpG	O
class	O
methylation	O
,	O
as	O
indicated	O
by	O
the	O
key	O
.	O

Continuous	O
variables	O
Serum	O
total	O
IgE	O
(	O
kU	O
·	O
L	O
−	O
1	O
)	O
was	O
measured	O
by	O
fluoroimmunoassay	O
using	O
the	O
Pharmacia	O
UNICAP	O
system	O
(	O
Pharmacia	O
and	O
Upjohn	O
Diagnostics	O
,	O
Uppsala	O
,	O
Sweden	O
).	O

When	O
the	O
requirement	O
was	O
not	O
met	O
,	O
we	O
randomly	O
sampled	O
from	O
the	O
vaccinated	O
cases	O
to	O
obtain	O
an	O
unvaccinated	O
to	O
vaccinated	O
ratio	O
greater	O
than	O
one	O
.	O

EAH	O
in	O
children	O
is	O
associated	O
with	O
higher	O
fasting	O
insulin	O
and	O
leptin	O
levels	O
(	O
64	O
),	O
2	O
hormones	O
that	O
regulate	O
appetite	O
and	O
body	O
weight	O
(	O
68	O
).	O

Findings	O
in	O
this	O
study	O
indicate	O
that	O
children	O
with	O
autism	O
had	O
a	O
significantly	O
higher	O
history	O
of	O
meconium	O
aspiration	O
syndrome	O
than	O
the	O
controls	O
[	O
43	O
].	O

Further	O
,	O
a	O
possible	O
association	O
exists	O
with	O
ventilation	O
of	O
neonates	O
[	O
16	O
].	O

Each	O
adult	O
egg	O
-	O
laying	O
hen	O
consumes	O
100	O
–	O
115	O
g	O
/	O
day	O
feeds	O
fortified	O
with	O
1600	O
IU	O
/	O
kg	O
Vitamin	O
D	O
(	O
both	O
Vitamin	O
D2	O
and	O
Vitamin	O
D3	O
),	O
as	O
indicated	O
by	O
Chinese	O
nutrition	O
standards	O
for	O
feeding	O
egg	O
-	O
laying	O
hens	O
.	O

Similarly	O
,	O
little	O
is	O
known	O
about	O
the	O
role	O
of	O
GR	O
-	O
P	O
,	O
a	O
truncated	O
isoform	O
that	O
lacks	O
a	O
large	O
part	O
of	O
the	O
ligand	O
-	O
binding	O
domain	O
,	O
including	O
the	O
domains	O
for	O
silencing	O
of	O
GR	O
in	O
the	O
absence	O
of	O
hormone	O
and	O
transcriptional	O
activation	O
[	O
24	O
].	O

Subgroup	O
analyses	O
revealed	O
some	O
potentially	O
key	O
findings	O
.	O

Labs	O
revealed	O
an	O
unremarkable	O
BMP	O
,	O
coagulation	O
study	O
,	O
and	O
CBC	O
with	O
a	O
hemoglobin	O
of	O
10	O
.	O
8	O
and	O
hematocrit	O
of	O
32	O
.	O
2	O
.	O

It	O
has	O
been	O
suggested	O
that	O
intrauterine	O
growth	O
patterns	O
improved	O
prediction	O
of	O
childhood	O
anthropometry	O
,	O
above	O
and	O
beyond	O
birth	O
weight	O
alone	O
.	O

Years	O
of	O
life	O
saved	O
will	O
be	O
based	O
on	O
any	O
difference	O
in	O
survival	O
of	O
mothers	O
and	O
infants	O
observed	O
during	O
the	O
trial	O
and	O
estimated	O
using	O
current	O
life	O
expectancy	O
in	O
Bangladesh	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

Optimal	O
management	O
of	O
these	O
disorders	O
during	O
pregnancy	O
is	O
vital	O
to	O
ensure	O
the	O
welfare	O
of	O
the	O
mother	O
and	O
the	O
baby	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Comparison	O
of	O
demographic	O
data	O
in	O
the	O
intervention	O
and	O
control	O
groupVariablesVitamin	O
DControl	O
p	O
-	O
valueAge	O
(	O
year	O
)	O
Mean	O
±	O
sd26	O
.	O
40	O
±	O
4	O
.	O
8826	O
.	O
22	O
±	O
4	O
.	O
330	O
.	O
80Job	O
N	O
(%)	O
0	O
.	O
96	O
Housewife72	O
(	O
96	O
)	O
75	O
(	O
96	O
.	O
2	O
)	O
Employed3	O
(	O
4	O
)	O
3	O
(	O
3	O
.	O
8	O
)	O
Education	O
N	O
(%)	O
0	O
.	O
55	O
High	O
school26	O
(	O
34	O
.	O
7	O
)	O
21	O
(	O
26	O
.	O
9	O
)	O
High	O
school	O
diploma34	O
(	O
45	O
.	O
3	O
)	O
38	O
(	O
48	O
.	O
7	O
)	O
University15	O
(	O
20	O
.	O
0	O
)	O
19	O
(	O
24	O
.	O
4	O
)	O
Parity0	O
.	O
17	O
Nullipara41	O
(	O
54	O
.	O
7	O
)	O
51	O
(	O
65	O
.	O
4	O
)	O
Multipara34	O
(	O
45	O
.	O
3	O
)	O
27	O
(	O
34	O
.	O
6	O
)	O
Using	O
others	O
supplements0	O
.	O
017	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Planned	O
pregnancy0	O
.	O
01	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Seasonal	O
distribution	O
in	O
onset	O
N	O
(%)	O
0	O
.	O
32	O
Autumn9	O
(	O
12	O
)	O
6	O
(	O
7	O
.	O
7	O
)	O
Winter11	O
(	O
14	O
.	O
7	O
)	O
7	O
(	O
9	O
)	O
Spring55	O
(	O
73	O
.	O
3	O
)	O
65	O
(	O
83	O
.	O
3	O
)	O
Sun	O
exposure	O
(	O
minutes	O
)	O
0	O
.	O
55	O
<	O
1514	O
(	O
21	O
.	O
9	O
)	O
12	O
(	O
16	O
.	O
7	O
)	O
15	O
–	O
3028	O
(	O
43	O
.	O
8	O
)	O
33	O
(	O
45	O
.	O
8	O
)	O
30	O
–	O
6010	O
(	O
15	O
.	O
6	O
)	O
17	O
(	O
23	O
.	O
6	O
)	O
>	O
6012	O
(	O
18	O
.	O
8	O
)	O
10	O
(	O
13	O
.	O
9	O
)	O
At	O
baseline	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
12	O
.	O
35	O
±	O
7	O
.	O
17	O
ng	O
/	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
4	O
and	O
49	O
.	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

Groups	O
denoted	O
by	O
different	O
letters	O
are	O
significantly	O
different	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

Prenatal	O
Vitamin	O
Use	O
and	O
Vitamin	O
D	O
Status	O
during	O
Pregnancy	O
,	O
Differences	O
by	O
Race	O
and	O
Overweight	O
Status	O
Abstract	O
Objective	O
We	O
aimed	B
to	B
study	I
whether	O
prenatal	O
vitamin	O
(	O
PNV	O
)	O
use	O
protects	O
against	O
low	O
25	O
(	O
OH	O
)	O
D	O
levels	O
in	O
all	O
women	O
and	O
particularly	O
in	O
obese	O
and	O
black	O
women	O
who	O
are	O
both	O
at	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
and	O
poor	O
pregnancy	O
outcomes	O
.	O

Exposing	O
fetal	O
rats	O
to	O
high	O
levels	O
of	O
glucocorticoids	O
reduces	O
birth	O
weight	O
and	O
results	O
in	O
adults	O
with	O
high	O
blood	O
levels	O
of	O
insulin	O
and	O
glucose	O
.	O

The	O
porcine	O
expression	O
patterns	O
in	O
this	O
study	O
showed	O
a	O
decreased	O
mRNA	O
expression	O
of	O
genes	O
associated	O
with	O
the	O
control	O
of	O
mitosis	O
and	O
cell	O
cycle	O
checkpoint	O
regulation	O
at	O
stage	O
94	O
dpc	O
in	O
LP	O
fetuses	O
.	O

Blood	O
samples	O
were	O
briefly	O
collected	O
into	O
tubes	O
containing	O
EDTA	O
(	O
6	O
%)	O
and	O
centrifuged	O
(	O
1500	O
g	O
for	O
10	O
min	O
at	O
4	O
°	O
C	O
).	O

Similarly	O
,	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
1	O
,	O
significantly	O
down	O
-	O
regulated	O
in	O
this	B
study	I
,	O
has	O
been	O
found	O
to	O
be	O
down	O
-	O
regulated	O
at	O
both	O
the	O
mRNA	O
and	O
protein	O
levels	O
in	O
post	O
-	O
mortem	O
schizophrenia	O
brain	O
tissue	O
(	O
thalamus	O
)[	O
48	O
]	O
Like	O
the	O
previous	O
proteomic	O
study	O
[	O
18	O
],	O
we	O
found	O
no	O
alterations	O
in	O
proteins	O
directly	O
associated	O
with	O
DA	O
signaling	O
.	O

This	O
relationship	O
was	O
also	O
present	O
when	O
the	O
IOM	O
threshold	O
for	O
adequacy	O
(	O
50	O
nmol	O
/	O
L	O
)	O
was	O
applied	O
(	O
p	O
=	O
0	O
.	O
05	O
,	O
OR	O
=	O
0	O
.	O
5	O
).	O

These	O
processes	O
are	O
complex	O
and	O
normal	O
development	O
is	O
dependent	O
on	O
several	O
factors	O
.	O

The	O
number	O
of	O
mature	O
glomeruli	O
was	O
20	O
%	O
lower	O
in	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1VitD	O
-	O
mice	O
,	O
and	O
there	O
was	O
no	O
difference	O
in	O
the	O
number	O
of	O
mature	O
glomeruli	O
between	O
the	O
F2	O
-	O
VitD	O
-	O
and	O
F2	O
-	O
SC	O
mice	O
at	O
this	O
age	O
.	O

Anthropometric	O
measurements	O
included	O
height	O
,	O
measured	O
to	O
the	O
nearest	O
0	O
.	O
1	O
cm	O
using	O
a	O
stadiometer	O
,	O
and	O
weight	O
,	O
assessed	O
to	O
the	O
nearest	O
0	O
.	O
1	O
kg	O
using	O
calibrated	O
electronic	O
scales	O
.	O

It	O
has	O
long	O
been	O
known	O
that	O
African	O
Americans	O
are	O
two	O
to	O
three	O
times	O
more	O
prone	O
to	O
myomas	O
than	O
European	O
Americans	O
.	O

Towards	O
the	O
end	O
of	O
the	O
pregnancy	O
,	O
insulin	O
requirements	O
can	O
drop	O
.	O

Overall	O
,	O
findings	O
from	O
the	O
current	O
study	O
support	O
a	O
stronger	O
role	O
for	O
maternal	O
intake	O
than	O
expenditure	O
in	O
predicting	O
offspring	O
weight	O
outcomes	O
,	O
but	O
additional	O
studies	O
with	O
objective	O
measures	O
of	O
physical	O
activity	O
(	O
e	O
.	O
g	O
.,	O
accelerometry	O
)	O
are	O
clearly	O
needed	O
.	O

This	O
leaves	O
the	O
important	O
question	O
of	O
exact	O
dosage	O
and	O
timing	O
of	O
delivery	O
requirements	O
for	O
future	O
studies	O
.	O

There	O
should	O
be	O
greater	O
emphasis	O
on	O
the	O
universal	O
provision	O
of	O
antenatal	O
corticosteroids	O
,	O
building	O
on	O
the	O
work	O
of	O
the	O
UN	O
Commission	O
on	O
Life	O
-	O
Saving	O
Commodities	O
for	O
Women	O
and	O
Children	O
as	O
an	O
opportunity	O
to	O
accelerate	O
progress	O
.	O

From	O
the	O
final	O
analysis	O
ten	O
questionnaires	O
were	O
excluded	O
representing	O
drop	O
-	O
outs	O
(	O
refusals	O
after	O
the	O
initial	O
moment	O
of	O
the	O
study	O
or	O
incomplete	O
questionnaires	O
).	O

These	O
spots	O
were	O
mapped	O
to	O
33	O
unique	O
proteins	O
.	O

In	O
a	O
very	O
recent	O
study	O
,	O
the	O
grizzly	O
bear	O
was	O
used	O
as	O
a	O
hibernation	O
model	O
,	O
in	O
which	O
obesity	O
is	O
a	O
natural	O
adaptation	O
to	O
survive	O
months	O
of	O
fasting	O
(	O
Nelson	O
et	O
al	O
.,	O
2014	O
).	O

No	O
lamellar	O
bone	O
or	O
cartilage	O
is	O
seen	O
.	O

Sunscreen	O
lotions	O
prevent	O
UV	O
radiation	O
from	O
reaching	O
the	O
skin	O
and	O
might	O
therefore	O
reduce	O
the	O
skin	O
’	O
s	O
vitamin	O
D	O
production	O
[	O
56	O
].	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
no	O
competing	O
interests	O
(	O
financial	O
or	O
personal	O
)	O
exist	O
with	O
regards	O
to	O
this	O
manuscript	O
.	O

PATCH	O
is	O
an	O
unselected	O
,	O
population	O
-	O
based	O
birth	O
cohort	O
study	O
investigating	O
the	O
risk	O
factors	O
for	O
immune	O
-	O
related	O
and	O
allergic	O
diseases	O
in	O
children	O
in	O
Keelung	O
,	O
a	O
city	O
in	O
northern	O
Taiwan	O
.	O

That	O
is	O
,	O
analyses	O
were	O
conducted	O
assuming	O
that	O
missing	O
values	O
had	O
,	O
firstly	O
,	O
a	O
substantially	O
greater	O
incidence	O
,	O
and	O
secondly	O
,	O
a	O
substantially	O
reduced	O
incidence	O
of	O
z	O
-	O
scores	O
>	O
90th	O
percentile	O
as	O
compared	O
with	O
the	O
observed	O
data	O
.	O

A	O
maternal	O
diet	O
high	O
in	O
fat	O
also	O
causes	O
long	O
-	O
term	O
harm	O
to	O
the	O
offspring	O
.	O

4	O
.	O

Several	O
studies	O
have	O
suggested	O
the	O
association	O
between	O
perinatal	O
factors	O
and	O
the	O
onset	O
of	O
autism	O
.	O

Allergies	O
or	O
hyperreactivities	O
have	O
been	O
classified	O
by	O
Gells	O
and	O
Coombs	O
into	O
types	O
I	O
through	O
IV	O
,	O
with	O
types	O
I	O
,	O
II	O
,	O
and	O
III	O
being	O
mediated	O
by	O
antibodies	O
or	O
immune	O
complexes	O
and	O
type	O
IV	O
reactions	O
as	O
well	O
as	O
chronic	O
stages	O
of	O
allergic	O
diseases	O
being	O
mediated	O
by	O
T	O
cells	O
[	O
1	O
].	O

Second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
.	O

After	O
that	O
,	O
several	O
studies	O
have	O
validated	O
its	O
use	O
throughout	O
the	O
antenatal	O
period	O
[	O
37	O
–	O
39	O
].	O

However	O
this	O
recommended	O
level	O
,	O
which	O
was	O
largely	O
arbitrarily	O
set	O
,	O
seems	O
to	O
be	O
less	O
helpful	O
to	O
improve	O
the	O
nutritional	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
.	O

P	O
<	O
0	O
.	O
05	O
was	O
considered	O
significant	O
.	O

Characteristics	O
of	O
the	O
8956	O
mother	O
–	O
child	O
pairs	O
who	O
were	O
included	O
in	O
the	O
analyses	O
and	O
those	O
of	O
the	O
3122	O
mother	O
–	O
child	O
pairs	O
with	O
information	O
on	O
maternal	O
diet	O
who	O
were	O
excluded	O
because	O
of	O
incomplete	O
outcome	O
data	O
are	O
compared	O
in	O
supplementary	O
table	O
E1	O
.	O

We	O
used	O
PyNAST	O
alignment	O
[	O
37	O
]	O
with	O
Greengenes	O
core	O
reference	O
[	O
38	O
,	O
39	O
]	O
to	O
build	O
OTU	O
tables	O
and	O
assign	O
taxonomy	O
[	O
39	O
,	O
40	O
].	O

Considering	O
that	O
reports	O
that	O
polytherapy	O
do	O
not	O
commonly	O
alter	O
the	O
course	O
and	O
outcome	O
of	O
the	O
baseline	O
disorder	O
,	O
2224indications	O
for	O
polytherapy	O
in	O
pregnant	O
women	O
should	O
be	O
seriously	O
considered	O
and	O
made	O
on	O
an	O
individual	O
basis	O
following	O
a	O
thorough	O
risk	O
/	O
benefit	O
analysis	O
.	O

Biochemical	O
screening	O
of	O
familial	O
disease	O
consists	O
of	O
serum	O
calcitonin	O
evaluation	O
,	O
and	O
genetic	O
screening	O
of	O
individuals	O
with	O
a	O
RET	O
mutation	O
may	O
also	O
be	O
performed	O
.	O

Importantly	O
,	O
as	O
Alvarez	O
–	O
Rodriguez	O
and	O
colleagues	O
have	O
found	O
a	O
negative	O
correlation	O
between	O
age	O
and	O
immune	O
function	O
in	O
healthy	O
adult	O
subjects	O
,	O
especially	O
those	O
over	O
the	O
age	O
of	O
60	O
[	O
15	O
],	O
perhaps	O
innate	O
immune	O
function	O
,	O
in	O
particular	O
cytokine	O
function	O
,	O
increases	O
with	O
age	O
for	O
a	O
period	O
of	O
time	O
,	O
reaches	O
a	O
threshold	O
and	O
then	O
decreases	O
later	O
in	O
life	O
.	O

The	O
plasma	O
levels	O
of	O
HDL	O
were	O
significantly	O
decreased	O
in	O
RC	O
males	O
and	O
females	O
.	O

Male	O
offspring	O
of	O
female	O
rats	O
with	O
a	O
history	O
of	O
fetal	O
exposure	O
to	O
glucocorticoids	O
also	O
exhibit	O
low	O
birth	O
weight	O
and	O
glucose	O
intolerance	O
—	O
a	O
multigenerational	O
effect	O
(	O
6	O
).	O

Concerns	O
have	O
been	O
expressed	O
about	O
the	O
use	O
of	O
glargine	O
in	O
pregnancy	O
,	O
because	O
of	O
its	O
potential	O
effect	O
on	O
mitogenesis	O
,	O
mediated	O
by	O
its	O
high	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
,	O
which	O
is	O
six	O
times	O
that	O
of	O
natural	O
insulin48	O
,	O
49Whilst	O
insulin	O
detemir	O
has	O
a	O
lower	O
binding	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
than	O
natural	O
insulin	O
,	O
there	O
is	O
even	O
less	O
information	O
regarding	O
its	O
use	O
in	O
pregnancy	O
.	O

In	O
contrast	O
,	O
the	O
LDL	O
was	O
two	O
-	O
fold	O
increased	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
artherosclerosis	O
within	O
the	O
artery	O
wall	O
and	O
poses	O
a	O
risk	O
for	O
cardiovascular	O
disease	O
.	O

In	O
the	O
homozygous	O
group	O
for	O
Tth111	O
I	O
polymorphism	O
,	O
mothers	O
with	O
negative	O
attitudes	O
towards	O
the	O
pregnancy	O
gave	O
birth	O
to	O
infants	O
with	O
significantly	O
lower	O
birth	O
weights	O
compared	O
to	O
women	O
with	O
positive	O
/	O
neutral	O
attitudes	O
.	O

The	O
predicted	O
probabilities	O
of	O
vitamin	O
D	O
deficiency	O
,	O
based	O
on	O
significant	O
predictors	O
in	O
the	O
multivariable	O
regression	O
model	O
,	O
are	O
shown	O
inFigure	O
2	O
.	O

Taking	O
into	O
consideration	O
that	O
participants	O
may	O
opt	O
out	O
of	O
the	O
project	O
(	O
at	O
25	O
%	O
rate	O
),	O
it	O
is	O
calculated	O
that	O
a	O
minimum	O
of	O
245	O
participants	O
should	O
be	O
recruited	O
.	O

However	O
,	O
the	O
previous	O
study	O
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	O
the	B
current	I
study	I
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

However	O
,	O
several	O
limitations	O
merit	O
discussion	O
and	O
consideration	O
.	O

Then	O
,	O
the	O
sample	O
was	O
purified	O
to	O
remove	O
any	O
residual	O
tailing	O
reagents	O
.	O

Methods	O
The	O
methods	O
and	O
primary	O
clinical	O
findings	O
of	O
the	O
LIMIT	O
randomised	O
trial	O
have	O
been	O
published	O
[	O
21	O
–	O
23	O
],	O
with	O
the	O
trial	O
registered	O
on	O
the	O
Australian	O
and	O
New	O
Zealand	O
Clinical	O
Trials	O
Registry	O
(	O
ACTRN12607000161426	O
).	O

This	O
data	O
does	O
not	O
apply	O
to	O
PCOS	O
patients	O
with	O
abnormally	O
elevated	O
AMH	O
levels	O
—	O
as	O
mentioned	O
earlier	O
,	O
in	O
this	O
group	O
,	O
VD	O
supplementation	O
results	O
with	O
AMH	O
level	O
normalization	O
[	O
26	O
].	O

The	O
25	O
%	O
prevalence	O
rate	O
of	O
NICU	O
admissions	O
found	O
in	O
the	O
exposed	O
group	O
of	O
the	O
present	O
study	O
is	O
the	O
same	O
as	O
that	O
reported	O
in	O
a	O
recent	O
retrospective	O
chart	O
review	O
,	O
although	O
only	O
16	O
women	O
were	O
assessed	O
.	O
43	O
Our	O
results	O
also	O
suggest	O
that	O
polytherapy	O
in	O
pregnancy	O
may	O
be	O
associated	O
with	O
shorter	O
gestation	O
and	O
increased	O
rates	O
of	O
LGA	O
neonates	O
,	O
instrumental	O
deliveries	O
,	O
fetal	O
distress	O
during	O
delivery	O
,	O
NICU	O
admissions	O
and	O
neonates	O
presenting	O
with	O
PNA	O
symptoms	O
.	O

Interestingly	O
,	O
the	O
ECS	O
is	O
implicated	O
in	O
the	O
intake	O
of	O
palatable	O
food	O
(	O
DiPatrizio	O
and	O
Simansky	O
,	O
2008	O
)	O
and	O
the	O
perception	O
of	O
sweet	O
taste	O
(	O
Niki	O
et	O
al	O
.,	O
2015	O
).	O

Women	O
who	O
delivered	O
a	O
live	O
-	O
born	O
infant	O
but	O
who	O
were	O
not	O
included	O
in	O
this	O
analysis	O
due	O
to	O
missing	O
25	O
(	O
OH	O
)	O
D	O
or	O
genetic	O
analysis	O
were	O
of	O
similar	O
age	O
,	O
smoking	O
status	O
,	O
and	O
BMI	O
to	O
those	O
included	O
in	O
the	O
analysis	O
(	O
P	O
>	O
0	O
.	O
05	O
for	O
all	O
).	O

Therefore	O
,	O
genetic	O
variations	O
in	O
vitamin	O
-	O
D	O
-	O
related	O
genes	O
might	O
also	O
affect	O
MS	O
risk	O
,	O
either	O
directly	O
or	O
by	O
modifying	O
the	O
effects	O
of	O
vitamin	O
D	O
.	O
40	O
Our	O
implications	O
for	O
future	O
research	O
and	O
MS	O
prevention	O
and	O
according	O
to	O
the	O
basis	O
of	O
the	O
results	O
of	O
the	O
only	O
longitudinal	O
study	O
of	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
and	O
MS	O
onset	O
,	O
18and	O
assum	O
-	O
ing	O
that	O
these	O
results	O
are	O
unbiased	O
and	O
vitamin	O
D	O
is	O
truly	O
protective	O
against	O
MS	O
,	O
over	O
70	O
%	O
of	O
MS	O
cases	O
in	O
the	O
USA	O
and	O
Europe	O
could	O
be	O
prevented	O
by	O
increasing	O
the	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
adolescents	O
and	O
young	O
adults	O
to	O
above	O
100	O
nmol	O
/	O
L	O
.	O
4142These	O
concentrations	O
are	O
commonly	O
found	O
only	O
in	O
individuals	O
with	O
outdoor	O
lifestyles	O
in	O
sunny	O
regions	O
,	O
but	O
could	O
be	O
reached	O
in	O
most	O
people	O
by	O
taking	O
1000	O
-	O
4000	O
IU	O
colecalciferol	O
daily	O
.	O
8254344Although	O
these	O
doses	O
are	O
largely	O
considered	O
safe	O
and	O
potentially	O
beneficial	O
for	O
other	O
outcomes	O
,	O
819confirmation	O
of	O
safety	O
and	O
efficacy	O
in	O
a	O
large	O
randomized	O
trial	O
is	O
needed	O
before	O
making	O
general	O
recommendations	O
.	O

Environmental	O
Risk	O
Factors	O
for	O
Atopy	O
The	O
causes	O
of	O
allergy	O
in	O
general	O
and	O
of	O
specific	O
sensitization	O
in	O
newborns	O
in	O
particular	O
have	O
not	O
yet	O
been	O
completely	O
determined	O
.	O

Salmeterol	O
is	O
the	O
preferred	O
agent	O
when	O
long	O
-	O
acting	O
β2	O
agonists	O
are	O
indicated	O
in	O
pregnant	O
women	O
as	O
add	O
-	O
on	O
treatment	O
of	O
persistent	O
asthma	O
.	O

In	O
general	O
,	O
treatment	O
of	O
asthma	O
and	O
allergic	O
diseases	O
does	O
not	O
differ	O
from	O
that	O
in	O
nonpregnant	O
women	O
.	O

Follow	O
-	O
up	O
testing	O
was	O
recommended	O
between	O
24	O
–	O
28	O
weeks	O
and	O
prior	O
to	O
delivery	O
by	O
provider	O
request	O
.	O

Information	O
on	O
medical	O
and	O
reproductive	O
histories	O
and	O
sociodemographic	O
and	O
lifestyle	O
characteristics	O
including	O
average	O
number	O
of	O
hours	O
of	O
sleep	O
before	O
and	O
during	O
early	O
pregnancy	O
was	O
collected	O
.	O

In	O
contrast	O
,	O
a	O
lower	O
weight	O
at	O
birth	O
has	O
been	O
described	O
in	O
several	O
studies	O
when	O
the	O
calorie	O
-	O
restricted	O
diet	O
was	O
prolonged	O
to	O
birth	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

A	O
successful	O
supplementation	O
program	O
must	O
include	O
training	O
of	O
health	O
care	O
system	O
workers	O
,	O
provision	O
of	O
accessible	O
educational	O
materials	O
for	O
the	O
target	O
group	O
and	O
the	O
broader	O
community	O
and	O
a	O
reliable	O
distribution	O
system	O
.	O

The	O
MGM	O
could	O
arguably	O
have	O
influenced	O
her	O
daughter	O
'	O
s	O
culinary	O
and	O
dietary	O
habits	O
and	O
hence	O
her	O
grandchild	O
'	O
s	O
BMI	O
,	O
25but	O
the	O
PGM	O
is	O
associated	O
with	O
the	O
paternal	O
granddaughter	O
and	O
not	O
her	O
paternal	O
grandson	O
.	O

These	O
soldiers	O
and	O
family	O
members	O
could	O
benefit	O
significantly	O
from	O
mHealth	O
programs	O
such	O
as	O
text4baby	O
because	O
it	O
is	O
a	O
free	O
resource	O
and	O
is	O
highly	O
portable	O
,	O
permitting	O
families	O
to	O
receive	O
these	O
messages	O
anywhere	O
in	O
the	O
world	O
where	O
text	O
messages	O
can	O
be	O
received	O
.	O

Although	O
we	O
did	O
not	O
collect	O
data	O
on	O
daily	O
temperature	O
,	O
the	O
temperatures	O
in	O
Ireland	O
are	O
relatively	O
stable	O
across	O
the	O
year	O
,	O
with	O
mean	O
temperature	O
of	O
5	O
.	O
3	O
°	O
C	O
in	O
January	O
and	O
15	O
.	O
6	O
°	O
C	O
in	O
July	O
[	O
47	O
],	O
reducing	O
the	O
likelihood	O
that	O
temperature	O
is	O
responsible	O
.	O

Infancy	O
and	O
Early	O
Childhood	O
Taste	O
acquisition	O
and	O
preference	O
The	O
biological	O
substrate	O
that	O
underlies	O
the	O
taste	O
and	O
rewarding	O
properties	O
of	O
foods	O
is	O
relevant	O
because	O
the	O
best	O
predictor	O
of	O
food	O
preference	O
is	O
whether	O
a	O
child	O
likes	O
the	O
taste	O
(	O
23	O
).	O

Results	O
We	O
identified	O
three	O
infant	O
gut	O
microbiome	O
clusters	O
,	O
characterized	O
by	O
increased	O
abundance	O
of	O
Bifidobacterium	O
,	O
Streptococcus	O
and	O
Clostridium	O
,	O
and	O
Bacteroides	O
,	O
respectively	O
,	O
overall	O
and	O
in	O
the	O
vaginally	O
delivered	O
infant	O
stratum	O
.	O

Murphy	O
et	O
al	O
.	O

Humans	O
get	O
vitamin	O
D	O
(	O
cholecalciferol	O
)	O
from	O
exposure	O
to	O
sunlight	O
,	O
diet	O
and	O
dietary	O
supplements	O
.	O

Despite	O
few	O
cases	O
of	O
IUFD	O
in	O
the	O
GraviD	O
cohort	O
,	O
our	O
results	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
may	O
be	O
linked	O
to	O
IUFD	O
.	O

And	O
in	O
order	O
to	O
determine	O
changes	O
over	O
time	O
,	O
the	O
repeated	O
measures	O
analysis	O
was	O
used	O
.	O

2	O
.	O
5	O
.	O

Nimitphong	O
et	O
al	O
.	O

Soap	O
and	O
water	O
were	O
observed	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
at	O
65	O
%	O
of	O
intervention	O
households	O
and	O
10	O
%	O
of	O
control	O
households	O
at	O
the	O
observation	O
conducted	O
at	O
postnatal	O
days	O
4	O
-	O
5	O
(	O
RR	O
=	O
5	O
.	O
6	O
,	O
95	O
%	O
CI	O
3	O
.	O
12	O
–	O
10	O
.	O
14	O
,	O
p	O
<	O
.	O
0001	O
)	O
(	O
Figure	O
4	O
).	O

However	O
,	O
diets	O
are	O
often	O
stable	O
,	O
and	O
a	O
mid	O
-	O
pregnancy	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)-	O
assessment	O
is	O
likely	O
to	O
be	O
sufficiently	O
representative	O
of	O
late	O
pregnancy	O
and	O
lactation	O
diet	O
in	O
a	O
high	O
proportion	O
of	O
individuals	O
[	O
25	O
,	O
26	O
].	O

When	O
the	O
item	O
was	O
unique	O
in	O
the	O
nutrient	O
profile	O
,	O
it	O
was	O
not	O
combined	O
(	O
e	O
.	O
g	O
.,	O
salt	O
).	O

Furthermore	O
,	O
women	O
were	O
asked	O
a	O
validated	O
,	O
single	O
-	O
item	O
question	O
on	O
food	O
insufficiency	O
–“	O
How	O
many	O
days	O
in	O
the	O
past	O
week	O
have	O
you	O
gone	O
hungry	O
?	O

Statistical	O
Analyses	O
Statistical	O
analyses	O
were	O
carried	O
out	O
using	O
StatView	O
(	O
Version	O
5	O
,	O
SAS	O
Institute	O
,	O
Cary	O
,	O
NC	O
)	O
statistical	O
packages	O
.	O

Imputation	O
of	O
missing	O
values	O
for	O
education	O
(	O
n	O
=	O
12	O
)	O
and	O
parity	O
(	O
n	O
=	O
2	O
)	O
were	O
conducted	O
using	O
the	O
median	O
value	O
in	O
subgroups	O
by	O
GDM	O
status	O
.	O

IPG	O
strips	O
were	O
reduced	O
,	O
alkylated	O
and	O
detergent	O
exchanged	O
using	O
SDS	O
equilibration	O
buffer	O
(	O
Proteome	O
Systems	O
,	O
20	O
min	O
)	O
and	O
loaded	O
onto	O
pre	O
-	O
cast	O
SDS	O
-	O
PAGE	O
gels	O
(	O
GelChip	O
™	O
2D	O
,	O
6	O
–	O
15	O
%,	O
10	O
×	O
15	O
cm	O
;	O
Proteome	O
Systems	O
)	O
for	O
second	O
dimension	O
molecular	O
mass	O
separation	O
using	O
the	O
ElectrophoreticIQ3	O
system	O
(	O
50mA	O
/	O
gel	O
,	O
15	O
°	O
C	O
for	O
90	O
min	O
).	O

In	O
other	O
words	O
,	O
this	O
system	O
might	O
not	O
be	O
effective	O
unless	O
there	O
is	O
existing	O
infection	O
with	O
pathogens	O
when	O
vitamin	O
D	O
supplementation	O
is	O
given	O
.	O

First	O
and	O
second	O
trimester	O
visfatin	O
levels	O
were	O
significant	O
independent	O
predictors	O
of	O
infant	O
’	O
s	O
weight	O
in	O
group	O
B	O
and	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
.	O

The	O
standard	O
text4baby	O
message	O
libraries	O
are	O
summarized	O
on	O
the	O
text4baby	O
website	O
[	O
37	O
].	O

However	O
,	O
in	O
contrary	O
to	O
these	O
reports	O
,	O
a	O
survey	O
in	O
Canadian	O
children	O
showed	O
that	O
both	O
low	O
and	O
high	O
vitamin	O
D	O
levels	O
were	O
related	O
to	O
increased	O
risk	O
of	O
wheeze	O
and	O
reduced	O
performance	O
of	O
lung	O
function	O
[	O
35	O
].	O

Source	O
:	O
Born	O
Too	O
Soon	O
,	O
Chapter	O
6	O
[	O
75	O
].	O

In	O
addition	O
,	O
mice	O
that	O
overexpress	O
osteocrin	O
have	O
elongated	O
bones	O
and	O
exhibit	O
a	O
kyphosis	O
phenotype	O
(	O
Moffatt	O
et	O
al	O
.	O

(	O
B	O
–	O
D	O
)	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
for	O
CC	O
vs	O
.	O
RC	O
males	O
;#	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
.	O

Thus	O
,	O
the	O
researchers	O
suggest	O
that	O
excess	O
iron	O
supplementation	O
can	O
cause	O
the	O
same	O
problems	O
it	O
is	O
supposed	O
to	O
correct	O
.	O

It	O
was	O
demonstrated	O
that	O
when	O
the	O
serotonin	O
levels	O
were	O
altered	O
by	O
SSRIs	O
during	O
early	O
development	O
of	O
brain	O
structure	O
,	O
the	O
functions	O
were	O
altered	O
.	O

The	O
IMF	O
content	O
in	O
the	O
LM	O
of	O
the	O
high	O
-	O
concentrate	O
group	O
(	O
31	O
.	O
7	O
%	O
±	O
5	O
.	O
4	O
%)	O
was	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
(	O
22	O
.	O
9	O
%±	O
5	O
.	O
3	O
%).	O

Service	O
limitations	O
impaired	O
the	O
delivery	O
of	O
optimal	O
care	O
.	O

A	O
comment	O
to	O
the	O
authors	O
(	O
20	O
)	O
detailed	O
the	O
evidence	O
that	O
antiepileptic	O
drugs	O
are	O
one	O
of	O
the	O
few	O
classes	O
of	O
drugs	O
that	O
consistently	O
and	O
significantly	O
interfere	O
with	O
vitamin	O
D	O
metabolism	O
,	O
lowering	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

Depending	O
on	O
the	O
offspring	O
'	O
s	O
nutritional	O
history	O
during	O
the	O
prenatal	O
and	O
lactational	O
periods	O
,	O
subsequent	O
nutrition	O
and	O
body	O
weight	O
gain	O
did	O
not	O
further	O
influence	O
offspring	O
reproductive	O
tempo	O
,	O
which	O
was	O
dominated	O
by	O
the	O
effect	O
of	O
prenatal	O
nutrition	O
.	O

Dietary	O
intake	O
of	O
fish	O
,	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
polyunsaturated	O
fatty	O
acids	O
and	O
vitamin	O
D	O
and	O
the	O
prevalence	O
of	O
psychotic	O
-	O
like	O
symptoms	O
in	O
a	O
cohort	O
of	O
33	O
000	O
women	O
from	O
the	O
general	O
population	O
Abstract	O
Background	O
Low	O
intake	O
of	O
fish	O
,	O
polyunsaturated	O
fatty	O
acids	O
(	O
PUFA	O
)	O
and	O
vitamin	O
D	O
deficiency	O
has	O
been	O
suggested	O
to	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

Gene	O
specific	O
DNA	O
methylation	O
will	O
be	O
assessed	O
using	O
the	O
Qiagen	O
EpiTech	O
system	O
.	O

A	O
meta	O
-	O
analysis	O
which	O
included	O
the	O
above	O
studies	O
as	O
well	O
as	O
others	O
examining	O
women	O
with	O
pre	O
-	O
existing	O
diabetes	O
,	O
with	O
745	O
glyburide	O
exposed	O
pregnancies	O
and	O
637	O
treated	O
with	O
insulin	O
,	O
has	O
been	O
performed	O
.	O
65This	O
study	O
found	O
that	O
glyburide	O
did	O
not	O
increase	O
the	O
risk	O
of	O
macrosomia	O
,	O
large	O
for	O
gestational	O
age	O
,	O
or	O
neonatal	O
hypoglycemia	O
,	O
but	O
did	O
not	O
examine	O
more	O
serious	O
consequences	O
such	O
as	O
perinatal	O
mortality	O
or	O
congenital	O
anomalies	O
.	O

For	O
plasma	O
separation	O
,	O
samples	O
were	O
centrifuged	O
at	O
3000	O
rpm	O
and	O
4	O
°	O
C	O
for	O
10	O
minutes	O
.	O

Introduction	O
There	O
were	O
15	O
million	O
preterm	O
births	O
(	O
PTB	O
)	O
(<	O
37	O
weeks	O
)	O
worldwide	O
and	O
more	O
than	O
1	O
million	O
infant	O
deaths	O
from	O
PTB	O
complications	O
in	O
2010	O
[	O
1	O
].	O

Therefore	O
,	O
determining	O
VD	O
status	O
of	O
those	O
patients	O
is	O
so	O
important	O
.	O

Information	O
on	O
BMI	O
at	O
T1	O
and	O
season	O
of	O
conception	O
(	O
December	O
–	O
May	O
or	O
June	O
–	O
November	O
)	O
was	O
obtained	O
from	O
the	O
medical	O
records	O
.	O

We	O
defined	O
as	O
a	O
new	O
episode	O
of	O
pneumonia	O
an	O
episode	O
happening	O
15	O
days	O
or	O
longer	O
after	O
the	O
first	O
.	O

Short	O
-	O
term	O
diets	O
comprised	O
solely	O
of	O
either	O
plant	O
or	O
animal	O
foods	O
have	O
been	O
shown	O
to	O
alter	O
the	O
human	O
gut	O
microbiome	O
[	O
3	O
].	O

Elemental	O
iron	O
powders	O
are	O
the	O
most	O
widely	O
used	O
iron	O
compound	O
in	O
fortification	O
programmes	O
since	O
about	O
50	O
years	O
[	O
32	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Raw	O
BMI	O
correlations	O
between	O
child	O
at	O
ages	O
0	O
,	O
5	O
and	O
9	O
years	O
and	O
family	O
members	O
,	O
with	O
sample	O
size	O
(	O
N	O
)	O
for	O
each	O
pairGroupChildMotherFatherMGMMGFPGMPGFChild	O
'	O
s	O
age	O
01	O
.	O
0000	O
.	O
1390	O
.	O
0540	O
.	O
1130	O
.	O
0630	O
.	O
0930	O
.	O
054p	O
Value0	O
.	O
002	O
*	O
0	O
.	O
2770	O
.	O
043	O
*	O
0	O
.	O
3760	O
.	O
1970	O
.	O
548N494402321201196125Child	O
'	O
s	O
age	O
5	O
0	O
.	O
1560	O
.	O
1610	O
.	O
1480	O
.	O
1150	O
.	O
0940	O
.	O
020p	O
Value	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
002	O
*	O
0	O
.	O
029	O
*	O
0	O
.	O
1910	O
.	O
2620	O
.	O
849N54037921713214491Child	O
'	O
s	O
age	O
9	O
0	O
.	O
2420	O
.	O
0610	O
.	O
2800	O
.	O
2440	O
.	O
0440	O
.	O
050p	O
Value	O
<	O
0	O
.	O
001	O
*	O
0	O
.	O
3690	O
.	O
001	O
*	O
0	O
.	O
024	O
*	O
0	O
.	O
6810	O
.	O
722N242218128858953	O
*	O
Significant	O
associations	O
,	O
mainly	O
in	O
the	O
maternal	O
line	O
.	O

Due	O
to	O
this	O
heterogeneity	O
a	O
qualitative	O
rather	O
than	O
quantitative	O
approach	O
was	O
deemed	O
appropriate	O
for	O
comparison	O
and	O
presentation	O
of	O
findings	O
.	O

The	O
aim	B
of	O
this	B
study	I
was	O
to	O
estimate	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
among	O
Belgian	O
pregnant	O
women	O
and	O
to	B
assess	I
the	O
determinants	O
of	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
and	O
third	O
trimester	O
of	O
pregnancy	O
.	O

The	O
mother	O
is	O
the	O
only	O
source	O
of	O
foetal	O
thyroid	O
hormones	O
from	O
conception	O
to	O
approximately	O
13	O
weeks	O
of	O
gestation	O
,	O
when	O
foetal	O
thyroid	O
function	O
has	O
developed14	O
-	O
16	O
.	O

The	O
Role	O
of	O
Vitamin	O
D	O
in	O
Reproductive	O
Health	O
—	O
A	O
Trojan	O
Horse	O
or	O
the	O
Golden	O
Fleece	O
?	O

After	O
adjusting	O
for	O
body	O
length	O
and	O
comparing	O
with	O
a	O
local	O
reference	O
,	O
the	O
high	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
still	O
had	O
significantly	O
lower	O
Rrs	O
than	O
did	O
the	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
group	O
(	O
Table	O
1	O
).	O

Hence	O
,	O
there	O
is	O
continuing	O
interest	O
in	O
determining	O
how	O
vitamin	O
D	O
influences	O
pregnancy	O
health	O
.	O

The	O
users	O
’	O
opinion	O
has	O
been	O
sought	B
here	B
and	O
it	O
is	O
noticed	O
that	O
they	O
recommend	O
ameliorations	O
in	O
the	O
interpersonal	O
interaction	O
with	O
staff	O
in	O
terms	O
of	O
more	O
comprehensive	O
health	O
talks	O
and	O
improvement	O
in	O
nursing	O
skills	O
,	O
better	O
infrastructures	O
(	O
like	O
good	O
toilet	O
facilities	O
and	O
comfortable	O
sitting	O
areas	O
)	O
and	O
tolerable	O
waiting	O
times	O
.	O

“	O
This	O
gives	O
us	O
more	O
confidence	O
that	O
the	O
association	O
is	O
not	O
due	O
to	O
reverse	O
causation	O
and	O
is	O
real	O
,”	O
says	O
Timmermann	O
.	O

Positional	O
cloning	O
of	O
the	O
Skm	O
mutants	O
The	O
Skm	O
mutations	O
originally	O
generated	O
on	O
a	O
129S1	O
background	O
were	O
segregated	O
on	O
a	O
mixed	O
genetic	O
background	O
of	O
129S1	O
,	O
129X1	O
,	O
and	O
DBA	O
/	O
2J	O
.	O

The	O
use	O
of	O
folic	O
acid	O
was	O
independently	O
associated	O
with	O
a	O
higher	O
level	O
of	O
formal	O
education	O
(	O
aOR	O
,	O
5	O
.	O
2	O
;	O
95	O
%	O
CI	O
,	O
2	O
.	O
1	O
-	O
12	O
.	O
8	O
)	O
and	O
an	O
early	O
start	O
in	O
prenatal	O
care	O
(	O
aOR	O
,	O
3	O
.	O
4	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
0	O
-	O
11	O
.	O
1	O
).	O

Early	O
pregnancy	O
25OHD	O
<	O
30	O
nmol	O
/	O
L	O
and	O
extended	O
winter	O
were	O
independently	O
associated	O
with	O
significantly	O
higher	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
(	O
B	O
=	O
0	O
.	O
15	O
and	O
0	O
.	O
13	O
,	O
respectively	O
).	O

We	O
found	O
that	O
among	O
the	O
subgroup	O
of	O
high	O
-	O
exposure	O
participants	O
,	O
text4baby	O
had	O
a	O
positive	O
effect	O
on	O
reducing	O
alcohol	O
use	O
behavior	O
of	O
pregnant	O
and	O
postpartum	O
women	O
.	O

Our	O
results	O
also	O
concur	O
with	O
findings	O
by	O
Morley	O
et	O
al	O
.	O

PFAS	O
are	O
used	O
as	O
stain	O
and	O
water	O
repellants	O
[	O
11	O
],	O
fire	O
fighting	O
foams	O
[	O
11	O
]	O
and	O
food	O
contact	O
material	O
[	O
3	O
]	O
while	O
PCBs	O
were	O
used	O
as	O
hydraulic	O
oil	O
additives	O
[	O
2	O
],	O
coolant	O
fluids	O
[	O
2	O
,	O
5	O
]	O
and	O
insulators	O
[	O
12	O
].	O

An	O
increase	O
in	O
serum	O
retinol	O
and	O
improved	O
anthropometric	O
status	O
(	O
weight	O
,	O
height	O
,	O
BMI	O
)	O
in	O
supplemented	O
girls	O
was	O
also	O
recorded	O
(	O
Hyder	O
et	O
al	O
2007	O
),	O
indicating	O
the	O
potential	O
benefits	O
of	O
MMN	O
supplementation	O
for	O
a	O
risk	O
group	O
attempting	O
to	O
satisfy	O
increased	O
nutritional	O
requirements	O
for	O
pubertal	O
growth	O
while	O
commonly	O
manifesting	O
a	O
substantial	O
degree	O
of	O
undernutrition	O
.	O

Background	O
Adequate	O
nutrition	O
during	O
pregnancy	O
is	O
associated	O
with	O
optimal	O
foetal	O
growth	O
[	O
1	O
,	O
2	O
],	O
normal	O
pregnancy	O
duration	O
[	O
3	O
]	O
and	O
a	O
decrease	O
in	O
the	O
risk	O
of	O
congenital	O
abnormalities	O
[	O
4	O
].	O

Another	O
point	O
that	O
needs	O
to	O
be	O
considered	O
is	O
the	O
measurements	O
error	O
in	O
nutritional	O
assessment	O
;	O
this	O
may	O
increase	O
the	O
likelihood	O
of	O
misclassification	O
,	O
contributing	O
to	O
the	O
discrepancy	O
among	O
our	O
results	O
.	O

In	O
the	O
present	B
study	I
,	O
we	O
used	O
the	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
as	O
greater	O
likelihood	O
of	O
having	O
depression	O
disorder	O
,	O
according	O
to	O
Mazhari	O
and	O
Nakhaee	O
’	O
s	O
study	O
in	O
Iranian	O
population	O
[	O
42	O
].	O

For	O
sustainable	O
effect	O
,	O
interventions	O
to	O
prevent	O
preterm	O
birth	O
in	O
the	O
preconception	O
and	O
antenatal	O
periods	O
and	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
must	O
be	O
integrated	O
within	O
the	O
existing	O
health	O
system	O
.	O

Adequate	O
vitamin	O
D	O
intake	O
is	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cancer	O
[	O
7	O
],[	O
8	O
],[	O
9	O
],[	O
10	O
],[	O
11	O
],	O
cardiovascular	O
diseases	O
[	O
12	O
],	O
autoimmune	O
diseases	O
[	O
13	O
],	O
neurological	O
disorders	O
[	O
14	O
]	O
and	O
diabetes	O
[	O
15	O
].	O

If	O
these	O
measures	O
are	O
unsuccessful	O
,	O
then	O
prescription	O
of	O
antiacid	O
drugs	O
should	O
be	O
considered	O
,	O
for	O
example	O
,	O
in	O
the	O
form	O
of	O
a	O
step	O
-	O
up	O
program	O
beginning	O
with	O
antacids	O
,	O
and	O
in	O
case	O
of	O
failure	O
with	O
histamine	O
-	O
2	O
receptor	O
antagonists	O
,	O
whereas	O
proton	O
pump	O
inhibitors	O
should	O
only	O
be	O
used	O
in	O
women	O
with	O
intractable	O
symptoms	O
or	O
complicated	O
reflux	O
disease	O
[	O
111	O
,	O
112	O
].	O

Furthermore	O
,	O
many	O
healthcare	O
facilities	O
in	O
Johannesburg	O
serve	O
a	O
predominantly	O
migrant	O
population	O
[	O
81	O
]	O
posing	O
a	O
challenge	O
for	O
longitudinal	O
data	O
collection	O
.	O

For	O
our	O
intention	O
-	O
to	O
-	O
treat	O
analysis	O
we	O
included	O
all	O
children	O
randomly	O
assigned	O
to	O
our	O
study	O
groups	O
.	O

Model	O
adjusted	O
for	O
reporting	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
),	O
age	O
,	O
race	O
,	O
calcium	O
,	O
iron	O
,	O
and	O
folic	O
acid	O
consumption	O
during	O
pregnancy	O
,	O
education	O
level	O
,	O
number	O
of	O
parturitions	O
,	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
at	O
first	O
antenatal	O
visit	O
,	O
and	O
sex	O
of	O
the	O
baby	O
.	O

The	O
effect	O
of	O
maternal	O
dairy	O
intake	O
on	O
infant	O
gut	O
microbiota	O
was	O
primarily	O
observed	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
.	O

The	O
up	O
-	O
to	O
-	O
date	O
annotation	O
of	O
Affymetrix	O
probe	O
-	O
sets	O
to	O
EnsEMBL	O
Sscofa	O
9	O
(	O
20	O
,	O
439	O
of	O
23	O
,	O
935	O
annotated	O
probe	O
-	O
sets	O
)	O
was	O
used	O
[	O
18	O
].	O

Additionally	O
,	O
RC	O
males	O
exhibited	O
an	O
increase	O
in	O
body	O
weight	O
than	O
RC	O
females	O
in	O
several	O
days	O
of	O
the	O
lactation	O
period	O
(	O
PND	O
1	O
and	O
PND	O
2	O
–	O
5	O
,	O
16	O
,	O
17	O
,	O
and	O
2	O
).	O

Introduction	O
Cathelicidin	O
(	O
Human	O
LL	O
-	O
37	O
),	O
activated	O
by	O
n	O
-	O
terminal	O
cleavage	O
of	O
the	O
propeptide	O
hCAP18	O
,	O
serves	O
as	O
a	O
cytokine	O
in	O
the	O
immune	O
system	O
as	O
well	O
as	O
an	O
antimicrobial	O
peptide	O
with	O
its	O
ability	O
to	O
form	O
an	O
α	O
-	O
helix	O
in	O
aqueous	O
solution	O
that	O
disrupts	O
the	O
lipid	O
membranes	O
of	O
invading	O
organisms	O
and	O
results	O
in	O
their	O
destruction	O
[	O
1	O
–	O
4	O
].	O

Hematoxylin	O
and	O
eosin	O
stain	O
,	O
same	O
magnification	O
in	O
all	O
pictures	O
.	O

The	O
generalisability	O
of	O
our	B
findings	I
may	O
be	O
limited	O
,	O
as	O
participants	O
had	O
previously	O
given	O
birth	O
to	O
a	O
macrosomic	O
infant	O
(>	O
4000	O
g	O
),	O
and	O
half	O
the	O
women	O
received	O
advice	O
to	O
follow	O
a	O
low	O
glycaemic	O
diet	O
.	O

There	O
are	O
few	O
trials	O
examining	O
the	O
efficacy	O
of	O
dietary	O
therapy	O
for	O
GDM	O
,	O
However	O
,	O
a	O
cluster	O
randomized	O
controlled	O
study	O
has	O
provided	O
support	O
for	O
Medical	O
Nutrition	O
Therapy	O
(	O
MNT	O
)	O
for	O
GDM	O
,	O
as	O
recommended	O
by	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
(	O
2004	O
).	O

All	O
the	O
AWCs	O
are	O
manned	O
by	O
members	O
from	O
the	O
ICDS	O
team	O
-	O
consisting	O
of	O
Anganwadi	O
helpers	O
,	O
Anganwadi	O
workers	O
,	O
Supervisors	O
,	O
Child	O
Development	O
Project	O
Officers	O
(	O
CDPOs	O
)	O
and	O
District	O
Program	O
Officers	O
(	O
1	O
,	O
4	O
).	O

Iron	O
deficiency	O
anaemia	O
accounts	O
for	O
75	O
–	O
95	O
%	O
of	O
cases	O
of	O
anaemia	O
in	O
pregnancy	O
[	O
9	O
].	O

2	O
Posterior	O
50	O
%	O
CIs	O
of	O
BHLM	O
regression	O
coefficients	O
,	O
HOME	O
Study	O
,	O
2003	O
-	O
2006	O
,	O
n	O
=	O
272	O
,	O
Cincinnati	O
,	O
OH	O
To	O
examine	O
the	O
impact	O
of	O
shrinkage	O
and	O
the	O
choice	O
of	O
prior	O
distributions	O
on	O
the	O
BHLM	O
results	O
,	O
we	O
applied	O
LASSO	O
and	O
Elastic	O
Net	O
to	O
the	O
phthalates	O
and	O
BPA	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
and	O
OCPs	O
.	O

A	O
more	O
recent	O
study	O
examined	O
the	O
peer	O
effects	O
on	O
adolescent	O
BMI	O
by	O
using	O
the	O
National	O
Longitudinal	O
Study	O
of	O
Adolescent	O
Health	O
(	O
98	O
).	O

Differences	O
in	O
ethnicity	O
[	O
21	O
],	O
solar	O
exposure	O
and	O
geographical	O
location	O
,	O
as	O
well	O
as	O
genetics	O
[	O
22	O
]	O
and	O
supplementation	O
[	O
23	O
–	O
25	O
],	O
are	O
known	O
to	O
affect	O
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
therefore	O
influence	O
study	O
outcomes	O
.	O

Table	O
3	O
summarizes	O
the	O
results	O
of	O
the	O
4	O
multivariable	O
linear	O
regression	O
models	O
assessing	O
factors	O
associated	O
with	O
the	O
natural	O
logarithm	O
of	O
the	O
cathelicidin	O
concentration	O
.	O

However	O
,	O
it	O
is	O
important	O
to	O
note	O
that	O
in	O
the	O
female	O
rat	O
,	O
sex	O
steroids	O
regulate	O
both	O
the	O
expression	O
and	O
function	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
,	O
so	O
a	O
potential	O
explanation	O
will	O
also	O
involve	O
the	O
impact	O
of	O
malnutrition	O
on	O
this	O
important	O
modulatory	O
system	O
,	O
as	O
it	O
was	O
described	O
previously	O
(	O
Bonnin	O
et	O
al	O
.,	O
1993	O
;	O
Rodríguez	O
de	O
Fonseca	O
et	O
al	O
.,	O
1994	O
).	O

Model	O
2	O
:	O
model	O
controlled	O
for	O
BMI	O
(	O
kg	O
/	O
m2	O
),	O
education	O
>	O
secondary	O
school	O
,	O
being	O
part	O
of	O
the	O
ROLO	O
study	O
intervention	O
group	O
,	O
early	O
-	O
pregnancy	O
energy	O
(	O
kcal	O
),	O
early	O
-	O
pregnancy	O
protein	O
(	O
g	O
),	O
early	O
-	O
pregnancy	O
fat	O
(	O
g	O
),	O
moderate	O
-	O
vigorous	O
activity	O
,	O
well	O
-	O
being	O
score	O
and	O
dietary	O
supplements	O
Post	O
-	O
hoc	O
analysis	O
-	O
exploring	O
potential	O
confounders	O
Dietary	O
intakes	O
,	O
lifestyle	O
behaviours	O
,	O
and	O
emotional	O
well	O
-	O
being	O
were	O
analysed	O
by	O
season	O
of	O
first	O
antenatal	O
visit	O
(	O
Additional	O
file1	O
:	O
Table	O
S2	O
).	O

There	O
are	O
some	O
differences	O
in	O
the	O
management	O
of	O
the	O
two	O
most	O
important	O
histotypes	O
:	O
DTC	O
(	O
differentiated	O
thyroid	O
cancer	O
:	O
follicular	O
and	O
papillary	O
cancer	O
)	O
and	O
MTC	O
(	O
medullary	O
thyroid	O
cancer	O
)	O
just	O
as	O
for	O
non	O
-	O
pregnant	O
patients	O
[	O
Boxes	O
1	O
-	O
2	O
].	O

Moreover	O
,	O
it	O
was	O
found	O
that	O
a	O
high	O
concentration	O
of	O
calcidiol	O
is	O
related	O
to	O
greater	O
endometriosis	O
incidence	O
,	O
which	O
was	O
explained	O
by	O
diminishing	O
elimination	O
of	O
endometrial	O
cells	O
that	O
pass	O
to	O
the	O
peritoneal	O
cavity	O
via	O
ovarian	O
reflux	O
.	O

PubMed	O
Central	O
:	O

The	O
initial	O
intervention	O
usually	O
entails	O
dietary	O
advice	O
,	O
individualized	O
if	O
possible	O
,	O
and	O
given	O
by	O
a	O
dietitian	O
.	O

End	O
Note	O
Research	O
for	O
this	O
article	O
was	O
supported	O
by	O
Hertha	O
Firnberg	O
stipend	O
T283	O
-	O
B13	O
and	O
SFB	O
F1808	O
-	O
B13	O
from	O
the	O
Austrian	O
Science	O
Fund	O
(	O
FWF	O
).	O

Similar	O
observations	O
were	O
obtained	O
by	O
adipose	O
tissue	O
-	O
specific	O
overexpression	O
of	O
PR	O
-	O
domain	O
-	O
containing	O
16	O
(	O
PRDM16	O
)	O
in	O
mice	O
.	O

Alternatively	O
,	O
higher	O
eggs	O
and	O
poultry	O
consumption	O
may	O
also	O
explain	O
the	O
high	O
detection	O
rate	O
.	O

Similarly	O
,	O
infants	O
on	O
Medicaid	O
,	O
a	O
marker	O
of	O
socioeconomic	O
status	O
,	O
had	O
higher	O
odds	O
of	O
vitamin	O
D	O
deficiency	O
(	O
odds	O
ratio	O
(	O
OR	O
)	O
2	O
.	O
3	O
,	O
95	O
%	O
CI	O
:	O
1	O
.	O
4	O
,	O
3	O
.	O
8	O
),	O
whereas	O
prenatal	O
vitamin	O
use	O
showed	O
a	O
protective	O
effect	O
(	O
OR	O
0	O
.	O
24	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
09	O
,	O
0	O
.	O
62	O
).	O

006	O
26769	O
.	O
4	O
0	O
.	O
003	O
No320533	O
.	O
3533	O
.	O
3	O
Obstetrician	O
Yes18555	O
.	O
425576	O
.	O
325576	O
.	O
3	O
No710	O
.	O
61725	O
.	O
81725	O
.	O
8Total	O
number	O
or	O
prenatal	O
visits	O
≤	O
422	O
.	O
8	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
>	O
419057	O
.	O
925477	O
.	O
425477	O
.	O
4Gestational	O
age	O
at	O
registration	O
(	O
months	O
)	O
<	O
418053	O
.	O
7	O
<	O
0	O
.	O
001	O
19257	O
.	O
3	O
0	O
.	O
019	O
24472	O
.	O
8	O
<	O
0	O
.	O
001	O
≥	O
41218	O
.	O
52741	O
.	O
52843	O
.	O
1Nutritional	O
questionnaire	O
score	O
Low710	O
.	O
1	O
<	O
0	O
.	O
001	O
2333	O
.	O
3	O
<	O
0	O
.	O
001	O
2231	O
.	O
9	O
<	O
0	O
.	O
001	O
Medium13747	O
.	O
114756	O
.	O
819274	O
.	O
3	O
High4865	O
.	O
84967	O
.	O
65879	O
.	O
7	O
The	O
proportion	O
of	O
less	O
well	O
-	O
educated	O
women	O
(	O
less	O
than	O
8	O
years	O
of	O
school	O
completed	O
)	O
using	O
folic	O
acid	O
(	O
p	O
=	O
.	O
007	O
),	O
iron	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
)	O
increased	O
with	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

Animals	O
were	O
shown	O
to	O
exhibit	O
enhanced	O
insulin	O
sensitivity	O
,	O
while	O
they	O
become	O
obese	O
and	O
to	O
develop	O
insulin	O
resistance	O
a	O
few	O
weeks	O
later	O
,	O
during	O
hibernation	O
,	O
to	O
finally	O
recover	O
their	O
insulin	O
sensitivity	O
upon	O
awakening	O
.	O

Our	O
results	O
of	O
the	O
protective	O
effect	O
of	O
fatty	O
fish	O
could	O
in	O
part	O
be	O
due	O
to	O
the	O
content	O
of	O
vitamin	O
D	O
.	O
While	O
the	O
epidemiological	O
evidence	O
linking	O
low	O
prenatal	O
vitamin	O
D	O
and	O
schizophrenia	O
remains	O
inconclusive	O
,	O
rodent	O
models	O
have	O
provided	O
compelling	O
evidence	O
about	O
the	O
role	O
of	O
vitamin	O
D	O
deficiency	O
for	O
brain	O
development	O
like	O
larger	O
lateral	O
volumes	O
[	O
36	O
],	O
subtle	O
memory	O
dysfunction	O
and	O
altered	O
attention	O
processing	O
[	O
37	O
]	O
which	O
have	O
implications	O
for	O
neuropsychiatric	O
disorders	O
.	O

We	O
intended	O
to	O
recruit	O
a	O
minimum	O
of	O
250	O
participants	O
.	O

The	O
registration	O
ID	O
isACTRN12612000588897	O
.	O

Ward	O
et	O
al	O
.	O

Studies	O
have	O
found	O
a	O
significant	O
association	O
between	O
maternal	O
prepregnancy	O
overweight	O
or	O
obesity	O
and	O
overweight	O
in	O
children	O
.	O

PubMed	O
Central	O
:	O

Methods	O
Study	O
Design	O
and	O
Participants	O
Between	O
2007	O
and	O
2009	O
,	O
2246	O
pregnant	O
women	O
enrolled	O
in	O
a	O
three	O
site	O
,	O
observational	O
cohort	O
study	O
of	O
the	O
prevention	O
of	O
preeclampsia	O
in	O
Boston	O
and	O
Philadelphia	O
.	O
20Women	O
provided	O
written	O
,	O
informed	O
consent	O
to	O
participate	O
and	O
the	O
Institutional	O
Review	O
Board	O
of	O
participating	O
institutions	O
approved	O
the	O
study	O
.	O

5	O
.	O

In	O
an	O
analysis	O
of	O
change	O
between	O
the	O
different	O
ages	O
,	O
differences	O
in	O
BMI	O
for	O
different	O
age	O
groups	O
are	O
calculated	O
and	O
regressed	O
on	O
the	O
BMI	O
of	O
each	O
of	O
the	O
other	O
family	O
members	O
in	O
turn	O
.	O

The	O
validity	O
of	O
the	O
fat	O
estimates	O
from	O
the	O
FFQ	O
assessed	O
using	O
Pearson	O
correlation	O
coefficients	O
between	O
FFQ	O
data	O
and	O
estimates	O
derived	O
from	O
weighed	O
food	O
records	O
varied	O
between	O
r	O
=	O
0	O
.	O
4	O
and	O
r	O
=	O
0	O
.	O
5	O
.	O

The	O
close	O
relationships	O
between	O
weight	O
and	O
length	O
and	O
initial	O
BMC	O
imply	O
that	O
calcium	O
transfer	O
across	O
the	O
placenta	O
is	O
closely	O
related	O
to	O
overall	O
nutrient	O
transfer	O
and	O
not	O
to	O
vitamin	O
D	O
status	O
(	O
7	O
).	O

Pregnant	O
patients	O
with	O
severe	O
or	O
uncontrolled	O
asthma	O
should	O
be	O
considered	O
high	O
-	O
risk	O
and	O
be	O
treated	O
promptly	O
and	O
optimally	O
to	O
ensure	O
a	O
favorable	O
outcome	O
for	O
mother	O
and	O
baby	O
.	O

This	O
group	O
also	O
received	O
routine	O
prenatal	O
care	O
.	O

The	O
mRNA	O
expression	O
levels	O
of	O
genes	O
associated	O
with	O
metabolic	O
processing	O
of	O
ketones	O
,	O
fatty	O
acids	O
,	O
bile	O
acids	O
,	O
and	O
hydrophobic	O
amino	O
acids	O
(	O
Val	O
,	O
Ile	O
,	O
Leu	O
)	O
as	O
well	O
as	O
'	O
mTOR	O
signaling	O
',	O
'	O
VEGF	O
signaling	O
',	O
and	O
'	O
glucocorticoid	O
receptor	O
signaling	O
',	O
were	O
increased	O
in	O
LP	O
offspring	O
at	O
stage	O
188	O
dpn	O
,	O
whereas	O
'	O
biosynthesis	O
of	O
steroids	O
'	O
was	O
found	O
to	O
be	O
diminished	O
.	O

In	O
utero	O
adaptation	O
may	O
lead	O
to	O
lifelong	O
changes	O
in	O
the	O
body	O
’	O
s	O
metabolism	O
,	O
hormone	O
regulation	O
,	O
and	O
the	O
number	O
of	O
cells	O
present	O
in	O
key	O
organs	O
[	O
14	O
,	O
157	O
,	O
158	O
].	O

found	O
that	O
5000	O
IU	O
vitamin	O
D	O
per	O
day	O
for	O
6	O
weeks	O
had	O
no	O
effect	O
on	O
men	O
and	O
women	O
’	O
s	O
cognitive	O
and	O
emotional	O
function	O
[	O
69	O
].	O

The	O
worst	O
results	O
were	O
obtained	O
in	O
patients	O
with	O
bioavailable	O
testosterone	O
level	O
below	O
11	O
.	O
6	O
nmol	O
/	O
l	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Data	O
are	O
reported	O
as	O
means	O
±	O
SEM	O
;	O
P	O
<	O
0	O
.	O
05	O
,	O
one	O
-	O
way	O
ANOVA	O
and	O
post	O
-	O
hoc	O
of	O
Tukey	O
'	O
s	O
test	O
:	O
†	O
compared	O
to	O
SC	O
counterpart	O
;	O
‡	O
compared	O
to	O
F1	O
generation	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g005	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Photomicrographs	O
of	O
the	O
developing	O
kidneys	O
of	O
offspring	O
at	O
birth	O
.	O

What	O
is	O
the	O
role	O
of	O
cholecalciferol	O
in	O
human	O
reproduction	O
?	O

Vasomotor	O
rhinitis	O
of	O
pregnancy	O
is	O
a	O
syndrome	O
of	O
nasal	O
congestion	O
and	O
vasomotor	O
instability	O
limited	O
to	O
the	O
gestational	O
period	O
.	O

Their	O
work	O
turned	O
up	O
mixed	O
results	O
,	O
which	O
are	O
hard	O
to	O
compare	O
due	O
to	O
differences	O
in	O
study	O
design	O
,	O
such	O
as	O
the	O
timing	O
of	O
sample	O
collection	O
.	O

Their	O
studies	O
suggest	O
that	O
the	O
abnormal	O
growth	O
in	O
children	O
with	O
autism	O
spectrum	O
disorders	O
may	O
be	O
related	O
to	O
the	O
causal	O
factors	O
that	O
also	O
increase	O
the	O
risk	O
for	O
ASD	O
,	O
as	O
it	O
was	O
found	O
that	O
children	O
with	O
ASD	O
had	O
proportionally	O
smaller	O
head	O
circumference	O
compared	O
to	O
height	O
during	O
their	O
first	O
year	O
of	O
life	O
,	O
which	O
was	O
absent	O
in	O
premature	O
/	O
low	O
birth	O
weight	O
children	O
with	O
ASD	O
.	O

Partial	O
adherence	O
to	O
the	O
model	O
of	O
care	O
may	O
have	O
attenuated	O
changes	O
in	O
medication	O
requirements	O
and	O
dietary	O
patterns	O
.	O

Therefore	O
,	O
breastmilk	O
,	O
a	O
normally	O
poor	O
source	O
of	O
vitamin	O
D	O
,	O
11becomes	O
even	O
more	O
deficient	O
.	O

The	O
median	O
concentration	O
of	O
serum	O
25	O
(	O
OH	O
)	O
D3	O
in	O
the	O
IG	O
was	O
to	O
62	O
.	O
10	O
nmol	O
/	O
l	O
after	O
the	O
intervention	O
,	O
showing	O
an	O
increase	O
of	O
around	O
158	O
%,	O
compared	O
to	O
before	O
intervention	O
(	O
24	O
.	O
25	O
nmol	O
/	O
l	O
)	O
whereas	O
the	O
CG	O
showed	O
a	O
decrease	O
of	O
around	O
4	O
.	O
5	O
%.	O

We	O
therefore	O
undertook	O
this	B
study	I
to	B
determine	I
whether	O
SNPs	O
within	O
the	O
vitamin	O
D	O
metabolism	O
pathway	O
known	O
to	O
modify	O
vitamin	O
D	O
status	O
are	O
also	O
associated	O
with	O
the	O
response	O
to	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O

In	O
particular	O
,	O
studies	O
examining	O
the	O
parental	O
and	O
grandparental	O
smoking	O
status	O
have	O
demonstrated	O
an	O
interesting	O
gender	O
-	O
specific	O
association	O
between	O
paternal	O
pre	O
-	O
conception	O
or	O
grandmaternal	O
in	O
utero	O
exposure	O
to	O
cigarette	O
smoke	O
and	O
increased	O
weight	O
-	O
related	O
issues	O
in	O
the	O
subsequent	O
sons	O
and	O
grandsons	O
,	O
but	O
not	O
daughters	O
or	O
granddaughters	O
(	O
Pembrey	O
et	O
al	O
.	O
2014	O
).	O

We	O
used	O
a	O
zero	O
replacement	O
procedure	O
and	O
log	O
-	O
ratio	O
transformation	O
to	O
account	O
for	O
the	O
zero	O
-	O
inflated	O
and	O
compositional	O
nature	O
of	O
the	O
data	O
[	O
48	O
]	O
before	O
running	O
linear	O
models	O
.	O

1c	O
;	O
Additional	O
file	O
1	O
:	O
Table	O
S2a	O
).	O

According	O
to	O
the	O
longitudinal	O
study	O
design	O
the	O
'	O
AMPK	O
(	O
AMP	O
-	O
dependent	O
activated	O
kinase	O
)	O
signaling	O
'	O
was	O
found	O
to	O
be	O
regulated	O
throughout	O
ontogenesis	O
in	O
AP	O
offspring	O
only	O
.	O

Future	O
research	O
is	O
needed	O
to	O
determine	O
whether	O
differences	O
in	O
postnatal	O
feeding	O
behaviors	O
might	O
explain	O
differential	O
growth	O
rates	O
in	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

Artificial	O
Insemination	O
and	O
Fertility	O
Medications	O
There	O
is	O
an	O
increase	O
in	O
prevalence	O
in	O
the	O
number	O
of	O
women	O
utilizing	O
fertility	O
measures	O
,	O
thus	O
calling	O
for	O
studies	O
to	O
determine	O
the	O
association	O
between	O
assisted	O
reproductive	O
therapy	O
and	O
neurodevelopmental	O
complications	O
,	O
and	O
more	O
specifically	O
autism	O
.	O

Previous	O
studies	O
on	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
have	O
reported	O
that	O
while	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
was	O
significantly	O
lower	O
in	O
women	O
with	O
PE	O
,	O
sPTB	O
,	O
GDM	O
and	O
those	O
who	O
delivered	O
a	O
small	O
-	O
for	O
gestational	O
age	O
(	O
SGA	O
)	O
infant	O
,	O
no	O
association	O
between	O
vitamin	O
D	O
deficiency	O
and	O
these	O
pregnancy	O
complications	O
was	O
found	O
after	O
adjusting	O
for	O
covariates	O
[	O
18	O
–	O
20	O
].	O

As	O
mentioned	O
above	O
,	O
BAT	O
is	O
the	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
both	O
cold	O
and	O
diet	O
-	O
induced	O
)	O
that	O
,	O
by	O
utilizing	O
large	O
quantities	O
of	O
glucose	O
and	O
lipids	O
from	O
the	O
circulation	O
,	O
can	O
promote	O
negative	O
energy	O
balance	O
.	O

The	O
same	O
report	O
estimated	O
that	O
up	O
to	O
2	O
kg	O
of	O
starch	O
/	O
d	O
can	O
be	O
digested	O
in	O
the	O
small	O
intestine	O
of	O
dairy	O
cows	O
;	O
the	O
average	O
starch	O
digestibility	O
in	O
the	O
small	O
intestine	O
was	O
60	O
.	O
6	O
%.	O

The	O
average	O
values	O
were	O
measured	O
and	O
equal	O
protein	O
loading	O
was	O
confirmed	O
by	O
probing	O
blots	O
with	O
beta	O
-	O
actin	O
antibody	O
and	O
is	O
expressed	O
as	O
a	O
percentage	O
of	O
the	O
SC	O
counterpart	O
.	O

Diet	O
affected	O
the	O
GD	O
in	O
10	O
-	O
day	O
-	O
old	O
offspring	O
(	O
P	O
<	O
0	O
.	O
0001	O
),	O
but	O
there	O
was	O
no	O
interaction	O
between	O
diet	O
and	O
generation	O
(	O
P	O
>	O
0	O
.	O
05	O
;	O
two	O
-	O
way	O
ANOVA	O
).	O

The	O
offspring	O
of	O
overweight	O
mothers	O
were	O
larger	O
at	O
birth	O
but	O
,	O
by	O
6	O
-	O
months	O
,	O
did	O
not	O
significantly	O
differ	O
from	O
those	O
of	O
normal	O
weight	O
mothers	O
.	O

Other	O
factors	O
include	O
poor	O
nutrition	O
,	O
crowding	O
,	O
seasonal	O
travel	O
,	O
hygiene	O
practices	O
,	O
cultural	O
practices	O
in	O
food	O
consumption	O
/	O
preparation	O
,	O
changes	O
in	O
herd	O
immunity	O
,	O
or	O
evolution	O
of	O
the	O
infectious	O
agent	O
over	O
time	O
.	O

Increases	O
in	O
stress	O
were	O
related	O
to	O
lower	O
offspring	O
weight	O
status	O
in	O
normal	O
weight	O
mothers	O
(	O
adjusted	O
analyses	O
)	O
and	O
overweight	O
/	O
obese	O
mothers	O
(	O
unadjusted	O
analyses	O
),	O
which	O
is	O
consistent	O
with	O
earlier	O
research	O
on	O
stress	O
in	O
relation	O
to	O
inadequate	O
GWG	O
[	O
45	O
]	O
and	O
long	O
-	O
term	O
offspring	O
health	O
[	O
46	O
].	O

The	O
sum	O
of	O
the	O
total	O
deposits	O
of	O
perirenal	O
and	O
perigonadal	O
fat	O
determines	O
the	O
amount	O
of	O
abdominal	O
fat	O
.	O

Information	O
on	O
the	O
child	O
'	O
s	O
free	O
sugar	O
consumption	O
at	O
age	O
3	O
years	O
,	O
as	O
well	O
as	O
maternal	O
and	O
paternal	O
sugar	O
consumption	O
at	O
4	O
years	O
post	O
-	O
partum	O
,	O
was	O
collected	O
by	O
a	O
similar	O
FFQ	O
.	O

Thirty	O
months	O
after	O
the	O
initial	O
treatment	O
of	O
the	O
thyroid	O
cancer	O
(	O
radioiodine	O
and	O
levothyroxine	O
),	O
remarkable	O
improvements	O
in	O
glycemia	O
were	O
noted	O
and	O
the	O
anti	O
-	O
diabetic	O
treatment	O
could	O
even	O
be	O
discontinued	O
.	O

In	O
these	O
studies	O
,	O
17	O
,	O
27as	O
well	O
as	O
ours	O
,	O
serum	O
calcium	O
level	O
considerably	O
increased	O
,	O
but	O
contrary	O
to	O
ours	O
,	O
they	O
reported	O
abnormal	O
calcium	O
level	O
in	O
7	O
%	O
to	O
12	O
%	O
of	O
the	O
patients	O
during	O
the	O
study	O
.	O

Almost	O
half	O
of	O
the	O
intervention	O
group	O
achieved	O
concentrations	O
of	O
30	O
ng	O
/	O
mL	O
[	O
59	O
].	O

Interventions	O
using	O
mobile	O
phones	O
are	O
growing	O
worldwide	O
,	O
and	O
some	O
are	O
achieving	O
significant	O
scale	O
and	O
population	O
-	O
level	O
reach	O
.	O

Studies	O
falling	O
into	O
category	O
3	O
provide	O
more	O
comprehensive	O
mechanistic	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
and	O
are	O
shown	O
inTable	O
1	O
.	O

Negative	O
maternal	O
energy	O
status	O
at	O
mid	O
-	O
gestation	O
(	O
80	O
%	O
of	O
the	O
energy	O
requirements	O
for	O
maintenance	O
of	O
body	O
weight	O
)	O
did	O
not	O
affect	O
MS	O
,	O
intramuscular	O
fat	O
percentage	O
,	O
and	O
HCW	O
,	O
but	O
increased	O
the	O
ratio	O
of	O
MS	O
to	O
12th	O
rib	O
fat	O
thickness	O
and	O
the	O
ratio	O
of	O
percent	O
intramuscular	O
fat	O
to	O
12th	O
rib	O
fat	O
thickness	O
in	O
offspring	O
compared	O
with	O
positive	O
energy	O
status	O
[	O
154	O
].	O

Introduction	O
Vitamin	O
D	O
is	O
crucial	O
not	O
only	O
for	O
calcium	O
metabolism	O
and	O
skeletal	O
health	O
but	O
also	O
in	O
the	O
homeostasis	O
of	O
many	O
other	O
systems	O
.	O

These	O
works	O
of	O
literature	O
were	O
obtained	O
from	O
the	O
commonly	O
used	O
medical	O
databases	O
such	O
as	O
PubMed	O
(	O
Medline	O
),	O
AJOL	O
,	O
and	O
Google	O
Scholar	O
;	O
in	O
addition	O
,	O
Cochrane	O
Library	O
was	O
used	O
as	O
source	O
for	O
systematic	O
reviews	O
on	O
the	O
subject	O
matter	O
.	O

Alcohol	O
Consumption	O
Alcohol	O
consumption	O
by	O
the	O
mother	O
during	O
pregnancy	O
is	O
associated	O
with	O
higher	O
total	O
IgE	O
levels	O
in	O
cord	O
blood	O
[	O
76	O
].	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

Verburg	O
et	O
al	O
.	O

(	O
2013	O
)*/†	O
Izzotti	O
et	O
al	O
.	O

Our	O
population	O
had	O
more	O
male	O
infants	O
than	O
female	O
infants	O
(	O
57	O
.	O
2	O
%	O
males	O
),	O
and	O
an	O
average	O
birth	O
weight	O
and	O
gestational	O
age	O
of	O
3427	O
g	O
and	O
39	O
.	O
3	O
weeks	O
,	O
respectively	O
.	O

In	O
contrast	O
,	O
LP	O
fetuses	O
showed	O
an	O
increased	O
expression	O
of	O
transcripts	O
associated	O
with	O
cell	O
division	O
within	O
the	O
corresponding	O
developmental	O
period	O
.	O

This	B
study	I
was	O
conducted	B
to	B
evaluate	I
early	O
life	O
bone	O
mineral	O
content	O
(	O
BMC	O
)	O
and	O
the	O
effects	O
of	O
three	O
months	O
of	O
vitamin	O
D	O
supplementation	O
in	O
breast	O
-	O
fed	O
Hispanic	O
and	O
non	O
-	O
Hispanic	O
Caucasian	O
(	O
henceforth	O
,	O
"	O
Caucasian	O
")	O
infants	O
on	O
vitamin	O
D	O
levels	O
.	O

As	O
expected	O
,	O
a	O
greater	O
proportion	O
of	O
CpGs	O
in	O
the	O
relatively	O
methylated	O
(	O
rightmost	O
)	O
classes	O
9	O
–	O
12	O
are	O
localized	O
in	O
repetitive	O
elements	O
(	O
Figure	O
2A	O
–	O
D	O
).	O

In	O
the	O
same	O
period	O
881	O
probe	O
-	O
sets	O
exhibited	O
ontogenetic	O
regulation	O
that	O
was	O
specific	O
to	O
LP	O
offspring	O
.	O

Rodents	O
for	O
instance	O
have	O
short	O
reproductive	O
cycles	O
closely	O
linked	O
with	O
circadian	O
rhythms	O
,	O
and	O
do	O
not	O
experience	O
menses	O
or	O
true	O
“	O
menopause	O
”	O
as	O
a	O
result	O
of	O
follicular	O
depletion	O
as	O
typically	O
observed	O
in	O
humans	O
,	O
although	O
follicular	O
depletion	O
does	O
occur	O
.	O

PubMed	O
Central	O
:	O

List	O
of	O
abbreviations	O
used	O
KMC	O
:	O
Kangaroo	O
Mother	O
Care	O
;	O
PMNCH	O
:	O
Partnership	O
for	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
pPROM	O
:	O
Prelabour	O
premature	O
rupture	O
of	O
membranes	O
;	O
RMNCH	O
:	O
Reproductive	O
,	O
Maternal	O
,	O
Newborn	O
and	O
Child	O
Health	O
;	O
STI	O
:	O
Sexually	O
Transmitted	O
Infection	O
;	O
WHO	O
:	O
World	O
Health	O
Organization	O
.	O

RESULTS	O
Food	O
Intake	O
,	O
Weight	O
Gain	O
and	O
Glucose	O
Response	O
There	O
was	O
no	O
difference	O
in	O
body	O
weight	O
at	O
birth	O
and	O
weaning	O
between	O
the	O
offspring	O
born	O
to	O
dams	O
on	O
the	O
HV	O
diet	O
compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
a	O
RV	O
diet	O
.	O

The	O
reality	O
is	O
that	O
the	O
actual	O
vitamin	O
D	O
requirement	O
during	O
pregnancy	O
is	O
not	O
known	O
.	O

The	O
detection	O
limit	O
of	O
the	O
human	O
cathelicidin	O
ELISA	O
was	O
0	O
.	O
14	O
ng	O
/	O
mL	O
.	O

Increasing	O
the	O
percentage	O
of	O
concentrate	O
(	O
60	O
%,	O
75	O
%,	O
and	O
90	O
%	O
concentrate	O
)	O
in	O
growing	O
diets	O
increased	O
MS	O
in	O
steers	O
[	O
118	O
].	O

The	O
business	O
community	O
:	O
Invest	O
•	O
Invest	O
additional	O
resources	O
to	O
develop	O
and	O
adapt	O
devices	O
and	O
commodities	O
to	O
prevent	O
and	O
treat	O
preterm	O
birth	O
in	O
low	O
-	O
income	O
settings	O
using	O
innovative	O
partnerships	O
and	O
business	O
models	O
.	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

In	O
early	O
pregnancy	O
,	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
winter	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
at	O
risk	O
of	O
25OHD	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
)	O
and	O
25OHD	O
inadequacy	O
(<	O
50	O
nmol	O
/	O
L	O
),	O
than	O
those	O
who	O
attended	O
their	O
first	O
antenatal	O
visit	O
in	O
extended	O
summer	O
(	O
Table2	O
).	O

In	O
children	O
,	O
serum	O
calcifediol	O
concentrations	O
should	O
be	O
maintained	O
at	O
50	O
nmol	O
/	O
L	O
(	O
20	O
ng	O
/	O
mL	O
)	O
or	O
greater	O
for	O
skeletal	O
benefits	O
.	O
6Vitamin	O
D	O
deficiency	O
rickets	O
in	O
children	O
younger	O
than	O
5	O
years	O
is	O
an	O
endemic	O
problem	O
in	O
developing	O
countries	O
,	O
ranging	O
from	O
5	O
–	O
45	O
%,	O
even	O
where	O
sunlight	O
is	O
abundant	O
,	O
1	O
,	O
2	O
,	O
7	O
,	O
8and	O
has	O
also	O
re	O
-	O
emerged	O
in	O
some	O
developed	O
countries	O
.	O
7	O
,	O
9	O
In	O
people	O
,	O
the	O
main	O
source	O
of	O
vitamin	O
D	O
is	O
through	O
the	O
action	O
of	O
ultraviolet	O
B	O
radiation	O
on	O
7	O
-	O
dehydrocholesterol	O
in	O
the	O
skin	O
,	O
with	O
small	O
amounts	O
derived	O
from	O
dietary	O
sources	O
.	O

The	O
increase	O
in	O
blood	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D3levels	O
in	O
response	O
to	O
decreased	O
calcium	O
intake	O
may	O
downregulate	O
preadipocyte	O
differentiation	O
,	O
thus	O
decreasing	O
beef	O
marbling	O
.	O

In	O
LGA	O
infants	O
,	O
hyperinsulinemia	O
in	O
fetal	O
period	O
leads	O
to	O
fetal	O
macrosomia	O
(	O
14	O
).	O

Before	O
doing	O
so	O
,	O
the	O
expression	O
of	O
GAS5	O
and	O
GRs	O
was	O
examined	O
in	O
BeWo	O
and	O
JEG	O
-	O
3	O
cells	O
without	O
administering	O
cortisol	O
.	O

The	O
mother	O
was	O
correlated	O
with	O
the	O
MGM	O
and	O
with	O
the	O
MGF	O
,	O
while	O
the	O
father	O
was	O
also	O
correlated	O
with	O
his	O
mother	O
and	O
father	O
.	O

3	O
.	O
4	O
.	O

Early	O
life	O
Early	O
embryo	O
and	O
germ	O
line	O
development	O
can	O
be	O
affected	O
by	O
in	O
utero	O
exposures	O
.	O

A	O
meta	O
-	O
analysis	O
of	O
prospective	O
observational	O
studies	O
,	O
reported	O
reductions	O
in	O
perinatal	O
mortality	O
(	O
stillbirth	O
and	O
early	O
neonatal	O
mortality	O
)	O
with	O
each	O
1	O
g	O
/	O
dl	O
increase	O
in	O
the	O
population	O
mean	O
haemoglobin	O
(	O
RR	O
0	O
.	O
72	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
65	O
–	O
0	O
.	O
81	O
)	O
[	O
9	O
].	O

Overall	O
,	O
the	O
Ministry	O
of	O
Women	O
and	O
Child	O
Development	O
has	O
been	O
given	O
the	O
responsibility	O
to	O
coordinate	O
monitoring	O
at	O
different	O
levels	O
(	O
5	O
).	O

Logistic	O
regression	O
was	O
used	O
to	O
estimate	O
odds	O
ratios	O
(	O
OR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
for	O
the	O
association	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
and	O
the	O
risk	O
of	O
PTB	O
.	O

Since	O
in	O
the	O
present	O
study	O
neonatal	O
growth	O
trajectories	O
in	O
pups	O
that	O
were	O
exposed	O
to	O
maternal	O
undernutrition	O
began	O
to	O
deviate	O
from	O
those	O
of	O
control	O
pups	O
at	O
a	O
time	O
that	O
coincides	O
with	O
a	O
neonatal	O
surge	O
in	O
circulating	O
leptin	O
concentrations	O
,	O
which	O
itself	O
is	O
nutritionally	O
influenced	O
[	O
49	O
],[	O
50	O
],	O
leptin	O
may	O
be	O
a	O
central	O
driver	O
in	O
initiating	O
maturational	O
changes	O
.	O

ADP	O
,	O
GEB	O
and	O
LIG	O
contributed	O
to	O
study	O
conceptualization	O
and	O
design	O
,	O
analysis	O
and	O
interpretation	O
of	O
data	O
and	O
writing	O
the	O
article	O
.	O

2	O
.	O
7	O
.	O

However	O
,	O
such	O
a	O
relation	O
has	O
not	O
yet	O
been	O
confirmed	O
.	O

Vitamin	O
C	O
increased	O
preadipocyte	O
growth	O
of	O
3T3	O
L1	O
cells	O
[	O
148	O
]	O
and	O
also	O
had	O
a	O
positive	O
effect	O
on	O
differentiation	O
of	O
sheep	O
preadipocytes	O
in	O
primary	O
culture	O
[	O
149	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Evaluation	O
of	O
the	O
association	O
of	O
influenza	O
vaccination	O
and	O
birth	O
outcomes	O
among	O
pregnant	O
women	O
by	O
trimester	O
of	O
vaccination	O
(	O
n	O
=	O
3268	O
),	O
post	O
-	O
partum	O
interview	O
,	O
July	O
–	O
December	O
2014	O
,	O
Managua	O
Province	O
,	O
Nicaragua	O
.	O
Birth	O
outcomesInfluenza	O
vaccine	O
2014	O
seasonInfluenza	O
vaccine	O
2014	O
seasonMultiple	O
Logistic	O
Regression	O
(	O
MLR	O
)	O
Propensity	O
score	O
Model	O
(	O
PSM	O
)†	O
+	O
MLRǂn	O
=	O
1600	O
×	O
1000	O
simulations	O
¥	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
aOR	O
(	O
95	O
%	O
CI	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
SGAi	O
)	O
1	O
.	O
03	O
*(	O
0	O
.	O
82	O
;	O
1	O
.	O
31	O
)	O
1	O
.	O
02	O
(	O
0	O
.	O
83	O
;	O
1	O
.	O
24	O
)	O
Preterm	O
birth	O
(	O
PTB	O
)	O
0	O
.	O
95	O
**(	O
0	O
.	O
75	O
;	O
1	O
.	O
20	O
)	O
0	O
.	O
88	O
(	O
0	O
.	O
73	O
;	O
1	O
.	O
06	O
)	O
Low	O
birth	O
weight	O
(	O
LBW	O
)	O
0	O
.	O
89	O
***(	O
0	O
.	O
66	O
;	O
1	O
.	O
22	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
62	O
;	O
1	O
.	O
06	O
)	O
aOR	O
=	O
Adjusted	O
Odds	O
Ratio	O
.	O

MicroRNA	O
RT	O
-	O
PCR	O
quantification	O
Total	O
RNA	O
was	O
extracted	O
from	O
liver	O
samples	O
using	O
the	O
TRIzol	O
reagent	O
(	O
Invitrogen	O
)	O
and	O
subsequently	O
purified	O
with	O
the	O
RNase	O
-	O
Free	O
DNase	O
Kit	O
(	O
Promega	O
)	O
according	O
to	O
the	O
manufacturer	O
׳	O
s	O
instructions	O
.	O

However	O
,	O
due	O
to	O
the	O
lack	O
of	O
sufficient	O
information	O
about	O
the	O
physiologic	O
role	O
of	O
visfatin	O
in	O
adults	O
,	O
its	O
source	O
and	O
regulation	O
mechanism	O
in	O
fetal	O
and	O
neonatal	O
stages	O
cannot	O
be	O
argued	O
absolutely	O
.	O

In	O
each	O
of	O
the	O
models	O
,	O
however	O
,	O
the	O
child	O
’	O
s	O
age	O
at	O
their	O
first	O
follow	O
-	O
up	O
visit	O
was	O
significantly	O
and	O
independently	O
positively	O
correlated	O
with	O
cathelicidin	O
.	O

The	O
role	O
of	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
during	O
pregnancy	O
to	O
increase	O
intestinal	O
calcium	O
absorption	O
is	O
since	O
long	O
acknowledged	O
[	O
24	O
].	O

In	O
other	O
words	O
,	O
the	O
respective	O
growth	O
of	O
the	O
BAT	O
and	O
WAT	O
depots	O
depends	O
on	O
the	O
maternal	O
diet	O
during	O
gestation	O
and	O
it	O
may	O
be	O
responsible	O
for	O
the	O
development	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
the	O
offspring	O
,	O
later	O
in	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

The	O
same	O
authors	O
suggested	O
that	O
total	O
IMF	O
within	O
the	O
LM	O
in	O
the	O
high	O
-	O
concentrate	O
group	O
might	O
be	O
greater	O
than	O
that	O
in	O
the	O
low	O
-	O
concentrate	O
group	O
by	O
stimulating	O
intramuscular	O
preadipocyte	O
differentiation	O
.	O

Discussion	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	O
of	O
pregnancy	O
that	O
occurs	O
in	O
4	O
out	O
of	O
100	O
,	O
000	O
pregnancies	O
as	O
discussed	O
by	O
Durr	O
[	O
1	O
].	O

Maternal	O
medical	O
records	O
were	O
reviewed	O
for	O
the	O
following	O
information	O
:	O
race	O
,	O
prepregnancy	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
and	O
BMI	O
at	O
delivery	O
,	O
insurance	O
status	O
,	O
prenatal	O
vitamin	O
use	O
and	O
maternal	O
complications	O
including	O
smoking	O
,	O
hypertension	O
,	O
diabetes	O
,	O
chorioamnionitis	O
,	O
preterm	O
labor	O
and	O
premature	O
rupture	O
of	O
membranes	O
.	O

We	O
find	O
no	O
support	O
for	O
this	O
in	O
our	O
results	O
,	O
since	O
,	O
the	O
effect	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
on	O
psychotic	O
-	O
like	O
symptoms	O
were	O
almost	O
similar	O
to	O
those	O
of	O
omega	O
-	O
3	O
fatty	O
acids	O
.	O

Final	O
live	O
-	O
birth	O
rates	O
were	O
31	O
%	O
among	O
vitamin	O
D	O
-	O
deficient	O
recipients	O
,	O
compared	O
with	O
59	O
%	O
among	O
vitamin	O
D	O
-	O
replete	O
recipients	O
.	O

Evaluation	O
of	O
context	O
-	O
specific	O
neonatal	O
care	O
packages	O
regarding	O
outcome	O
,	O
cost	O
and	O
economic	O
results	O
is	O
important	O
,	O
including	O
adaptations	O
such	O
as	O
task	O
shifting	O
to	O
various	O
cadres	O
and	O
use	O
of	O
innovative	O
technologies	O
[	O
41	O
].	O

Associations	O
with	O
baseline	O
25	O
(	O
OH	O
)	O
D	O
Among	O
all	O
682	O
women	O
,	O
the	O
common	O
allele	O
(	O
T	O
)	O
of	O
rs12785878	O
(	O
DHCR7	O
)	O
was	O
associated	O
with	O
greater	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
Table	O
2	O
).	O

Although	O
no	O
causality	O
was	O
found	O
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

To	O
assess	O
participants	O
'	O
information	O
regarding	O
age	O
and	O
gender	O
,	O
marital	O
status	O
,	O
and	O
educational	O
level	O
,	O
we	O
used	O
a	O
standard	O
self	O
-	O
reported	O
questionnaire	O
.	O

To	O
our	O
knowledge	O
,	O
only	O
three	O
randomised	O
trials	O
involving	O
the	O
provision	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
[	O
15	O
–	O
17	O
]	O
have	O
conducted	O
and	O
reported	O
findings	O
of	O
follow	O
-	O
up	O
to	O
6	O
months	O
after	O
birth	O
[	O
18	O
–	O
20	O
].	O

Since	O
having	O
had	O
a	O
previous	O
PTB	O
is	O
a	O
significant	O
risk	O
factor	O
for	O
a	O
recurrent	O
PTB	O
,	O
we	O
also	O
assessed	B
the	O
relationship	O
between	O
PTB	O
and	O
25	O
(	O
OH	O
)	O
D	O
for	O
these	O
women	O
separately	O
.	O

Linear	O
regression	O
procedures	O
were	O
used	O
to	O
estimate	O
maternal	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
while	O
adjusting	O
for	O
confounding	O
by	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
.	O

The	O
Growing	O
Up	O
Today	O
Study	O
found	O
that	O
subjective	O
social	O
status	O
in	O
the	O
school	O
environment	O
predicted	O
BMI	O
in	O
adolescent	O
girls	O
(	O
96	O
).	O

Second	O
,	O
it	O
provides	O
one	O
of	O
the	O
most	O
comprehensive	O
studies	O
to	O
date	O
evaluating	O
the	O
effect	O
of	O
mHealth	O
on	O
the	O
health	O
of	O
pregnant	O
military	O
female	O
soldiers	O
and	O
family	O
members	O
.	O

Bonferrroni	O
analysis	O
indicated	O
that	O
CC	O
and	O
RC	O
adult	O
females	O
displayed	O
higher	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adult	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
).	O

To	B
more	O-
precisely	O-
identify	I
which	O
microbial	O
taxa	O
contribute	O
to	O
the	O
observed	O
differences	O
in	O
infant	O
stool	O
microbial	O
community	O
composition	O
by	O
maternal	O
dietary	O
factors	O
,	O
we	O
used	O
a	O
series	O
of	O
linear	O
models	O
to	B
test	I
the	O
relationships	O
between	O
each	O
maternal	O
dietary	O
factor	O
and	O
each	O
OTU	O
.	O

For	O
instance	O
,	O
at	O
a	O
mean	O
maternal	O
BMI	O
of	O
32	O
.	O
3	O
kg	O
m	O
−	O
2	O
,	O
an	O
infant	O
who	O
is	O
black	O
,	O
on	O
Medicaid	O
and	O
no	O
prenatal	O
vitamin	O
use	O
has	O
an	O
86	O
%	O
(	O
95	O
%	O
CI	O
:	O
82	O
,	O
97	O
)	O
probability	O
of	O
vitamin	O
D	O
deficiency	O
,	O
whereas	O
a	O
black	O
infant	O
who	O
is	O
not	O
on	O
Medicaid	O
and	O
with	O
prenatal	O
vitamin	O
use	O
has	O
a	O
66	O
%	O
(	O
95	O
%	O
CI	O
:	O
44	O
,	O
67	O
)	O
probability	O
of	O
vitamin	O
D	O
deficiency	O
.	O

In	O
addition	O
,	O
the	O
urine	O
urea	O
(+	O
433	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
and	O
creatinine	O
(+	O
175	O
%,	O
P	O
<	O
0	O
.	O
0001	O
)	O
values	O
were	O
significantly	O
higher	O
in	O
the	O
F1	O
-	O
VitD	O
-	O
mice	O
than	O
in	O
the	O
F1	O
-	O
SC	O
mice	O
.	O

The	O
respondents	O
also	O
wished	O
that	O
the	O
health	O
talks	O
(	O
16	O
.	O
3	O
%)	O
should	O
be	O
more	O
regular	O
and	O
that	O
primigravida	O
should	O
be	O
encouraged	O
to	O
come	O
regularly	O
.	O

Among	O
253	O
women	O
enrolled	O
,	O
intervention	O
households	O
were	O
between	O
5	O
.	O
7	O
and	O
15	O
.	O
2	O
times	O
as	O
likely	O
as	O
control	O
households	O
to	O
have	O
soap	O
and	O
water	O
present	O
at	O
the	O
handwashing	O
station	O
in	O
the	O
baby	O
'	O
s	O
sleeping	O
area	O
.	O

Women	O
with	O
missing	O
covariates	O
were	O
not	O
included	O
in	O
final	O
multivariable	O
models	O
.	O

[	O
47	O
],	O
we	O
identified	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
at	O
6	O
weeks	O
of	O
age	O
using	O
the	O
partitioning	O
around	O
medoids	O
(	O
PAM	O
)	O
method	O
of	O
clustering	O
on	O
generalized	O
UniFrac	O
distances	O
.	O

For	O
example	O
,	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
undernutrition	O
have	O
been	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
developing	O
various	O
adult	O
-	O
onset	O
diseases	O
,	O
including	O
psychiatric	O
disorders	O
,	O
type	O
2	O
diabetes	O
and	O
obesity	O
,	O
in	O
numerous	O
famine	O
cohorts	O
such	O
as	O
the	O
Dutch	O
Hunger	O
Winter	O
,	O
the	O
Chinese	O
Great	O
Leap	O
Forward	O
and	O
the	O
Överkalix	O
cohorts	O
(	O
Lumey	O
et	O
al	O
.	O
2011	O
;	O
Pembrey	O
et	O
al	O
.	O
2014	O
).	O

Papillary	O
thyroid	O
cancer	O
is	O
the	O
most	O
common	O
histological	O
type	O
detected	O
in	O
pregnant	O
women	O
,	O
and	O
in	O
most	O
series	O
90	O
%	O
to	O
95	O
%	O
of	O
thyroid	O
carcinoma	O
diagnosed	O
are	O
Stage	O
I	O
disease	O
,	O
with	O
the	O
majority	O
found	O
in	O
the	O
first	O
trimester	O
of	O
pregnancy	O
during	O
the	O
first	O
antenatal	O
visit	O
.	O

Promotion	O
of	O
handwashing	O
with	O
soap	O
before	O
umbilical	O
cord	O
care	O
should	O
be	O
emphasized	O
in	O
antenatal	O
and	O
neonatal	O
care	O
messaging	O
,	O
given	O
existing	O
evidence	O
supporting	O
prevention	O
of	O
umbilical	O
cord	O
infections	O
by	O
caregiver	O
handwashing	O
.	O

Causal	O
biological	O
mechanisms	O
for	O
the	O
observed	O
positive	O
,	O
though	O
statistically	O
in	O
-	O
significant	O
association	O
between	O
long	O
sleep	O
duration	O
and	O
GDM	O
are	O
not	O
clear	O
.	O

Abstract	O
An	O
international	O
case	O
-	O
control	O
study	O
of	O
primary	O
pediatric	O
brain	O
tumors	O
included	O
interviews	O
with	O
mothers	O
of	O
cases	O
diagnosed	O
from	O
1976	O
to	O
1994	O
and	O
mothers	O
of	O
population	O
controls	O
.	O

At	O
that	O
time	O
no	O
trials	O
had	O
reported	O
the	O
effects	O
of	O
IFA	O
on	O
neonatal	O
mortality	O
,	O
although	O
these	O
supplements	O
were	O
known	O
to	O
benefit	O
both	O
maternal	O
and	O
infant	O
health	O
[	O
3	O
].	O

Wrote	O
the	O
paper	O
:	O
MO	O
KW	O
.	O

However	O
,	O
the	O
depression	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
217	O
).	O

This	O
may	O
be	O
explained	O
,	O
in	O
part	O
,	O
by	O
inadequate	O
control	O
of	O
related	O
risk	O
factors	O
and	O
confounders	O
in	O
statistical	O
analyses	O
,	O
variations	O
between	O
assays	O
that	O
measure	O
vitamin	O
D	O
and	O
significant	O
heterogeneity	O
between	O
studied	O
populations	O
[	O
6	O
].	O

Transcriptional	O
excursions	O
regarding	O
cell	O
maintenance	O
and	O
proliferation	O
Mammalian	O
cell	O
division	O
is	O
precisely	O
regulated	O
by	O
variate	O
factors	O
and	O
functional	O
networks	O
.	O

It	O
is	O
associated	O
with	O
inadequate	O
invasion	O
of	O
extravillous	O
trophoblasts	O
and	O
inadequate	O
angiogenesis	O
,	O
with	O
insufficient	O
conversion	O
of	O
arterial	O
spiral	O
arteries	O
in	O
the	O
decidua	O
[	O
1	O
].	O

Other	O
mitigating	O
factors	O
may	O
include	O
a	O
greater	O
intake	O
of	O
saturated	O
fat	O
in	O
the	O
form	O
of	O
milk	O
and	O
butter	O
,	O
as	O
well	O
as	O
a	O
greater	O
number	O
of	O
older	O
siblings	O
living	O
at	O
home	O
in	O
rural	O
/	O
farm	O
communities	O
[	O
116	O
].	O

All	O
RNA	O
samples	O
were	O
stored	O
at	O
-	O
80	O
°	O
C	O
until	O
downstream	O
analysis	O
was	O
performed	O
.	O

This	B
paper	I
was	O
limited	O
to	O
the	O
six	O
randomised	O
and	O
quasi	O
-	O
randomised	O
trials	O
(	O
listed	O
inTable	O
1	O
)	O
on	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
,	O
which	O
met	O
at	O
least	O
one	O
of	O
the	O
following	O
inclusion	O
criteria	O
:	O
(	O
i	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
ii	O
)	O
comparison	O
between	O
daily	O
routine	O
oral	O
supplementation	O
with	O
iron	O
or	O
ironfolic	O
acid	O
and	O
routine	O
-	O
intermittent	O
(	O
weekly	O
and	O
twice	O
weekly	O
)	O
regimens	O
;	O
(	O
iii	O
)	O
comparison	O
between	O
intermittent	O
oral	O
iron	O
or	O
ironfolic	O
acid	O
supplementation	O
and	O
no	O
supplementation	O
/	O
placebo	O
;	O
(	O
iv	O
)	O
comparison	O
between	O
intravenous	O
route	O
versus	O
oral	O
route	O
of	O
iron	O
supplementation	O
;	O
(	O
v	O
)	O
comparison	O
between	O
food	O
fortification	O
with	O
iron	O
and	O
no	O
fortification	O
/	O
placebo	O
.	O

The	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
20	O
ng	O
/	O
ml	O
(	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
following	O
variables	O
as	O
predictors	O
in	O
the	O
model	O
:	O
season	O
,	O
age	O
,	O
trimester	O
of	O
pregnancy	O
,	O
region	O
,	O
BMI	O
,	O
smoking	O
behaviour	O
,	O
alcohol	O
consumption	O
,	O
use	O
of	O
vitamin	O
D	O
-	O
containing	O
food	O
supplements	O
,	O
fish	O
consumption	O
,	O
milk	O
and	O
dairy	O
product	O
consumption	O
,	O
education	O
level	O
,	O
ethnicity	O
,	O
parity	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekdays	O
,	O
exposure	O
to	O
sunlight	O
during	O
weekend	O
days	O
,	O
use	O
of	O
sunscreen	O
lotion	O
,	O
use	O
of	O
solarium	O
,	O
shadow	O
or	O
sun	O
preference	O
and	O
sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
(	O
yes	O
/	O
no	O
question	O
).	O

Based	O
on	O
1000	O
simulations	O
when	O
requirement	O
one	O
-	O
to	O
-	O
two	O
vaccinated	O
-	O
to	O
-	O
unvaccinated	O
proportion	O
for	O
good	O
propensity	O
score	O
matching	O
was	O
not	O
met	O
;	O
point	O
estimate	O
and	O
lower	O
and	O
upper	O
confidence	O
interval	O
represent	O
50th	O
,	O
25th	O
and	O
97	O
.	O
5th	O
percentiles	O
of	O
point	O
estimates	O
(	O
n	O
=	O
1000	O
),	O
respectively	O
.	O

They	O
were	O
originally	O
thought	O
to	O
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

INTRODUCTION	O
Vitamin	O
D	O
has	O
been	O
a	O
hot	O
topic	O
in	O
the	O
medical	O
world	O
for	O
the	O
past	O
10	O
years	O
.	O

In	O
addition	O
,	O
lower	O
marginal	O
significant	O
chance	O
of	O
having	O
low	O
weight	O
infant	O
was	O
found	O
among	O
women	O
who	O
were	O
in	O
the	O
top	O
adherence	O
of	O
traditional	O
dietary	O
pattern	O
[	O
OR	O
0	O
.	O
76	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
32	O
-	O
1	O
.	O
77	O
),	O
P	O
=	O
0	O
.	O
05	O
]	O
in	O
the	O
crude	O
model	O
.	O

Birth	O
weight	O
and	O
gestational	O
age	O
were	O
recorded	O
for	O
each	O
infant	O
.	O

This	O
study	O
concluded	O
that	O
abnormal	O
maternal	O
gestational	O
weight	O
indirectly	O
caused	O
an	O
increased	O
chance	O
of	O
developing	O
ASD	O
[	O
49	O
].	O

Methods	O
Animals	O
and	O
sample	O
collection	O
Animal	O
care	O
and	O
tissue	O
collection	O
processes	O
followed	O
the	O
guidelines	O
of	O
the	O
German	O
Law	O
of	O
Animal	O
Protection	O
and	O
the	O
experimental	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Care	O
Committee	O
of	O
the	O
State	O
Mecklenburg	O
-	O
Vorpommern	O
(	O
Landesamt	O
für	O
Landwirtschaft	O
,	O
Lebensmittelsicherheit	O
und	O
Fischerei	O
,	O
Mecklenburg	O
-	O
Vorpommern	O
,	O
Germany	O
;	O
LVL	O
MV	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
1	O
-	O
006	O
/	O
04	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
05	O
/	O
06	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
013	O
/	O
06	O
).	O

While	O
the	O
intervention	O
increased	O
the	O
frequency	O
of	O
handwashing	O
,	O
mothers	O
and	O
others	O
washed	O
hands	O
with	O
soap	O
at	O
less	O
than	O
10	O
%	O
of	O
the	O
times	O
we	O
recommended	O
for	O
handwashing	O
.	O

Both	O
during	O
suppressive	O
or	O
substitutive	O
therapy	O
,	O
L	O
-	O
T4	O
requirement	O
increases	O
very	O
early	O
during	O
pregnancy	O
,	O
reaching	O
a	O
plateau	O
after	O
16thto	O
20thweeks	O
of	O
gestation	O
,	O
with	O
a	O
required	O
L	O
-	O
T4	O
dosage	O
approximately	O
30	O
to	O
50	O
%	O
higher	O
than	O
that	O
administered	O
before	O
pregnancy	O
.	O

The	O
sample	O
size	O
necessary	O
to	O
define	O
a	O
twofold	O
increase	O
of	O
malformation	O
rates	O
of	O
1	O
–	O
3	O
%	O
above	O
the	O
baseline	O
was	O
insufficient	O
.	O

Of	O
the	O
study	O
population	O
,	O
97	O
%	O
were	O
vitamin	O
D	O
sufficient	O
[	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
].	O

The	O
influence	O
of	O
maternal	O
sensitization	O
on	O
the	O
immune	O
response	O
of	O
newborns	O
was	O
recently	O
shown	O
in	O
a	O
human	O
observational	O
study	O
of	O
AR	O
,	O
in	O
which	O
only	O
the	O
organ	O
-	O
specific	O
symptoms	O
of	O
the	O
mother	O
but	O
not	O
the	O
father	O
were	O
demonstrated	O
to	O
be	O
relevant	O
for	O
the	O
imprinting	O
of	O
the	O
child	O
[	O
55	O
].	O

Motivated	O
by	O
the	O
variation	O
in	O
sequence	O
features	O
(	O
bioinformatic	O
attributes	O
)	O
observed	O
between	O
RPMM	O
-	O
based	O
classes	O
,	O
we	O
next	O
performed	O
a	O
bioinformatically	O
informed	O
clustering	O
of	O
CpG	O
loci	O
into	O
classes	O
,	O
grouping	O
CpGs	O
according	O
to	O
their	O
sequence	O
context	O
:	O
presence	O
within	O
a	O
CGI	O
,	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
Alu	O
,	O
or	O
MIR	O
element	O
,	O
or	O
PcG	O
target	O
gene	O
and	O
proximity	O
(≤	O
1	O
,	O
000	O
bases	O
)	O
to	O
any	O
TFBS	O
.	O

Interpretation	O
of	O
the	O
effect	O
of	O
supplementation	O
on	O
ESR	O
is	O
complex	O
(	O
Breckenridge	O
and	O
Okpanachi	O
1976	O
)	O
but	O
the	O
reduction	O
in	O
ESR	O
following	O
supplementation	O
could	O
indicate	O
a	O
ameliorating	O
effect	O
of	O
MMN	O
on	O
systemic	O
inflammation	O
.	O

This	O
would	O
have	O
allowed	O
for	O
a	O
more	O
expansive	O
definition	O
of	O
the	O
relationship	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
perinatal	O
outcomes	O
.	O

Funding	O
This	O
work	O
was	O
supported	O
by	O
the	O
Instituto	O
de	O
Salud	O
Carlos	O
III	O
,	O
Ministerio	O
de	O
Economía	O
y	O
Competitividad	O
con	O
-	O
founded	O
by	O
UE	O
-	O
ERDF	O
program	O
(	O
CP12	O
/	O
03109	O
and	O
PI16	O
/	O
01374	O
to	O
JS	O
,	O
PI12	O
/	O
02261	O
to	O
FR	O
,	O
and	O
PSI	O
-	O
2012	O
-	O
35388	O
to	O
RG	O
),	O
Red	O
de	O
Trastornos	O
Adictivos	O
(	O
RD12	O
/	O
0028	O
/	O
0001	O
to	O
FR	O
),	O
CIBERobn	O
,	O
Consejería	O
de	O
Economía	O
,	O
Innovación	O
y	O
Ciencia	O
,	O
Junta	O
de	O
Andalucía	O
,	O
UE	O
/	O
ERDF	O
(	O
PI45403	O
,	O
CTS	O
-	O
8221	O
,	O
CTS	O
-	O
433	O
to	O
FR	O
),	O
Consejería	O
de	O
Salud	O
,	O
Junta	O
de	O
Andalucía	O
,	O
UE	O
/	O
ERDF	O
(	O
SAS111224	O
to	O
JS	O
and	O
FR	O
.	O

The	O
BP	O
of	O
the	O
F2	O
-	O
VitD	O
-	O
mice	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
F2	O
-	O
SC	O
mice	O
only	O
at	O
6	O
months	O
of	O
age	O
(+	O
8	O
%;	O
P	O
<	O
0	O
.	O
05	O
).	O

We	O
will	O
base	O
the	O
data	O
for	O
the	O
cost	O
-	O
effectiveness	O
analysis	O
on	O
the	O
costs	O
and	O
outcomes	O
observed	O
in	O
the	O
trial	O
.	O

DNA	O
methylation	O
and	O
in	O
utero	O
exposures	O
.	O

Similarly	O
,	O
a	O
pooled	O
analysis	O
from	O
Pakistan	O
on	O
8512	O
live	O
births	O
reported	O
maternal	O
antenatal	O
IFA	O
supplements	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
death	O
on	O
day	O
0	O
by	O
33	O
%	O
and	O
during	O
the	O
neonatal	O
period	O
by	O
29	O
%.	O

Building	O
the	O
platform	O
to	O
accelerate	O
research	O
Underlying	O
this	O
entire	O
research	O
agenda	O
is	O
the	O
development	O
and	O
implementation	O
of	O
the	O
capacity	O
to	O
advance	O
the	O
science	O
of	O
prevention	O
of	O
preterm	O
birth	O
,	O
manage	O
preterm	O
labour	O
and	O
improve	O
care	O
of	O
premature	O
babies	O
.	O

Courtesy	O
U	O
.	O
S	O
.	O
National	O
Archives	O
There	O
are	O
other	O
reasons	O
why	O
reported	O
associations	O
may	O
not	O
actually	O
reveal	O
much	O
about	O
environmental	O
impacts	O
on	O
lactation	O
.	O

The	O
arms	O
were	O
similar	O
with	O
respect	O
to	O
roof	O
and	O
wall	O
materials	O
.	O

All	O
parents	O
provided	O
written	O
informed	O
consent	O
at	O
recruitment	O
,	O
and	O
a	O
small	O
honorarium	O
was	O
provided	O
.	O

Phthalates	O
are	O
used	O
as	O
plasticizers	O
[	O
1	O
,	O
4	O
,	O
5	O
,	O
8	O
]	O
and	O
also	O
found	O
in	O
personal	O
care	O
and	O
consumer	O
products	O
[	O
1	O
,	O
3	O
,	O
7	O
].	O

Results	O
for	O
the	O
38	O
infants	O
(	O
19	O
Hispanic	O
and	O
19	O
Caucasian	O
),	O
with	O
the	O
values	O
obtained	O
initially	O
,	O
are	O
shown	O
in	O
Table1	O
.	O

Methods	O
Study	O
Design	O
and	O
Participants	O
We	O
examined	O
baseline	O
data	O
(	O
N	O
=	O
123	O
)	O
from	O
a	O
randomized	O
controlled	O
trial	O
,	O
Madre	O
Sana	O
,	O
Bebé	O
Sano	O
(	O
Healthy	O
Mother	O
,	O
Healthy	O
Baby	O
),	O
designed	O
to	O
prevent	O
excessive	O
GWG	O
.	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
alone	O
advanced	O
the	O
age	O
of	O
puberty	O
in	O
female	O
offspring	O
born	O
to	O
dams	O
fed	O
a	O
control	O
diet	O
during	O
pregnancy	O
and	O
lactation	O
(	O
p	O
<	O
0	O
.	O
001	O
,	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Age	O
and	O
weight	O
at	O
puberty	O
in	O
female	O
offspring	O
.	O
GroupsPubertal	O
Age	O
(	O
days	O
)	O
Pubertal	O
Weight	O
(	O
g	O
)	O
Cont	O
+	O
C	O
34	O
.	O
6	O
±	O
0	O
.	O
5121	O
.	O
5	O
±	O
3	O
.	O
7	O
Cont	O
+	O
HF	O
32	O
.	O
8	O
±	O
0	O
.	O
4116	O
.	O
7	O
±	O
6	O
.	O
3	O
UN	O
P	O
+	O
C	O
33	O
.	O
3	O
±	O
0	O
.	O
3111	O
.	O
6	O
±	O
5	O
.	O
6	O
UN	O
P	O
+	O
HF	O
31	O
.	O
8	O
±	O
0	O
.	O
2105	O
.	O
9	O
±	O
2	O
.	O
4	O
UN	O
L	O
+	O
C	O
33	O
.	O
5	O
±	O
0	O
.	O
394	O
.	O
6	O
±	O
3	O
.	O
8	O
UN	O
L	O
+	O
HF	O
31	O
.	O
8	O
±	O
0	O
.	O
392	O
.	O
1	O
±	O
2	O
.	O
8	O
UN	O
PL	O
+	O
C	O
33	O
.	O
3	O
±	O
0	O
.	O
484	O
.	O
9	O
±	O
3	O
.	O
6	O
UN	O
PL	O
+	O
HF	O
30	O
.	O
7	O
±	O
0	O
.	O
377	O
.	O
9	O
±	O
3	O
.	O
3	O
MHF	O
+	O
C	O
33	O
.	O
0	O
±	O
0	O
.	O
3114	O
.	O
4	O
±	O
2	O
.	O
4	O
MHF	O
+	O
HF	O
32	O
.	O
6	O
±	O
0	O
.	O
7122	O
.	O
5	O
±	O
5	O
.	O
0	O
PLHF	O
+	O
C	O
32	O
.	O
7	O
±	O
0	O
.	O
4108	O
.	O
6	O
±	O
2	O
.	O
7	O
PLHF	O
+	O
HF	O
31	O
.	O
4	O
±	O
0	O
.	O
5103	O
.	O
8	O
±	O
3	O
.	O
8	O
effect	O
of	O
maternal	O
diet	O
across	O
groups	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

Civil	O
society	O
:	O
Invest	O
•	O
Advocate	O
for	O
increased	O
attention	O
to	O
the	O
health	O
of	O
women	O
,	O
newborns	O
and	O
children	O
through	O
strengthening	O
parent	O
groups	O
and	O
conducting	O
national	O
campaigns	O
focusing	O
on	O
preterm	O
birth	O
.	O

At	O
30	O
weeks	O
,	O
341	O
(	O
94	O
%;	O
160	O
overweight	O
/	O
obese	O
and	O
181	O
normal	O
weight	O
)	O
attended	O
the	O
assessment	O
visit	O
.	O

Scaling	O
up	O
preterm	O
birth	O
interventions	O
within	O
the	O
existing	O
health	O
system	O
There	O
is	O
increasing	O
global	O
consensus	O
around	O
essential	O
reproductive	O
,	O
maternal	O
,	O
newborn	O
and	O
child	O
health	O
(	O
RMNCH	O
)	O
interventions	O
[	O
22	O
,	O
23	O
],	O
including	O
those	O
to	O
address	O
preterm	O
birth	O
(	O
Figure2	O
).	O

Newborn	O
and	O
infant	O
children	O
have	O
greater	O
contact	O
with	O
these	O
contaminants	O
since	O
they	O
lie	O
,	O
crawl	O
and	O
play	O
near	O
the	O
ground	O
and	O
frequently	O
place	O
their	O
hands	O
,	O
objects	O
or	O
food	O
in	O
their	O
mouths	O
[	O
29	O
,	O
33	O
,	O
34	O
].	O

in	O
Oslo	O
,	O
prevalence	O
of	O
depression	O
at	O
28	O
weeks	O
was	O
13	O
%	O
in	O
all	O
of	O
samples	O
.	O

Background	O
Even	O
though	O
psychoses	O
are	O
relatively	O
rare	O
,	O
between	O
5	O
-	O
15	O
%	O
of	O
the	O
general	O
population	O
has	O
been	O
estimated	O
to	O
report	O
single	O
schizophrenia	O
-	O
like	O
symptoms	O
like	O
delusions	O
,	O
magical	O
thinking	O
,	O
and	O
hearing	O
internal	O
voices	O
at	O
some	O
point	O
in	O
their	O
lifetime	O
[	O
1	O
-	O
3	O
].	O

This	O
assumption	O
is	O
based	O
on	O
the	O
fact	O
that	O
the	O
main	O
risk	O
factors	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
(	O
sun	O
exposure	O
and	O
/	O
or	O
ethnicity	O
)	O
are	O
common	O
to	O
many	O
European	O
countries	O
.	O

A	O
total	O
of	O
70	O
.	O
3	O
%	O
(	O
663	O
/	O
943	O
)	O
of	O
the	O
participants	O
reported	O
being	O
married	O
.	O

Additionally	O
,	O
for	O
women	O
with	O
a	O
prior	O
PTB	O
,	O
the	O
substantial	O
decrease	O
in	O
recurrent	O
PTB	O
risk	O
(	O
80	O
%)	O
for	O
≥	O
40	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
indicates	O
that	O
improving	O
vitamin	O
D	O
status	O
in	O
this	O
high	O
risk	O
subgroup	O
could	O
sizably	O
reduce	O
PTB	O
rates	O
.	O

Infant	O
Anthropometrics	O
Trained	O
research	O
staff	O
abstracted	O
infant	O
and	O
child	O
weight	O
and	O
length	O
from	O
obstetric	O
and	O
pediatric	O
records	O
.	O

Control	O
We	O
used	O
usual	O
iron	O
supplementation	O
program	O
as	O
the	O
comparator	O
.	O

It	O
should	O
be	O
noted	O
here	O
that	O
the	O
interactions	O
presented	O
in	O
the	O
networks	O
are	O
not	O
specific	O
for	O
porcine	O
liver	O
tissue	O
,	O
as	O
the	O
database	O
contains	O
literature	O
from	O
many	O
different	O
research	O
areas	O
.	O

Our	O
Elastic	O
Net	O
analysis	O
identified	O
1	O
EDC	O
in	O
common	O
with	O
Lenters	O
et	O
al	O
.	O

Moreover	O
,	O
the	O
role	O
of	O
BAT	O
activation	O
appears	O
to	O
be	O
broader	O
than	O
solely	O
the	O
promotion	O
of	O
negative	O
energy	O
balance	O
(	O
for	O
rev	O
.,	O
see	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

In	O
many	O
previous	O
studies	O
,	O
participants	O
had	O
various	O
ethnic	O
backgrounds	O
which	O
could	O
affect	O
both	O
vitamin	O
D	O
status	O
and	O
their	O
risk	O
of	O
GDM	O
[	O
7	O
,	O
38	O
].	O

Daily	O
consumption	O
of	O
vegetables	O
,	O
fruits	O
,	O
legumes	O
,	O
soy	O
,	O
and	O
nuts	O
,	O
whole	O
grains	O
,	O
fish	O
and	O
seafood	O
,	O
and	O
monounsaturated	O
to	O
saturated	O
fat	O
ratio	O
(	O
MUFA	O
:	O
SFA	O
)	O
above	O
the	O
median	O
is	O
considered	O
healthful	O
and	O
confers	O
1	O
point	O
to	O
the	O
aMED	O
score	O
.	O

2007	O
;	O
Choi	O
et	O
al	O
.	O

Thus	O
,	O
the	O
common	O
estimate	O
of	O
heritability	O
assuming	O
additive	O
genetic	O
effects	O
may	O
not	O
work	O
for	O
height	O
.	O
36However	O
,	O
at	O
ages	O
0	O
and	O
9	O
,	O
height	O
was	O
primarily	O
correlated	O
in	O
the	O
nuclear	O
family	O
and	O
similar	O
correlations	O
were	O
observed	O
for	O
the	O
parents	O
with	O
the	O
grandparents	O
.	O

The	O
items	O
that	O
were	O
too	O
difficult	O
,	O
too	O
easy	O
,	O
or	O
that	O
were	O
found	O
to	O
have	O
near	O
-	O
zero	O
or	O
negative	O
discrimination	O
were	O
eliminated	O
.	O

The	O
median	O
BMI	O
of	O
the	O
cohort	O
was	O
31	O
.	O
0	O
kg	O
/	O
m2	O
(	O
Inter	O
Quartile	O
Range	O
(	O
IQR	O
)	O
27	O
.	O
8	O
–	O
35	O
.	O
6	O
kg	O
/	O
m2	O
),	O
with	O
42	O
.	O
1	O
%	O
of	O
women	O
overweight	O
,	O
and	O
57	O
.	O
9	O
%	O
obese	O
.	O

This	O
increase	O
in	O
C	O
-	O
reactive	O
protein	O
has	O
been	O
found	O
to	O
have	O
a	O
correlation	O
with	O
a	O
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
29	O
].	O

MTRL	O
,	O
MV	O
,	O
RNB	O
,	O
and	O
FA	O
did	O
the	O
animal	O
experiments	O
and	O
sampling	O
.	O

These	O
data	O
suggest	O
that	O
prenatal	O
care	O
providers	O
of	O
low	O
-	O
income	O
,	O
minority	O
women	O
in	O
particular	O
should	O
make	O
healthy	O
maternal	O
weight	O
gain	O
targets	O
a	O
priority	O
in	O
their	O
care	O
to	O
prevent	O
excessive	O
weight	O
gain	O
during	O
pregnancy	O
and	O
the	O
associated	O
complications	O
.	O

Women	O
were	O
encouraged	O
to	O
set	O
achievable	O
goals	O
for	O
change	O
,	O
supported	O
to	O
make	O
these	O
lifestyle	O
changes	O
,	O
to	O
identify	O
potential	O
barriers	O
and	O
enablers	O
to	O
their	O
implementation	O
,	O
and	O
to	O
self	O
-	O
monitor	O
their	O
progress	O
[	O
21	O
,	O
22	O
].	O

Acute	O
aortic	O
dissection	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
has	O
been	O
attributed	O
to	O
hemodynamic	O
alterations	O
that	O
occur	O
in	O
late	O
pregnancy	O
.	O

In	O
addition	O
,	O
immature	O
and	O
mature	O
glomeruli	O
were	O
estimated	O
at	O
birth	O
and	O
on	O
day	O
10	O
,	O
when	O
glomerular	O
development	O
is	O
completed	O
.	O

Nonetheless	O
the	O
woman	O
should	O
be	O
advised	O
regarding	O
appropriate	O
hypoglycemia	O
prevention	O
and	O
management	O
measures	O
.	O

Differential	O
expression	O
of	O
genes	O
related	O
to	O
lipid	O
,	O
ketone	O
body	O
,	O
and	O
amino	O
acid	O
metabolism	O
indicate	O
that	O
the	O
offspring	O
of	O
both	O
groups	O
uses	O
different	O
metabolic	O
directions	O
in	O
response	O
to	O
identical	O
nutritional	O
condition	O
during	O
postnatal	O
life	O
.	O

They	O
were	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
based	O
on	O
new	O
perspective	O
towards	O
normal	O
serum	O
vitamin	O
D	O
concentration	O
[	O
46	O
].	O

Any	O
explanation	O
for	O
these	O
dimorphisms	O
should	O
be	O
supported	O
by	O
the	O
elevated	O
gene	O
expression	O
of	O
Cnr2	O
in	O
the	O
liver	O
and	O
PAT	O
of	O
the	O
RC	O
female	O
offspring	O
compared	O
to	O
those	O
of	O
the	O
RC	O
males	O
.	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

PubMed	O
Central	O
:	O

The	O
country	O
was	O
divided	O
into	O
two	O
regions	O
.	O

This	O
was	O
then	O
carried	O
out	O
separately	O
for	O
boys	O
and	O
girls	O
.	O

The	O
study	O
tested	O
2	O
primary	O
hypotheses	O
:	O
(	O
1	O
)	O
text4baby	O
group	O
participants	O
would	O
demonstrate	O
increased	O
health	O
-	O
promoting	O
behaviors	O
and	O
decreased	O
risk	O
behaviors	O
compared	O
to	O
control	O
at	O
postpartum	O
follow	O
-	O
up	O
and	O
(	O
2	O
)	O
text4baby	O
participants	O
would	O
demonstrate	O
a	O
dose	O
-	O
response	O
effect	O
of	O
receiving	O
the	O
text	O
messages	O
in	O
which	O
higher	O
doses	O
of	O
text	O
messages	O
would	O
produce	O
greater	O
behavioral	O
outcomes	O
.	O

1	O
.	O

The	O
researchers	O
chose	O
this	O
period	O
as	O
a	O
more	O
accurate	O
reflection	O
of	O
each	O
woman	O
’	O
s	O
typical	O
diet	O
,	O
compared	O
to	O
pregnancy	O
,	O
when	O
diet	O
can	O
vary	O
with	O
the	O
degree	O
of	O
nausea	O
experienced	O
.	O

Only	O
few	O
of	O
these	O
polymorphisms	O
are	O
functionally	O
relevant	O
and	O
these	O
are	O
the	O
Tth111	O
I	O
,	O
the	O
ER22	O
/	O
23EK	O
,	O
the	O
N363S	O
,	O
the	O
—	O
already	O
mentioned	O
—	O
Bcl	O
I	O
,	O
and	O
the	O
GR	O
-	O
9	O
β	O
.	O

However	O
,	O
although	O
bitter	O
tastes	O
are	O
innately	O
disliked	O
,	O
with	O
repeated	O
exposure	O
,	O
infants	O
can	O
come	O
to	O
like	O
certain	O
foods	O
that	O
are	O
bitter	O
,	O
particularly	O
some	O
vegetables	O
(	O
31	O
-	O
34	O
).	O

It	O
also	O
includes	O
a	O
medical	O
plan	O
for	O
the	O
infant	O
.	O

Logistic	O
regression	O
for	O
caries	O
status	O
was	O
also	O
performed	O
,	O
revealing	O
that	O
lower	O
household	O
income	O
,	O
poorer	O
ratings	O
of	O
children	O
’	O
s	O
general	O
health	O
,	O
and	O
lower	O
vitamin	O
D	O
levels	O
were	O
significantly	O
associated	O
with	O
S	O
-	O
ECC	O
(	O
Table	O
4	O
).	O

Prevalence	O
of	O
postpartum	O
depression	O
varies	O
throughout	O
the	O
world	O
;	O
however	O
researchers	O
have	O
used	O
different	O
scales	O
and	O
cut	O
off	O
points	O
to	O
describe	O
this	O
psychological	O
disorder	O
.	O

Cox	O
proportional	O
hazards	O
mixed	O
models	O
will	O
be	O
used	O
for	O
mortality	O
outcomes	O
&	O
will	O
include	O
groundwater	O
iron	O
level	O
as	O
an	O
interaction	O
term	O
in	O
the	O
mortality	O
model	O
.	O

Surveys	O
were	O
self	O
-	O
administered	O
and	O
baseline	O
surveys	O
were	O
completed	O
usually	O
in	O
clinic	O
,	O
with	O
a	O
small	O
number	O
completed	O
remotely	O
online	O
.	O

Significantly	O
more	O
children	O
with	O
S	O
-	O
ECC	O
had	O
suboptimal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
(<	O
75	O
nmol	O
/	O
L	O
)	O
compared	O
to	O
their	O
caries	O
-	O
free	O
peers	O
(	O
p	O
=	O
0	O
.	O
006	O
)	O
(	O
Table	O
2	O
).	O

Wang	O
et	O
al	O
[	O
144	O
]	O
suggested	O
that	O
the	O
vitamin	O
D	O
receptor	O
(	O
VDR	O
)	O
competes	O
with	O
PPARG	O
for	O
binding	O
to	O
the	O
retinoid	O
X	O
receptor	O
(	O
RXR	O
).	O

Maternal	O
characteristics	O
which	O
differed	O
across	O
quintiles	O
of	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
included	O
age	O
,	O
parity	O
,	O
pregnancy	O
size	O
,	O
season	O
of	O
birth	O
,	O
breastfeeding	O
duration	O
,	O
educational	O
level	O
,	O
ethnicity	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
anxiety	O
level	O
,	O
tobacco	O
exposure	O
and	O
infection	O
during	O
pregnancy	O
.	O

Returning	O
to	O
our	O
data	O
,	O
weight	O
recovery	O
in	O
offspring	O
may	O
occur	O
as	O
a	O
result	O
of	O
an	O
accelerated	O
catch	O
-	O
up	O
growth	O
before	O
birth	O
caused	O
by	O
an	O
ad	O
libitum	O
maternal	O
feeding	O
.	O

Abstract	O
In	O
the	O
last	O
decade	O
,	O
vitamin	O
D	O
was	O
in	O
the	O
spotlight	O
in	O
many	O
fields	O
of	O
research	O
.	O

The	O
inclusion	O
and	O
exclusion	O
criteria	O
for	O
participants	O
were	O
designed	O
as	O
such	O
to	O
obtain	O
a	O
sample	O
of	O
generally	O
healthy	O
women	O
,	O
who	O
are	O
able	O
to	O
speak	O
the	O
local	O
language	O
and	O
who	O
could	O
be	O
followed	O
-	O
up	O
from	O
early	O
pregnancy	O
until	O
the	O
infants	O
are	O
12	O
months	O
old	O
.	O

Participants	O
were	O
selected	O
in	O
a	O
convenience	O
manner	O
.	O

Parenteral	O
iron	O
sucrose	O
complex	O
is	O
known	O
to	O
have	O
several	O
advantages	O
because	O
of	O
its	O
low	O
-	O
allergenic	O
properties	O
and	O
consequently	O
,	O
an	O
extremely	O
low	O
incidence	O
of	O
severe	O
side	O
effects	O
such	O
as	O
anaphylactic	O
reactions	O
[	O
47	O
,	O
48	O
];	O
however	O
,	O
its	O
use	O
requires	O
caution	O
as	O
it	O
may	O
not	O
be	O
completely	O
devoid	O
of	O
side	O
effect	O
.	O

Nommsen	O
-	O
Rivers	O
,	O
the	O
perinatal	O
nutrition	O
expert	O
from	O
the	O
University	O
of	O
Cincinnati	O
,	O
initiated	O
breastfeeding	O
studies	O
in	O
both	O
California	O
and	O
Ohio	O
,	O
which	O
were	O
part	O
of	O
the	O
World	O
Health	O
Organization	O
Multicentre	O
Growth	O
Reference	O
Study	O
.	O
30	O
“	O
Our	O
goal	O
was	O
to	O
enable	O
as	O
many	O
women	O
as	O
possible	O
to	O
follow	O
breastfeeding	O
guidelines	O
by	O
providing	O
lactation	O
support	O
,”	O
she	O
says	O
.	O

Of	O
the	O
patients	O
,	O
79	O
.	O
2	O
%	O
of	O
IG	O
and	O
81	O
.	O
9	O
%	O
of	O
CG	O
suffered	O
to	O
some	O
degree	O
from	O
vitamin	O
D	O
deficiency	O
.	O

Although	O
prepregnancy	O
weight	O
was	O
self	O
-	O
reported	O
,	O
our	O
research	O
has	O
found	O
that	O
women	O
in	O
this	O
study	O
were	O
quite	O
accurate	O
in	O
recalling	O
prepregnancy	O
weight	O
[	O
16	O
].	O

In	O
healthy	O
controls	O
,	O
25	O
[	O
OH	O
]	O
D	O
has	O
shown	O
to	O
be	O
positively	O
correlated	O
with	O
AMH	O
status	O
,	O
presenting	O
seasonal	O
variance	O
[	O
25	O
].	O

4	O
.	O

Moreover	O
,	O
further	O
research	O
is	O
required	O
in	O
order	O
to	O
separate	O
the	O
effects	O
of	O
polytherapy	O
from	O
the	O
baseline	O
mental	O
illness	O
,	O
as	O
well	O
as	O
the	O
genetic	O
and	O
environmental	O
confounders	O
on	O
pregnancy	O
outcome	O
,	O
particularly	O
as	O
those	O
receiving	O
psychotropic	O
polytherapy	O
may	O
suffer	O
from	O
more	O
severe	O
and	O
persistent	O
psychiatric	O
disorders	O
.	O

Focusing	O
on	O
post	O
-	O
natal	O
issues	O
was	O
not	O
usually	O
appealing	O
to	O
pregnant	O
women	O
who	O
were	O
more	O
eager	O
to	O
learn	O
about	O
labor	O
.	O

PubMed	O
Central	O
:	O

In	O
addition	O
to	O
this	O
,	O
a	O
special	O
call	O
centre	O
will	O
be	O
set	O
up	O
centrally	O
where	O
trained	O
nutrition	O
counsellors	O
will	O
systematically	O
make	O
bi	O
-	O
weekly	O
calls	O
to	O
monitor	O
compliance	O
with	O
the	O
supplementation	O
regime	O
.	O

PubMed	O
Central	O
:	O

There	O
was	O
a	O
65	O
%	O
lower	O
risk	O
of	O
PTB	O
among	O
white	O
women	O
with	O
25	O
(	O
OH	O
)	O
D	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
<	O
20	O
ng	O
/	O
mL	O
(	O
OR	O
=	O
0	O
.	O
35	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
13	O
–	O
0	O
.	O
92	O
,	O
p	O
=	O
0	O
.	O
03	O
;	O
AAR	O
=	O
13	O
.	O
8	O
%;	O
NNT	O
=	O
7	O
)	O
and	O
a	O
68	O
%	O
lower	O
risk	O
among	O
non	O
-	O
white	O
women	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
14	O
–	O
0	O
.	O
74	O
,	O
p	O
=	O
0	O
.	O
008	O
;	O
AAR	O
=	O
11	O
.	O
7	O
%;	O
NNT	O
=	O
9	O
).	O

This	O
suggests	O
the	O
possibility	O
that	O
some	O
infants	O
who	O
would	O
never	O
have	O
developed	O
atopy	O
would	O
undergo	O
preventive	O
regimens	O
,	O
whereas	O
others	O
who	O
become	O
symptomatic	O
in	O
early	O
life	O
would	O
not	O
have	O
received	O
adequate	O
advice	O
.	O

Women	O
who	O
have	O
a	O
weight	O
gain	O
target	O
that	O
is	O
concordant	O
with	O
IOM	O
recommendation	O
are	O
less	O
likely	O
to	O
have	O
excessive	O
weight	O
gain	O
[	O
4	O
].	O

RNA	O
Fluorescent	O
In	O
Situ	O
Hybridization	O
(	O
FISH	O
)	O
The	O
slides	O
of	O
the	O
paraffin	O
embedded	O
placental	O
tissue	O
samples	O
were	O
placed	O
in	O
a	O
coplin	O
jar	O
and	O
deparaffinised	O
for	O
30	O
minutes	O
at	O
37	O
°	O
C	O
using	O
Histo	O
-	O
Clear	O
(	O
Fisher	O
Scientific	O
,	O
UK	O
).	O

In	O
addition	O
,	O
participants	O
with	O
GDM	O
in	O
this	B
study	I
were	O
mostly	O
urban	O
residents	O
with	O
a	O
higher	O
socioeconomic	O
status	O
.	O

Women	O
were	O
recruited	O
between	O
13	O
and	O
19	O
weeks	O
of	O
pregnancy	O
from	O
prenatal	O
clinics	O
between	O
2003	O
and	O
2006	O
.	O

Smoking	O
Maternal	O
smoking	O
and	O
passive	O
exposure	O
to	O
smoke	O
should	O
both	O
be	O
avoided	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

In	O
May	O
2014	O
,	O
Nicaragua	O
expanded	O
influenza	O
vaccination	O
to	O
all	O
pregnant	O
women	O
in	O
the	O
country	O
.	O

Vitamin	O
D	O
status	O
is	O
determined	O
by	O
measuring	O
circulating	O
serum	O
levels	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D2	O
+	O
3	O
(	O
25	O
(	O
OH	O
)	O
D	O
).	O

Ninety	O
-	O
nine	O
women	O
(	O
76	O
.	O
2	O
%),	O
25	O
women	O
(	O
19	O
.	O
2	O
%),	O
and	O
six	O
women	O
(	O
4	O
.	O
6	O
%)	O
had	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
,	O
20	O
–	O
29	O
and	O
≥	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

Prevention	O
strategies	O
for	O
iron	O
deficiency	O
and	O
maternal	O
anaemia	O
include	O
nutritional	O
education	O
,	O
promoting	O
the	O
intake	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
,	O
and	O
food	O
fortification	O
[	O
13	O
].	O

In	O
contrast	O
,	O
rs10741657	O
(	O
CYP2R1	O
)	O
(	O
β	O
=	O
−	O
5	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
−	O
8	O
.	O
2	O
to	O
−	O
2	O
.	O
2	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
001	O
)	O
and	O
rs2282679	O
(	O
GC	O
)	O
(	O
β	O
=	O
4	O
.	O
2	O
nmol	O
/	O
L	O
;	O
95	O
%	O
CI	O
,	O
0	O
.	O
9	O
to	O
7	O
.	O
5	O
nmol	O
/	O
L	O
;	O
P	O
=	O
0	O
.	O
01	O
)	O
were	O
associated	O
with	O
achieved	O
25	O
(	O
OH	O
)	O
D	O
status	O
following	O
supplementation	O
,	O
whereas	O
rs12785878	O
and	O
rs6013897	O
(	O
CYP24A1	O
)	O
were	O
not	O
.	O

Johnson	O
et	O
al	O
.	O

A	O
possible	O
association	O
between	O
fetal	O
sex	O
,	O
vitamin	O
D	O
status	O
and	O
GDM	O
provides	O
further	O
questions	O
and	O
encourages	O
continual	O
research	O
and	O
discussion	O
into	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
pregnancy	O
,	O
particularly	O
in	O
vitamin	O
D	O
replete	O
populations	O
.	O

More	O
than	O
half	O
of	O
the	O
surveyed	O
women	O
(	O
57	O
%)	O
reported	O
having	O
at	O
least	O
one	O
chronic	O
condition	O
(	O
obesity	O
,	O
diabetes	O
,	O
asthma	O
,	O
renal	O
disease	O
,	O
liver	O
disease	O
,	O
blood	O
disease	O
,	O
neurologic	O
disease	O
);	O
conditions	O
were	O
more	O
common	O
among	O
vaccinated	O
(	O
60	O
%)	O
than	O
unvaccinated	O
women	O
(	O
53	O
%)	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
01	O
).	O

Indeed	O
,	O
18	O
human	O
cohort	O
and	O
20	O
rodent	O
studies	O
within	O
PubMed	O
reported	O
a	O
lack	O
of	O
epigenetically	O
related	O
toxicity	O
(	O
Supplementary	O
Table	O
4	O
).	O

Associated	O
symptoms	O
include	O
nausea	O
,	O
vomiting	O
,	O
diaphoresis	O
,	O
and	O
light	O
-	O
headedness	O
.	O

Low	O
25OHD	O
at	O
the	O
first	O
antenatal	O
visit	O
was	O
not	O
associated	O
with	O
insulin	O
resistance	O
in	O
early	O
or	O
late	O
pregnancy	O
when	O
controlling	O
for	O
season	O
and	O
confounders	O
.	O

Waist	O
and	O
hip	O
circumferences	O
were	O
measured	O
using	O
inextensible	O
tape	O
.	O

Diagnostic	O
Services	O
of	O
Manitoba	O
laboratory	O
reference	O
ranges	O
were	O
adopted	O
for	O
calcium	O
(	O
2	O
.	O
1	O
-	O
2	O
.	O
6	O
mmol	O
/	O
L	O
),	O
albumin	O
(	O
35	O
–	O
47	O
g	O
/	O
L	O
for	O
those	O
<	O
48	O
months	O
and	O
33	O
–	O
39	O
g	O
/	O
L	O
for	O
those	O
≥	O
48	O
months	O
),	O
and	O
PTH	O
(	O
7	O
–	O
50	O
ng	O
/	O
L	O
).	O

One	O
OTU	O
classified	O
to	O
the	O
genus	O
Corynebacterium	O
was	O
negatively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
(	O
p	O
=	O
0	O
.	O
0044	O
),	O
and	O
one	O
each	O
OTU	O
classified	O
to	O
the	O
species	O
Acinetobacter	O
rhizosphaerae	O
(	O
p	O
=	O
0	O
.	O
0040	O
)	O
and	O
to	O
the	O
family	O
Ruminococcaceae	O
(	O
p	O
=	O
0	O
.	O
0061	O
),	O
respectively	O
,	O
were	O
also	O
positively	O
associated	O
with	O
maternal	O
dairy	O
intake	O
,	O
but	O
we	O
did	O
not	O
observe	O
multiple	O
related	O
OTUs	O
with	O
similar	O
associations	O
.	O

Household	O
pets	O
were	O
assessed	O
during	O
pregnancy	O
and	O
serum	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
)	O
in	O
cord	O
blood	O
was	O
used	O
as	O
the	O
measure	O
of	O
vitamin	O
D	O
and	O
a	O
marker	O
of	O
maternal	O
level	O
.	O

Previous	O
studies	O
have	O
shown	O
a	O
positive	O
association	O
between	O
socioeconomic	O
status	O
and	O
vitamin	O
D	O
in	O
both	O
pregnant	O
and	O
non	O
-	O
pregnant	O
women	O
[	O
36	O
,	O
37	O
].	O

However	O
,	O
meta	O
-	O
analysis	O
of	O
the	O
4	O
case	O
-	O
control	O
studies	O
revealed	O
a	O
significantly	O
increased	O
risk	O
of	O
oral	O
clefts	O
in	O
infants	O
of	O
corticosteroid	O
-	O
treated	O
mothers	O
(	O
odds	O
ratio	O
,	O
3	O
.	O
35	O
;	O
confidence	O
interval	O
1	O
.	O
97	O
-	O
5	O
.	O
69	O
)	O
[	O
12	O
].	O

The	O
informed	O
consent	O
form	O
is	O
given	O
to	O
the	O
participant	O
to	O
read	O
,	O
consider	O
and	O
discuss	O
with	O
her	O
partner	O
and	O
/	O
or	O
family	O
.	O

Transplacental	O
transfer	O
occurs	O
,	O
67	O
,	O
81and	O
until	O
studies	O
demonstrating	O
safety	O
are	O
performed	O
,	O
they	O
should	O
be	O
avoided	O
in	O
pregnancy	O
.	O

Background	O
Insufficient	O
sleep	O
duration	O
and	O
poor	O
sleep	O
quality	O
are	O
considered	O
to	O
be	O
endemic	O
in	O
modern	O
society	O
.	O

Yet	O
,	O
contrary	O
to	O
many	O
studies	O
,	O
associations	O
between	O
high	O
25	O
(	O
OH	O
)	O
D	O
and	O
GDM	O
have	O
been	O
reported	O
[	O
27	O
,	O
28	O
].	O

However	O
,	O
the	O
findings	O
in	O
our	B
study	I
appear	O
meaningful	O
in	O
that	O
the	O
provision	O
of	O
vitamin	O
D	O
at	O
a	O
dose	O
of	O
400	O
IU	O
/	O
day	O
led	O
to	O
mean	O
values	O
that	O
were	O
above	O
30	O
ng	O
/	O
mL	O
regardless	O
of	O
starting	O
value	O
or	O
ethnicity	O
.	O

MGF	O
,	O
maternal	O
grandfather	O
;	O
MGM	O
,	O
maternal	O
grandmother	O
;	O
PGF	O
,	O
paternal	O
grandfather	O
;	O
PGM	O
,	O
paternal	O
grandmother	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Experimental	O
design	O
.	O

Vitamin	O
D	O
is	O
definitely	O
not	O
a	O
Trojan	O
Horse	O
in	O
reproductive	O
health	O
since	O
there	O
were	O
no	O
adverse	O
effects	O
reported	O
for	O
vitamin	O
D	O
intake	O
of	O
up	O
to	O
10	O
,	O
000	O
IU	O
/	O
d	O
[	O
66	O
],	O
but	O
to	O
proclaim	O
it	O
the	O
Golden	O
Fleece	O
,	O
more	O
evidence	O
is	O
still	O
required	O
.	O

The	O
seasonal	O
variations	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
detected	O
in	O
these	O
subjects	O
are	O
consistent	O
with	O
natural	O
environmental	O
changes	O
in	O
the	O
area	O
of	O
residence	O
.	O

Of	O
these	O
,	O
78	O
.	O
5	O
%	O
(	O
n	O
=	O
285	O
/	O
363	O
;	O
132	O
overweight	O
/	O
obese	O
and	O
153	O
normal	O
weight	O
)	O
had	O
pediatrician	O
records	O
at	O
birth	O
and	O
68	O
.	O
6	O
%	O
(	O
n	O
=	O
249	O
/	O
363	O
;	O
121	O
overweight	O
/	O
obese	O
and	O
128	O
normal	O
weight	O
)	O
had	O
pediatrician	O
information	O
at	O
6	O
months	O
.	O

(	O
2013	O
)*/†	O
FormaldehydeRatAge	O
-	O
related	O
accumulation	O
(	O
0	O
.	O
07	O
–	O
0	O
.	O
5	O
mM	O
)	O
Injection	O
(	O
ih	O
)	O
(	O
1	O
µl	O
of	O
0	O
.	O
5	O
mM	O
)	O
Adulthood	O
LifetimeAdulthoodBehavioral	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryTong	O
et	O
al	O
.	O

The	O
seven	O
studies	O
,	O
which	O
demonstrated	O
a	O
benefit	O
in	O
neurodevelopment	O
,	O
had	O
a	O
follow	O
up	O
time	O
ranging	O
from	O
six	O
months	O
to	O
nine	O
years	O
.	O

Our	O
results	O
suggest	O
that	O
habitual	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
precede	O
the	O
clinical	O
diagnosis	O
of	O
GDM	O
.	O

The	O
RNA	O
from	O
the	O
homogenized	O
samples	O
was	O
isolated	O
using	O
Trizol	O
reagent	O
and	O
chloroform	O
extraction	O
by	O
the	O
manufacturer	O
’	O
s	O
protocol	O
(	O
Invitrogen	O
,	O
Grand	O
Island	O
,	O
NY	O
,	O
USA	O
)	O
and	O
quantified	O
by	O
Nanodrop	O
1000	O
.	O

Key	O
components	O
in	O
terms	O
of	O
cell	O
cycle	O
regulation	O
are	O
cyclins	O
.	O

These	O
findings	O
are	O
compatible	O
with	O
a	O
previous	O
report	O
of	O
early	O
puberty	O
following	O
high	O
fat	O
nutrition	O
during	O
pregnancy	O
[	O
57	O
].	O

Some	O
researchers	O
defined	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
lower	O
than	O
50	O
nmol	O
/	O
L	O
as	O
diagnostic	O
criteria	O
for	O
Vitamin	O
D	O
deficiency	O
,	O
50	O
–	O
75	O
nmol	O
/	O
L	O
as	O
inadequate	O
,	O
and	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
as	O
adequate	O
[	O
4	O
,	O
6	O
,	O
7	O
].	O

For	O
a	O
second	O
filtering	O
step	O
standard	O
deviations	O
were	O
calculated	O
for	O
each	O
probe	O
-	O
set	O
over	O
all	O
subsets	O
of	O
arrays	O
of	O
the	O
particular	O
comparisons	O
.	O

Differences	O
in	O
age	O
,	O
health	O
and	O
initial	O
vitamin	O
D	O
status	O
between	O
cohorts	O
,	O
as	O
well	O
as	O
study	O
design	O
,	O
may	O
explain	O
the	O
conflicting	O
data	O
.	O

Introduction	O
Anthropometric	O
measurements	O
,	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
of	O
newborn	O
infants	O
,	O
are	O
widely	O
assessed	B
as	O
determinants	O
of	O
impaired	O
fetal	O
growth	O
,	O
intrauterine	O
environment	O
,	O
and	O
maternal	O
nutrition	O
[	O
1	O
].	O

The	O
production	O
of	O
highly	O
marbled	O
beef	O
in	O
Korea	O
is	O
essential	O
to	O
compete	O
with	O
cheap	O
imported	O
beef	O
that	O
has	O
a	O
relatively	O
low	O
marbling	O
score	O
(	O
MS	O
).	O

Analysis	O
of	O
data	O
from	O
the	O
Massachusetts	O
Male	O
Aging	O
Study	O
revealed	O
that	O
short	O
sleep	O
duration	O
at	O
baseline	O
(≤	O
5	O
or	O
6	O
hours	O
per	O
night	O
)	O
was	O
associated	O
with	O
elevated	O
risk	O
of	O
developing	O
incident	O
type	O
2	O
diabetes	O
after	O
adjustment	O
for	O
covariates	O
,	O
including	O
age	O
,	O
hypertension	O
,	O
smoking	O
,	O
self	O
-	O
rated	O
health	O
,	O
waist	O
circumference	O
,	O
education	O
,	O
total	O
testosterone	O
and	O
cortisol	O
[	O
11	O
].	O

There	O
is	O
strong	O
evidence	O
that	O
maternal	O
iron	O
deficiency	O
anaemia	O
increases	O
the	O
risk	O
of	O
adverse	O
perinatal	O
outcomes	O
.	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

Dopamine	O
projections	O
involve	O
a	O
range	O
of	O
cortical	O
and	O
subcortical	O
regions	O
,	O
however	O
its	O
role	O
in	O
the	O
nucleus	O
accumbens	O
has	O
been	O
of	O
particular	O
interest	O
with	O
respect	O
to	O
neuropsychiatric	O
disorders	O
[	O
14	O
]–[	O
16	O
].	O

The	O
United	O
Nations	O
and	O
other	O
multilateral	O
organistions	O
:	O
Invest	O
•	O
Support	O
countries	O
develop	O
and	O
align	O
their	O
national	O
health	O
plans	O
,	O
including	O
costing	O
and	O
tracking	O
implementation	O
to	O
achieve	O
the	O
health	O
MDGs	O
and	O
preterm	O
birth	O
mortality	O
-	O
reduction	O
targets	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

"	O
Cured	O
"	O
patients	O
Pregnant	O
patients	O
with	O
a	O
history	O
of	O
previously	O
treated	O
DTC	O
with	O
no	O
evidence	O
of	O
recurrent	O
or	O
persistent	O
disease	O
by	O
imaging	O
and	O
by	O
thyroglobulin	O
measurement	O
.	O

In	O
the	O
same	O
study	O
,	O
LM	O
area	O
also	O
increased	O
linearly	O
with	O
increasing	O
HCW	O
.	O

In	O
contrast	O
,	O
the	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
show	O
changes	O
in	O
body	O
weight	O
and	O
adiposity	O
,	O
but	O
exhibited	O
higher	O
levels	O
of	O
LDL	O
and	O
glucose	O
in	O
plasma	O
,	O
and	O
a	O
reduction	O
in	O
chocolate	O
preference	O
at	O
adolescence	O
and	O
total	O
caloric	O
intake	O
at	O
adulthood	O
.	O

Given	O
the	O
predominance	O
of	O
polytherapy	O
involving	O
these	O
two	O
classes	O
of	O
medications	O
in	O
the	O
treatment	O
of	O
various	O
psychiatric	O
disorders	O
in	O
pregnant	O
women	O
,	O
designing	O
future	O
cohort	O
studies	O
aimed	O
at	O
investigating	O
the	O
relative	O
and	O
combined	O
effects	O
of	O
prenatal	O
exposure	O
to	O
SGAs	O
and	O
antidepressants	O
is	O
of	O
considerable	O
importance	O
.	O

A	O
range	O
of	O
studies	O
(	O
proteomics	O
,	O
genomics	O
,	O
gene	O
association	O
studies	O
)	O
have	O
linked	O
schizophrenia	O
with	O
alterations	O
in	O
malate	O
dehydrogenase	O
cytoplasmic	O
(	O
MDHC	O
,	O
now	O
known	O
as	O
malic	O
enzyme	O
2	O
)[	O
42	O
]–[	O
47	O
].	O

Maternal	O
average	O
nightly	O
sleep	O
duration	O
during	O
pregnancy	O
was	O
ascertained	O
by	O
asking	O
women	O
the	O
following	O
question	O
:	O
"	O
Since	O
becoming	O
pregnant	O
,	O
how	O
many	O
hours	O
per	O
night	O
do	O
you	O
sleep	O
?"	O

Thus	O
,	O
it	O
is	O
clear	O
that	O
a	O
southern	O
US	O
location	O
is	O
not	O
protective	O
against	O
seasonal	O
deficiency	O
of	O
vitamin	O
D	O
or	O
low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
.	O

The	O
latitude	O
of	O
Houston	O
,	O
TX	O
is	O
29	O
degrees	O
,	O
more	O
southern	O
than	O
the	O
typically	O
used	O
latitude	O
cutoff	O
of	O
Atlanta	O
,	O
Georgia	O
of	O
33	O
degrees	O
for	O
sunlight	O
exposure	O
to	O
lead	O
to	O
vitamin	O
D	O
formation	O
in	O
the	O
dermis	O
to	O
occur	O
throughout	O
the	O
year	O
.	O

Surveys	O
were	O
conducted	O
to	O
assess	O
program	O
impact	O
,	O
compliance	O
and	O
cost	O
[	O
13	O
],[	O
14	O
].	O

These	O
results	O
suggest	O
that	O
visfatin	O
may	O
play	O
an	O
important	O
role	O
in	O
maternal	O
-	O
fetal	O
metabolic	O
interaction	O
.	O

Linear	O
regression	O
was	O
used	O
to	B
examine	I
the	O
association	O
between	O
the	O
four	O
SNPs	O
and	O
the	O
outcomes	O
using	O
an	O
additive	O
model	O
with	O
the	O
homozygous	O
low	O
-	O
frequency	O
allele	O
(	O
for	O
this	O
cohort	O
)	O
as	O
the	O
reference	O
group	O
.	O

It	O
can	O
be	O
observed	O
that	O
a	O
slight	O
increase	O
in	O
fT4	O
and	O
a	O
reduction	O
in	O
TSH	O
occur	O
between	O
the	O
9thand	O
12thweeks	O
of	O
gestation	O
;	O
subsequently	O
,	O
HCG	O
levels	O
decrease	O
and	O
TSH	O
reaches	O
normal	O
non	O
-	O
pregnant	O
levels	O
.	O

However	O
,	O
Baiz	O
et	O
al	O
.	O

A	O
unique	O
form	O
of	O
urticaria	O
associated	O
with	O
pregnancy	O
,	O
which	O
tends	O
to	O
recur	O
in	O
subsequent	O
pregnancies	O
(	O
pregnancy	O
urticaria	O
),	O
has	O
been	O
reported	O
[	O
45	O
].	O

Women	O
with	O
a	O
≥	O
30	O
nmol	O
/	O
L	O
increment	O
in	O
25OHD	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Children	O
'	O
s	O
patterns	O
of	O
weight	O
gain	O
vary	O
by	O
sex	O
and	O
age	O
(	O
85	O
),	O
and	O
during	O
stages	O
of	O
rapid	O
growth	O
,	O
caloric	O
requirements	O
increase	O
.	O

Identifying	B
caries	O
-	O
free	O
controls	O
living	O
in	O
these	O
same	O
communities	O
proved	O
challenging	O
.	O

Limited	O
information	O
is	O
available	O
on	O
the	O
effects	O
of	O
the	O
dietary	O
energy	O
-	O
to	O
-	O
protein	O
ratio	O
on	O
IMF	O
content	O
in	O
cattle	O
.	O

For	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
,	O
there	O
was	O
a	O
58	O
%	O
lower	O
risk	O
of	O
spontaneous	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
42	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
89	O
,	O
p	O
=	O
0	O
.	O
02	O
;	O
AAR	O
=	O
4	O
.	O
8	O
%;	O
NNT	O
=	O
21	O
)	O
and	O
a	O
61	O
%	O
lower	O
risk	O
of	O
indicated	O
PTB	O
(	O
OR	O
=	O
0	O
.	O
39	O
,	O
95	O
%	O
CI	O
=	O
0	O
.	O
20	O
–	O
0	O
.	O
76	O
,	O
p	O
=	O
0	O
.	O
006	O
;	O
AAR	O
=	O
6	O
.	O
5	O
%;	O
NNT	O
=	O
15	O
)	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0180483	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Association	O
between	O
maternal	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
and	O
the	O
risk	O
of	O
preterm	O
birth	O
by	O
preterm	O
birth	O
subtype	O
.	O
Spontaneous	O
Preterm	O
Birth	O
RatesSpontaneous	O
Preterm	O
Birth	O
:	O
ORIndicated	O
Preterm	O
Birth	O
RatesIndicated	O
Preterm	O
Birth	O
:	O
OR	O
(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)(<	O
37	O
Weeks	O
)(	O
95	O
%	O
CI	O
)<	O
20	O
ng	O
/	O
mL	O
(	O
N	O
=	O
248	O
)	O
21	O
(	O
8	O
%)	O
1	O
.	O
028	O
(	O
11	O
%)	O
1	O
.	O
0N	O
preterm	O
(%)	O
20	O
to	O
<	O
30	O
ng	O
/	O
mL	O
(	O
N	O
=	O
267	O
)	O
17	O
(	O
6	O
%)	O
0	O
.	O
7416	O
(	O
6	O
%)	O
0	O
.	O
50	O
N	O
preterm	O
(%)(	O
0	O
.	O
38	O
,	O
1	O
.	O
43	O
)	O
(	O
0	O
.	O
26	O
,	O
0	O
.	O
95	O
)	O
30	O
to	O
<	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
255	O
)	O
16	O
(	O
6	O
%)	O
0	O
.	O
7216	O
(	O
6	O
%)	O
0	O
.	O
53	O
N	O
preterm	O
(%)(	O
0	O
.	O
37	O
,	O
1	O
.	O
42	O
)	O
(	O
0	O
.	O
28	O
,	O
0	O
.	O
99	O
)	O
≥	O
40	O
ng	O
/	O
mL	O
(	O
N	O
=	O
294	O
)	O
11	O
(	O
4	O
%)	O
0	O
.	O
42	O
14	O
(	O
5	O
%)	O
0	O
.	O
39	O
N	O
preterm	O
(%)	O
(	O
0	O
.	O
20	O
,	O
0	O
.	O
89	O
)(	O
0	O
.	O
20	O
,	O
0	O
.	O
76	O
)	O
Bold	O
values	O
signify	O
significance	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O

This	O
is	O
similar	O
to	O
that	O
which	O
has	O
previously	O
been	O
shown	O
in	O
the	O
relationship	O
between	O
vitamin	O
D	O
status	O
at	O
≤	O
26	O
weeks	O
’	O
gestation	O
and	O
placental	O
pathology	O
in	O
pregnancy	O
[	O
51	O
]	O
suggesting	O
that	O
male	O
and	O
female	O
fetuses	O
respond	O
differently	O
to	O
maternal	O
vitamin	O
D	O
status	O
.	O

If	O
this	O
is	O
the	O
case	O
,	O
adult	O
health	O
outcomes	O
may	O
reflect	O
season	O
of	O
birth	O
if	O
food	O
intake	O
is	O
seasonal	O
,	O
and	O
if	O
exposure	O
occurs	O
at	O
a	O
critical	O
stage	O
of	O
fetal	O
development	O
.	O

Among	O
women	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
overweight	O
,	O
obesity	O
and	O
smoking	O
were	O
more	O
common	O
,	O
and	O
this	O
group	O
also	O
contained	O
more	O
women	O
who	O
had	O
migrated	O
to	O
Sweden	O
.	O

The	O
overall	O
aim	B
of	O
the	O
present	B
study	I
was	O
to	B
investigate	I
the	O
impact	O
of	O
differing	O
nutritional	O
exposures	O
(	O
standard	O
rat	O
chow	O
,	O
high	O
fat	O
or	O
caloric	O
restriction	O
)	O
during	O
intrauterine	O
and	O
early	O
postnatal	O
life	O
on	O
pubertal	O
onset	O
and	O
ovarian	O
function	O
in	O
female	O
rat	O
offspring	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fishDietary	O
intakePositive	O
psychotic	O
-	O
like	O
symptomsaLow	O
level	O
groupMiddle	O
level	O
groupHigh	O
level	O
groupEnergy	O
adjustedMultivariatebEnergy	O
adjustedMultivariatebNo	O
.	O
No	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CINo	O
.	O
RR95	O
%	O
CIRR95	O
%	O
CI	O
Salmon	O
-	O
type	O
fish	O
and	O
herring	O
/	O
mackerel	O
,	O
frequency	O
never5	O
027Ref	O
.	O
4	O
0902521	O
-	O
3	O
per	O
month5	O
9624	O
5470	O
.	O
930	O
.	O
88	O
-	O
0	O
.	O
980	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052160	O
.	O
720	O
.	O
60	O
-	O
0	O
.	O
860	O
.	O
81c0	O
.	O
66	O
-	O
0	O
.	O
981	O
per	O
week6	O
3814	O
7270	O
.	O
900	O
.	O
85	O
-	O
0	O
.	O
950	O
.	O
99c0	O
.	O
93	O
-	O
1	O
.	O
052480	O
.	O
760	O
.	O
64	O
-	O
0	O
.	O
900	O
.	O
92c0	O
.	O
75	O
-	O
1	O
.	O
12	O
≥	O
2	O
per	O
week4945261	O
.	O
271	O
.	O
12	O
-	O
1	O
.	O
431	O
.	O
32c1	O
.	O
15	O
-	O
1	O
.	O
51481	O
.	O
741	O
.	O
26	O
-	O
2	O
.	O
391	O
.	O
90c1	O
.	O
34	O
-	O
2	O
.	O
70	O
Cod	O
/	O
saithe	O
/	O
pike	O
,	O
frequency	O
never1	O
289Ref	O
.	O
1	O
136961	O
-	O
3	O
per	O
month7	O
0095	O
3110	O
.	O
850	O
.	O
78	O
-	O
0	O
.	O
930	O
.	O
89d0	O
.	O
82	O
-	O
0	O
.	O
983220	O
.	O
620	O
.	O
49	O
-	O
0	O
.	O
780	O
.	O
70d0	O
.	O
55	O
-	O
0	O
.	O
891	O
per	O
week8	O
0966	O
1850	O
.	O
840	O
.	O
77	O
-	O
0	O
.	O
920	O
.	O
87d0	O
.	O
80	O
-	O
0	O
.	O
952700	O
.	O
430	O
.	O
34	O
-	O
0	O
.	O
550	O
.	O
46d0	O
.	O
36	O
-	O
0	O
.	O
59	O
≥	O
2	O
per	O
week1	O
4701	O
2580	O
.	O
930	O
.	O
83	O
-	O
1	O
.	O
040	O
.	O
90d0	O
.	O
81	O
-	O
1	O
.	O
01760	O
.	O
690	O
.	O
50	O
-	O
0	O
.	O
930	O
.	O
57d0	O
.	O
41	O
-	O
0	O
.	O
79	O
Shellfish	O
,	O
frequency	O
never4	O
540Ref	O
.	O
3	O
8152431	O
-	O
3	O
per	O
month11	O
0758	O
2190	O
.	O
880	O
.	O
84	O
-	O
0	O
.	O
930	O
.	O
90e0	O
.	O
85	O
-	O
0	O
.	O
954120	O
.	O
700	O
.	O
59	O
-	O
0	O
.	O
820	O
.	O
78e0	O
.	O
66	O
-	O
0	O
.	O
931	O
per	O
week1	O
8931	O
4530	O
.	O
910	O
.	O
84	O
-	O
0	O
.	O
990	O
.	O
92e0	O
.	O
84	O
-	O
1	O
.	O
00780	O
.	O
770	O
.	O
59	O
-	O
1	O
.	O
000	O
.	O
84e0	O
.	O
64	O
-	O
1	O
.	O
11	O
≥	O
2	O
per	O
week3564031	O
.	O
341	O
.	O
15	O
-	O
1	O
.	O
551	O
.	O
28e1	O
.	O
09	O
-	O
1	O
.	O
49311	O
.	O
701	O
.	O
16	O
-	O
2	O
.	O
481	O
.	O
42e0	O
.	O
94	O
-	O
2	O
.	O
14	O
All	O
fish	O
and	O
seafood	O
,	O
frequency	O
never533Ref	O
.	O
476441	O
-	O
3	O
per	O
month1	O
1319960	O
.	O
960	O
.	O
82	O
-	O
1	O
.	O
110	O
.	O
96	O
f0	O
.	O
83	O
-	O
1	O
.	O
12840	O
.	O
870	O
.	O
60	O
-	O
1	O
.	O
270	O
.	O
89	O
f0	O
.	O
61	O
-	O
1	O
.	O
311	O
per	O
week7	O
0255	O
4500	O
.	O
830	O
.	O
73	O
-	O
0	O
.	O
950	O
.	O
86	O
f0	O
.	O
76	O
-	O
0	O
.	O
892900	O
.	O
480	O
.	O
34	O
-	O
0	O
.	O
670	O
.	O
51	O
f0	O
.	O
36	O
-	O
0	O
.	O
712	O
per	O
week7	O
2155	O
2610	O
.	O
770	O
.	O
68	O
-	O
0	O
.	O
880	O
.	O
82	O
f0	O
.	O
71	O
-	O
0	O
.	O
932640	O
.	O
420	O
.	O
30	O
-	O
0	O
.	O
580	O
.	O
45	O
f0	O
.	O
32	O
-	O
0	O
.	O
643	O
-	O
4	O
per	O
week1	O
9871	O
6680	O
.	O
880	O
.	O
77	O
-	O
1	O
.	O
020	O
.	O
93	O
f0	O
.	O
80	O
-	O
1	O
.	O
07800	O
.	O
450	O
.	O
31	O
-	O
0	O
.	O
660	O
.	O
47	O
f0	O
.	O
31	O
-	O
0	O
.	O
70	O
>	O
5	O
per	O
week5205411	O
.	O
090	O
.	O
92	O
-	O
1	O
.	O
301	O
.	O
13	O
f0	O
.	O
94	O
-	O
1	O
.	O
35551	O
.	O
190	O
.	O
78	O
-	O
1	O
.	O
811	O
.	O
12	O
f0	O
.	O
72	O
-	O
1	O
.	O
74	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bIn	O
the	O
multivariate	O
analysis	O
presented	O
,	O
we	O
initially	O
tested	O
the	O
effects	O
of	O
adjusting	O
also	O
for	O
BMI	O
,	O
level	O
of	O
education	O
,	O
country	O
of	O
birth	O
,	O
smoking	O
,	O
dietary	O
intake	O
of	O
meat	O
,	O
dairy	O
products	O
,	O
fruits	O
,	O
cereals	O
and	O
refined	O
sugar	O
,	O
rheumatoid	O
arthritis	O
,	O
gluten	O
intolerance	O
,	O
diabetes	O
and	O
multivitamin	O
supplement	O
.	O

Significant	O
correlations	O
were	O
observed	O
in	O
both	O
groups	O
between	O
first	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
002	O
,	O
ra	O
=	O
0	O
.	O
713	O
,	O
pb	O
=	O
0	O
.	O
005	O
,	O
rb	O
=-	O
0	O
.	O
540	O
,	O
in	O
A	O
and	O
B	O
group	O
,	O
respectively	O
)	O
and	O
second	O
trimester	O
visfatin	O
(	O
pa	O
=	O
0	O
.	O
009	O
,	O
ra	O
=	O
0	O
.	O
628	O
and	O
pb	O
=	O
0	O
.	O
008	O
,	O
rb	O
=-	O
0	O
.	O
518	O
,	O
in	O
groups	O
A	O
and	O
B	O
,	O
respectively	O
)	O
with	O
infant	O
’	O
s	O
height	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

These	O
metabolites	O
were	O
analyzed	O
using	O
commercial	O
kits	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
a	O
Hitachi	O
737	O
Automatic	O
Analyzer	O
(	O
Hitachi	O
Ltd	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Although	O
cord	O
blood	O
25	O
(	O
OH	O
)	O
D	O
levels	O
do	O
correlate	O
to	O
maternal	O
levels	O
,	O
factors	O
that	O
affect	O
fetal	O
growth	O
may	O
not	O
be	O
uniform	O
throughout	O
pregnancy	O
and	O
this	O
difference	O
in	O
timing	O
could	O
affect	O
study	O
findings	O
.	O
1	O
,	O
3	O
,	O
4	O
,	O
5	O
,	O
6In	O
addition	O
,	O
maternal	O
characteristics	O
such	O
as	O
obesity	O
or	O
pre	O
-	O
eclampsia	O
could	O
also	O
affect	O
results	O
that	O
may	O
not	O
have	O
been	O
seen	O
if	O
vitamin	O
D	O
samples	O
were	O
obtained	O
during	O
early	O
pregnancy	O
.	O

Data	O
Collection	O
2	O
.	O
2	O
.	O
1	O
.	O

Insulin	O
is	O
still	O
the	O
mainstay	O
of	O
pharmacological	O
treatment	O
of	O
GDM	O
,	O
and	O
this	O
is	O
ideally	O
administered	O
in	O
a	O
basal	O
bolus	O
regimen	O
.	O

This	O
system	O
will	O
allow	O
the	O
field	O
supervisors	O
to	O
monitor	O
the	O
performance	O
of	O
individual	O
data	O
collectors	O
.	O

The	O
latter	O
result	O
did	O
not	O
remain	O
significant	O
after	O
multivariate	O
adjustment	O
(	O
Table2	O
).	O

Prepregnancy	O
smoking	O
status	O
was	O
assessed	O
as	O
number	O
of	O
cigarettes	O
per	O
day	O
.	O

The	O
responses	O
in	O
the	O
questionnaires	O
were	O
transcribed	O
into	O
EPIInfo	O
version	O
3	O
.	O
5	O
.	O
1	O
database	O
(	O
CDC	O
/	O
WHO	O
,	O
Atlanta	O
,	O
USA	O
).	O

Another	O
potential	O
drawback	O
should	O
be	O
also	O
considered	O
.	O

Also	O
,	O
our	B
study	I
showed	O
significant	O
discrepancy	O
between	O
the	O
two	O
groups	O
according	O
to	O
the	O
rate	O
of	O
deficiency	O
,	O
insufficiency	O
and	O
normal	O
range	O
of	O
vitamin	O
D	O
categories	O
(	O
P	O
=	O
0	O
.	O
021	O
).	O

Maternal	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
≥	O
40	O
ng	O
/	O
mL	O
associated	O
with	O
60	O
%	O
lower	O
preterm	O
birth	O
risk	O
among	O
general	O
obstetrical	O
patients	O
at	O
an	O
urban	O
medical	O
center	O
Abstract	O
Background	O
Given	O
the	O
high	O
rate	O
of	O
preterm	O
birth	O
(	O
PTB	O
)	O
nationwide	O
and	O
data	O
from	O
RCTs	O
demonstrating	O
risk	O
reduction	O
with	O
vitamin	O
D	O
supplementation	O
,	O
the	O
Medical	O
University	O
of	O
South	O
Carolina	O
(	O
MUSC	O
)	O
implemented	O
a	O
new	O
standard	O
of	O
care	O
for	O
pregnant	O
women	O
to	O
receive	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
.	O

The	O
primary	O
outcome	O
was	O
neonatal	O
bone	O
mass	O
.	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

Maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
transfers	O
to	O
the	O
fetus	O
by	O
the	O
placenta	O
.	O

Conclusion	O
To	O
conclude	O
,	O
UCP1	O
is	O
an	O
excellent	O
target	O
to	O
struggle	O
diabetes	O
and	O
decrease	O
body	O
fat	O
mass	O
,	O
improving	O
whole	O
metabolism	O
.	O

All	O
sows	O
were	O
fed	O
AP	O
lactation	O
diets	O
.	O

Vitamin	O
D	O
testing	O
and	O
supplementation	O
of	O
pregnant	O
women	O
is	O
a	O
safe	O
,	O
affordable	O
prevention	O
tool	O
that	O
could	O
substantially	O
reduce	O
the	O
occurrence	O
of	O
PTB	O
and	O
the	O
heavy	O
burden	O
of	O
associated	O
morbidity	O
,	O
mortality	O
and	O
economic	O
costs	O
.	O

Introduction	O
Across	O
the	O
globe	O
,	O
>	O
1	O
.	O
46	O
billion	O
adults	O
[	O
1	O
],	O
and	O
170	O
million	O
children	O
[	O
2	O
],	O
are	O
overweight	O
or	O
obese	O
.	O

Some	O
sires	O
may	O
have	O
high	O
breeding	O
value	O
for	O
both	O
IMF	O
and	O
YG	O
,	O
and	O
selection	O
of	O
such	O
sires	O
is	O
likely	O
to	O
be	O
beneficial	O
for	O
increasing	O
IMF	O
deposition	O
without	O
decreasing	O
YG	O
.	O

Investigators	O
have	O
shown	O
that	O
self	O
-	O
reported	O
snoring	O
correlates	O
well	O
with	O
objective	O
findings	O
from	O
nocturnal	O
polysomnography	O
,	O
especially	O
in	O
frequent	O
snorers	O
[	O
40	O
].	O

Adequate	O
intravascular	O
volume	O
repletion	O
and	O
oxygenation	O
are	O
particularly	O
important	O
in	O
the	O
management	O
of	O
anaphylaxis	O
during	O
pregnancy	O
to	O
prevent	O
both	O
maternal	O
and	O
fetal	O
complications	O
.	O

However	O
,	O
new	O
evidence	O
suggests	O
that	O
vitamin	O
D	O
could	O
be	O
vital	O
to	O
normal	O
fetal	O
development	O
and	O
that	O
vitamin	O
D	O
restriction	O
in	O
this	O
period	O
may	O
affect	O
chronic	O
disease	O
susceptibility	O
post	O
-	O
natal	O
life	O
[	O
8	O
].	O

Due	O
to	O
the	O
normal	O
dietary	O
conditions	O
at	O
juvenile	O
and	O
adult	O
stages	O
the	O
alterations	O
found	O
here	O
can	O
be	O
regarded	O
as	O
fetal	O
nutritional	O
programming	O
.	O

The	O
level	O
of	O
25	O
-	O
hydroxy	O
Vitamin	O
D	O
(	O
25	O
-	O
OH	O
Vit	O
D	O
)	O
and	O
the	O
sources	O
of	O
Vitamin	O
D	O
intake	O
and	O
the	O
frequency	O
of	O
food	O
consumption	O
rich	O
in	O
Vitamin	O
D	O
were	O
investigated	B
.	O

Variables	O
influencing	O
the	O
formation	O
of	O
previtamin	O
D3	O
in	O
the	O
skin	O
include	O
skin	O
pigmentation	O
and	O
intensity	O
of	O
the	O
solar	O
UV	O
light	O
[	O
52	O
]–[	O
55	O
].	O

We	O
further	O
increased	O
the	O
desired	O
sample	O
to	O
200	O
per	O
arm	O
to	O
account	O
for	O
potential	O
loss	O
to	O
follow	O
-	O
up	O
,	O
and	O
adverse	O
perinatal	O
outcomes	O
such	O
as	O
maternal	O
or	O
neonatal	O
death	O
,	O
since	O
structured	O
observations	O
would	O
not	O
be	O
feasible	O
or	O
appropriate	O
in	O
such	O
cases	O
.	O

RMMCH	O
is	O
a	O
provincial	O
hospital	O
focusing	O
on	O
maternal	O
and	O
paediatric	O
healthcare	O
,	O
delivering	O
more	O
than	O
10	O
,	O
000	O
babies	O
annually	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
plasma	O
levels	O
of	O
leptin	O
,	O
metabolites	O
,	O
alkaline	O
phosphatase	O
,	O
and	O
hepatic	O
transaminases	O
in	O
adult	O
offspring	O
Two	O
-	O
way	O
ANOVA	O
showed	O
an	O
effect	O
of	O
prenatal	O
diet	O
on	O
the	O
plasma	O
levels	O
of	O
glucose	O
,	O
the	O
lipid	O
profile	O
(	O
triglycerides	O
,	O
HDL	O
,	O
LDL	O
,	O
and	O
VLDL	O
)	O
and	O
urea	O
(	O
Table1	O
).	O

The	O
latter	O
exposure	O
was	O
not	O
associated	O
with	O
any	O
outcome	O
(	O
data	O
not	O
shown	O
).	O

In	O
this	O
software	O
,	O
the	O
artifacts	O
were	O
corrected	O
with	O
a	O
moderated	O
filter	O
,	O
and	O
the	O
time	O
-	O
domain	O
components	O
were	O
calculated	O
.	O

Women	O
who	O
were	O
lost	O
to	O
follow	O
-	O
up	O
had	O
moved	O
and	O
their	O
medical	O
records	O
could	O
not	O
be	O
retrieved	O
.	O

A	O
more	O
subtly	O
calibrated	O
iron	O
supplementation	O
during	O
pregnancy	O
may	O
be	O
as	O
effective	O
as	O
current	O
public	O
health	O
recommendations	O
,	O
and	O
perhaps	O
safer	O
.	O

Eukaryotic	O
cells	O
evolved	O
elaborate	O
mechanisms	O
to	O
verify	O
the	O
fidelity	O
of	O
cell	O
division	O
.	O

This	B
study	I
finds	O
that	O
85	O
.	O
7	O
%	O
of	O
pregnant	O
women	O
received	O
supplements	O
containing	O
Vitamin	O
D	O
.	O
Their	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
levels	O
were	O
higher	O
than	O
those	O
without	O
supplement	O
use	O
.	O

A	O
dose	O
of	O
600	O
,	O
000	O
IU	O
vitamin	O
D	O
resulted	O
in	O
hypercalcemia	O
,	O
therefore	O
,	O
it	O
can	O
not	O
be	O
regarded	O
a	O
safe	O
dose	O
.	O
17There	O
is	O
no	O
study	O
to	O
evaluate	O
vitamin	O
D	O
status	O
in	O
mothers	O
with	O
previous	O
GDM	O
,	O
and	O
present	O
oral	O
vitamin	O
D	O
products	O
are	O
not	O
fully	O
effective	O
,	O
16therefore	O
,	O
this	B
study	I
was	O
designed	B
to	B
evaluate	I
the	O
effect	O
of	O
intramuscular	O
injection	O
of	O
300	O
,	O
000	O
IU	O
during	O
a	O
three	O
-	O
month	O
period	O
.	O

The	O
parent	O
-	O
trial	O
was	O
subjected	O
to	O
the	O
scrutiny	O
of	O
an	O
independent	O
Data	O
Safety	O
and	O
Monitoring	O
Board	O
and	O
operated	O
under	O
the	O
auspices	O
of	O
Good	O
Clinical	O
Practice	O
guidelines	O
(	O
MRC	O
1999	O
).	O

On	O
the	O
other	O
hand	O
,	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
depression	O
in	O
non	O
-	O
pregnant	O
people	O
are	O
not	O
entirely	O
clear	O
.	O

In	O
pooled	O
data	O
of	O
different	O
sexes	O
(	O
cows	O
,	O
bulls	O
,	O
and	O
steers	O
)	O
of	O
Korean	O
cattle	O
,	O
MS	O
and	O
LM	O
area	O
increased	O
with	O
increasing	O
carcass	O
weight	O
from	O
143	O
to	O
536	O
kg	O
[	O
39	O
].	O

The	O
PBDE	O
μβestimate	O
was	O
-	O
4	O
g	O
,	O
95	O
%	O
CI	O
(-	O
31	O
,	O
22	O
).	O

Both	O
the	O
lack	O
of	O
receipt	O
of	O
clinical	O
guidance	O
and	O
the	O
recollection	O
of	O
inaccurate	O
information	O
observed	O
in	O
this	B
study	I
are	O
of	O
concern	O
because	O
receipt	O
of	O
provider	O
advice	O
has	O
been	O
shown	O
in	O
prior	O
work	O
to	O
be	O
the	O
most	O
important	O
predictor	O
of	O
a	O
woman	O
’	O
s	O
weight	O
gain	O
target	O
[	O
6	O
].	O

It	O
is	O
worth	O
noting	O
that	O
some	O
genomic	O
regions	O
escape	O
this	O
first	O
global	O
‘	O
reset	O
’,	O
including	O
imprinted	O
control	O
regions	O
(	O
ICRs	O
)	O
and	O
the	O
most	O
active	O
TEs	O
.	O

We	O
found	O
some	O
evidence	O
that	O
PFAS	O
,	O
DMP	O
and	O
Pb	O
were	O
associated	O
with	O
small	O
reductions	O
in	O
birth	O
weight	O
.	O

The	O
SNPs	O
included	O
in	O
this	O
analysis	O
were	O
chosen	O
based	O
on	O
findings	O
in	O
the	O
previous	O
GWAS	O
,	O
which	O
included	O
only	O
individuals	O
of	O
European	O
ancestry	O
(	O
8	O
).	O

Our	O
present	O
findings	O
indicate	O
a	O
reduction	O
in	O
activity	O
of	O
the	O
parasympathetic	O
ANS	O
associated	O
with	O
low	O
birth	O
weight	O
.	O

Two	O
hundred	O
and	O
seventy	O
(	O
69	O
.	O
9	O
%)	O
respondents	O
attended	O
ANC	O
at	O
the	O
health	O
centre	O
corresponding	O
to	O
their	O
catchment	O
health	O
area	O
while	O
30	O
.	O
1	O
%	O
attended	O
at	O
a	O
different	O
health	O
centre	O
out	O
of	O
their	O
catchment	O
health	O
area	O
(	O
Figure	O
2	O
).	O

Women	O
living	O
in	O
a	O
nursing	O
home	O
have	O
a	O
higher	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
than	O
in	O
free	O
-	O
living	O
women	O
,	O
39	O
.	O
8	O
%	O
compared	O
to	O
30	O
%,	O
respectively	O
[	O
13	O
].	O

Girls	O
who	O
ranked	O
themselves	O
at	O
the	O
low	O
end	O
of	O
school	O
social	O
status	O
were	O
69	O
%	O
more	O
likely	O
to	O
have	O
a	O
BMI	O
2	O
kg	O
/	O
m2higher	O
than	O
that	O
of	O
girls	O
of	O
higher	O
subjective	O
social	O
status	O
.	O

This	O
hospital	O
performs	O
approximately	O
85	O
%	O
of	O
all	O
obstetrical	O
deliveries	O
in	O
Providence	O
County	O
(	O
the	O
largest	O
population	O
center	O
in	O
Rhode	O
Island	O
)	O
and	O
approximately	O
74	O
%	O
of	O
all	O
deliveries	O
in	O
Rhode	O
Island	O
.	O

Food	O
intake	O
and	O
body	O
weight	O
of	O
the	O
dams	O
and	O
pups	O
were	O
3	O
–	O
4	O
days	O
per	O
week	O
and	O
/	O
or	O
weekly	O
measured	O
along	O
lactation	O
and	O
post	O
-	O
weaning	O
periods	O
(	O
infancy	O
,	O
adolescence	O
,	O
and	O
adulthood	O
).	O

However	O
,	O
folate	O
had	O
fewer	O
effects	O
on	O
the	O
hypothalamus	O
of	O
offspring	O
born	O
to	O
HV	O
dams	O
.	O

2	O
.	O
2	O
.	O
4	O
.	O

The	O
adequate	O
intake	O
of	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
lactation	O
is	O
unknown	O
,	O
although	O
it	O
appears	O
to	O
be	O
greater	O
than	O
the	O
current	O
dietary	O
recommendations	O
of	O
400	O
IU	O
/	O
d	O
or	O
10	O
µg	O
/	O
d	O
[	O
58	O
].	O

These	O
associations	O
were	O
strongest	O
in	O
nonsmokers	O
.	O
16	O
Caption	O
(	O
FIG	O
)	O
Lactation	O
support	O
includes	O
teaching	O
women	O
techniques	O
to	O
breastfeed	O
and	O
build	O
their	O
milk	O
supply	O
,	O
as	O
well	O
as	O
reassuring	O
them	O
of	O
their	O
ability	O
to	O
nourish	O
their	O
infants	O
.	O

Furthermore	O
,	O
there	O
are	O
new	O
therapeutic	O
approaches	O
under	O
validation	O
for	O
advanced	O
or	O
recurrent	O
disease46	O
-	O
48	O
.	O

Skin	O
color	O
and	O
modern	O
practices	O
of	O
cosmetic	O
dermatology	O
(	O
sun	O
tan	O
lotions	O
and	O
creams	O
,	O
etc	O
.)	O

[	O
37	O
–	O
41	O
].	O

The	O
mean	O
serum	O
cord	O
25	O
(	O
OH	O
)	O
D	O
values	O
for	O
each	O
group	O
were	O
22	O
.	O
3	O
±	O
9	O
.	O
4	O
ng	O
/	O
mL	O
for	O
Caucasian	O
and	O
16	O
.	O
4	O
±	O
6	O
.	O
5	O
ng	O
/	O
mL	O
for	O
Hispanic	O
infants	O
(	O
p	O
=	O
0	O
.	O
013	O
for	O
difference	O
).	O

Cancer	O
Causes	O
Control	O
15	O
(	O
6	O
):	O
559	O
–	O
570	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
(	O
25	O
-(	O
OH	O
)	O
D	O
)	O
concentrations	O
were	O
measured	O
by	O
radioimmunoassay	O
(	O
Diasorin	O
,	O
Stillwater	O
,	O
MN	O
,	O
USA	O
).	O

If	O
so	O
,	O
then	O
in	O
terms	O
of	O
policy	O
and	O
guidelines	O
,	O
it	O
is	O
hard	O
to	O
know	O
what	O
regimen	O
to	O
recommend	O
for	O
future	O
trials	O
,	O
given	O
that	O
clinical	O
practice	O
and	O
evidence	O
suggests	O
that	O
daily	O
or	O
weekly	O
supplementations	O
though	O
ideal	O
are	O
not	O
complied	O
with13	O
,	O
14and	O
are	O
impractical	O
for	O
families	O
,	O
especially	O
in	O
developing	O
countries	O
,	O
and	O
food	O
fortification	O
at	O
the	O
population	O
level	O
will	O
not	O
be	O
an	O
option	O
during	O
exclusive	O
breastfeeding	O
periods	O
(	O
aged	O
<	O
6	O
months	O
),	O
nor	O
is	O
it	O
likely	O
to	O
be	O
adequate	O
in	O
highly	O
deficient	O
populations	O
.	O

The	O
specimens	O
were	O
centrifuged	O
for	O
20	O
minutes	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

We	O
selected	O
infants	O
from	O
inner	O
-	O
city	O
Kabul	O
because	O
we	O
knew	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency12and	O
incidence	O
of	O
pneumonia3	O
,	O
15were	O
high	O
.	O

It	O
was	O
determined	O
that	O
both	O
maternal	O
race	O
and	O
marital	O
status	O
(	O
both	O
missing	O
for	O
215	O
/	O
943	O
,	O
22	O
.	O
7	O
%	O
of	O
baseline	O
participants	O
)	O
were	O
potentially	O
variables	O
that	O
were	O
differentially	O
missing	O
for	O
women	O
of	O
certain	O
racial	O
and	O
marital	O
statuses	O
.	O

Statistical	O
analyses	O
compared	O
cathelicidin	O
concentrations	O
with	O
concentrations	O
of	O
25	O
(	O
OH	O
)	O
D	O
at	O
various	O
time	O
points	O
(	O
maternal	O
levels	O
throughout	O
pregnancy	O
,	O
at	O
birth	O
,	O
and	O
child	O
’	O
s	O
current	O
level	O
);	O
and	O
with	O
race	O
/	O
ethnicity	O
,	O
age	O
,	O
gender	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
and	O
frequency	O
of	O
infections	O
using	O
Student	O
’	O
s	O
t	O
-	O
test	O
,	O
χ2	O
,	O
Wilcoxon	O
ranked	O
-	O
sum	O
analysis	O
,	O
and	O
multivariate	O
regression	O
.	O

LiST	O
is	O
a	O
free	O
and	O
widely	O
used	O
module	O
in	O
a	O
demographic	O
software	O
package	O
called	O
Spectrum	O
,	O
which	O
allows	O
the	O
user	O
to	O
compare	O
the	O
effects	O
of	O
different	O
interventions	O
on	O
the	O
numbers	O
of	O
maternal	O
,	O
neonatal	O
and	O
child	O
deaths	O
and	O
stillbirths	O
,	O
as	O
well	O
as	O
stunting	O
and	O
wasting	O
[	O
43	O
].	O

Trafficking	O
of	O
cells	O
could	O
therefore	O
be	O
responsible	O
for	O
the	O
passing	O
of	O
allergy	O
risk	O
from	O
mother	O
to	O
fetus	O
.	O

Whilst	O
the	O
latter	O
studies	O
were	O
not	O
specifically	O
performed	O
in	O
women	O
with	O
GDM	O
,	O
they	O
suggest	O
that	O
the	O
concept	O
of	O
GI	O
is	O
valid	O
in	O
pregnancy	O
,	O
and	O
it	O
would	O
be	O
appropriate	O
to	O
recommend	O
low	O
GI	O
carbohydrate	O
to	O
women	O
with	O
GDM	O
.	O

We	O
evaluated	B
growth	O
,	O
timing	O
of	O
reproductive	O
maturation	O
and	O
adult	O
ovarian	O
function	O
.	O

Although	O
essential	O
amino	O
acids	O
are	O
needed	O
for	O
growth	O
,	O
anabolic	O
and	O
developmental	O
processes	O
,	O
transcriptional	O
levels	O
of	O
genes	O
leading	O
to	O
degradation	O
of	O
those	O
dietary	O
valuable	O
compounds	O
is	O
forced	O
during	O
postnatal	O
development	O
in	O
LP	O
offspring	O
.	O

Study	O
also	O
has	O
shown	O
that	O
serum	O
25	O
-	O
OH	O
VitD2	O
detection	O
rate	O
is	O
less	O
than	O
5	O
%	O
in	O
China	O
[	O
4	O
].	O

Retinoic	O
acid	O
positively	O
regulates	O
growth	O
hormone	O
gene	O
expression	O
[	O
135	O
]	O
and	O
decreases	O
fat	O
deposition	O
and	O
IMF	O
in	O
steers	O
[	O
136	O
].	O

Many	O
pre	O
-	O
existing	O
chronic	O
conditions	O
and	O
medical	O
complications	O
of	O
pregnancy	O
may	O
result	O
in	O
increased	O
risk	O
of	O
preterm	O
delivery	O
,	O
such	O
as	O
pre	O
-	O
eclampsia	O
,	O
hypertension	O
,	O
aberrations	O
in	O
placentation	O
and	O
placental	O
growth	O
,	O
diabetes	O
and	O
infectious	O
diseases	O
.	O

Current	O
NICE	O
guidance	O
states	O
clearly	O
that	O
pregnant	O
women	O
are	O
informed	O
,	O
at	O
their	O
first	O
antenatal	O
booking	O
,	O
of	O
the	O
importance	O
of	O
adequate	O
vitamin	O
D	O
during	O
pregnancy	O
and	O
after	O
,	O
to	O
maintain	O
their	O
own	O
and	O
their	O
baby	O
'	O
s	O
health	O
.	O

Considering	O
that	O
exposure	O
to	O
SGA	O
monotherapy	O
was	O
not	O
associated	O
with	O
birth	O
defects	O
in	O
our	O
cohort	O
and	O
that	O
the	O
majority	O
of	O
pregnant	O
women	O
with	O
psychiatric	O
disorders	O
are	O
on	O
psychotropic	O
drug	O
polytherapy	O
,	O
research	O
on	O
the	O
reproductive	O
safety	O
of	O
these	O
medications	O
should	O
reflect	O
this	O
reality	O
.	O

Meanwhile	O
,	O
fewer	O
children	O
with	O
S	O
-	O
ECC	O
were	O
breastfed	O
compared	O
to	O
the	O
caries	O
-	O
free	O
group	O
(	O
p	O
<	O
0	O
.	O
001	O
).	O

Overall	O
,	O
for	O
approximately	O
half	O
of	O
the	O
participants	O
(	O
46	O
%)	O
the	O
baby	O
included	O
in	O
the	O
study	O
was	O
their	O
first	O
;	O
however	O
,	O
being	O
a	O
first	O
-	O
time	O
mother	O
was	O
more	O
frequent	O
among	O
those	O
vaccinated	O
than	O
unvaccinated	O
(	O
49	O
%	O
vs	O
.	O
43	O
%,	O
respectively	O
).	O

The	O
total	O
mean	O
was	O
19	O
.	O
4	O
±	O
3	O
.	O
9	O
ng	O
/	O
mL	O
[	O
56	O
].	O

Furthermore	O
,	O
the	O
median	O
age	O
of	O
miners	O
with	O
lung	O
cancer	O
was	O
44	O
years	O
,	O
compared	O
with	O
63	O
years	O
for	O
nonminers	O
with	O
other	O
cancers	O
.	O
18Decades	O
after	O
their	O
exposure	O
ended	O
,	O
standardized	O
mortality	O
ratios	O
and	O
relative	O
risks	O
for	O
lung	O
cancer	O
and	O
other	O
respiratory	O
problems	O
were	O
still	O
nearly	O
four	O
times	O
higher	O
in	O
Navajo	O
miners	O
than	O
in	O
nonminers	O
.	O
19	O
Community	O
Exposure	O
to	O
Uranium	O
Getting	O
the	O
ore	O
out	O
of	O
the	O
ground	O
was	O
only	O
the	O
first	O
step	O
in	O
a	O
long	O
process	O
.	O

Further	O
questions	O
arise	O
with	O
respect	O
to	O
the	O
previous	O
treatment	O
trial	O
in	O
the	O
same	O
region	O
of	O
Kabul	O
,	O
which	O
showed	O
that	O
a	O
single	O
high	O
-	O
dose	O
supplementation	O
with	O
100	O
000	O
IU	O
vitamin	O
D3given	O
orally	O
to	O
young	O
children	O
,	O
along	O
with	O
antibiotic	O
treatment	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
reduced	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
.	O
3The	O
inconsistent	O
results	O
could	O
be	O
related	O
to	O
the	O
evidence	O
that	O
stimulation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
macrophages	O
and	O
monocytes	O
by	O
bacterial	O
antigens	O
is	O
important	O
in	O
up	O
-	O
regulation	O
of	O
CYP27B1	O
and	O
the	O
vitamin	O
D	O
receptor	O
,	O
5which	O
are	O
crucial	O
in	O
production	O
of	O
cathelicidins	O
in	O
vitamin	O
-	O
D	O
-	O
depleted	O
individuals	O
.	O

For	O
the	O
GRs	O
,	O
significantly	O
higher	O
expression	O
levels	O
were	O
detected	O
only	O
for	O
GR	O
γ	O
and	O
GR	O
-	O
P	O
in	O
the	O
JEG	O
-	O
3	O
cells	O
compared	O
to	O
the	O
BeWo	O
cells	O
(	O
Figure	O
3	O
(	O
b	O
)).	O

Food	O
fortification	O
with	O
iron	O
has	O
thus	O
become	O
a	O
promising	O
approach	O
for	O
preventing	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
the	O
premise	O
that	O
modification	O
in	O
the	O
fetal	O
environment	O
could	O
alter	O
ANS	O
development	O
.	O

CT	O
revealed	O
a	O
Stanford	O
type	O
A	O
aortic	O
dissection	O
involving	O
the	O
ascending	O
and	O
descending	O
aorta	O
.	O

Supplementary	O
material10	O
.	O
1183	O
/	O
13993003	O
.	O
00073	O
-	O
2017	O
.	O
Supp1	O
Please	O
note	O
:	O
supplementary	O
material	O
is	O
not	O
edited	O
by	O
the	O
Editorial	O
Office	O
,	O
and	O
is	O
uploaded	O
as	O
it	O
has	O
been	O
supplied	O
by	O
the	O
author	O
.	O

Current	O
international	O
dietary	O
guidelines	O
advise	O
people	O
to	O
reduce	O
their	O
consumption	O
of	O
sugar	O
,	O
and	O
more	O
particularly	O
free	O
sugars	O
,	O
which	O
comprise	O
sugars	O
(	O
monosaccharides	O
and	O
disaccharides	O
)	O
added	O
to	O
foods	O
or	O
drinks	O
by	O
the	O
manufacturer	O
,	O
cook	O
or	O
consumer	O
,	O
and	O
sugars	O
naturally	O
present	O
in	O
honey	O
,	O
syrups	O
and	O
unsweetened	O
fruit	O
juices	O
[	O
4	O
].	O

A	O
comparison	O
of	O
the	O
maternal	O
characteristics	O
between	O
those	O
included	O
(	O
n	O
=	O
334	O
)	O
and	O
excluded	O
from	O
the	O
original	O
ROLO	O
study	O
is	O
included	O
in	O
Additional	O
file1	O
:	O
Table	O
S1	O
.	O

Risk	O
for	O
glioma	O
also	O
is	O
nearly	O
equal	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
individuals	O
but	O
higher	O
for	O
right	O
-	O
handers	O
.	O

Tissue	O
Collection	O
Whole	O
rat	O
brains	O
were	O
removed	O
rapidly	O
after	O
decapitation	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
and	O
immediately	O
frozen	O
on	O
dry	O
ice	O
,	O
and	O
then	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Discussion	O
Exposure	O
to	O
extended	O
winter	O
in	O
early	O
pregnancy	O
is	O
associated	O
with	O
increased	O
insulin	O
resistance	O
in	O
early	O
and	O
late	O
pregnancy	O
,	O
and	O
increased	O
fasting	O
glucose	O
in	O
late	O
pregnancy	O
,	O
independent	O
of	O
25OHD	O
status	O
.	O

Exposure	O
assessment	O
Data	O
on	O
maternal	O
diet	O
in	O
pregnancy	O
were	O
collected	O
by	O
a	O
food	O
frequency	O
questionnaire	O
(	O
FFQ	O
)	O
at	O
32	O
weeks	O
gestation	O
,	O
covering	O
all	O
the	O
main	O
foods	O
consumed	O
in	O
Britain	O
[	O
13	O
].	O

[	O
24	O
]	O
adjusted	O
for	O
both	O
maternal	O
and	O
child	O
diets	O
.	O

Regular	O
assessments	O
of	O
TSH	O
and	O
fT4	O
levels	O
every	O
6	O
/	O
8	O
weeks	O
during	O
pregnancy	O
and	O
breast	O
-	O
feeding	O
are	O
required	O
to	O
ensure	O
an	O
adequate	O
dose	O
of	O
levothyroxine	O
.	O

However	O
,	O
when	O
LMP	O
was	O
determined	O
to	O
be	O
unreliable	O
,	O
we	O
calculated	O
gestational	O
age	O
at	O
delivery	O
using	O
data	O
from	O
an	O
ultrasound	O
.	O

We	O
re	O
-	O
analysed	O
a	O
subsample	O
of	O
77	O
samples	O
and	O
verified	O
the	O
correction	O
(	O
adjusted	O
R2	O
=	O
0	O
.	O
922	O
,	O
SEE	O
=	O
9	O
.	O
2	O
nmol	O
/	O
l	O
).	O

Studies	O
suggest	O
that	O
children	O
who	O
are	O
exposed	O
to	O
food	O
advertisements	O
eat	O
more	O
.	O

The	O
brains	O
were	O
thawed	O
on	O
ice	O
and	O
the	O
right	O
and	O
left	O
sides	O
of	O
the	O
hypothalamus	O
were	O
dissected	O
separately	O
using	O
the	O
method	O
described	O
previously	O
.	O
14The	O
optic	O
chiasma	O
was	O
used	O
as	O
demarcation	O
for	O
the	O
anterior	O
part	O
of	O
the	O
hypothalamus	O
.	O

In	O
contrast	O
to	O
BMP7	O
and	O
BMP8B	O
,	O
BMP4	O
was	O
shown	O
to	O
promote	O
the	O
differentiation	O
of	O
mesenchymal	O
stem	O
cells	O
into	O
white	O
adipocytes	O
,	O
inducing	O
fat	O
storage	O
and	O
decreasing	O
energy	O
expenditure	O
in	O
rodents	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Ethical	O
considerations	O
The	O
study	O
was	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
the	O
“	O
Grigore	O
T	O
.	O
Popa	O
”	O
University	O
of	O
Medicine	O
and	O
Pharmacy	O
in	O
Iaşi	O
and	O
permission	O
to	O
administer	O
the	O
questionnaires	O
was	O
received	O
from	O
the	O
Cuza	O
-	O
Vodă	O
Obstetrics	O
and	O
Gynaecology	O
Clinical	O
Hospital	O
.	O

Vitamin	O
D	O
status	O
and	O
GDM	O
In	O
our	O
cohort	O
GDM	O
was	O
present	O
in	O
81	O
of	O
the	O
723	O
women	O
(	O
11	O
%).	O

Methods	O
Serum	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
(	O
25	O
(	O
OH	O
)	O
D	O
)	O
was	O
measured	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
in	O
2800	O
women	O
from	O
Adelaide	O
and	O
Auckland	O
who	O
participated	O
in	O
the	O
multi	O
-	O
centre	O
,	O
prospective	O
cohort	O
SCreening	O
fOr	O
Pregnancy	O
Endpoints	O
(	O
SCOPE	O
)	O
study	O
.	O

Background	O
Early	O
Childhood	O
Caries	O
(	O
ECC	O
)	O
is	O
the	O
most	O
common	O
chronic	O
disease	O
of	O
childhood	O
and	O
is	O
defined	O
as	O
any	O
decay	O
in	O
the	O
primary	O
dentition	O
of	O
children	O
<	O
72	O
months	O
of	O
age	O
[	O
1	O
,	O
2	O
].	O

In	O
addition	O
,	O
it	O
is	O
found	O
very	O
useful	O
in	O
developing	O
countries	O
where	O
the	O
rate	O
of	O
compliance	O
with	O
preventive	O
treatment	O
of	O
iron	O
is	O
poor	O
[	O
4	O
].	O

Black	O
infants	O
had	O
3	O
.	O
6	O
greater	O
adjusted	O
odds	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
2	O
.	O
4	O
,	O
5	O
.	O
6	O
)	O
of	O
vitamin	O
D	O
deficiency	O
when	O
compared	O
with	O
white	O
infants	O
.	O

Studies	O
focused	O
on	O
high	O
-	O
risk	O
populations	O
,	O
for	O
example	O
,	O
veiled	O
,	O
dark	O
-	O
skinned	O
or	O
obese	O
women	O
in	O
Australia	O
and	O
New	O
Zealand	O
,	O
report	O
between	O
50	O
and	O
94	O
%	O
of	O
women	O
to	O
be	O
vitamin	O
D	O
deficient	O
[	O
8	O
–	O
10	O
].	O

In	O
both	O
models	O
,	O
we	O
observed	O
a	O
trend	O
whereby	O
the	O
later	O
in	O
pregnancy	O
a	O
women	O
received	O
vaccination	O
the	O
lower	O
her	O
adjusted	O
odds	O
of	O
PTB	O
.	O

This	O
process	O
is	O
active	O
and	O
specific	O
,	O
much	O
like	O
the	O
process	O
of	O
sensitization	O
[	O
119	O
].	O

Twelve	O
weeks	O
after	O
the	O
administration	O
of	O
a	O
single	O
dose	O
of	O
300	O
,	O
000	O
IU	O
of	O
vitamin	O
D	O
,	O
this	O
figure	O
was	O
4	O
.	O
2	O
%	O
and	O
71	O
.	O
4	O
%	O
for	O
the	O
IG	O
and	O
CG	O
,	O
respectively	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

In	O
total	O
we	O
found	O
13	O
,	O
357	O
probe	O
-	O
sets	O
expressed	O
within	O
94	O
dpc	O
and	O
1	O
dpn	O
(	O
1	O
dpn	O
and	O
28	O
dpn	O
:	O
13	O
,	O
259	O
;	O
28	O
dpn	O
and	O
188	O
dpn	O
:	O
12	O
,	O
637	O
)	O
according	O
to	O
MAS5	O
analysis	O
(	O
Table1	O
).	O

Specifically	O
,	O
Bonferroni	O
analysis	O
indicated	O
that	O
RC	O
males	O
also	O
displayed	O
higher	O
body	O
weight	O
than	O
CC	O
males	O
in	O
several	O
weeks	O
of	O
the	O
post	O
-	O
weaning	O
period	O
that	O
comprise	O
the	O
adulthood	O
(	O
postnatal	O
weeks	O
15	O
–	O
18	O
and	O
postnatal	O
week	O
19	O
).	O

We	O
will	O
also	O
exclude	O
three	O
Upazilas	O
from	O
Gazipur	O
because	O
of	O
the	O
high	O
number	O
of	O
garment	O
industries	O
,	O
which	O
would	O
have	O
high	O
numbers	O
of	O
working	O
women	O
and	O
would	O
be	O
difficult	O
to	O
follow	O
-	O
up	O
and	O
eight	O
Upazilas	O
from	O
Mymensingh	O
because	O
of	O
the	O
high	O
prevalence	O
of	O
malaria	O
and	O
kalazar	O
.	O

We	O
only	O
found	O
a	O
difference	O
between	O
RC	O
and	O
CC	O
female	O
offspring	O
at	O
PND	O
20	O
.	O

Atopy	O
For	O
newborns	O
at	O
suspected	O
risk	O
for	O
atopy	O
,	O
that	O
is	O
,	O
with	O
a	O
history	O
of	O
atopy	O
/	O
allergy	O
in	O
a	O
first	O
-	O
degree	O
relative	O
(	O
parents	O
,	O
siblings	O
),	O
exposure	O
to	O
irritating	O
air	O
pollutants	O
and	O
airborne	O
allergens	O
such	O
as	O
molds	O
should	O
be	O
minimized	O
.	O

Results	O
from	O
a	O
review	O
of	O
several	O
randomized	O
clinical	O
trials	O
of	O
PUFA	O
treatment	O
of	O
schizophrenia	O
were	O
inconclusive	O
,	O
although	O
,	O
it	O
seems	O
that	O
supplementation	O
of	O
especially	O
EPA	O
to	O
these	O
patients	O
may	O
have	O
a	O
positive	O
effect	O
on	O
their	O
schizophrenic	O
symptoms	O
[	O
17	O
].	O

Fenton	O
and	O
colleagues	O
have	O
shown	O
that	O
gestational	O
exposure	O
to	O
PFOA	O
altered	O
the	O
normal	O
formation	O
of	O
the	O
milk	O
duct	O
system	O
in	O
mice	O
.	O
26In	O
a	O
multigenerational	O
mouse	O
follow	O
-	O
up	O
study	O
,	O
they	O
showed	O
that	O
PFOA	O
exposure	O
not	O
only	O
impaired	O
the	O
mouse	O
mothers	O
’	O
ability	O
to	O
lactate	O
,	O
but	O
also	O
adversely	O
affected	O
prenatal	O
development	O
of	O
the	O
mammary	O
gland	O
in	O
their	O
female	O
offspring	O
.	O

The	O
obtained	O
factors	O
are	O
linear	O
combinations	O
of	O
the	O
included	O
variables	O
,	O
explaining	O
as	O
much	O
variation	O
in	O
the	O
original	O
variables	O
as	O
possible	O
.	O

3	O
.	O
3	O
.	O

Oka	O
[	O
134	O
]	O
recommended	O
that	O
vitamin	O
A	O
-	O
deficient	O
levels	O
not	O
fall	O
below	O
30	O
IU	O
/	O
dL	O
to	O
enhance	O
MS	O
and	O
maintain	O
health	O
.	O

Differences	O
markedly	O
less	O
than	O
are	O
less	O
likely	O
to	O
be	O
biologically	O
relevant	O
and	O
this	B
study	I
was	O
not	O
designed	O
to	O
identify	O
small	O
differences	O
.	O

This	O
study	O
is	O
one	O
of	O
the	O
first	O
to	B
prospectively	O-
examine	I
impacts	O
of	O
prenatal	O
diet	O
,	O
physical	O
activity	O
,	O
and	O
psychosocial	O
exposures	O
on	O
offspring	O
weight	O
outcomes	O
in	O
a	O
diverse	O
sample	O
.	O

Offspring	O
biometry	O
Body	O
mass	O
(	O
Figures	O
1and2	O
)	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0041740	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Body	O
mass	O
evolution	O
in	O
both	O
the	O
F1	O
and	O
F2	O
generations	O
at	O
earlier	O
stages	O
of	O
development	O
.	O

The	O
association	O
between	O
diet	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risks	O
(	O
RR	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
and	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
.	O

The	O
EPDS	O
is	O
a	O
10	O
-	O
item	O
scale	O
assessing	O
depressive	O
symptoms	O
experienced	O
in	O
the	O
past	O
7	O
days	O
[	O
51	O
],	O
which	O
has	O
been	O
validated	O
for	O
assessing	O
perinatal	O
depression	O
in	O
African	O
settings	O
,	O
including	O
South	O
Africa	O
[	O
52	O
].	O

Participants	O
with	O
an	O
energy	O
intake	O
outside	O
the	O
first	O
(	O
2261	O
kJ	O
/	O
d	O
)	O
and	O
99th	O
(	O
12	O
335	O
kJ	O
/	O
d	O
)	O
percentiles	O
were	O
excluded	O
from	O
the	O
analysis	O
(	O
n	O
=	O
687	O
).	O

Antidepressants	O
were	O
most	O
frequently	O
used	O
in	O
conjunction	O
with	O
an	O
SGA	O
(	O
54	O
.	O
1	O
%),	O
followed	O
by	O
benzodiazepines	O
(	O
15	O
.	O
8	O
%)	O
and	O
anticonvulsants	O
(	O
14	O
.	O
3	O
%),	O
primarily	O
lamotrigine	O
(	O
table	O
1	O
).	O

In	O
Finland	O
,	O
Baum	O
et	O
al	O
.	O

But	O
,	O
adjustment	O
for	O
multivitamin	O
supplement	O
intake	O
,	O
containing	O
vitamin	O
D	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Discussion	O
These	O
data	O
demonstrate	B
that	O
intrauterine	O
,	O
lactational	O
and	O
post	O
-	O
weaning	O
nutritional	O
histories	O
make	O
differential	O
contributions	O
to	O
the	O
age	O
of	O
puberty	O
in	O
the	O
female	O
rat	O
,	O
and	O
lead	O
to	O
persistent	O
effects	O
on	O
ovarian	O
function	O
extending	O
into	O
adulthood	O
.	O

No	O
prior	O
studies	O
have	O
specifically	O
examined	O
impacts	O
of	O
maternal	O
intake	O
of	O
sweets	O
or	O
soft	O
drinks	O
in	O
pregnancy	O
on	O
offspring	O
weight	O
parameters	O
.	O

[	O
36	O
]	O
also	O
observed	O
a	O
negative	O
correlation	O
between	O
birth	O
weight	O
and	O
heart	O
rate	O
in	O
response	O
to	O
psychological	O
stress	O
in	O
women	O
.	O

The	O
mechanism	O
of	O
PTH	O
reduction	O
is	O
that	O
an	O
increased	O
serum	O
vitamin	O
D	O
leads	O
to	O
a	O
decrease	O
in	O
PTH	O
gene	O
translation	O
,	O
and	O
thus	O
PTH	O
secretion	O
.	O

Our	O
results	O
showed	O
several	O
factors	O
to	O
be	O
significant	O
,	O
including	O
BMI	O
at	O
delivery	O
,	O
pre	O
-	O
eclampsia	O
,	O
Medicaid	O
status	O
(	O
as	O
a	O
measure	O
of	O
socioeconomic	O
status	O
)	O
and	O
prenatal	O
vitamin	O
use	O
.	O

This	B
supplement	O
identifies	O
risks	O
for	O
preterm	O
birth	O
and	O
the	O
solutions	O
needed	O
to	O
reduce	O
those	O
risks	O
across	O
the	O
RMNCH	O
continuum	O
;	O
yet	O
for	O
many	O
of	O
these	O
risks	O
,	O
we	O
do	O
not	O
have	O
effective	O
solutions	O
.	O

The	O
prevalence	O
of	O
vitamin	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
is	O
high	O
in	O
many	O
European	O
countries	O
[	O
36	O
]–[	O
43	O
]	O
and	O
some	O
studies	O
suggest	O
that	O
pregnant	O
women	O
in	O
Europe	O
are	O
also	O
at	O
high	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
29	O
],[	O
30	O
].	O

Thyroid	O
hormones	O
(	O
thyroid	O
stimulating	O
hormone	O
,	O
thyroglobulin	O
,	O
total	O
thyroxine	O
)	O
will	O
be	O
determined	O
in	O
whole	O
blood	O
spots	O
by	O
using	O
electrochemiluminescence	O
immunoassays	O
.	O

To	O
calculate	O
individual	O
food	O
intake	O
when	O
animals	O
were	O
housed	O
in	O
groups	O
,	O
total	O
food	O
intake	O
from	O
each	O
cage	O
was	O
measured	O
and	O
equally	O
divided	O
according	O
to	O
the	O
number	O
of	O
pups	O
per	O
cage	O
.	O

Elevated	O
folate	O
levels	O
in	O
the	O
brain	O
and	O
plasma	O
at	O
maturity	O
confirmed	O
the	O
folate	O
content	O
of	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
,	O
and	O
importantly	O
,	O
revealed	O
that	O
the	O
brain	O
responds	O
to	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Uterine	O
Myomas	O
Last	O
year	O
gave	O
us	O
a	O
new	O
insight	O
on	O
VD	O
-	O
related	O
gene	O
polymorphism	O
and	O
the	O
risk	O
of	O
uterine	O
myomas	O
(	O
UM	O
).	O

A	O
relatively	O
low	O
proportion	O
of	O
women	O
in	O
our	O
study	O
used	O
iron	O
supplements	O
(	O
45	O
.	O
3	O
%),	O
although	O
these	O
are	O
provided	O
free	O
of	O
charge	O
to	O
women	O
after	O
the	O
16thweek	O
of	O
pregnancy	O
.	O

Materials	O
and	O
methods	O
Cross	O
-	O
sectional	O
study	O
of	O
76	O
pregnant	O
women	O
who	O
were	O
referred	O
to	O
a	O
multidisciplinary	O
clinic	O
for	O
high	O
risk	O
pregnancies	O
,	O
in	O
a	O
tertiary	O
hospital	O
in	O
southern	O
Brazil	O
,	O
at	O
the	O
time	O
of	O
GDM	O
diagnosis	O
.	O

Fifteen	O
(	O
62	O
.	O
5	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
moderate	O
vitamin	O
D	O
deficiency	O
,	O
which	O
decreased	O
to	O
zero	O
after	O
the	O
intervention	O
(	O
table	O
3	O
).	O

Based	O
on	O
the	O
main	O
effects	O
on	O
adiposity	O
,	O
the	O
perirenal	O
fat	O
was	O
considered	O
the	O
most	O
suitable	O
adipose	O
tissue	O
for	O
gene	O
expression	O
analysis	O
.	O

We	O
recommended	O
handwashing	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
after	O
fecal	O
contact	O
,	O
and	O
before	O
food	O
preparation	O
.	O

Preterm	O
birth	O
is	O
not	O
a	O
single	O
condition	O
,	O
but	O
a	O
single	O
outcome	O
(	O
birth	O
before	O
37	O
completed	O
weeks	O
)	O
due	O
to	O
multiple	O
causes	O
.	O

Differences	O
in	O
25	O
(	O
OH	O
)	O
D	O
between	O
Hispanic	O
and	O
Caucasian	O
infants	O
may	O
be	O
related	O
to	O
lifestyle	O
including	O
sunshine	O
exposure	O
.	O

Considerable	O
controversy	O
still	O
exists	O
over	O
the	O
optimal	O
extent	O
of	O
primary	O
surgical	O
resection	O
.	O

However	O
,	O
Burgaz	O
et	O
al	O
.	O

Thus	O
,	O
both	O
maternal	O
underfeeding	O
or	O
overfeeding	O
were	O
reported	O
to	O
exert	O
a	O
predisposing	O
effect	O
for	O
the	O
development	O
of	O
later	O
obesity	O
(	O
Breton	O
,	O
2013	O
).	O

Global	O
methylation	O
status	O
of	O
hypothalamic	O
genomic	O
DNA	O
was	O
determined	O
by	O
the	O
in	O
vitro	O
methyl	O
acceptance	O
assay	O
method	O
as	O
described	O
previously	O
.	O
18	O
,	O
19This	O
assay	O
involves3H	O
-	O
methyl	O
-	O
S	O
-	O
adenosylmethionine	O
(	O
New	O
England	O
Nuclear	O
,	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
as	O
a	O
methyl	O
donor	O
mediated	O
by	O
Sss1	O
DNA	O
methyltransferase	O
(	O
New	O
England	O
Biolabs	O
,	O
Pickering	O
,	O
ON	O
,	O
Canada	O
).	O

Fish	O
Intake	O
during	O
Pregnancy	O
and	O
Foetal	O
Neurodevelopment	O
—	O
A	O
Systematic	O
Review	O
of	O
the	O
Evidence	O
Abstract	O
Fish	O
is	O
a	O
source	O
of	O
several	O
nutrients	O
that	O
are	O
important	O
for	O
healthy	O
foetal	O
development	O
.	O

Birth	O
weight	O
,	O
gestational	O
age	O
,	O
and	O
preterm	O
birth	O
may	O
correlate	O
with	O
autism	O
and	O
intellectual	O
disabilities	O
.	O

This	O
finding	O
was	O
not	O
explained	O
solely	O
by	O
social	O
ties	O
between	O
people	O
who	O
were	O
already	O
obese	O
.	O

Further	O
study	O
is	O
necessary	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
C	O
on	O
MS	O
and	O
QG	O
in	O
other	O
breeds	O
of	O
beef	O
cattle	O
.	O

Many	O
studies	O
have	O
shown	O
that	O
those	O
born	O
in	O
winter	O
and	O
spring	O
have	O
a	O
significantly	O
increased	O
risk	O
of	O
developing	O
schizophrenia	O
[	O
2	O
],	O
and	O
that	O
those	O
born	O
at	O
higher	O
latitudes	O
are	O
also	O
at	O
increased	O
risk	O
of	O
schizophrenia	O
[	O
3	O
].	O

Previously	O
we	O
explored	O
the	O
genomic	O
and	O
proteomic	O
characteristics	O
of	O
frontal	O
cortex	O
and	O
the	O
hippocampus	O
in	O
the	O
adult	O
DVD	O
rat	O
[	O
18	O
],[	O
19	O
].	O

Dietary	O
sources	O
of	O
vitamin	O
D	O
include	O
:	O
Fatty	O
fish	O
species	O
,	O
such	O
as	O
Catfish	O
,	O
Salmon	O
,	O
Mackerel	O
,	O
Tuna	O
etc	O
.,	O
egg	O
,	O
beef	O
and	O
fish	O
liver	O
oils	O
.	O

However	O
,	O
they	O
suggested	O
that	O
this	O
applied	O
only	O
in	O
developed	O
countries	O
and	O
when	O
no	O
adjustments	O
for	O
confounders	O
were	O
made	O
[	O
6	O
].	O

Those	O
homes	O
where	O
the	O
carer	O
or	O
infant	O
was	O
absent	O
were	O
revisited	O
again	O
within	O
4	O
weeks	O
of	O
the	O
recruitment	O
period	O
.	O

Associations	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
We	O
separately	O
assessed	B
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
infant	O
gut	O
microbiome	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

Sources	O
of	O
vitamin	O
D	O
The	O
most	O
important	O
source	O
of	O
vitamin	O
D	O
is	O
the	O
skin	O
'	O
s	O
synthesis	O
of	O
the	O
vitamin	O
from	O
sunlight	O
.	O

Pregnancy	O
does	O
not	O
seem	O
to	O
be	O
compromised	O
by	O
thyroid	O
cancer	O
.	O

He	O
also	O
suggests	O
that	O
if	O
a	O
lactating	O
mother	O
were	O
informed	O
of	O
the	O
contaminant	O
levels	O
in	O
her	O
milk	O
,	O
she	O
may	O
be	O
scared	O
to	O
continue	O
breastfeeding	O
or	O
even	O
discouraged	O
from	O
doing	O
so	O
by	O
her	O
healthcare	O
provider	O
.	O

Conclusions	O
Iron	O
deficiency	O
remains	O
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

Analyses	O
were	O
performed	O
to	O
test	O
for	O
effect	O
modification	O
by	O
maternal	O
BMI	O
category	O
.	O

classified	O
childhood	O
wheezing	O
into	O
four	O
distinct	O
phenotypes	O
:	O
no	O
wheezing	O
,	O
transient	O
early	O
wheezing	O
,	O
late	O
-	O
onset	O
wheezing	O
,	O
and	O
persistent	O
wheezing	O
[	O
16	O
].	O

The	O
ECS	O
keeps	O
a	O
homeostatic	O
role	O
in	O
regulating	O
energy	O
balance	O
and	O
food	O
intake	O
(	O
Cristino	O
et	O
al	O
.,	O
2014	O
),	O
and	O
its	O
overactivation	O
,	O
mainly	O
via	O
CB1	O
receptors	O
,	O
favors	O
the	O
energy	O
accumulation	O
,	O
increases	O
the	O
appetite	O
for	O
highly	O
palatable	O
foods	O
,	O
decreases	O
the	O
satiety	O
and	O
reduces	O
the	O
energy	O
expenditure	O
.	O

In	O
addition	O
,	O
a	O
recent	O
meta	O
-	O
analysis	O
found	O
a	O
strong	O
association	O
between	O
receipt	O
of	O
influenza	O
vaccination	O
and	O
reduced	O
likelihood	O
of	O
PTB	O
and	O
LBW	O
,	O
and	O
the	O
magnitude	O
of	O
the	O
association	O
that	O
Nunes	O
et	O
al	O
.	O

Thyroid	O
hormones	O
are	O
major	O
factors	O
for	O
the	O
normal	O
development	O
of	O
foetal	O
brain	O
,	O
and	O
until	O
the	O
end	O
of	O
the	O
first	O
trimester	O
,	O
when	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
thyroid	O
axis	O
becomes	O
functional	O
,	O
the	O
foetal	O
brain	O
is	O
strictly	O
dependent	O
on	O
local	O
deiodination	O
of	O
maternal	O
thyroxine7	O
-	O
12	O
.	O

Therefore	O
,	O
these	O
three	O
subjects	O
were	O
included	O
in	O
the	O
analysis	O
.	O

At	O
the	O
time	O
of	O
enrolment	O
,	O
we	O
will	O
assign	O
each	O
mother	O
a	O
box	O
consisting	O
of	O
8	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

Although	O
,	O
the	O
point	O
estimates	O
indicated	O
a	O
marginal	O
increased	O
risk	O
for	O
developing	O
any	O
pregnancy	O
complication	O
with	O
severe	O
(<	O
25	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
those	O
who	O
had	O
levels	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
(	O
aRR	O
:	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
).	O

A	O
parallel	O
increase	O
in	O
BAT	O
activity	O
and	O
cold	O
-	O
induced	O
energy	O
expenditure	O
was	O
also	O
observed	O
in	O
response	O
to	O
acute	O
cold	O
exposure	O
in	O
subjects	O
with	O
low	O
BAT	O
activity	O
,	O
demonstrating	O
the	O
possible	O
occurrence	O
of	O
BAT	O
recruitment	O
in	O
humans	O
(	O
Yoneshiro	O
et	O
al	O
.,	O
2013	O
).	O

In	O
a	O
four	O
-	O
arm	O
cluster	O
-	O
randomized	O
controlled	O
trial	O
in	O
Pakistan	O
investigating	O
the	O
neonatal	O
mortality	O
effects	O
of	O
umbilical	O
cord	O
cleansing	O
with	O
chlorhexidine	O
and	O
handwashing	O
with	O
soap	O
promotion	O
separately	O
and	O
together	O
,	O
Soofi	O
and	O
colleagues	O
found	O
no	O
benefit	O
from	O
promoting	O
handwashing	O
with	O
soap	O
[	O
9	O
].	O

Making	O
more	O
than	O
four	O
prenatal	O
visits	O
was	O
also	O
associated	O
with	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
intake	O
,	O
a	O
positive	O
association	O
that	O
persisted	O
after	O
adjusting	O
for	O
socio	O
-	O
demographic	O
factors	O
(	O
Table	O
5	O
).	O

The	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
)	O
was	O
significantly	O
lower	O
among	O
third	O
than	O
first	O
trimester	O
pregnant	O
women	O
(	O
Table	O
5	O
).	O

For	O
example	O
,	O
the	O
fact	O
that	O
prenatal	O
folate	O
supplementation	O
substantially	O
reduces	O
the	O
risk	O
of	O
neural	O
tube	O
defect	O
only	O
if	O
it	O
is	O
taken	O
preconceptually	O
is	O
well	O
known	O
but	O
improving	O
vitamin	O
A	O
status	O
before	O
pregnancy	O
has	O
also	O
been	O
shown	O
to	O
have	O
a	O
dramatic	O
and	O
as	O
yet	O
unexplained	O
effect	O
on	O
maternal	O
morbidity	O
and	O
mortality	O
(	O
West	O
et	O
al	O
1999	O
).	O

F1	O
-	O
VitD	O
-	O
offspring	O
were	O
weaker	O
than	O
the	O
F1	O
-	O
SC	O
offspring	O
.	O

With	O
evidence	O
of	O
the	O
program	O
'	O
s	O
positive	O
impact	O
on	O
women	O
'	O
s	O
iron	O
status	O
the	O
weekly	O
supplement	O
program	O
with	O
twice	O
-	O
yearly	O
de	O
-	O
worming	O
was	O
scaled	O
up	O
to	O
province	O
level	O
(	O
with	O
an	O
estimated	O
target	O
group	O
of	O
250	O
,	O
000	O
women	O
of	O
reproductive	O
age	O
)	O
commencing	O
March	O
2008	O
.	O

If	O
adequate	O
amounts	O
of	O
vitamin	O
D	O
prevent	O
autism	O
,	O
one	O
would	O
expect	O
children	O
with	O
rickets	O
to	O
have	O
an	O
increased	O
risk	O
of	O
autism	O
.	O

Multicollinearity	O
was	O
evaluated	O
using	O
variance	O
inflation	O
factor	O
(	O
VIF	O
)	O
and	O
significance	O
level	O
was	O
set	O
at	O
P	O
<	O
0	O
.	O
05	O
.	O

A	O
study	O
of	O
15	O
,	O
390	O
Brazilian	O
students	O
was	O
unable	O
to	O
detect	O
a	O
difference	O
in	O
the	O
season	O
of	O
birth	O
between	O
right	O
-	O
and	O
left	O
-	O
handers	O
.	O

Additionally	O
,	O
there	O
have	O
been	O
studies	O
that	O
used	O
combinations	O
of	O
mobile	O
phone	O
and	O
other	O
new	O
technologies	O
for	O
weight	O
control	O
and	O
found	O
positive	O
effects	O
[	O
18	O
].	O

The	O
mean	O
body	O
weight	O
and	O
body	O
length	O
at	O
birth	O
were	O
3	O
.	O
0	O
±	O
0	O
.	O
6	O
kg	O
and	O
48	O
.	O
4	O
±	O
9	O
.	O
9	O
cm	O
respectively	O
.	O

A	O
70	O
%	O
lower	O
risk	O
of	O
PTB	O
was	O
found	O
for	O
women	O
≥	O
20	O
ng	O
/	O
mL	O
vs	O
.	O
<	O
20	O
ng	O
/	O
mL	O
in	O
a	O
study	O
by	O
Perez	O
-	O
Ferre	O
et	O
al	O
.	O

Note	O
that	O
confidence	O
intervals	O
for	O
beta	O
coefficients	O
from	O
LASSO	O
and	O
Elastic	O
Net	O
are	O
not	O
available	O
using	O
standard	O
software	O
,	O
and	O
calculating	O
standard	O
errors	O
for	O
parameter	O
estimates	O
is	O
challenging	O
because	O
the	O
shrinkage	O
estimation	O
produces	O
biased	O
estimates	O
for	O
large	O
coefficients	O
.	O

These	O
CpG	O
rich	O
CGIs	O
are	O
non	O
-	O
randomly	O
distributed	O
throughout	O
the	O
mammalian	O
genome	O
,	O
being	O
predominantly	O
associated	O
with	O
regulatory	O
elements	O
such	O
as	O
promoters	O
(	O
Deaton	O
&	O
Bird2011	O
).	O

To	O
explore	O
relationships	O
between	O
race	O
,	O
vitamin	O
D	O
levels	O
and	O
SGA	O
,	O
we	O
first	O
evaluated	B
race	O
as	O
a	O
predictor	O
of	O
vitamin	O
D	O
levels	O
(	O
sufficient	O
or	O
deficient	O
)	O
in	O
cord	O
blood	O
and	O
assessed	B
for	O
potential	O
confounders	O
:	O
Medicaid	O
status	O
,	O
BMI	O
at	O
delivery	O
,	O
hypertension	O
,	O
maternal	O
age	O
and	O
prenatal	O
vitamin	O
use	O
.	O

)—	O
High	O
Frequency	O
in	O
Normalized	O
Units	O
.	O

Caregivers	O
completed	O
a	O
questionnaire	O
administered	O
by	O
staff	O
which	O
collected	O
information	O
about	O
the	O
child	O
and	O
caregiver	O
,	O
dietary	O
intakes	O
,	O
use	O
of	O
supplements	O
,	O
sun	O
exposure	O
and	O
skin	O
pigmentation	O
,	O
oral	O
hygiene	O
behaviours	O
,	O
and	O
socioeconomic	O
factors	O
including	O
household	O
income	O
,	O
parental	O
education	O
level	O
,	O
and	O
receipt	O
of	O
government	O
assistance	O
[	O
12	O
].	O

Acetate	O
or	O
glucose	O
is	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
[	O
85	O
].	O

In	O
the	O
second	O
trimester	O
,	O
blood	O
volume	O
increases	O
by	O
45	O
%	O
with	O
an	O
increase	O
in	O
plasma	O
volume	O
of	O
50	O
%;	O
red	O
cell	O
mass	O
is	O
raised	O
by	O
35	O
%	O
which	O
amounts	O
to	O
about	O
450	O
mg	O
of	O
iron	O
in	O
a	O
55	O
kg	O
woman	O
[	O
4	O
].	O

We	O
assessed	O
differences	O
between	O
the	O
study	O
arms	O
,	O
with	O
respect	O
to	O
observed	O
handwashing	O
with	O
soap	O
among	O
other	O
family	O
members	O
interacting	O
with	O
the	O
neonate	O
.	O

Conclusions	O
In	O
summary	O
,	O
we	O
have	O
demonstrated	O
that	O
in	O
the	O
rat	O
,	O
pre	O
-	O
and	O
postnatal	O
nutritional	O
histories	O
together	O
influence	O
both	O
ovarian	O
function	O
and	O
the	O
tempo	O
of	O
reproductive	O
maturation	O
in	O
female	O
offspring	O
.	O

Background	O
:	O
Since	O
classical	O
development	O
of	O
medicine	O
in	O
1920	O
,	O
Vitamin	O
D	O
(	O
cholecalciferol	O
,	O
VD	O
)	O
was	O
strongly	O
associated	O
with	O
rickets	O
,	O
after	O
observation	O
that	O
cod	O
liver	O
consumption	O
leads	O
to	O
a	O
regression	O
in	O
rickets	O
symptoms	O
[	O
3	O
].	O

Serum	O
levels	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
reflects	O
the	O
body	O
’	O
s	O
vitamin	O
D	O
reserves	O
and	O
this	O
is	O
a	O
well	O
-	O
known	O
indicator	O
for	O
examining	O
vitamin	O
D	O
status	O
[	O
15	O
].	O

The	O
neonates	O
in	O
the	O
exposed	O
and	O
comparison	O
groups	O
did	O
not	O
differ	O
in	O
birth	O
weight	O
or	O
in	O
the	O
proportion	O
of	O
those	O
who	O
were	O
small	O
for	O
gestational	O
age	O
(<	O
10th	O
centile	O
).	O

On	O
initial	O
presentation	O
,	O
her	O
BP	O
was	O
94	O
/	O
30	O
mmHg	O
,	O
heart	O
rate	O
71	O
beats	O
/	O
min	O
,	O
respiratory	O
rate	O
16	O
breaths	O
/	O
min	O
,	O
oxygen	O
saturation	O
99	O
%	O
on	O
room	O
air	O
,	O
and	O
temperature	O
of	O
95	O
.	O
3	O
°	O
F	O
(	O
35	O
.	O
1	O
°	O
C	O
).	O

Long	O
-	O
Term	O
Effects	O
of	O
Prenatal	O
Exposure	O
to	O
Undernutrition	O
on	O
Cannabinoid	O
Receptor	O
-	O
Related	O
Behaviors	O
:	O
Sex	O
and	O
Tissue	O
-	O
Specific	O
Alterations	O
in	O
the	O
mRNA	O
Expression	O
of	O
Cannabinoid	O
Receptors	O
and	O
Lipid	O
Metabolic	O
Regulators	O
Abstract	O
Maternal	O
malnutrition	O
causes	O
long	O
-	O
lasting	O
alterations	O
in	O
feeding	O
behavior	O
and	O
energy	O
homeostasis	O
in	O
offspring	O
.	O

Our	O
cluster	O
is	O
one	O
BRAC	O
PO	O
area	O
that	O
consists	O
of	O
~	O
13	O
,	O
000	O
people	O
.	O

It	O
is	O
structurally	O
similar	O
to	O
estrogen	O
,	O
testosterone	O
,	O
progesterone	O
and	O
all	O
the	O
steroid	O
hormones	O
.	O

Both	O
questionnaires	O
are	O
interviewer	O
administered	O
.	O

This	O
involves	O
global	O
DNA	O
demethylation	O
and	O
changes	O
in	O
histone	O
modifications	O
and	O
non	O
-	O
coding	O
RNA	O
expression	O
to	O
effectively	O
‘	O
reset	O
’	O
the	O
zygote	O
epigenome	O
and	O
thus	O
genome	O
.	O

Similarly	O
,	O
maternal	O
prenatal	O
behaviors	O
may	O
differentially	O
impact	O
birth	O
and	O
6	O
months	O
offspring	O
weights	O
(	O
e	O
.	O
g	O
.,	O
protein	O
impacting	O
6	O
month	O
but	O
not	O
birth	O
weight	O
in	O
the	O
current	O
study	O
).	O

Additionally	O
,	O
the	O
discordance	O
of	O
handedness	O
in	O
twin	O
studies	O
illustrates	O
that	O
genetics	O
alone	O
cannot	O
explain	O
the	O
development	O
of	O
handedness	O
[	O
202	O
–	O
207	O
].	O

Introduction	O
Risk	O
of	O
obesity	O
is	O
shaped	O
,	O
in	O
large	O
part	O
,	O
by	O
early	O
life	O
events	O
starting	O
during	O
gestation	O
.	O

Interestingly	O
,	O
the	O
CB2	O
receptor	O
activation	O
was	O
associated	O
with	O
anti	O
-	O
obesity	O
effects	O
(	O
Verty	O
et	O
al	O
.,	O
2015	O
)	O
and	O
a	O
decreased	O
risk	O
for	O
cardiovascular	O
diseases	O
.	O

These	O
functional	O
and	O
behavioral	O
changes	O
may	O
contribute	O
to	O
the	O
signs	O
and	O
symptoms	O
of	O
autism	O
[	O
27	O
].	O

Food	O
restriction	O
in	O
dams	O
produced	O
a	O
decrease	O
in	O
caloric	O
intake	O
of	O
female	O
offspring	O
treated	O
with	O
AM251	O
(	O
Figure3H	O
).	O

Moreover	O
,	O
vitamin	O
D	O
is	O
associated	O
with	O
premature	O
births	O
,	O
obesity	O
and	O
renal	O
dysfunction	O
in	O
adulthood	O
,	O
making	O
it	O
more	O
than	O
an	O
essential	O
fat	O
-	O
soluble	O
vitamin	O
responsible	O
for	O
calcium	O
metabolism	O
[	O
9	O
],[	O
10	O
].	O

The	O
fieldworkers	O
followed	O
up	O
the	O
children	O
every	O
2	O
weeks	O
until	O
June	O
,	O
2009	O
,	O
to	O
obtain	O
background	O
information	O
,	O
assess	O
illness	O
(	O
symptom	O
history	O
and	O
examination	O
of	O
chest	O
in	O
-	O
drawing	O
,	O
body	O
temperature	O
[	O
Thermoval	O
Classic	O
Hartmann	O
digital	O
thermometer	O
],	O
signs	O
of	O
dehydration	O
by	O
skin	O
pinching	O
,	O
respiratory	O
rate	O
count	O
over	O
1	O
min	O
with	O
a	O
stopwatch	O
),	O
and	O
to	O
refer	O
to	O
the	O
study	O
hospital	O
if	O
needed	O
.	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

In	O
a	O
systematic	O
review	O
by	O
Halbreich	O
and	O
Karkun	O
,	O
the	O
studies	O
from	O
40	O
different	O
countries	O
were	O
reviewed	O
.	O

Latitude	O
is	O
an	O
important	O
determinant	O
of	O
vitamin	O
D	O
status	O
since	O
the	O
amount	O
of	O
UVB	O
that	O
penetrates	O
the	O
earth	O
'	O
s	O
surface	O
decreases	O
markedly	O
with	O
increasing	O
latitude	O
[	O
8	O
].	O

We	O
will	O
train	O
the	O
BRAC	O
village	O
workers	O
and	O
volunteers	O
in	O
sub	O
-	O
district	O
health	O
centres	O
to	O
detect	O
and	O
monitor	O
pregnancies	O
,	O
to	O
maintain	O
pregnancy	O
records	O
,	O
to	O
manage	O
supply	O
and	O
distribution	O
of	O
supplements	O
,	O
communication	O
and	O
counselling	O
skills	O
for	O
behaviour	O
change	O
related	O
to	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

“	O
We	O
didn	O
’	O
t	O
know	O
what	O
it	O
is	O
.	O

Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
lower	O
in	O
the	O
women	O
recruited	O
in	O
Adelaide	O
when	O
compared	O
to	O
the	O
women	O
recruited	O
in	O
Auckland	O
and	O
remained	O
lower	O
after	O
adjusting	O
for	O
covariates	O
including	O
maternal	O
body	O
mass	O
index	O
and	O
socioeconomic	O
index	O
(	O
Adelaide	O
:	O
58	O
.	O
4	O
±	O
50	O
.	O
3	O
vs	O
.	O
Auckland	O
:	O
70	O
.	O
2	O
±	O
54	O
.	O
5	O
nmol	O
/	O
L	O
,	O
P	O
<	O
0	O
.	O
001	O
).	O

At	O
six	O
months	O
,	O
both	O
the	O
F1	O
and	O
F2	O
VitD	O
-	O
groups	O
were	O
heavier	O
than	O
their	O
SC	O
counterparts	O
(+	O
17	O
%	O
in	O
F1	O
,	O
+	O
15	O
%	O
in	O
F2	O
,	O
P	O
<	O
0	O
.	O
05	O
).	O

Also	O
,	O
blood	O
samples	O
were	O
used	O
to	O
prepare	O
serums	O
,	O
which	O
were	O
kept	O
frozen	O
at	O
-	O
80	O
°	O
C	O
until	O
analysis	O
.	O

After	O
28	O
hours	O
of	O
incubation	O
with	O
VD2or	O
VD3	O
,	O
the	O
cells	O
demonstrated	O
lower	O
production	O
of	O
granulocytes	O
and	O
macrophages	O
colony	O
stimulating	O
factor	O
,	O
interleukin	O
6	O
,	O
Tumor	O
Necrosis	O
Factor	O
,	O
and	O
an	O
increase	O
in	O
mRNA	O
expression	O
for	O
Cathelicidin	O
Antimicrobial	O
Peptide	O
(	O
CAP	O
),	O
which	O
has	O
a	O
direct	O
antibacterial	O
activity	O
[	O
15	O
].	O

Moreover	O
,	O
there	O
were	O
additional	O
studies	O
that	O
have	O
investigated	O
environmentally	O
induced	O
epigenetic	O
changes	O
without	O
simultaneously	O
assessing	O
any	O
phenotypic	O
/	O
toxicological	O
endpoints	O
and	O
/	O
or	O
focused	O
on	O
acute	O
exposures	O
(	O
less	O
than	O
24	O
h	O
).	O

For	O
1	O
hospital	O
(	O
n	O
=	O
23	O
women	O
)	O
certain	O
questions	O
(	O
mainly	O
nationality	O
,	O
ethnicity	O
,	O
education	O
level	O
)	O
needed	O
to	O
be	O
omitted	O
from	O
the	O
questionnaire	O
upon	O
decision	O
of	O
the	O
ethical	O
committee	O
of	O
this	O
particular	O
hospital	O
.	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Geographical	O
distribution	O
of	O
the	O
55	O
hospitals	O
visited	O
in	O
Belgium	O
and	O
the	O
number	O
of	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
investigated	O
by	O
site	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
of	O
pregnant	O
women	O
Belgium	O
2010	O
–	O
2011	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t001	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Number	O
of	O
pregnant	O
women	O
by	O
region	O
,	O
trimester	O
and	O
age	O
(	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
Belgium	O
,	O
2010	O
–	O
2011	O
).	O
RegionsBrussels	O
**	O
Flanders	O
**	O
WalloniaAge	O
(	O
years	O
)	O
1sttrimester3rdtrimester1sttrimester3rdtrimester1sttrimester3rdtrimester15	O
–	O
20721110211721	O
–	O
2534277751567326	O
–	O
304139108149765831	O
–	O
3534536975494536	O
–	O
4014142319132441	O
–	O
45231332Total132138289307218219	O
6	O
missing	O
data	O
for	O
age	O
.	O

When	O
corporate	O
and	O
government	O
officials	O
appeared	O
in	O
the	O
spill	O
’	O
s	O
aftermath	O
and	O
began	O
inquiring	O
into	O
exposure	O
to	O
the	O
slurry	O
and	O
potential	O
health	O
problems	O
,	O
the	O
Navajo	O
people	O
finally	O
learned	O
the	O
truth	O
—	O
far	O
from	O
being	O
harmless	O
,	O
these	O
uranium	O
mines	O
were	O
poisoning	O
people	O
,	O
and	O
researchers	O
say	O
they	O
will	O
continue	O
to	O
do	O
so	O
for	O
decades	O
to	O
come	O
.	O

A	O
Comparative	O
Study	O
of	O
25	O
(	O
OH	O
)	O
Vitamin	O
D	O
Serum	O
Levels	O
in	O
Patients	O
with	O
Multiple	O
Sclerosis	O
and	O
Control	O
Group	O
in	O
Isfahan	O
,	O
Iran	O
Abstract	O
Objectives	O
:	O
There	O
is	O
no	O
study	O
about	O
correlation	O
between	O
vitamin	O
D	O
serum	O
level	O
and	O
multiple	O
sclerosis	O
(	O
MS	O
)	O
in	O
Iran	O
.	O

There	O
are	O
differences	O
in	O
optimal	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
but	O
nowadays	O
internationally	O
accepted	O
normal	O
range	O
is	O
between	O
75	O
nmol	O
/	O
L	O
and	O
200	O
nmol	O
/	O
L	O
,	O
and	O
we	O
consider	O
serum	O
level	O
below	O
75	O
nmol	O
/	O
L	O
and	O
below	O
2	O
nmol	O
/	O
L	O
as	O
insufficiency	O
and	O
deficiency	O
,	O
respectively	O
.	O
42325Even	O
it	O
seems	O
to	O
achieve	O
the	O
prevention	O
of	O
autoimmune	O
diseases	O
,	O
the	O
serum	O
level	O
of	O
vitamin	O
D	O
must	O
be	O
higher	O
than	O
the	O
level	O
required	O
to	O
reduce	O
osteoporosis	O
(	O
higher	O
than	O
75	O
nmol	O
/	O
L	O
).	O
4In	O
attention	O
to	O
high	O
prevalence	O
of	O
MS	O
in	O
Iran	O
and	O
especially	O
in	O
Isfahan	O
which	O
is	O
about	O
43	O
.	O
5	O
/	O
100	O
,	O
0002627and	O
given	O
that	O
Iran	O
is	O
located	O
in	O
an	O
latitude	O
of	O
32	O
°	O
50	O
’	O
and	O
longitude	O
of	O
51	O
°	O
43	O
’	O
with	O
enough	O
sun	O
exposure	O
and	O
because	O
nobody	O
investigated	B
the	O
relationship	O
between	O
vitamin	O
D	O
,	O
as	O
an	O
environmental	O
agent	O
,	O
and	O
MS	O
disease	O
in	O
Iran	O
before	O
,	O
we	O
decided	B
to	O
compare	O
the	O
serum	O
level	O
of	O
25	O
-	O
hydroxy	O
vitamin	O
D	O
in	O
MS	O
patients	O
and	O
healthy	O
control	O
group	O
in	O
Isfahan	O
region	O
.	O

For	O
laryngeal	O
spasm	O
,	O
intubation	O
and	O
,	O
in	O
rare	O
cases	O
,	O
tracheotomy	O
may	O
be	O
necessary	O
.	O

Our	O
recent	O
study	O
also	O
revealed	O
that	O
growth	O
performance	O
was	O
not	O
affected	O
by	O
mild	O
heat	O
stress	O
in	O
Korean	O
cattle	O
[	O
83	O
].	O

PA01	O
.	O
78	O
.	O

Statistical	O
analysis	O
was	O
performed	O
by	O
Student	O
'	O
s	O
t	O
-	O
test	O
and	O
by	O
ANOVA	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
in	O
Johannesburg	O
only	O
45	O
%	O
of	O
women	O
access	O
ANC	O
before	O
20	O
weeks	O
gestation	O
and	O
only	O
23	O
%	O
in	O
their	O
first	O
trimester	O
(	O
as	O
reported	O
from	O
other	O
urban	O
areas	O
)	O
[	O
30	O
].	O

The	O
following	O
were	O
found	O
not	O
to	O
be	O
associated	O
with	O
oesophageal	O
cancer	O
:	O
consumption	O
of	O
sheep	O
'	O
s	O
milk	O
and	O
yoghurt	O
,	O
sesame	O
oil	O
,	O
chewing	O
of	O
nass	O
,	O
making	O
of	O
carpets	O
,	O
use	O
of	O
pregnancy	O
diets	O
,	O
salting	O
and	O
sun	O
-	O
drying	O
of	O
meat	O
and	O
use	O
of	O
wild	O
spinach	O
.	O

Age	O
,	O
depression	O
score	O
,	O
amount	O
of	O
sun	O
exposure	O
and	O
seasons	O
were	O
compared	O
between	O
women	O
with	O
25	O
-	O
hydroxyvitamin	O
D	O
concentrations	O
of	O
<	O
20	O
ng	O
/	O
mL	O
and	O
who	O
had	O
concentrations	O
of	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
Table	O
2	O
).	O

All	O
53	O
exposure	O
variables	O
from	O
5	O
chemical	O
classes	O
were	O
included	O
in	O
the	O
final	O
BHLM	O
model	O
for	O
analysis	O
.	O

Individual	O
humans	O
demonstrate	O
substantial	O
genetic	O
differences	O
and	O
so	O
an	O
individual	O
’	O
s	O
underlying	O
genetics	O
could	O
have	O
a	O
huge	O
effect	O
on	O
his	O
/	O
her	O
susceptibility	O
to	O
a	O
particular	O
environmental	O
exposure	O
,	O
depending	O
on	O
his	O
/	O
her	O
metabolism	O
,	O
adaptability	O
,	O
gender	O
,	O
age	O
,	O
previous	O
exposures	O
,	O
etc	O
.	O

This	O
sensitivity	O
could	O
be	O
one	O
mechanism	O
linking	O
maternal	O
stress	O
to	O
fetal	O
development	O
.	O

All	O
samples	O
were	O
run	O
in	O
duplicates	O
and	O
the	O
entire	O
assay	O
was	O
performed	O
twice	O
.	O

These	O
DNA	O
repetitive	O
elements	O
are	O
made	O
up	O
of	O
interspersed	O
and	O
tandem	O
repeats	O
and	O
comprise	O
at	O
least	O
half	O
of	O
the	O
human	O
genome	O
(	O
Zamudio	O
and	O
Bourc	O
’	O
his	O
2010	O
).	O

Study	O
staff	O
also	O
improved	O
access	O
to	O
handwashing	O
materials	O
in	O
the	O
physical	O
environment	O
to	O
facilitate	O
handwashing	O
[	O
18	O
,	O
19	O
].	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Nephrin	O
does	O
not	O
affect	O
podocyte	O
apoptosis	O
and	O
gene	O
expression	O
patterns	O
[	O
36	O
].	O

2	O
.	O

Adaptive	O
versus	O
adverse	O
epigenetic	O
change	O
Epigenetic	O
change	O
offers	O
a	O
much	O
more	O
versatile	O
,	O
reversible	O
and	O
rapid	O
way	O
for	O
adapting	O
to	O
changes	O
in	O
our	O
environment	O
compared	O
with	O
genetic	O
mutation	O
.	O

These	O
cohorts	O
often	O
have	O
limited	O
availability	O
of	O
appropriate	O
biosample	O
at	O
appropriate	O
collection	O
windows	O
(	O
Bakulski	O
&	O
Fallin2014	O
).	O

A	O
10	O
-	O
fold	O
increase	O
in	O
Pb	O
exposure	O
was	O
associated	O
with	O
a	O
45	O
g	O
birth	O
weight	O
reduction	O
(	O
50	O
%	O
CI	O
(-	O
68	O
,	O
-	O
22	O
),	O
while	O
increased	O
exposure	O
to	O
DMP	O
was	O
associated	O
with	O
a	O
-	O
57	O
g	O
(	O
50	O
%	O
CI	O
(-	O
79	O
,	O
-	O
34	O
))	O
change	O
in	O
birth	O
weight	O
.	O

Among	O
pregnant	O
women	O
,	O
IDA	O
has	O
been	O
associated	O
with	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
[	O
11	O
].	O

In	O
male	O
offspring	O
at	O
six	O
months	O
of	O
age	O
,	O
no	O
differences	O
were	O
found	O
after	O
the	O
24	O
h	O
observation	O
of	O
water	O
intake	O
.	O

All	O
statistical	O
analyses	O
were	O
conducted	O
using	O
the	O
IBM	O
SPSS	O
program	O
for	O
Windows	O
,	O
version	O
22	O
(	O
IBM	O
,	O
Chicago	O
,	O
IL	O
,	O
USA	O
).	O

This	O
may	O
have	O
been	O
especially	O
relevant	O
in	O
our	O
measurement	O
of	O
maternal	O
tobacco	O
,	O
alcohol	O
,	O
and	O
prenatal	O
vitamin	O
use	O
and	O
could	O
have	O
potentially	O
introduced	O
a	O
bias	O
toward	O
the	O
null	O
.	O

Four	O
(	O
16	O
.	O
7	O
%)	O
of	O
the	O
subjects	O
in	O
the	O
IG	O
were	O
suffering	O
from	O
a	O
mild	O
vitamin	O
D	O
deficiency	O
,	O
which	O
was	O
reduced	O
to	O
one	O
(	O
4	O
.	O
2	O
%)	O
after	O
the	O
intervention	O
.	O

No	O
differences	O
were	O
seen	O
in	O
the	O
nasopharyngeal	O
bacteria	O
colonization	O
rate	O
between	O
the	O
low	O
and	O
high	O
25	O
(	O
OH	O
)	O
D	O
groups	O
of	O
the	O
maternal	O
or	O
cord	O
serum	O
.	O

Perinatal	O
outcomes	O
of	O
exposed	O
and	O
healthy	O
comparison	O
groups	O
Maternal	O
characteristics	O
Exposed	O
and	O
control	O
women	O
did	O
not	O
differ	O
with	O
respect	O
to	O
maternal	O
age	O
at	O
conception	O
.	O

In	O
addition	O
the	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
10	O
ng	O
/	O
ml	O
(	O
severe	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
severe	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
same	O
predictors	O
in	O
the	O
model	O
.	O

For	O
protein	O
identification	O
,	O
approximately	O
0	O
.	O
8	O
µl	O
of	O
the	O
peptide	O
mixture	O
was	O
spotted	O
onto	O
a	O
target	O
plate	O
and	O
covered	O
with	O
the	O
same	O
volume	O
of	O
matrix	O
solution	O
(	O
α	O
-	O
cyano	O
-	O
4	O
-	O
hydroxy	O
cinnamic	O
acid	O
(	O
Sigma	O
),	O
8	O
mg	O
/	O
ml	O
in	O
70	O
%	O
(	O
v	O
/	O
v	O
)	O
acetonitrile	O
/	O
1	O
%	O
(	O
v	O
/	O
v	O
)	O
formic	O
acid	O
)	O
and	O
allowed	O
to	O
air	O
dry	O
.	O

Mechanisms	O
regulating	O
pubertal	O
onset	O
are	O
no	O
doubt	O
multifactorial	O
.	O

BHLM	O
uses	O
shrinkage	O
estimation	O
to	O
bias	O
the	O
regression	O
coefficient	O
estimates	O
towards	O
the	O
group	O
mean	O
parameter	O
.	O

An	O
analysis	O
of	O
10	O
developing	O
countries	O
reported	O
$	O
0	O
.	O
32	O
per	O
head	O
or	O
0	O
.	O
57	O
%	O
of	O
gross	O
domestic	O
product	O
as	O
a	O
median	O
value	O
of	O
physical	O
productivity	O
loss	O
per	O
year	O
resulting	O
from	O
iron	O
deficiency	O
[	O
13	O
].	O

In	O
the	O
early	O
1960s	O
,	O
Williams	O
,	O
et	O
al	O
.	O

The	O
castration	O
rate	O
of	O
bulls	O
has	O
been	O
increasing	O
in	O
Korea	O
in	O
the	O
21st	O
century	O
,	O
and	O
it	O
was	O
about	O
95	O
%	O
in	O
2013	O
[	O
59	O
].	O

Therefore	O
,	O
examining	O
childhood	O
nutrition	O
and	O
obesity	O
from	O
a	O
developmental	O
perspective	O
is	O
warranted	O
.	O

*	O
P	O
-	O
value	O
<	O
0	O
.	O
05	O
from	O
Student	O
t	O
test	O
for	O
continuous	O
variable	O
or	O
from	O
Chi	O
-	O
Square	O
test	O
for	O
categorical	O
variables	O
.	O

Roughly	O
two	O
-	O
thirds	O
of	O
the	O
participants	O
were	O
white	O
,	O
and	O
half	O
had	O
attained	O
a	O
college	O
degree	O
or	O
higher	O
.	O

Angus	O
crossbred	O
cattle	O
exposed	O
to	O
greater	O
heat	O
stress	O
tend	O
to	O
have	O
a	O
greater	O
MS	O
[	O
82	O
].	O

Results	O
were	O
considered	O
statistically	O
significant	O
if	O
P	O
<	O
0	O
.	O
05	O
.	O

The	O
epidemiological	O
data	O
from	O
the	O
Dutch	O
Famine	O
have	O
showed	O
that	O
people	O
whose	O
mothers	O
were	O
exposed	O
to	O
undernutrition	O
in	O
early	O
gestation	O
developed	O
more	O
metabolic	O
abnormalities	O
than	O
people	O
exposed	O
in	O
other	O
pregnancy	O
stages	O
(	O
Roseboom	O
et	O
al	O
.,	O
2006	O
).	O

),	O
overweight	O
or	O
obesity	O
,	O
excessive	O
gestational	O
weight	O
gain	O
,	O
excessive	O
central	O
body	O
fat	O
deposition	O
,	O
family	O
history	O
of	O
diabetes	O
,	O
short	O
stature	O
(<	O
1	O
.	O
50	O
m	O
),	O
excessive	O
fetal	O
growth	O
,	O
polyhydramnios	O
,	O
hypertension	O
or	O
preeclampsia	O
in	O
the	O
current	O
pregnancy	O
,	O
history	O
of	O
recurrent	O
miscarriage	O
,	O
offspring	O
malformation	O
,	O
fetal	O
or	O
neonatal	O
death	O
,	O
macrosomia	O
,	O
GDM	O
during	O
prior	O
pregnancies	O
and	O
polycystic	O
ovary	O
syndrome	O
.	O

These	O
findings	O
were	O
preserved	O
even	O
after	O
adjusting	O
for	O
these	O
confounders	O
.	O

Epigenetic	O
regulation	O
of	O
gene	O
expression	O
.	O

Therefore	O
,	O
it	O
is	O
possible	O
that	O
the	O
RAS	O
hyperactivity	O
could	O
,	O
at	O
least	O
in	O
part	O
,	O
mediate	O
the	O
impairment	O
of	O
cardiac	O
vagal	O
tone	O
observed	O
in	O
low	O
birth	O
weight	O
children	O
.	O

With	O
respect	O
to	O
partial	O
implementation	O
of	O
preventive	O
treatment	O
,	O
local	O
health	O
staff	O
should	O
be	O
encouraged	O
on	O
adherence	O
to	O
the	O
guidelines	O
on	O
antenatal	O
care	O
package	O
at	O
any	O
given	O
antenatal	O
visit	O
so	O
that	O
partial	O
implementation	O
of	O
preventive	O
treatments	O
is	O
minimized	O
.	O

Neither	O
BMI	O
,	O
nor	O
percent	O
fat	O
were	O
found	O
to	O
correlate	O
with	O
cathelicidin	O
concentration	O
.	O

Any	O
misclassification	O
of	O
other	O
causes	O
of	O
raised	O
respiratory	O
rate	O
as	O
pneumonia	O
,	O
under	O
-	O
reporting	O
,	O
or	O
over	O
-	O
reporting	O
would	O
be	O
distributed	O
equally	O
between	O
the	O
two	O
groups	O
since	O
the	O
families	O
,	O
doctors	O
,	O
radiographers	O
,	O
radiologists	O
,	O
and	O
data	O
entry	O
staff	O
were	O
masked	O
to	O
the	O
randomisation	O
groupings	O
and	O
the	O
randomisation	O
was	O
successful	O
since	O
the	O
characteristics	O
were	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

Even	O
though	O
our	O
results	O
highlight	O
the	O
importance	O
of	O
nutritional	O
knowledge	O
in	O
the	O
decision	O
to	O
use	O
iron	O
or	O
folic	O
acid	O
,	O
we	O
cannot	O
draw	O
conclusions	O
about	O
overall	O
compliance	O
with	O
supplement	O
regimes	O
,	O
because	O
we	O
did	O
not	O
record	O
the	O
dose	O
or	O
duration	O
of	O
iron	O
,	O
folic	O
acid	O
or	O
multivitamin	O
use	O
.	O

Among	O
EDCs	O
,	O
broad	O
classes	O
include	O
phthalates	O
and	O
phenols	O
(	O
e	O
.	O
g	O
.,	O
bisphenol	O
A	O
[	O
BPA	O
]),	O
perfluoroalkyl	O
substances	O
(	O
PFAS	O
),	O
polychlorinated	O
biphenyls	O
(	O
PCBs	O
),	O
polybrominated	O
diphenyl	O
ethers	O
(	O
PBDEs	O
),	O
and	O
organochlorine	O
pesticides	O
(	O
OCPs	O
).	O

Thus	O
,	O
both	O
prenatal	O
and	O
maternal	O
variables	O
can	O
increase	O
the	O
risk	O
of	O
obesity	O
in	O
even	O
the	O
youngest	O
children	O
,	O
long	O
before	O
social	O
factors	O
have	O
an	O
influence	O
.	O

Additionally	O
,	O
to	O
better	O
understand	O
the	O
impact	O
of	O
the	O
BHLM	O
shrinkage	O
on	O
the	O
regression	O
coefficients	O
,	O
we	O
re	O
-	O
analyzed	O
the	O
data	O
using	O
both	O
LASSO	O
and	O
Elastic	O
Net	O
.	O

However	O
,	O
there	O
was	O
no	O
gestational	O
HV	O
diet	O
effect	O
on	O
expression	O
of	O
leptin	O
and	O
insulin	O
receptors	O
,	O
which	O
are	O
known	O
to	O
modulate	O
expression	O
of	O
orexigenic	O
and	O
anorexigenic	O
neurons	O
regulating	O
energy	O
intake	O
.	O
24	O
–	O
26Despite	O
this	O
lack	O
of	O
difference	O
,	O
other	O
neurons	O
downstream	O
regulating	O
food	O
intake	O
such	O
as	O
POMC	O
and	O
BDNF	O
may	O
be	O
affected	O
by	O
the	O
high	O
vitamin	O
diets	O
.	O

Future	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
offspring	O
weight	O
and	O
,	O
potentially	O
,	O
analysis	O
of	O
growth	O
velocities	O
[	O
51	O
]	O
might	O
better	O
inform	O
how	O
and	O
when	O
nutrient	O
exposures	O
in	O
pregnancy	O
impact	O
growth	O
.	O

In	O
conclusion	O
,	O
this	B
novel	O-
cohort	O-
study	I
shows	O
clear	O
familial	O
associations	O
across	O
three	O
generations	O
for	O
height	O
in	O
both	O
lineages	O
,	O
but	O
the	O
BMI	O
pattern	O
is	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O

Outcome	O
measurements	O
Neonatal	O
deaths	O
We	O
will	O
investigate	O
all	O
neonatal	O
deaths	O
reported	O
by	O
the	O
SS	O
to	O
the	O
Field	O
Implementers	O
or	O
by	O
maternal	O
recall	O
at	O
the	O
final	O
follow	O
-	O
up	O
visit	O
at	O
42	O
days	O
postpartum	O
,	O
using	O
standard	O
questionnaires	O
collected	O
by	O
trained	O
staff	O
.	O

Furthermore	O
,	O
follow	O
-	O
up	O
of	O
280	O
infants	O
(	O
35	O
%	O
of	O
the	O
randomised	O
cohort	O
)	O
at	O
6	O
-	O
months	O
of	O
age	O
demonstrated	O
no	O
evidence	O
of	O
an	O
effect	O
of	O
the	O
intervention	O
on	O
early	O
infant	O
measures	O
of	O
growth	O
or	O
adiposity	O
[	O
19	O
].	O

Megan	O
Romano	O
,	O
then	O
a	O
postdoctoral	O
research	O
associate	O
at	O
Brown	O
University	O
,	O
looked	O
at	O
336	O
women	O
who	O
gave	O
birth	O
at	O
Cincinnati	O
hospitals	O
.	O

Methylation	O
levels	O
of	O
long	O
interspersed	O
nuclear	O
element	O
-	O
1	O
(	O
LINE	O
-	O
1	O
)	O
and	O
the	O
Alu	O
element	O
AluYb8	O
were	O
determined	O
in	O
380	O
placental	O
samples	O
from	O
term	O
deliveries	O
using	O
bisulfite	O
pyrosequencing	O
.	O

From	O
an	O
evolutionary	O
perspective	O
,	O
these	O
senses	O
,	O
which	O
are	O
well	O
developed	O
at	O
birth	O
,	O
function	O
as	O
gatekeepers	O
throughout	O
life	O
(	O
26	O
).	O

Overall	O
,	O
participants	O
included	O
in	O
this	O
analysis	O
tended	O
to	O
be	O
Caucasian	O
,	O
well	O
-	O
educated	O
,	O
and	O
married	O
.	O

For	O
the	O
N363S	O
polymorphism	O
,	O
specific	O
PCR	O
primers	O
were	O
used	O
:	O
5	O
′-	O
AGTACCTCTGGAGGACA	O
G	O
AT	O
-	O
3	O
′	O
and	O
5	O
′-	O
GTCCATTCTTAAGAAACAGG	O
-	O
3	O
′	O
under	O
the	O
same	O
PCR	O
conditions	O
.	O

Most	O
subject	O
characteristics	O
and	O
maternal	O
dietary	O
factors	O
were	O
not	O
different	O
between	O
delivery	O
mode	O
groups	O
(	O
Table	O
1	O
).	O

Multivariable	O
linear	O
regression	O
[	O
5	O
,	O
13	O
,	O
24	O
]	O
with	O
selected	O
predictors	O
[	O
30	O
]	O
is	O
another	O
method	O
,	O
but	O
it	O
can	O
produce	O
unreliable	O
estimates	O
due	O
to	O
the	O
highly	O
correlated	O
nature	O
of	O
some	O
EDCs	O
[	O
31	O
].	O

Offspring	O
of	O
mothers	O
enrolled	O
in	O
an	O
NICHD	O
pregnancy	O
vitamin	O
D	O
supplementation	O
trial	O
(	O
results	O
of	O
which	O
were	O
previously	O
published	O
[	O
21	O
,	O
22	O
])	O
were	O
seen	O
in	O
follow	O
-	O
up	O
from	O
ages	O
2	O
–	O
7	O
years	O
during	O
a	O
three	O
-	O
year	O
study	O
period	O
.	O

Thus	O
,	O
the	O
down	O
-	O
expression	O
of	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
in	O
the	O
PAT	O
of	O
RC	O
male	O
offspring	O
is	O
consistent	O
with	O
an	O
obese	O
phenotype	O
,	O
hyperleptinemia	O
,	O
adiposity	O
,	O
and	O
alterations	O
in	O
lipid	O
metabolism	O
in	O
absence	O
of	O
increased	O
food	O
intake	O
,	O
as	O
was	O
previously	O
described	O
in	O
animals	O
with	O
deficiency	O
of	O
FAAH	O
and	O
MAGL	O
(	O
Tourino	O
et	O
al	O
.,	O
2010	O
;	O
Geurts	O
et	O
al	O
.,	O
2015	O
).	O

Trial	O
outcomes	O
The	O
primary	O
trial	O
outcome	O
will	O
be	O
the	O
difference	O
in	O
the	O
neonatal	O
mortality	O
rate	O
between	O
the	O
intervention	O
and	O
control	O
areas	O
.	O

Our	O
high	O
level	O
symptoms	O
group	O
consisted	O
of	O
840	O
persons	O
or	O
about	O
2	O
.	O
5	O
%	O
of	O
the	O
whole	O
study	O
group	O
.	O

We	O
will	O
randomly	O
select	O
100	O
clusters	O
with	O
an	O
equal	O
number	O
of	O
clusters	O
in	O
each	O
arm	O
.	O

At	O
this	O
stage	O
the	O
animals	O
experienced	O
a	O
kind	O
of	O
release	O
from	O
metabolic	O
burden	O
after	O
cross	O
-	O
fostering	O
and	O
suckling	O
.	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

A	O
novel	O
observation	O
of	O
our	B
study	I
is	O
that	O
the	O
hypothalamic	O
feeding	O
pathways	O
respond	O
to	O
the	O
vitamin	O
content	O
of	O
the	O
post	O
-	O
weaning	O
diet	O
.	O

Each	O
strip	O
will	O
consist	O
of	O
15	O
capsules	O
.	O

We	O
assessed	O
nutritional	O
knowledge	O
using	O
a	O
standardized	O
questionnaire	O
divided	O
into	O
three	O
sections	O
:	O
general	O
nutritional	O
recommendations	O
for	O
pregnant	O
women	O
;	O
the	O
roles	O
of	O
nutrients	O
;	O
and	O
sources	O
of	O
nutrients	O
.	O

However	O
,	O
familial	O
occurrences	O
(	O
Miller	O
et	O
al	O
.	O

Of	O
all	O
pregnant	O
women	O
included	O
,	O
640	O
were	O
in	O
the	O
first	O
,	O
666	O
were	O
in	O
the	O
third	O
and	O
2	O
were	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
.	O

Offspring	O
'	O
s	O
BMI	O
was	O
correlated	O
to	O
a	O
lesser	O
extent	O
with	O
that	O
of	O
the	O
maternal	O
grandmother	O
while	O
for	O
girls	O
only	O
there	O
was	O
an	O
association	O
with	O
that	O
of	O
the	O
paternal	O
grandmother	O
at	O
ages	O
0	O
and	O
5	O
(	O
correlation	O
coefficients	O
0	O
.	O
25	O
,	O
0	O
.	O
28	O
,	O
p	O
values	O
0	O
.	O
02	O
,	O
0	O
.	O
01	O
,	O
respectively	O
).	O

We	O
used	O
FGDs	O
to	O
understand	O
both	O
perceptions	O
regarding	O
the	O
need	O
for	O
IFA	O
tablets	O
during	O
pregnancy	O
and	O
the	O
state	O
of	O
IFA	O
supplementation	O
programmes	O
.	O

In	O
addition	O
,	O
10	O
%	O
of	O
the	O
questionnaires	O
were	O
doubled	O
-	O
checked	O
by	O
a	O
co	O
-	O
investigator	O
,	O
different	O
from	O
the	O
original	O
data	O
entry	O
person	O
.	O

An	O
optimal	O
level	O
of	O
vitamin	O
D	O
concentration	O
in	O
blood	O
serum	O
should	O
range	O
between	O
50	O
and	O
125	O
nmol	O
/	O
L	O
[	O
10	O
],	O
even	O
though	O
some	O
environmental	O
studies	O
imply	O
that	O
the	O
target	O
level	O
should	O
be	O
set	O
much	O
higher	O
—	O
up	O
to	O
250	O
,	O
or	O
even	O
at	O
300	O
nmol	O
/	O
L	O
[	O
11	O
,	O
12	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Association	O
between	O
caries	O
status	O
and	O
child	O
and	O
caregiver	O
characteristicsVariableOverall	O
valueCaries	O
statusP	O
valueS	O
-	O
ECCCaries	O
-	O
freeN	O
(%)	O
95	O
%	O
CIN	O
(%)	O
95	O
%	O
CIChild	O
Child	O
’	O
s	O
age	O
(	O
Months	O
)†	O
40	O
.	O
8	O
±	O
14	O
.	O
142	O
.	O
0	O
±	O
11	O
.	O
9	O
/	O
39	O
.	O
4	O
±	O
16	O
.	O
3	O
/	O
0	O
.	O
14Sex	O
*	O
Male13670	O
(	O
51	O
.	O
5	O
)	O
43	O
.	O
1	O
,	O
59	O
.	O
966	O
(	O
48	O
.	O
5	O
)	O
40	O
.	O
1	O
,	O
56	O
.	O
90	O
.	O
37Female13074	O
(	O
56	O
.	O
9	O
)	O
48	O
.	O
4	O
,	O
65	O
.	O
456	O
(	O
43	O
.	O
1	O
)	O
34	O
.	O
6	O
,	O
51	O
.	O
6	O
Height	O
(	O
cm	O
)†	O
98	O
.	O
4	O
±	O
9	O
.	O
799	O
.	O
3	O
±	O
8	O
.	O
1	O
/	O
97	O
.	O
3	O
±	O
11	O
.	O
1	O
/	O
0	O
.	O
10Weight	O
(	O
kg	O
)†	O
16	O
.	O
4	O
±	O
3	O
.	O
717	O
.	O
0	O
±	O
3	O
.	O
3	O
/	O
15	O
.	O
8	O
±	O
4	O
.	O
0	O
/	O
0	O
.	O
01Skin	O
colour	O
*	O
Dark	O
/	O
Mid	O
-	O
colour11676	O
(	O
65	O
.	O
6	O
)	O
56	O
.	O
9	O
,	O
74	O
.	O
240	O
(	O
34	O
.	O
5	O
)	O
25	O
.	O
8	O
,	O
43	O
.	O
10	O
.	O
001Light15068	O
(	O
45	O
.	O
3	O
)	O
37	O
.	O
4	O
,	O
53	O
.	O
382	O
(	O
54	O
.	O
7	O
)	O
46	O
.	O
7	O
,	O
62	O
.	O
6	O
Multivitamin	O
Use	O
*	O
Yes14376	O
(	O
53	O
.	O
1	O
)	O
45	O
.	O
0	O
,	O
61	O
.	O
367	O
(	O
46	O
.	O
9	O
)	O
38	O
.	O
7	O
,	O
55	O
.	O
00	O
.	O
73No12368	O
(	O
55	O
.	O
3	O
)	O
46	O
.	O
5	O
,	O
64	O
.	O
155	O
(	O
44	O
.	O
7	O
)	O
35	O
.	O
9	O
,	O
53	O
.	O
5	O
Age	O
started	O
cleaning	O
mouth	O
(	O
Months	O
)†	O
12	O
.	O
9	O
±	O
8	O
.	O
614	O
.	O
5	O
±	O
9	O
.	O
5	O
/	O
10	O
.	O
9	O
±	O
7	O
.	O
1	O
/<	O
0	O
.	O
001Mean	O
age	O
at	O
first	O
dental	O
visit	O
(	O
Months	O
)†	O
26	O
.	O
2	O
±	O
11	O
.	O
827	O
.	O
0	O
±	O
11	O
.	O
9	O
/	O
24	O
.	O
7	O
±	O
11	O
.	O
7	O
/	O
0	O
.	O
17Breast	O
-	O
fed	O
*	O
Yes20493	O
(	O
45	O
.	O
6	O
)	O
38	O
.	O
8	O
,	O
52	O
.	O
4111	O
(	O
54	O
.	O
4	O
)	O
48	O
.	O
0	O
,	O
61	O
.	O
0	O
<	O
0	O
.	O
001No6150	O
(	O
82	O
.	O
0	O
)	O
72	O
.	O
3	O
,	O
91	O
.	O
611	O
(	O
18	O
.	O
0	O
)	O
8	O
.	O
4	O
,	O
27	O
.	O
7	O
Bottle	O
-	O
fed	O
*	O
Yes194114	O
(	O
58	O
.	O
8	O
)	O
51	O
.	O
8	O
,	O
65	O
.	O
780	O
(	O
41	O
.	O
2	O
)	O
34	O
.	O
3	O
,	O
48	O
.	O
20	O
.	O
01No7129	O
(	O
40	O
.	O
8	O
)	O
29	O
.	O
4	O
,	O
52	O
.	O
342	O
(	O
59	O
.	O
2	O
)	O
47	O
.	O
7	O
,	O
70	O
.	O
6	O
Parent	O
/	O
Caregiver	O
Caregiver	O
status	O
Mother247132	O
(	O
53	O
.	O
4	O
)	O
47	O
.	O
2	O
,	O
59	O
.	O
7115	O
(	O
46	O
.	O
6	O
)	O
40	O
.	O
0	O
,	O
53	O
.	O
00	O
.	O
62Father159	O
(	O
60	O
.	O
0	O
)	O
35	O
.	O
2	O
,	O
84	O
.	O
86	O
(	O
40	O
.	O
0	O
)	O
15	O
.	O
2	O
,	O
64	O
.	O
8	O
Other43	O
(	O
75	O
.	O
0	O
)	O
32	O
.	O
6	O
,	O
117	O
.	O
41	O
(	O
25	O
.	O
0	O
)-	O
17	O
.	O
4	O
,	O
67	O
.	O
4	O
Graduated	O
high	O
school	O
*	O
<	O
0	O
.	O
001Grade	O
12	O
or	O
higher19786	O
(	O
43	O
.	O
7	O
)	O
36	O
.	O
7	O
,	O
50	O
.	O
6111	O
(	O
56	O
.	O
3	O
)	O
49	O
.	O
4	O
,	O
63	O
.	O
3	O
<	O
Grade	O
126655	O
(	O
83	O
.	O
3	O
)	O
74	O
.	O
0	O
,	O
92	O
.	O
011	O
(	O
16	O
.	O
7	O
)	O
7	O
.	O
7	O
,	O
25	O
.	O
7	O
Afford	O
dental	O
care	O
*	O
Yes222123	O
(	O
55	O
.	O
4	O
)	O
48	O
.	O
9	O
,	O
61	O
.	O
999	O
(	O
44	O
.	O
6	O
)	O
38	O
.	O
1	O
,	O
51	O
.	O
10	O
.	O
28No4119	O
(	O
46	O
.	O
3	O
)	O
331	O
.	O
1	O
,	O
61	O
.	O
622	O
(	O
53	O
.	O
7	O
)	O
38	O
.	O
0	O
,	O
69	O
.	O
0	O
Receives	O
social	O
assistance	O
*	O
<	O
0	O
.	O
001Yes10381	O
(	O
78	O
.	O
6	O
)	O
70	O
.	O
7	O
,	O
86	O
.	O
622	O
(	O
21	O
.	O
4	O
)	O
13	O
.	O
4	O
,	O
29	O
.	O
3	O
No15861	O
(	O
38	O
.	O
6	O
)	O
31	O
.	O
0	O
,	O
46	O
.	O
297	O
(	O
61	O
.	O
4	O
)	O
53	O
.	O
8	O
,	O
69	O
.	O
0	O
Yearly	O
household	O
income	O
*	O
<	O
0	O
.	O
001	O
<$	O
28	O
00011985	O
(	O
71	O
.	O
4	O
)	O
63	O
.	O
3	O
,	O
79	O
.	O
534	O
(	O
28	O
.	O
6	O
)	O
20	O
.	O
5	O
,	O
36	O
.	O
7	O
>$	O
28	O
00013447	O
(	O
35	O
.	O
1	O
)	O
27	O
.	O
0	O
,	O
43	O
.	O
087	O
(	O
64	O
.	O
9	O
)	O
56	O
.	O
8	O
,	O
73	O
.	O
0	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

Our	O
data	O
are	O
consistent	O
with	O
other	O
similar	O
cohort	O
data	O
.	O

In	O
order	O
to	O
further	O
investigate	O
the	O
effect	O
of	O
maternal	O
caloric	O
restriction	O
on	O
feeding	O
behavior	O
we	O
performed	O
a	O
compulsive	O
feeding	O
test	O
in	O
the	O
adult	O
offspring	O
.	O

The	O
results	O
are	O
given	O
in	O
Additional	O
file1	O
:	O
Figure	O
S4	O
.	O

Female	O
service	O
members	O
and	O
spouses	O
of	O
active	O
duty	O
soldiers	O
are	O
a	O
group	O
exposed	O
to	O
multiple	O
stressors	O
that	O
may	O
increase	O
health	O
risks	O
during	O
pregnancy	O
[	O
33	O
-	O
35	O
].	O

The	O
only	O
significant	O
predictor	O
found	O
was	O
group	O
affiliation	O
(	O
p	O
<	O
0	O
.	O
001	O
;	O
Otable	O
2	O
).	O

More	O
than	O
20	O
%	O
of	O
the	O
women	O
in	O
the	O
sample	O
were	O
from	O
non	O
-	O
Caucasian	O
origin	O
.	O

Potentially	O
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

Changes	O
in	O
BMI	O
with	O
age	O
In	O
an	O
analysis	O
of	O
change	O
from	O
birth	O
to	O
5	O
years	O
,	O
the	O
weight	O
difference	O
of	O
the	O
child	O
was	O
calculated	O
(	O
age	O
5	O
–	O
0	O
)	O
and	O
regressed	O
on	O
the	O
other	O
family	O
members	O
’	O
weight	O
.	O

The	O
potential	O
for	O
such	O
adaptations	O
is	O
already	O
acknowledged	O
at	O
the	O
OECD	O
,	O
but	O
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	O
validation	O
work	O
is	O
needed	O
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

In	O
particular	O
,	O
a	O
7	O
.	O
5	O
-	O
fold	O
OR	O
(	O
95	O
%	O
CI	O
=	O
1	O
.	O
3	O
–	O
44	O
.	O
9	O
)	O
for	O
low	O
grade	O
astrocytoma	O
has	O
been	O
observed	O
for	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

However	O
,	O
most	O
of	O
the	O
evidence	O
is	O
from	O
observational	O
epidemiological	O
studies	O
except	O
for	O
a	O
very	O
few	O
randomised	O
controlled	O
trials	O
.	O

Although	O
poor	O
lung	O
function	O
performance	O
and	O
an	O
increased	O
risk	O
of	O
respiratory	O
tract	O
infection	O
were	O
related	O
to	O
relatively	O
low	O
cord	O
serum	O
vitamin	O
D	O
levels	O
,	O
further	O
extrapolating	O
the	O
effects	O
of	O
vitamin	O
D	O
on	O
the	O
respiratory	O
function	O
of	O
the	O
general	O
infant	O
population	O
might	O
still	O
be	O
difficult	O
.	O

per	O
quintile	O
effect	O
).	O

Interestingly	O
,	O
there	O
were	O
consistent	O
positive	O
correlations	O
between	O
BW	O
with	O
parameters	O
of	O
the	O
time	O
domain	O
(	O
RMSSD	O
:	O
r	O
=	O
0	O
.	O
328	O
,	O
P	O
=	O
0	O
.	O
001	O
;	O
PNN50	O
:	O
r	O
=	O
0	O
.	O
386	O
,	O
P	O
=	O
0	O
.	O
001	O
)	O
(	O
Fig	O
2	O
)	O
and	O
frequency	O
domain	O
(	O
HF	O
:	O
r	O
=	O
0	O
.	O
332	O
,	O
P	O
=	O
0	O
.	O
002	O
)	O
(	O
Fig	O
3	O
),	O
suggesting	O
that	O
impaired	O
vagal	O
modulation	O
to	O
the	O
heart	O
in	O
children	O
is	O
influenced	O
by	O
low	O
birth	O
weight	O
.	O

The	O
TSH	O
concentration	O
generally	O
lies	O
within	O
the	O
normal	O
range	O
after	O
the	O
16th	O
to	O
18th	O
week11171920	O
.	O

To	O
convert	O
serum	O
vitamin	O
D	O
levels	O
from	O
ng	O
/	O
mL	O
to	O
nmol	O
/	O
L	O
,	O
multiply	O
by	O
2	O
.	O
5	O
.	O

Folate	O
deficiency	O
was	O
associated	O
with	O
an	O
increase	O
in	O
DNA	O
damage	O
in	O
spermatocytes	O
.	O

These	O
in	O
vitro	O
and	O
in	O
vivo	O
observations	O
together	O
are	O
highly	O
suggestive	O
of	O
a	O
functional	O
link	O
between	O
stress	O
and	O
this	O
ncRNA	O
.	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

Sustained	O
effort	O
by	O
healthcare	O
leaders	O
and	O
advocates	O
at	O
all	O
levels	O
,	O
inside	O
and	O
outside	O
of	O
government	O
,	O
has	O
elevated	O
the	O
issue	O
of	O
preterm	O
birth	O
on	O
the	O
nation	O
'	O
s	O
health	O
agenda	O
,	O
contributing	O
to	O
an	O
announcement	O
of	O
new	O
federal	O
resources	O
to	O
test	O
promising	O
practices	O
in	O
February	O
2012	O
.	O

Earlier	O
studies	O
have	O
mostly	O
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
[	O
13	O
]	O
and	O
few	O
data	O
are	O
available	O
linking	O
habitual	O
diet	O
to	O
neonatal	O
anthropometric	O
measurements	O
.	O

Main	O
Outcome	O
Measure	O
:	O
25	O
(	O
OH	O
)	O
D	O
at	O
randomization	O
and	O
34	O
weeks	O
of	O
gestation	O
were	O
measured	O
in	O
a	O
single	O
batch	O
(	O
Liaison	O
;	O
Diasorin	O
,	O
Dartford	O
,	O
UK	O
).	O

Mothers	O
are	O
instructed	O
on	O
how	O
to	O
complete	O
the	O
calendar	O
and	O
to	O
return	O
completed	O
calendars	O
at	O
each	O
visit	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
A	O
research	O
pipeline	O
advancing	O
knowledge	O
to	O
address	O
preterm	O
birth	O
.	O
DescriptionDiscoveryDevelopmentDeliveryCharacterise	O
the	O
problemUnderstand	O
the	O
problemCreate	O
and	O
develop	O
new	O
interventionsAdvance	O
equitable	O
access	O
to	O
interventionsResearch	O
aimDescriptive	O
epidemiology	O
to	O
understand	O
determinants	O
,	O
advance	O
definitionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDevelopment	O
of	O
new	O
interventions	O
or	O
adapting	O
or	O
improving	O
existing	O
interventionsDelivery	O
of	O
interventions	O
at	O
scale	O
through	O
innovative	O
approachesPreterm	O
prevention	O
research	O
themes	O
•	O
Improve	O
collection	O
,	O
analysis	O
,	O
interpretation	O
,	O
application	O
of	O
epidemiological	O
data	O
for	O
:•	O
Refining	O
,	O
disseminating	O
standard	O
definitions	O
of	O
exposures	O
,	O
outcomes	O
and	O
phenotypes	O
•	O
Further	O
understanding	O
of	O
risk	O
factors	O
for	O
preterm	O
birth	O
•	O
Monitoring	O
and	O
evaluating	O
impact	O
of	O
interventions	O
•	O
Improving	O
the	O
estimates	O
and	O
data	O
collection	O
systems	O
•	O
Increase	O
knowledge	O
of	O
the	O
biology	O
of	O
normal	O
and	O
abnormal	O
pregnancy	O
•	O
Better	O
understand	O
modifiable	O
mechanisms	O
contributing	O
to	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
preconceptual	O
or	O
antenatal	O
nutrition	O
,	O
infection	O
and	O
immune	O
response	O
)•	O
Advance	O
understanding	O
of	O
underlying	O
pathophysiology	O
of	O
preterm	O
newborns	O
and	O
impact	O
of	O
co	O
-	O
morbidities	O
on	O
outcomes	O
in	O
different	O
country	O
settings	O
•	O
Create	O
,	O
develop	O
new	O
interventions	O
(	O
e	O
.	O
g	O
.,	O
novel	O
approaches	O
to	O
preventing	O
preterm	O
birth	O
)•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
or	O
expand	O
utilisation	O
and	O
access	O
•	O
Evaluate	O
impact	O
,	O
cost	O
and	O
process	O
of	O
known	O
interventions	O
to	O
reduce	O
preterm	O
birth	O
(	O
e	O
.	O
g	O
.,	O
family	O
planning	O
,	O
STI	O
management	O
,	O
malaria	O
prevention	O
)•	O
Social	O
behaviour	O
change	O
research	O
to	O
address	O
lifestyle	O
factors	O
and	O
other	O
risks	O
for	O
preterm	O
birth	O
•	O
Effective	O
approaches	O
to	O
increase	O
use	O
of	O
antenatal	O
steroids	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
settingsPremature	O
baby	O
care	O
research	O
themes	O
•	O
Create	O
new	O
devices	O
and	O
drugs	O
for	O
preterm	O
babies	O
that	O
are	O
feasible	O
to	O
use	O
in	O
low	O
-	O
income	O
settings	O
•	O
Adapt	O
existing	O
interventions	O
to	O
increase	O
effect	O
,	O
reduce	O
cost	O
,	O
and	O
/	O
or	O
improve	O
deliverability	O
in	O
challenging	O
settings	O
or	O
at	O
community	O
level	O
(	O
e	O
.	O
g	O
.,	O
robust	O
,	O
simpler	O
technologies	O
)•	O
Implementation	O
research	O
to	O
adapt	O
and	O
scale	O
up	O
context	O
-	O
specific	O
packages	O
of	O
care	O
for	O
preterm	O
babies	O
(	O
e	O
.	O
g	O
.,	O
examining	O
task	O
shifting	O
,	O
innovative	O
commodities	O
,	O
etc	O
.	O

We	O
report	O
that	O
early	O
life	O
caloric	O
restriction	O
,	O
either	O
before	O
birth	O
or	O
during	O
lactation	O
,	O
consistently	O
accelerates	O
the	O
age	O
of	O
maturation	O
.	O

For	O
continuous	O
outcomes	O
,	O
differences	O
in	O
means	O
with	O
95	O
%	O
CI	O
were	O
estimated	O
using	O
linear	O
regression	O
.	O

We	O
collected	O
self	O
-	O
reported	O
data	O
regarding	O
socio	O
-	O
demographic	O
characteristics	O
,	O
number	O
of	O
prenatal	O
check	O
-	O
ups	O
and	O
the	O
use	O
of	O
folic	O
acid	O
,	O
iron	O
and	O
multivitamin	O
supplements	O
during	O
pregnancy	O
.	O

Indeed	O
,	O
discrepancies	O
were	O
also	O
found	O
in	O
the	O
literature	O
.	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	O
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	O
light	O
of	O
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	O
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

Mean	O
birth	O
weights	O
of	O
LP	O
newborn	O
piglets	O
used	O
for	O
microarray	O
analyses	O
were	O
numerically	O
lower	O
than	O
birth	O
weights	O
of	O
AP	O
offspring	O
(	O
LP	O
:	O
1	O
.	O
21	O
±	O
0	O
.	O
30	O
kg	O
,	O
AP	O
:	O
1	O
.	O
36	O
±	O
0	O
.	O
31	O
kg	O
,	O
P	O
=	O
0	O
.	O
08	O
,	O
n	O
=	O
32	O
).	O

Therefore	O
,	O
the	O
high	O
risk	O
of	O
cardiometabolic	O
diseases	O
among	O
these	O
children	O
could	O
be	O
attributed	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
a	O
reduction	O
in	O
the	O
protective	O
actions	O
of	O
the	O
cardiac	O
vagal	O
tone	O
.	O

NPR	O
-	O
C	O
acts	O
as	O
a	O
clearance	O
receptor	O
for	O
these	O
peptides	O
through	O
an	O
endocytic	O
mechanism	O
that	O
involves	O
recycling	O
of	O
the	O
receptor	O
at	O
the	O
cellular	O
membrane	O
(	O
Rubattu	O
et	O
al	O
.	O

A	O
negative	O
and	O
significant	O
correlation	O
was	O
separately	O
found	O
between	O
infant	O
’	O
s	O
weight	O
and	O
the	O
first	O
(	O
p1	O
=	O
0	O
.	O
024	O
,	O
r1	O
=-	O
0	O
.	O
450	O
)	O
and	O
second	O
trimester	O
visfatin	O
levels	O
(	O
p2	O
=	O
0	O
.	O
005	O
,	O
r2	O
=-	O
0	O
.	O
540	O
)	O
in	O
group	O
B	O
.	O

Also	O
,	O
postpregnancy	O
dietary	O
habits	O
and	O
choices	O
may	O
be	O
different	O
compared	O
with	O
prepregnancy	O
.	O

report	O
,	O
the	O
Somali	O
immigrants	O
in	O
Sweden	O
call	O
autism	O
the	O
‘	O
Swedish	O
disease	O
’	O
and	O
Somali	O
immigrants	O
in	O
Minnesota	O
call	O
it	O
the	O
‘	O
American	O
disease	O
,’	O
but	O
in	O
equatorial	O
Somalia	O
,	O
autism	O
has	O
no	O
name	O
.	O

Women	O
were	O
recruited	O
at	O
the	O
time	O
of	O
their	O
first	O
prenatal	O
visit	O
from	O
one	O
of	O
six	O
obstetric	O
offices	O
serving	O
a	O
socioeconomic	O
and	O
ethnically	O
diverse	O
population	O
in	O
Providence	O
,	O
RI	O
from	O
2006	O
to	O
2008	O
.	O

In	O
their	O
cross	O
sectional	O
study	O
of	O
740	O
Canadians	O
(	O
323	O
men	O
and	O
417	O
women	O
),	O
Chaput	O
et	O
al	O
noted	O
that	O
short	O
sleep	O
duration	O
(<	O
7	O
hours	O
)	O
was	O
associated	O
with	O
prevalent	O
type	O
2	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
58	O
;	O
95	O
%	O
CI	O
1	O
.	O
13	O
-	O
2	O
.	O
31	O
)	O
[	O
33	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
ECS	O
gene	O
expression	O
in	O
hypothalamus	O
,	O
liver	O
,	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
ECS	O
components	O
(	O
Cnr1	O
,	O
Cnr2	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
was	O
evaluated	O
in	O
the	O
hypothalamus	O
,	O
the	O
liver	O
and	O
the	O
PAT	O
of	O
male	O
and	O
female	O
offspring	O
from	O
rat	O
dams	O
which	O
were	O
exposed	O
to	O
an	O
ad	O
libitum	O
access	O
of	O
a	O
standard	O
chow	O
(	O
CC	O
)	O
or	O
a	O
20	O
%-	O
restricted	O
access	O
of	O
the	O
same	O
standard	O
chow	O
(	O
RC	O
)	O
during	O
pregestational	O
(	O
2	O
weeks	O
)	O
and	O
gestational	O
periods	O
(	O
Figure4	O
).	O

This	O
study	O
therefore	O
fills	O
a	O
major	O
gap	O
in	O
the	O
cost	O
literature	O
,	O
namely	O
estimating	O
the	O
cost	O
of	O
implementing	O
weekly	O
iron	O
supplementation	O
programs	O
.	O

We	O
considered	O
infants	O
with	O
cord	O
25	O
(	O
OH	O
)	O
D	O
below	O
20	O
ng	O
/	O
mL	O
compared	O
to	O
those	O
above	O
20	O
ng	O
/	O
mL	O
regardless	O
of	O
ethnicity	O
.	O

Follow	O
-	O
up	O
assessments	O
of	O
mothers	O
include	O
anthropometric	O
measures	O
,	O
diet	O
history	O
,	O
nutrient	O
status	O
,	O
blood	O
pressure	O
,	O
breast	O
milk	O
composition	O
,	O
and	O
measures	O
of	O
postnatal	O
depression	O
and	O
fatigue	O
.	O

Children	O
were	O
assessed	O
based	O
on	O
the	O
ministry	O
of	O
health	O
’	O
s	O
questionnaire	O
for	O
children	O
under	O
8	O
years	O
of	O
age	O
.	O

Thus	O
,	O
environmentally	O
induced	O
epigenetic	O
changes	O
may	O
not	O
always	O
be	O
mechanistically	O
involved	O
in	O
adverse	O
effects	O
;	O
instead	O
,	O
they	O
may	O
act	O
as	O
markers	O
of	O
past	O
exposures	O
(	O
Bakulski	O
&	O
Fallin2014	O
),	O
or	O
represent	O
adaptations	O
involved	O
in	O
maintaining	O
cellular	O
homeostasis	O
.	O

Yet	O
,	O
visfatin	O
’	O
s	O
regulatory	O
and	O
release	O
mechanisms	O
in	O
the	O
fetus	O
and	O
neonate	O
are	O
still	O
unclear	O
(	O
5	O
).	O

Pregnancy	O
data	O
are	O
collected	O
at	O
the	O
antenatal	O
care	O
(	O
ANC	O
)	O
clinic	O
of	O
RMMCH	O
in	O
addition	O
to	O
routine	O
care	O
.	O

Recruitment	O
took	O
place	O
over	O
this	O
time	O
period	O
until	O
the	O
targeted	O
sample	O
was	O
reached	O
.	O

In	O
The	O
Gambia	O
,	O
as	O
in	O
other	O
parts	O
of	O
sub	O
-	O
Saharan	O
Africa	O
,	O
seasonal	O
multiple	O
micronutrient	O
deficiencies	O
are	O
common	O
(	O
Bates	O
et	O
al	O
1984	O
,	O
Powers	O
and	O
Bates	O
1987	O
),	O
and	O
maternal	O
anaemia	O
and	O
its	O
sequelae	O
remain	O
frequent	O
problems	O
,	O
particularly	O
in	O
rural	O
areas	O
(	O
Powers	O
and	O
Bates	O
1987	O
,	O
Topley	O
1968	O
).	O

Male	O
Infertility	O
Factor	O
Should	O
males	O
visiting	O
infertility	O
clinics	O
be	O
treated	O
with	O
VD	O
preparations	O
?	O

Missing	O
values	O
of	O
other	O
variables	O
were	O
not	O
imputed	O
.	O

Of	O
the	O
32	O
Navajo	O
men	O
who	O
developed	O
lung	O
cancer	O
,	O
72	O
%	O
had	O
worked	O
as	O
uranium	O
miners	O
,	O
compared	O
with	O
none	O
of	O
the	O
controls	O
.	O

Although	O
the	O
incidence	O
of	O
infant	O
wheeze	O
was	O
similar	O
between	O
the	O
groups	O
,	O
the	O
percentage	O
of	O
respiratory	O
tract	O
infection	O
was	O
significantly	O
higher	O
in	O
infants	O
with	O
a	O
low	O
cord	O
serum	O
25	O
(	O
OH	O
)	O
D	O
level	O
(	O
Table	O
1	O
).	O

We	O
documented	O
2	O
(	O
2	O
%)	O
stillbirths	O
and	O
4	O
(	O
3	O
%)	O
neonatal	O
deaths	O
in	O
the	O
intervention	O
arm	O
and	O
6	O
(	O
5	O
%)	O
stillbirths	O
and	O
2	O
(	O
6	O
%)	O
neonatal	O
deaths	O
in	O
the	O
control	O
arm	O
.	O

Plasma	O
concentrations	O
of	O
insulin	O
were	O
determined	O
by	O
the	O
Human	O
Endocrine	O
Panel	O
.	O

A	O
significant	O
percent	O
of	O
infants	O
with	O
a	O
history	O
of	O
respiratory	O
syncytial	O
virus	O
(	O
RSV	O
)	O
bronchiolitis	O
infection	O
,	O
which	O
peaks	O
during	O
the	O
winter	O
season	O
,	O
develop	O
asthma	O
[	O
64	O
].	O

Conclusion	O
:	O
Maternal	O
serum	O
visfatin	O
level	O
shows	O
a	O
relationship	O
with	O
fetal	O
and	O
infant	O
anthropometric	O
indicators	O
,	O
with	O
different	O
effects	O
in	O
the	O
two	O
groups	O
,	O
suggesting	O
visfatin	O
dysfunction	O
in	O
the	O
overweight	O
group	O
before	O
pregnancy	O
.	O

It	O
has	O
been	O
hypothesised	O
that	O
vitamin	O
D	O
insufficiency	O
could	O
account	O
for	O
some	O
of	O
the	O
increased	O
risk	O
of	O
schizophrenia	O
observed	O
among	O
dark	O
-	O
skinned	O
immigrants	O
moving	O
to	O
countries	O
with	O
less	O
sun	O
exposure	O
[	O
12	O
].	O

Furthermore	O
,	O
few	O
data	O
have	O
evaluated	B
Hispanic	O
infants	O
who	O
may	O
be	O
at	O
high	O
-	O
risk	O
for	O
low	O
vitamin	O
D	O
status	O
due	O
to	O
poor	O
maternal	O
vitamin	O
D	O
intake	O
[	O
4	O
].	O

Substantial	O
racial	O
disparities	O
in	O
PTB	O
rates	O
have	O
also	O
been	O
found	O
in	O
the	O
United	O
States	O
:	O
18	O
%	O
among	O
African	O
Americans	O
,	O
12	O
%	O
among	O
Hispanics	O
,	O
and	O
11	O
%	O
among	O
whites	O
in	O
2009	O
[	O
2	O
].	O

The	O
health	O
of	O
the	O
adult	O
South	O
African	O
population	O
is	O
a	O
concern	O
.	O

In	O
addition	O
to	O
the	O
increased	O
costs	O
and	O
animal	O
welfare	O
issues	O
associated	O
with	O
housing	O
and	O
monitoring	O
up	O
to	O
the	O
natural	O
death	O
of	O
the	O
animals	O
,	O
there	O
is	O
also	O
the	O
confounding	O
factor	O
of	O
increased	O
background	O
pathology	O
with	O
age	O
.	O

Ward	O
et	O
al	O
[	O
140	O
]	O
examined	O
nutrigenetic	O
interactions	O
between	O
the	O
alcohol	O
dehydrogenase	O
1C	O
(	O
ADH1C	O
)	O
single	O
nucleotide	O
polymorphism	O
(	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
)	O
and	O
vitamin	O
A	O
levels	O
and	O
the	O
impact	O
on	O
IMF	O
deposition	O
in	O
Angus	O
-	O
cross	O
steers	O
.	O

Data	O
collection	O
tools	O
In	O
this	O
study	O
,	O
we	O
used	O
the	O
Edinburgh	O
Postnatal	O
Depression	O
scale	O
(	O
EPDS	O
)	O
in	O
order	O
to	O
evaluate	O
depression	O
levels	O
.	O

A	O
systematic	O
review	O
in	O
2005	O
found	O
that	O
up	O
to	O
70	O
%	O
of	O
neonatal	O
deaths	O
,	O
worldwide	O
,	O
could	O
be	O
averted	O
by	O
implementing	O
sixteen	O
evidence	O
-	O
based	O
interventions	O
at	O
near	O
universal	O
coverage	O
(	O
99	O
%)	O
that	O
incorporated	O
preconception	O
,	O
antenatal	O
,	O
intrapartum	O
and	O
postnatal	O
interventions	O
[	O
3	O
].	O

Part	O
of	O
an	O
adaptive	O
response	O
to	O
early	O
life	O
nutritional	O
challenge	O
might	O
therefore	O
be	O
expected	O
to	O
be	O
an	O
acceleration	O
in	O
the	O
age	O
of	O
reproductive	O
maturation	O
,	O
provided	O
that	O
the	O
organism	O
can	O
metabolically	O
sustain	O
earlier	O
reproduction	O
without	O
further	O
compromising	O
its	O
own	O
viability	O
.	O

Proteins	O
were	O
extracted	O
in	O
homogenizing	O
buffer	O
with	O
protease	O
inhibitors	O
.	O

Further	O
,	O
a	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
can	O
not	O
be	O
concluded	O
from	O
this	O
study	O
.	O

Likewise	O
it	O
should	O
be	O
unacceptable	O
for	O
almost	O
3	O
million	O
newborns	O
,	O
to	O
die	O
,	O
including	O
those	O
who	O
are	O
born	O
too	O
soon	O
.	O

Some	O
of	O
the	O
best	O
mHealth	O
evidence	O
comes	O
from	O
smoking	O
cessation	O
studies	O
[	O
9	O
,	O
10	O
].	O

Vertebral	O
malformations	O
that	O
cause	O
kyphosis	O
or	O
scoliosis	O
are	O
an	O
important	O
health	O
problem	O
that	O
can	O
result	O
in	O
disability	O
and	O
suffering	O
attributable	O
to	O
both	O
physical	O
pain	O
and	O
psychological	O
distress	O
from	O
the	O
disfigurement	O
.	O

In	O
summer	O
,	O
light	O
-	O
skinned	O
people	O
who	O
spend	O
at	O
least	O
15	O
minutes	O
outside	O
during	O
the	O
day	O
with	O
their	O
hands	O
and	O
face	O
exposed	O
will	O
have	O
adequate	O
vitamin	O
D	O
levels	O
.	O

On	O
the	O
other	O
hand	O
,	O
Wilkerson	O
et	O
al	O
.	O

The	O
economic	O
analysis	O
will	O
estimate	O
the	O
incremental	O
cost	O
per	O
life	O
saved	O
per	O
year	O
of	O
the	O
intervention	O
over	O
standard	O
care	O
.	O

A	O
team	O
including	O
nutritionist	O
and	O
epidemiologist	O
Esther	O
Casanueva	O
of	O
the	O
National	O
Institute	O
of	O
Perinatology	O
Isidro	O
Espinosa	O
de	O
los	O
Reyes	O
(	O
INPerIER	O
)	O
in	O
Mexico	O
City	O
and	O
colleagues	O
elsewhere	O
in	O
Mexico	O
City	O
and	O
California	O
studied	O
116	O
women	O
receiving	O
prenatal	O
care	O
at	O
INPerIER	O
.	O

Pregnancy	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
was	O
measured	O
on	O
average	O
at	O
11	O
weeks	O
of	O
gestation	O
,	O
and	O
GDM	O
was	O
diagnosed	O
on	O
average	O
at	O
26	O
weeks	O
of	O
gestation	O
in	O
both	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

Leukotriene	O
modifiers	O
may	O
be	O
used	O
as	O
alternative	O
add	O
-	O
on	O
treatment	O
;	O
montelukast	O
and	O
zafirlukast	O
are	O
the	O
preferred	O
antileukotriene	O
drugs	O
(	O
but	O
zileuton	O
is	O
not	O
).	O

The	O
diagnosis	O
and	O
treatment	O
of	O
drug	O
allergy	O
are	O
the	O
same	O
in	O
pregnant	O
as	O
in	O
nonpregnant	O
patients	O
.	O

It	O
has	O
long	O
been	O
suggested	O
that	O
5mC	O
can	O
be	O
removed	O
by	O
both	O
passive	O
(	O
through	O
lack	O
of	O
maintenance	O
during	O
replication	O
)	O
and	O
active	O
(	O
enzymatic	O
)	O
mechanisms	O
.	O

The	O
tests	O
adhered	O
to	O
American	O
Thoracic	O
Society	O
(	O
ATS	O
)	O
criteria	O
for	O
standardisation	O
and	O
reproducibility	O
of	O
flow	O
–	O
volume	O
measurement	O
[	O
18	O
],	O
with	O
the	O
exception	O
of	O
ATS	O
recommendations	O
for	O
duration	O
of	O
expiration	O
[	O
19	O
];	O
as	O
many	O
children	O
did	O
not	O
fulfil	O
forced	O
expiratory	O
time	O
>	O
6	O
s	O
end	O
-	O
of	O
-	O
test	O
criteria	O
,	O
a	O
minimal	O
volume	O
change	O
over	O
the	O
final	O
1	O
s	O
was	O
used	O
.	O

The	O
initial	O
weight	O
of	O
the	O
child	O
was	O
also	O
included	O
in	O
the	O
regression	O
to	O
adjust	O
for	O
regression	O
towards	O
the	O
mean	O
.	O

Furthermore	O
,	O
during	O
pregnancy	O
,	O
nasal	O
congestion	O
can	O
worsen	O
,	O
although	O
the	O
exact	O
mechanism	O
for	O
this	O
is	O
not	O
defined	O
.	O

With	O
few	O
exceptions	O
(	O
e	O
.	O
g	O
.,	O
PFOA	O
),	O
median	O
concentrations	O
among	O
HOME	O
Study	O
participants	O
tended	O
to	O
be	O
similar	O
to	O
concentrations	O
observed	O
in	O
US	O
women	O
(	O
Table2	O
).	O

DNA	O
methylation	O
involves	O
the	O
addition	O
of	O
a	O
methyl	O
group	O
,	O
primarily	O
to	O
the	O
C5	O
of	O
cytosine	O
within	O
cytosine	O
–	O
phosphate	O
–	O
guanine	O
dinucelotides	O
(	O
CpGs	O
)	O
to	O
produce	O
5	O
-	O
methylcytosine	O
(	O
5mC	O
).	O

Maternal	O
Diet	O
During	O
Lactation	O
Regarding	O
maternal	O
lactation	O
diets	O
,	O
a	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
[	O
99	O
]	O
found	O
some	O
evidence	O
of	O
reduced	O
atopic	O
dermatitis	O
,	O
but	O
suggested	O
that	O
more	O
studies	O
are	O
needed	O
.	O

All	O
the	O
studies	O
shown	O
here	B
demonstrated	O
associations	O
among	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

The	O
fixed	O
effects	O
are	O
chosen	O
to	O
account	O
for	O
different	O
mean	O
levels	O
of	O
BMI	O
for	O
the	O
sexes	O
and	O
for	O
different	O
generations	O
.	O

Further	O
,	O
it	O
would	O
be	O
of	O
interest	O
to	O
study	O
if	O
dietary	O
aspects	O
are	O
associated	O
with	O
separable	O
latent	O
dimensions	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
and	O
if	O
the	O
associations	O
are	O
valid	O
for	O
men	O
and	O
for	O
other	O
age	O
groups	O
.	O

Both	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
were	O
corrected	O
by	O
applying	O
a	O
linear	O
regression	O
equation	O
(	O
Oct	O
2014	O
value	O
(	O
nmol	O
/	O
L	O
)	O
=	O
[(	O
early	O
2014	O
value	O
)	O
–	O
8	O
.	O
2	O
]	O
/	O
0	O
.	O
99	O
)	O
provided	O
by	O
the	O
manufacturer	O
because	O
of	O
methodological	O
changes	O
in	O
the	O
IDS	O
-	O
iSYS	O
system	O
between	O
2014	O
and	O
2016	O
(	O
see	O
Additional	O
file	O
1	O
).	O

This	O
study	O
was	O
reviewed	O
and	O
approved	O
by	O
the	O
Research	O
and	O
Ethical	O
Review	O
Committees	O
at	O
icddr	O
,	O
b	O
:	O
International	O
Centre	O
for	O
Diarrhoeal	O
Diseases	O
Research	O
,	O
Bangladesh	O
(	O
PR	O
-	O
10036	O
).	O

Obesity	O
has	O
profound	O
effects	O
on	O
tissue	O
insulin	O
sensitivity	O
,	O
and	O
therefore	O
on	O
systemic	O
glucose	O
homeostasis	O
.	O

Infant	O
Feeding	O
:	O
(	O
breast	O
,	O
formula	O
,	O
or	O
a	O
combination	O
of	O
the	O
two	O
),	O
as	O
assessed	O
by	O
questionnaire	O
completed	O
by	O
the	O
infant	O
’	O
s	O
primary	O
caregiver	O
.	O

Although	O
the	O
literature	O
from	O
rigorous	O
studies	O
of	O
smoking	O
cessation	O
,	O
treatment	O
adherence	O
,	O
and	O
some	O
other	O
chronic	O
disease	O
prevention	O
and	O
management	O
studies	O
show	O
that	O
mHealth	O
programs	O
can	O
promote	O
behavior	O
change	O
,	O
more	O
randomized	O
controlled	O
trials	O
(	O
RCTs	O
)	O
are	O
needed	O
[	O
11	O
].	O

Modern	O
day	O
cosmetology	O
and	O
our	O
urbanization	O
has	O
eclipsed	O
the	O
sunlight	O
and	O
it	O
is	O
impossible	O
is	O
to	O
fulfill	O
daily	O
intake	O
via	O
diet	O
as	O
a	O
large	O
amount	O
of	O
vitamin	O
D	O
needs	O
to	O
be	O
consumed	O
.	O

The	O
Guidelines	O
for	O
maternity	O
care	O
in	O
South	O
Africa	O
[	O
26	O
]	O
therefore	O
recommend	O
routine	O
nutritional	O
assessment	O
–	O
such	O
as	O
measuring	O
mid	O
-	O
upper	O
arm	O
circumference	O
and	O
haemoglobin	O
levels	O
–	O
and	O
daily	O
supplementation	O
of	O
200	O
mg	O
ferrous	O
sulphate	O
,	O
1000	O
mg	O
calcium	O
and	O
5	O
mg	O
folic	O
acid	O
.	O

Introduction	O
In	O
2013	O
,	O
an	O
estimated	O
2	O
.	O
8	O
million	O
deaths	O
occurred	O
in	O
the	O
neonatal	O
period	O
globally	O
[	O
1	O
].	O

Vitamin	O
D	O
has	O
effects	O
on	O
the	O
immune	O
system	O
,	O
cytokines	O
,	O
and	O
antibacterial	O
peptides	O
that	O
are	O
likely	O
to	O
regulate	O
the	O
bacterial	O
flora	O
.	O

It	O
has	O
been	O
estimated	O
that	O
exposure	O
to	O
sunlight	O
for	O
usually	O
no	O
more	O
than	O
5	O
-	O
15	O
min	O
/	O
d	O
between	O
10	O
AM	O
and	O
3	O
PM	O
,	O
in	O
the	O
spring	O
,	O
summer	O
,	O
and	O
fall	O
at	O
latitudes	O
above	O
and	O
below	O
35	O
°	O
(	O
and	O
all	O
year	O
near	O
the	O
equator	O
)	O
to	O
exposed	O
parts	O
of	O
the	O
body	O
involving	O
“	O
arms	O
,	O
legs	O
and	O
face	O
“	O
provides	O
the	O
body	O
with	O
its	O
required	O
1000	O
IU	O
of	O
cholecalciferol	O
.	O

Study	O
has	O
found	O
that	O
the	O
prevalence	O
of	O
Vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
66	O
–	O
96	O
%	O
[	O
7	O
].	O

No	O
current	O
medical	O
illness	O
;	O
4	O
).	O

Thus	O
,	O
there	O
is	O
a	O
lack	O
of	O
published	O
information	O
regarding	O
the	O
efficacy	O
of	O
perinatal	O
handwashing	O
promotion	O
interventions	O
on	O
maternal	O
handwashing	O
behavior	O
in	O
the	O
neonatal	O
period	O
and	O
on	O
neonatal	O
mortality	O
.	O

This	O
ability	O
has	O
been	O
documented	O
at	O
meals	O
(	O
42	O
,	O
43	O
)	O
and	O
during	O
the	O
course	O
of	O
a	O
day	O
(	O
44	O
).	O

In	O
the	O
treatment	O
group	O
,	O
the	O
aim	O
was	O
to	O
maintain	O
a	O
fasting	O
glucose	O
level	O
of	O
<	O
5	O
.	O
5	O
mmol	O
/	O
L	O
,	O
and	O
2	O
hour	O
post	O
-	O
prandial	O
reading	O
<	O
7	O
.	O
0	O
mmol	O
/	O
L	O
.	O

It	O
is	O
known	O
that	O
1	O
,	O
25	O
[	O
OH	O
]	O
2D	O
is	O
responsible	O
for	O
increasing	O
intracellular	O
Ca	O
+	O
2concentration	O
and	O
the	O
activity	O
of	O
acrosine	O
,	O
which	O
is	O
accountable	O
for	O
acrosome	O
reactions	O
that	O
are	O
essential	O
for	O
the	O
fertilization	O
process	O
.	O

Among	O
them	O
,	O
70	O
women	O
(	O
45	O
.	O
8	O
%)	O
scored	O
<	O
9	O
and	O
83	O
women	O
(	O
54	O
.	O
2	O
%)	O
scored	O
9	O
–	O
13	O
.	O

They	O
do	O
,	O
however	O
,	O
agree	O
with	O
previously	O
published	O
studies	O
[	O
14	O
,	O
39	O
,	O
45	O
,	O
46	O
].	O

Benefit	O
-	O
Cost	O
Analysis	O
Effectiveness	O
data	O
were	O
obtained	O
from	O
the	O
two	O
pilot	O
districts	O
,	O
which	O
were	O
surveyed	O
at	O
baseline	O
and	O
at	O
3	O
,	O
12	O
and	O
30	O
months	O
post	O
-	O
implementation	O
for	O
the	O
impact	O
on	O
anaemia	O
and	O
helminth	O
infection	O
status	O
,	O
and	O
independent	O
compliance	O
monitoring	O
at	O
10	O
weeks	O
,	O
18	O
and	O
36	O
months	O
post	O
-	O
implementation	O
.	O

In	O
conclusion	O
,	O
developmental	O
vitamin	O
D	O
deficiency	O
is	O
associated	O
with	O
subtle	O
changes	O
in	O
a	O
range	O
of	O
proteins	O
in	O
the	O
nucleus	O
accumbens	O
.	O

The	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
an	O
increased	O
gene	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
Cnr1	O
and	O
Cnr2	O
in	O
the	O
hypothalamus	O
,	O
and	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
the	O
eCBs	O
-	O
metabolizing	O
enzymes	O
Napepld	O
in	O
liver	O
,	O
and	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
PAT	O
.	O

The	O
primary	O
form	O
of	O
vitamin	O
D	O
,	O
colecalciferol	O
(	O
vitamin	O
D3	O
),	O
is	O
available	O
from	O
two	O
sources	O
:	O
skin	O
exposure	O
to	O
ultraviolet	O
B	O
radiation	O
(	O
UVB	O
)	O
in	O
sunlight	O
and	O
diet	O
.	O

A	O
simple	O
linear	O
regression	O
was	O
used	O
to	O
determine	O
the	O
correlation	O
of	O
25	O
(	O
OH	O
)	O
D	O
levels	O
between	O
maternal	O
and	O
cord	O
serum	O
.	O

Although	O
this	O
is	O
probably	O
true	O
,	O
a	O
sufficient	O
serum	O
concentrations	O
for	O
the	O
immunological	O
effects	O
of	O
vitamin	O
D	O
is	O
unknown	O
and	O
could	O
be	O
higher	O
or	O
lower	O
than	O
that	O
of	O
the	O
skeletal	O
system	O
accepted	O
concentrations	O
.	O
6The	O
need	O
for	O
a	O
steady	O
state	O
is	O
currently	O
highly	O
speculative	O
and	O
relates	O
to	O
vitamin	O
D2supplementation	O
for	O
negative	O
cancer22and	O
bone	O
outcomes	O
.	O
23	O
Our	O
findings	O
are	O
at	O
odds	O
with	O
smaller	O
case	O
-	O
control	O
hospital	O
studies	O
that	O
show	O
an	O
enhanced	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
or	O
rickets	O
in	O
children	O
with	O
pneumonia	O
and	O
the	O
increasing	O
evidence	O
suggesting	O
that	O
calcitriol	O
,	O
the	O
biologically	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
has	O
an	O
important	O
role	O
in	O
the	O
human	O
immune	O
system	O
.	O
4A	O
systematic	O
review	O
of	O
the	O
role	O
of	O
vitamin	O
D	O
supplementation	O
in	O
infectious	O
diseases	O
had	O
mixed	O
findings	O
,	O
concluding	O
that	O
more	O
rigorously	O
designed	O
clinical	O
trials	O
are	O
needed	O
(	O
panel	O
).	O
25No	O
studies	O
report	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
radiologically	O
confirmed	O
pneumonias	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
birth	O
weight	O
,	O
length	O
,	O
head	O
circumference	O
SD	O
-	O
scores	O
and	O
ponderal	O
index	O
z	O
-	O
score	O
between	O
(	O
a	O
)	O
maternal	O
prepregnancy	O
BMI	O
groups	O
of	O
underweight	O
,	O
normal	O
weight	O
,	O
overweight	O
and	O
obese	O
;	O
(	O
b	O
)	O
mothers	O
’	O
inadequate	O
GWG	O
,	O
adequate	O
GWG	O
and	O
excessive	O
GWG	O
;	O
(	O
c	O
)	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
;	O
(	O
d	O
)	O
suboptimal	O
and	O
optimal	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
;	O
and	O
(	O
e	O
)	O
suboptimal	O
and	O
optimal	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
.	O
Statistical	O
significance	O
is	O
denoted	O
by	O
*	O
P	O
<	O
0	O
.	O
05	O
,	O
**	O
P	O
<	O
0	O
.	O
01	O
and	O
***	O
P	O
<	O
0	O
.	O
001	O
.	O

Seven	O
of	O
the	O
eight	O
reviewed	O
articles	O
showed	O
a	O
beneficial	O
impact	O
on	O
certain	O
measures	O
of	O
offspring	O
neurodevelopment	O
with	O
fish	O
intake	O
ranging	O
from	O
less	O
than	O
one	O
to	O
three	O
or	O
more	O
servings	O
of	O
fish	O
per	O
week	O
.	O

Forty	O
-	O
four	O
per	O
cent	O
,	O
16	O
.	O
5	O
%	O
and	O
11	O
.	O
3	O
%	O
of	O
women	O
in	O
the	O
exposed	O
group	O
reported	O
the	O
use	O
of	O
two	O
,	O
three	O
and	O
four	O
or	O
more	O
psychotropic	O
medications	O
,	O
respectively	O
.	O

If	O
the	O
proportion	O
of	O
non	O
-	O
urbanized	O
participants	O
was	O
high	O
in	O
the	O
study	O
population	O
this	O
could	O
have	O
confounded	O
our	O
results	O
,	O
nevertheless	O
this	O
is	O
not	O
the	O
case	O
in	O
the	O
Swedish	O
population	O
.	O

The	O
newly	O
synthesized	O
cytokines	O
and	O
chemokines	O
lead	O
to	O
the	O
late	O
-	O
phase	O
reaction	O
associated	O
with	O
tissue	O
edema	O
by	O
recruitment	O
and	O
activation	O
of	O
additional	O
inflammatory	O
cells	O
,	O
including	O
basophils	O
,	O
eosinophils	O
,	O
and	O
T	O
helper	O
type	O
2	O
(	O
Th2	O
)	O
lymphocytes	O
[	O
6	O
].	O

Information	O
includes	O
medication	O
use	O
(	O
including	O
vaccines	O
),	O
HIV	O
status	O
,	O
obstetric	O
history	O
,	O
hospital	O
admission	O
during	O
pregnancy	O
,	O
use	O
of	O
alcohol	O
,	O
and	O
exposure	O
to	O
passive	O
smoking	O
.	O

Very	O
early	O
in	O
pregnancy	O
,	O
the	O
increase	O
in	O
oestrogen	O
levels	O
causes	O
an	O
approximate	O
doubling	O
in	O
thyroxine	O
-	O
binding	O
globulin	O
(	O
TBG	O
)	O
that	O
can	O
lead	O
to	O
an	O
increases	O
in	O
total	O
T4	O
concentration	O
and	O
a	O
reduced	O
free	O
fraction	O
(	O
Table	O
I	O
).	O

Women	O
who	O
terminated	O
the	O
pregnancy	O
(	O
N	O
=	O
31	O
),	O
were	O
lost	O
to	O
follow	O
-	O
up	O
(	O
N	O
=	O
13	O
)	O
or	O
carried	O
more	O
than	O
one	O
foetus	O
(	O
N	O
=	O
26	O
)	O
were	O
excluded	O
from	O
the	O
present	O
analyses	O
.	O

This	O
puzzling	O
finding	O
may	O
be	O
due	O
to	O
unknown	O
or	O
known	O
unhealthy	O
constituents	O
of	O
fatty	O
fish	O
.	O

The	O
EPDS	O
was	O
originally	O
utilized	O
in	O
the	O
postpartum	O
period	O
only	O
.	O

With	O
thanks	O
to	O
Boston	O
Consulting	O
Group	O
.	O

Therefore	O
,	O
an	O
average	O
daily	O
dose	O
of	O
4	O
–	O
6	O
mg	O
of	O
iron	O
is	O
required	O
in	O
the	O
second	O
and	O
third	O
trimesters	O
of	O
pregnancy	O
[	O
14	O
].	O

Unfortunately	O
,	O
we	O
do	O
not	O
have	O
any	O
information	O
about	O
the	O
use	O
of	O
such	O
supplements	O
during	O
follow	O
-	O
up	O
.	O

Wells	O
,	O
in	O
a	O
recent	O
commentary	O
,	O
indicates	O
the	O
need	O
for	O
such	O
cross	O
-	O
generational	O
grandparental	O
data	O
to	O
understand	O
more	O
fully	O
the	O
influence	O
of	O
maternal	O
and	O
paternal	O
lineages	O
on	O
growth	O
and	O
development	O
.	O
19	O
In	O
a	O
previous	O
study	O
employing	O
primarily	O
self	O
-	O
reported	O
data	O
,	O
we	O
showed	O
that	O
BMI	O
appeared	O
to	O
be	O
strongly	O
familial	O
in	O
the	O
maternal	O
line	O
,	O
23and	O
we	O
have	O
shown	O
that	O
familial	O
dietary	O
patterns	O
are	O
also	O
stronger	O
in	O
the	O
maternal	O
line	O
.	O
2425The	O
present	O
analysis	O
of	O
BMI	O
has	O
extended	O
this	O
to	O
include	O
both	O
birth	O
weight	O
and	O
data	O
when	O
the	O
children	O
were	O
aged	O
9	O
years	O
and	O
shows	O
this	O
strong	O
maternal	O
pattern	O
consistently	O
for	O
children	O
while	O
height	O
,	O
by	O
comparison	O
,	O
is	O
heritable	O
across	O
lineages	O
.	O

Two	O
mothers	O
(	O
1	O
Hispanic	O
,	O
1	O
Caucasian	O
)	O
reported	O
covering	O
their	O
face	O
and	O
body	O
due	O
to	O
their	O
religious	O
beliefs	O
.	O

Rates	O
of	O
severe	O
anemia	O
in	O
women	O
of	O
reproductive	O
age	O
fell	O
from	O
1	O
.	O
1	O
%	O
to	O
0	O
%	O
after	O
3	O
months	O
of	O
the	O
intervention	O
[	O
15	O
].	O

The	O
fold	O
changes	O
were	O
uniformly	O
small	O
,	O
with	O
the	O
largest	O
FC	O
being	O
−	O
1	O
.	O
67	O
(	O
MEPD	O
).	O

To	O
clarify	O
the	O
TFBSs	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	O
with	O
either	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
gene	O
set	O
enrichment	O
analysis	O
(	O
GSEA	O
)	O
(	O
Subramanian	O
et	O
al	O
.	O

Future	O
research	O
should	O
focus	O
on	O
polytherapy	O
in	O
pregnancy	O
in	O
order	O
to	O
define	O
its	O
reproductive	O
safety	O
and	O
to	O
separate	O
the	O
effects	O
of	O
medication	O
exposure	O
,	O
underlying	O
psychopathology	O
and	O
associated	O
comorbidities	O
.	O

Statistical	O
Analysis	O
Analysis	O
was	O
completed	O
using	O
the	O
cathelicidin	O
concentration	O
values	O
obtained	O
from	O
each	O
child	O
’	O
s	O
yearly	O
follow	O
-	O
up	O
visit	O
.	O

The	O
only	O
exclusion	O
criterion	O
was	O
pregnancy	O
exceeding	O
16	O
gestational	O
weeks	O
at	O
inclusion	O
.	O

Due	O
to	O
the	O
lack	O
of	O
conclusive	O
evidence	O
,	O
we	O
cannot	O
recommend	O
the	O
ubiquitous	O
use	O
of	O
prenatal	O
vitamins	O
,	O
in	O
particular	O
folate	O
,	O
in	O
men	O
attempting	O
to	O
plan	O
a	O
pregnancy	O
with	O
their	O
female	O
partner	O
at	O
this	O
time	O
.	O

Previous	O
studies	O
have	O
focused	O
on	O
cathelicidin	O
and	O
vitamin	O
D	O
concentrations	O
in	O
patient	O
populations	O
affected	O
by	O
various	O
illnesses	O
or	O
diseases	O
[	O
6	O
],	O
such	O
as	O
tuberculosis	O
[	O
7	O
],	O
pneumonia	O
[	O
8	O
],	O
sepsis	O
[	O
9	O
],	O
HIV	O
[	O
10	O
–	O
12	O
],	O
and	O
end	O
-	O
stage	O
renal	O
disease	O
hemodialysis	O
[	O
13	O
],	O
as	O
well	O
as	O
healthy	O
adult	O
populations	O
[	O
14	O
–	O
19	O
].	O

They	O
concluded	O
that	O
the	O
TT	O
genotype	O
of	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
is	O
related	O
to	O
greater	O
IMF	O
than	O
the	O
CC	O
genotype	O
when	O
vitamin	O
A	O
is	O
restricted	O
,	O
and	O
ADH1C	O
c	O
.-	O
64T	O
>	O
C	O
could	O
be	O
a	O
genetic	O
marker	O
for	O
enhancing	O
marbling	O
in	O
feedlot	O
steers	O
.	O

Groundwater	O
iron	O
We	O
will	O
measure	O
the	O
level	O
of	O
groundwater	O
iron	O
in	O
all	O
the	O
households	O
of	O
our	O
study	O
using	O
a	O
validated	O
test	O
kit	O
tool	O
[±	O
0	O
.	O
1	O
mg	O
/	O
L	O
,	O
FerroVer	O
method	O
,	O
HACH	O
Iron	O
Test	O
kit	O
,	O
Model	O
IR	O
-	O
18B	O
].	O

The	O
2005	O
autism	O
prevalence	O
rate	O
among	O
school	O
-	O
aged	O
children	O
,	O
after	O
controlling	O
for	O
differences	O
in	O
population	O
size	O
,	O
demographic	O
characteristics	O
,	O
per	O
capita	O
income	O
and	O
state	O
,	O
was	O
higher	O
in	O
cloudy	O
areas	O
.	O

Lower	O
maternal	O
vitamin	O
D	O
status	O
was	O
associated	O
with	O
lower	O
bone	O
mineral	O
concentration	O
and	O
impaired	O
glucose	O
homeostasis	O
in	O
newborn	O
infants	O
.	O

The	O
authors	O
concluded	O
that	O
higher	O
subjective	O
social	O
standing	O
in	O
school	O
might	O
protect	O
against	O
weight	O
gain	O
in	O
adolescent	O
girls	O
.	O

Model	O
system	O
Stage	O
of	O
development	O
Environmental	O
exposureSpeciesRoute	O
of	O
administrationExposureEffectAdverse	O
phenotype	O
(	O
s	O
)	O
Epigenetic	O
change	O
(	O
s	O
)	O
ReferenceChemicals	O
Bisphenol	O
A	O
(	O
BPA	O
)	O
Mouse	O
RatOral	O
(	O
diet	O
)	O
(	O
50	O
µg	O
-	O
50	O
mg	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
40	O
–	O
200	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Injection	O
(	O
not	O
specified	O
)	O
(	O
20	O
or	O
40	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Combinations	O
of	O
:	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
In	O
utero	O
Lactation	O
Neonatal	O
Childhood	O
Adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adulthood	O
F0	O
-	O
F2generationsReproductive	O
,	O
neurological	O
,	O
behavioral	O
,	O
metabolic	O
and	O
cardiac	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryChao	O
et	O
al	O
.	O

While	O
statistically	O
significant	O
,	O
the	O
clinical	O
significance	O
of	O
such	O
a	O
small	O
difference	O
is	O
questionable	O
,	O
the	O
findings	O
also	O
consistent	O
with	O
a	O
chance	O
occurrence	O
,	O
particularly	O
as	O
this	O
was	O
a	O
secondary	O
outcome	O
,	O
and	O
no	O
other	O
statistically	O
significant	O
differences	O
were	O
identified	O
between	O
the	O
treatment	O
groups	O
in	O
infant	O
BMI	O
,	O
abdominal	O
circumference	O
,	O
or	O
the	O
remainder	O
of	O
infant	O
anthropometric	O
measures	O
obtained	O
.	O

Thus	O
,	O
genes	O
and	O
pathways	O
identified	O
as	O
regulated	O
in	O
one	O
offspring	O
group	O
were	O
either	O
unregulated	O
or	O
showed	O
an	O
opposite	O
direction	O
of	O
regulation	O
in	O
the	O
corresponding	O
ontogenetic	O
period	O
within	O
the	O
other	O
dietary	O
group	O
.	O

The	O
association	O
of	O
later	O
life	O
health	O
with	O
pre	O
-	O
conception	O
,	O
in	O
utero	O
or	O
childhood	O
environmental	O
factors	O
has	O
led	O
to	O
the	O
“	O
Developmental	O
Origins	O
of	O
Health	O
and	O
Disease	O
”	O
(	O
DOHaD	O
)	O
hypothesis	O
(	O
Wadhwa	O
et	O
al	O
.	O
2009	O
).	O

Packs	O
of	O
study	O
treatment	O
were	O
randomly	O
assigned	O
in	O
a	O
1	O
:	O
1	O
ratio	O
by	O
Sharp	O
Clinical	O
Services	O
by	O
a	O
computer	O
-	O
generated	O
sequence	O
in	O
randomly	O
permuted	O
blocks	O
of	O
10	O
,	O
starting	O
randomly	O
midway	O
through	O
the	O
block	O
,	O
and	O
sequentially	O
numbered	O
,	O
before	O
delivery	O
to	O
the	O
study	O
sites	O
,	O
and	O
then	O
dispensed	O
in	O
order	O
by	O
each	O
study	O
pharmacist	O
.	O

NPR3	O
contains	O
an	O
extracellular	O
domain	O
(	O
ECD	O
),	O
transmembrane	O
(	O
TM	O
)	O
domain	O
,	O
and	O
cytoplasmic	O
domain	O
(	O
CD	O
).	O

In	O
this	O
study	O
only	O
183	O
autistic	O
children	O
were	O
considered	O
and	O
medical	O
conditions	O
of	O
the	O
mother	O
based	O
on	O
a	O
maternal	O
self	O
-	O
report	O
[	O
18	O
].	O

2002	O
),	O
and	O
localization	O
within	O
each	O
of	O
the	O
following	O
classes	O
of	O
repetitive	O
element	O
as	O
defined	O
by	O
the	O
Repeatmasker	O
track	O
of	O
Genomes	O
Browser	O
:	O
Alu	O
,	O
LINE	O
-	O
1	O
,	O
LINE	O
-	O
2	O
,	O
and	O
mammalian	O
wide	O
-	O
interspersed	O
repeat	O
elements	O
(	O
MIRs	O
).	O

Reduction	O
of	O
energy	O
intake	O
induced	O
SIRT1	O
in	O
brain	O
(	O
21	O
).	O

Subject	O
scanning	O
does	O
not	O
take	O
place	O
unless	O
all	O
quality	O
control	O
results	O
fall	O
within	O
acceptable	O
limits	O
.	O

Differences	O
in	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
among	O
both	O
regions	O
were	O
not	O
significant	O
.	O

Search	O
Strategy	O
Medline	O
,	O
Scopus	O
,	O
Web	O
of	O
Science	O
,	O
ScienceDirect	O
and	O
the	O
Cochrane	O
Library	O
were	O
searched	O
using	O
terms	O
outlined	O
inTable	O
1	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t001_Table	O
1	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Database	O
search	O
strategy	O
.	O
Search	O
termsKeywords	O
searchedBOOLEAN	O
operatorTerm	O
1Pregnant	O
or	O
pregnancyPregnan	O
*	O
ANDTerm	O
2Fish	O
or	O
seafoodFishseafoodORANDTerm	O
3Neurodevelopment	O
or	O
neurodevelopmental	O
or	O
cognition	O
or	O
cognitiveNeurodevelopment	O
*	O
cogniti	O
*	O
OR	O
The	O
Dietitians	O
Association	O
of	O
Australia	O
Process	O
Manual	O
for	O
review	O
of	O
the	O
Australian	O
Dietary	O
Guidelines	O
[	O
15	O
]	O
was	O
the	O
basis	O
for	O
reviewing	O
the	O
articles	O
and	O
guided	O
the	O
concluding	O
evidence	O
statement	O
.	O

Study	O
Design	O
:	O
Cord	O
blood	O
vitamin	O
D	O
levels	O
were	O
measured	O
in	O
438	O
infants	O
(	O
276	O
black	O
and	O
162	O
white	O
).	O

Cytokines	O
and	O
hepcidin	O
will	O
be	O
determined	O
using	O
ELISA	O
.	O

These	O
effects	O
are	O
partly	O
interrelated	O
,	O
but	O
can	O
also	O
be	O
dissociated	O
and	O
exerted	O
by	O
different	O
UCP1	O
-	O
expressing	O
types	O
of	O
adipocytes	O
(	O
i	O
.	O
e	O
.,	O
brown	O
and	O
“	O
brite	O
”	O
adipocytes	O
).	O

An	O
associated	O
issue	O
is	O
that	O
,	O
after	O
the	O
start	O
of	O
our	O
trial	O
,	O
speculations	O
arose	O
that	O
high	O
fluctuations	O
of	O
natural	O
or	O
supplemented	O
vitamin	O
D	O
intake	O
might	O
be	O
linked	O
to	O
negative	O
outcomes	O
.	O

To	O
confirm	O
the	O
presence	O
of	O
the	O
Bcl	O
I	O
polymorphism	O
,	O
17	O
μ	O
L	O
of	O
the	O
PCR	O
product	O
was	O
digested	O
with	O
2	O
μ	O
L	O
of	O
10x	O
Restriction	O
Endonuclease	O
Buffer	O
and	O
15	O
U	O
of	O
the	O
restriction	O
enzyme	O
Bcl	O
I	O
(	O
New	O
England	O
Biolabs	O
,	O
UK	O
)	O
for	O
1	O
.	O
5	O
hr	O
at	O
50	O
°	O
C	O
.	O

Diet	O
The	O
“	O
developmental	O
plasticity	O
hypothesis	O
”	O
refers	O
to	O
the	O
critical	O
developmental	O
period	O
in	O
utero	O
when	O
the	O
fetus	O
is	O
plastic	O
and	O
adaptively	O
imprints	O
to	O
its	O
environment	O
.	O

In	O
Utero	O
Exposures	O
,	O
Infant	O
Growth	O
,	O
and	O
DNA	O
Methylation	O
of	O
Repetitive	O
Elements	O
and	O
Developmentally	O
Related	O
Genes	O
in	O
Human	O
Placenta	O
Abstract	O
Background	O
:	O
Fetal	O
programming	O
describes	O
the	O
theory	O
linking	O
environmental	O
conditions	O
during	O
embryonic	O
and	O
fetal	O
development	O
with	O
risk	O
of	O
diseases	O
later	O
in	O
life	O
.	O

These	O
results	O
will	O
supply	O
context	O
to	O
intervention	O
studies	O
with	O
the	O
aim	O
to	O
improve	O
maternal	O
as	O
well	O
as	O
offspring	O
health	O
in	O
South	O
Africa	O
.	O

Chest	O
and	O
soft	O
tissue	O
neck	O
X	O
-	O
ray	O
were	O
normal	O
.	O

Adjusted	O
mean	O
±	O
SEM	O
values	O
of	O
pregnancy	O
25	O
(	O
OH	O
)	O
D	O
(	O
a	O
)	O
and	O
UCB	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
(	O
nmol	O
/	O
L	O
)	O
(	O
b	O
)	O
in	O
GDM	O
and	O
non	O
-	O
GDM	O
mothers	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

Abstract	O
Background	O
Pet	O
keeping	O
has	O
been	O
linked	O
with	O
decreased	O
risk	O
of	O
allergic	O
sensitization	O
,	O
which	O
has	O
been	O
associated	O
with	O
the	O
Hygiene	O
Hypothesis	O
;	O
and	O
more	O
recently	O
,	O
by	O
ourselves	O
and	O
others	O
,	O
to	O
particular	O
home	O
microbiome	O
patterns	O
.	O

One	O
trial	O
in	O
schoolchildren28	O
(	O
measuring	O
influenza	O
A	O
antigen	O
from	O
swabs	O
)	O
found	O
a	O
statistically	O
significant	O
reduced	O
incidence	O
in	O
the	O
intervention	O
group	O
(	O
RR	O
0	O
·	O
58	O
,	O
95	O
%	O
CI	O
0	O
·	O
34	O
–	O
0	O
·	O
99	O
).	O

[	O
25	O
]	O
As	O
expected	O
,	O
low	O
concentration	O
of	O
25	O
(	O
OH	O
)	O
D	O
is	O
a	O
risk	O
factor	O
for	O
insulin	O
resistance	O
,	O
glucose	O
intolerance	O
,	O
and	O
features	O
of	O
metabolic	O
syndrome	O
in	O
normoglycemic	O
subjects	O
.	O

Sensible	O
sun	O
exposure	O
and	O
education	O
of	O
the	O
public	O
about	O
the	O
beneficial	O
effects	O
of	O
some	O
limited	O
sun	O
exposure	O
to	O
satisfy	O
their	O
body	O
'	O
s	O
vitamin	O
D	O
requirements	O
should	O
be	O
implemented	O
.	O

All	O
procedures	O
were	O
conducted	O
in	O
a	O
quiet	O
room	O
with	O
minimum	O
disturbance	O
between	O
9	O
:	O
00	O
and	O
11	O
:	O
00	O
am	O
.	O

The	O
statistical	O
analysis	O
is	O
novel	O
,	O
using	O
mixed	O
-	O
model	O
techniques	O
that	O
enable	O
all	O
the	O
data	O
to	O
be	O
utilised	O
including	O
incomplete	O
families	O
.	O

Results	O
:	O
Black	O
race	O
,	O
Medicaid	O
status	O
,	O
mean	O
body	O
mass	O
index	O
at	O
delivery	O
and	O
lack	O
of	O
prenatal	O
vitamin	O
use	O
were	O
associated	O
with	O
vitamin	O
D	O
deficiency	O
.	O

The	O
PRISMA	O
statement	O
process	O
was	O
followed	O
[	O
17	O
]	O
as	O
shown	O
inFigure	O
1	O
.	O

As	O
a	O
result	O
,	O
breastfeeding	O
studies	O
may	O
not	O
pass	O
muster	O
with	O
funding	O
committees	O
,	O
says	O
Raju	O
.	O

Neonatal	O
data	O
collected	O
at	O
birth	O
from	O
the	O
medical	O
file	O
include	O
date	O
and	O
time	O
of	O
birth	O
,	O
gender	O
,	O
Apgar	O
score	O
(	O
at	O
1	O
and	O
5	O
min	O
)	O
[	O
56	O
],	O
vital	O
signs	O
,	O
medical	O
interventions	O
required	O
,	O
foetal	O
distress	O
and	O
presence	O
of	O
meconium	O
stained	O
liquor	O
.	O

of	O
commonly	O
regulated	O
probe	O
-	O
sets	O
of	O
LP	O
and	O
AP	O
offspring	O
(	O
intersection	O
)	O
94	O
dpc	O
12	O
,	O
6507	O
,	O
9371	O
,	O
001	O
(	O
541	O
up	O
,	O
460	O
down	O
)	O
1	O
dpn	O
12	O
,	O
0059	O
,	O
0991	O
(	O
0	O
up	O
,	O
1	O
down	O
)	O
28	O
dpn	O
12	O
,	O
3078	O
,	O
250483	O
(	O
214	O
up	O
,	O
269	O
down	O
)	O
188	O
dpn	O
11	O
,	O
7848	O
,	O
9432	O
,	O
084	O
(	O
952	O
up	O
,	O
1	O
,	O
132	O
down	O
)	O
developmental	O
period	O
1	O
13	O
,	O
35710	O
,	O
2938	O
,	O
166	O
(	O
3	O
,	O
731	O
up	O
,	O
4	O
,	O
435	O
down	O
)	O
1	O
,	O
042	O
(	O
384	O
up	O
,	O
658	O
down	O
)	O
1	O
,	O
034	O
(	O
503	O
up	O
,	O
531	O
down	O
)	O
6	O
,	O
090	O
(	O
2	O
,	O
844	O
up	O
,	O
3	O
,	O
246	O
down	O
)	O
developmental	O
period	O
2	O
13	O
,	O
35910	O
,	O
3178	O
,	O
329	O
(	O
4	O
,	O
118	O
up	O
,	O
4	O
,	O
211	O
down	O
)	O
881	O
(	O
423	O
up	O
,	O
458	O
down	O
)	O
991	O
(	O
448	O
up	O
,	O
543	O
down	O
)	O
6	O
,	O
457	O
(	O
3	O
,	O
247	O
up	O
,	O
3	O
,	O
210	O
down	O
)	O
developmental	O
period	O
3	O
12	O
,	O
6378	O
,	O
8926	O
,	O
612	O
(	O
2	O
,	O
810	O
up	O
,	O
3	O
,	O
803	O
down	O
)	O
1	O
,	O
959	O
(	O
834	O
up	O
,	O
1	O
,	O
125	O
down	O
)	O
1	O
,	O
549	O
(	O
697	O
up	O
,	O
852	O
down	O
)	O
3	O
,	O
104	O
(	O
1	O
,	O
279	O
up	O
,	O
1	O
,	O
825	O
down	O
)	O
Developmental	O
period	O
1	O
indicates	O
the	O
comparisons	O
between	O
stages	O
94	O
dpc	O
and	O
1	O
dpn	O
;	O
Developmental	O
period	O
2	O
indicates	O
the	O
comparisons	O
between	O
stages	O
1	O
dpc	O
and	O
28	O
dpn	O
;	O
Developmental	O
period	O
3	O
indicates	O
the	O
comparisons	O
between	O
stages	O
28	O
dpc	O
and	O
188	O
dpn	O
;	O
'	O
Up	O
'	O
indicates	O
higher	O
expression	O
values	O
of	O
later	O
stages	O
,	O
'	O
down	O
'	O
indicates	O
lower	O
expression	O
values	O
at	O
later	O
stages	O
.	O

The	O
participants	O
were	O
selected	O
from	O
one	O
prenatal	O
clinic	O
.	O

Iranian	O
usual	O
diet	O
also	O
contains	O
high	O
amounts	O
of	O
salt	O
,	O
which	O
means	O
that	O
salt	O
intake	O
among	O
them	O
is	O
almost	O
twofold	O
the	O
recommended	O
levels	O
.	O

Two	O
Dimensional	O
Gel	O
Electrophoresis	O
Protein	O
concentration	O
was	O
determined	O
by	O
the	O
Bradford	O
method	O
[	O
24	O
].	O

Fourth	O
,	O
we	O
based	O
our	O
calculation	O
of	O
gestational	O
age	O
at	O
delivery	O
on	O
LMP	O
which	O
is	O
known	O
to	O
be	O
subject	O
to	O
recall	O
bias	O
and	O
could	O
have	O
introduced	O
errors	O
in	O
our	O
calculations	O
[	O
53	O
].	O

This	O
vitamin	O
is	O
photosynthesized	O
by	O
ultraviolet	O
-	O
B	O
radiation	O
in	O
the	O
epidermis	O
.	O

PubMed	O
Central	O
:	O

They	O
are	O
listed	O
in	O
the	O
table	O
footnotes	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Estimated	O
lives	O
saved	O
of	O
premature	O
babies	O
in	O
settings	O
with	O
universal	O
coverage	O
of	O
interventionsIntervention	O
reaching	O
95	O
%	O
coverageAlso	O
saves	O
mothers	O
or	O
other	O
babiesBy	O
2015By	O
2025	O
%	O
Deaths	O
avertedLives	O
saved	O
%	O
Deaths	O
avertedLives	O
savedFamily	O
planning	O
*	O
M	O
,	O
SB	O
,	O
N24228	O
,	O
00032345	O
,	O
000Antenatal	O
corticosteroidsN40373	O
,	O
00041444	O
,	O
000Antibiotics	O
for	O
pPRoMN985	O
,	O
0009101	O
,	O
000Immediate	O
assessment	O
and	O
simple	O
care	O
of	O
all	O
babiesN544	O
,	O
000553	O
,	O
000Neonatal	O
resuscitationN765	O
,	O
000777	O
,	O
000Thermal	O
careN15142	O
,	O
00016171	O
,	O
000Kangaroo	O
mother	O
careN48452	O
,	O
00048531	O
,	O
000Interventions	O
implemented	O
togetherM	O
,	O
SB	O
,	O
N81757	O
,	O
00084921	O
,	O
000	O
Note	O
:	O
interventions	O
marked	O
with	O
M	O
will	O
also	O
save	O
maternal	O
lives	O
,	O
SB	O
would	O
avert	O
stillbirth	O
,	O
and	O
N	O
will	O
save	O
newborns	O
dying	O
from	O
causes	O
other	O
than	O
preterm	O
birth	O
.	O

The	O
mean	O
total	O
number	O
of	O
combined	O
visits	O
was	O
9	O
.	O
58	O
±	O
4	O
.	O
88	O
:	O
18	O
%	O
of	O
participants	O
made	O
≤	O
4	O
visits	O
,	O
28	O
.	O
5	O
%	O
made	O
between	O
5	O
–	O
9	O
visits	O
and	O
53	O
.	O
3	O
%	O
had	O
≥	O
10	O
visits	O
.	O

†	O
Mann	O
-	O
Whitney	O
U	O
test	O
.	O

Obesogenic	O
phenotype	O
of	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
multivitamin	O
diet	O
is	O
prevented	O
by	O
a	O
post	O
-	O
weaning	O
high	O
multivitamin	O
or	O
high	O
folate	O
diet	O
Abstract	O
Background	O
High	O
multivitamin	O
(	O
10	O
-	O
fold	O
AIN	O
-	O
93G	O
,	O
HV	O
)	O
diets	O
fed	O
during	O
pregnancy	O
to	O
Wistar	O
rats	O
increase	O
characteristics	O
of	O
metabolic	O
syndrome	O
in	O
offspring	O
when	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

In	O
a	O
study	O
by	O
Cekmez	O
et	O
al	O
.	O

It	O
is	O
still	O
unknown	O
whether	O
both	O
,	O
the	O
endocannabinoid	O
(	O
eCB	O
)	O
machinery	O
and	O
the	O
lipid	O
metabolism	O
are	O
implicated	O
in	O
long	O
-	O
term	O
adaptive	O
responses	O
to	O
fetal	O
reprogramming	O
caused	O
by	O
maternal	O
undernutrition	O
.	O

Overall	O
the	O
data	O
support	O
the	O
hypothesis	O
that	O
the	O
cause	O
of	O
the	O
phenotype	O
of	O
HV	O
offspring	O
fed	O
RV	O
diets	O
may	O
be	O
accounted	O
for	O
by	O
its	O
effects	O
in	O
utero	O
on	O
development	O
of	O
hypothalamic	O
pathways	O
of	O
intake	O
regulation	O
,	O
leading	O
to	O
excess	O
food	O
intake	O
,	O
and	O
consequently	O
increased	O
body	O
weight	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
.	O
4Offspring	O
born	O
to	O
dams	O
fed	O
the	O
HV	O
diet	O
during	O
pregnancy	O
had	O
lower	O
expression	O
of	O
POMC	O
and	O
BDNF	O
,	O
which	O
are	O
anorexigenic	O
(	O
appetite	O
-	O
suppressing	O
)	O
genes	O
,	O
20	O
,	O
21compared	O
to	O
those	O
born	O
to	O
dams	O
on	O
the	O
RV	O
diet	O
.	O

Generalized	O
estimating	O
equations	O
(	O
GEE	O
)	O
logistic	O
regression	O
was	O
used	O
to	O
construct	O
separate	O
models	O
for	O
each	O
of	O
the	O
attitudes	O
,	O
beliefs	O
,	O
and	O
behavioral	O
outcomes	O
over	O
the	O
3	O
follow	O
-	O
up	O
periods	O
,	O
estimating	O
population	O
-	O
attributable	O
effects	O
for	O
treatment	O
vs	O
control	O
groups	O
,	O
and	O
high	O
(	O
more	O
than	O
the	O
median	O
message	O
exposure	O
of	O
224	O
days	O
)	O
vs	O
lower	O
intervention	O
exposure	O
.	O

Thus	O
far	O
,	O
studies	O
on	O
delayed	O
introduction	O
of	O
solids	O
led	O
to	O
conflicting	O
results	O
.	O

The	O
appropriate	O
age	O
for	O
,	O
and	O
duration	O
of	O
,	O
vitamin	O
A	O
deple	O
tion	O
or	O
supplementation	O
have	O
been	O
suggested	O
as	O
important	O
factors	O
that	O
affect	O
MS	O
.	O
Oka	O
et	O
al	O
[	O
134	O
]	O
reported	O
that	O
restricting	O
vitamin	O
A	O
in	O
15	O
-	O
month	O
-	O
old	O
cattle	O
until	O
the	O
final	O
finishing	O
phase	O
(	O
29	O
months	O
of	O
age	O
)	O
increased	O
MS	O
,	O
but	O
not	O
in	O
23	O
-	O
month	O
-	O
old	O
cattle	O
prior	O
to	O
finishing	O
.	O

The	O
restriction	O
enzyme	O
Tsp509I	O
(	O
10	O
U	O
)	O
was	O
used	O
to	O
digest	O
the	O
PCR	O
products	O
at	O
65	O
°	O
C	O
for	O
4	O
hours	O
.	O

Schizophrenia	O
and	O
schizoaffective	O
disorders	O
accounted	O
for	O
3	O
%	O
and	O
1	O
.	O
5	O
%,	O
respectively	O
,	O
of	O
the	O
exposed	O
cohort	O
.	O

Satiety	O
responsiveness	O
,	O
a	O
separate	O
dimension	O
of	O
child	O
intake	O
regulation	O
,	O
has	O
recently	O
been	O
linked	O
to	O
variations	O
in	O
the	O
FTO	O
gene	O
(	O
69	O
),	O
which	O
confers	O
obesity	O
risk	O
and	O
is	O
highly	O
expressed	O
in	O
the	O
hypothalamus	O
,	O
a	O
center	O
of	O
appetite	O
regulation	O
in	O
the	O
brain	O
.	O

Unlike	O
most	O
organs	O
,	O
which	O
develop	O
mostly	O
in	O
utero	O
,	O
the	O
mammary	O
gland	O
develops	O
in	O
stages	O
:	O
before	O
birth	O
,	O
at	O
puberty	O
,	O
and	O
in	O
pregnancy	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

We	O
have	O
shown	O
recently	O
that	O
feeding	O
a	O
diet	O
containing	O
10	O
-	O
fold	O
the	O
recommended	O
multivitamin	O
content	O
(	O
HV	O
)	O
to	O
Wistar	O
rats	O
during	O
pregnancy	O
results	O
in	O
increased	O
food	O
intake	O
,	O
obesity	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
in	O
both	O
adult	O
male4and	O
female5offspring	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

Similar	O
to	O
other	O
aspects	O
of	O
appetite	O
regulation	O
(	O
70	O
,	O
71	O
),	O
EAH	O
appears	O
to	O
become	O
more	O
problematic	O
throughout	O
childhood	O
(	O
45	O
,	O
72	O
).	O

Implications	O
for	O
research	O
and	O
practice	O
are	O
also	O
discussed	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Associations	O
between	O
use	O
of	O
supplements	O
and	O
socio	O
-	O
demographic	O
factors	O
,	O
pre	O
-	O
natal	O
care	O
and	O
nutritional	O
knowledge	O
Folic	O
acidIronVitamins	O
YES	O
YES	O
YES	O
N	O
%	O
pn	O
%	O
pn	O
%	O
p	O
Urban	O
environment13863	O
.	O
6	O
<	O
0	O
.	O
001	O
17178	O
.	O
80	O
.	O
1417178	O
.	O
8	O
<	O
0	O
.	O
001	O
Rural	O
environment5436	O
.	O
410155	O
.	O
210155	O
.	O
2Education	O
(	O
number	O
of	O
years	O
)	O
≤	O
8115	O
.	O
7	O
<	O
0	O
.	O
001	O
4524	O
.	O
9	O
<	O
0	O
.	O
001	O
4315	O
.	O
8	O
<	O
0	O
.	O
001	O
9	O
-	O
128242	O
.	O
77541	O
.	O
411040	O
.	O
4	O
>	O
129951	O
.	O
6	O
6133	O
.	O
7	O
11943	O
.	O
8	O
Age	O
(	O
years	O
old	O
)	O
<	O
1800	O
<	O
0	O
.	O
001	O
942	O
.	O
9	O
0	O
.	O
043	O
942	O
.	O
9	O
0	O
.	O
011	O
≥	O
1819250	O
.	O
726369	O
.	O
426369	O
.	O
4Number	O
of	O
births	O
≤	O
217352	O
.	O
624273	O
.	O
624273	O
.	O
6	O
>	O
21926	O
.	O
83042	O
.	O
33042	O
.	O
3Wanted	O
pregnancy17949	O
.	O
9	O
0	O
.	O
017	O
25470	O
.	O
8	O
0	O
.	O
009	O
25470	O
.	O
8	O
<	O
0	O
.	O
001	O
Unwanted	O
pregnancy1230	O
.	O
01742	O
.	O
51742	O
.	O
5	O
Married17654	O
.	O
5	O
<	O
0	O
.	O
001	O
23572	O
.	O
8	O
0	O
.	O
01	O
23572	O
.	O
8	O
<	O
0	O
.	O
001	O
Single1620	O
.	O
83748	O
.	O
13748	O
.	O
1Pregnancy	O
registration	O
General	O
practitioner	O
Yes18949	O
.	O
1	O
0	O
.	O
027	O
26769	O
.	O
40	O
.	O

AA	O
exists	O
in	O
limited	O
levels	O
in	O
liver	O
,	O
meat	O
and	O
eggs	O
,	O
but	O
can	O
be	O
metabolized	O
in	O
humans	O
from	O
other	O
fatty	O
acids	O
in	O
the	O
omega	O
-	O
6	O
fatty	O
acid	O
family	O
.	O

There	O
were	O
no	O
differences	O
in	O
neonatal	O
outcomes	O
.	O

Methylation	O
extent	O
was	O
calculated	O
as	O
the	O
mean	O
LINE	O
-	O
1	O
methylation	O
of	O
four	O
positions	O
in	O
the	O
element	O
and	O
mean	O
AluYb8	O
methylation	O
of	O
five	O
positions	O
in	O
the	O
element	O
.	O

Likewise	O
,	O
non	O
-	O
vaccination	O
status	O
was	O
corroborated	O
if	O
no	O
information	O
on	O
vaccination	O
including	O
specific	O
date	O
for	O
vaccination	O
was	O
identified	O
from	O
these	O
sources	O
.	O

However	O
,	O
why	O
would	O
foreign	O
air	O
pollution	O
of	O
today	O
do	O
what	O
American	O
air	O
pollution	O
of	O
the	O
1950s	O
and	O
60s	O
could	O
not	O
?	O

Results	O
We	O
evaluated	O
pregnant	O
women	O
aged	O
20	O
to	O
46	O
yrs	O
.	O

Folate	O
Status	O
Both	O
brain	O
(	O
Figure	O
6a	O
)	O
and	O
plasma	O
(	O
Figure	O
6b	O
)	O
folate	O
levels	O
were	O
unaffected	O
by	O
the	O
diets	O
of	O
the	O
dams	O
but	O
were	O
elevated	O
by	O
the	O
high	O
multivitamin	O
or	O
high	O
folate	O
pup	O
diet	O
.	O

β	O
:	O
Parameter	O
estimate	O
indicating	O
the	O
alteration	O
in	O
HRV	O
components	O
caused	O
by	O
one	O
unit	O
of	O
change	O
in	O
the	O
independent	O
variable	O
;	O
SE	O
:	O
Standard	O
error	O
;	O
CI	O
:	O
Confidence	O
interval	O
;	O
BMI	O
—	O
Body	O
Mass	O
Index	O
;	O
RMSSD	O
—	O
Root	O
Mean	O
Square	O
of	O
Successive	O
Differences	O
;	O
pNN50	O
—	O
Percentage	O
of	O
Differences	O
Between	O
Adjacent	O
Normal	O
-	O
to	O
-	O
Normal	O
Intervals	O
that	O
is	O
Greater	O
than	O
50	O
Milliseconds	O
;	O
HF	O
(	O
n	O
.	O
u	O
.	O

Women	O
in	O
the	O
highest	O
quartile	O
of	O
healthy	O
dietary	O
pattern	O
were	O
more	O
likely	O
to	O
be	O
employed	O
and	O
graduated	O
and	O
have	O
employed	O
husband	O
,	O
history	O
of	O
IUGR	O
,	O
and	O
less	O
history	O
of	O
early	O
delivery	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Repeat	O
element	O
methylation	O
markers	O
grouped	O
by	O
in	O
utero	O
exposures	O
.	O
Group	O
mean	O
±	O
SDExposure	O
n	O
LINE	O
-	O
1AluYb8Array	O
-	O
based	O
methylationSexMale19051	O
.	O
7	O
±	O
4	O
.	O
465	O
.	O
3	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012Female19051	O
.	O
7	O
±	O
4	O
.	O
964	O
.	O
6	O
±	O
3	O
.	O
30	O
.	O
237	O
±	O
0	O
.	O
013	O
p	O
-	O
Value0	O
.	O
900	O
.	O
040	O
.	O
28Maternal	O
ethnicityCaucasian21751	O
.	O
4	O
±	O
4	O
.	O
564	O
.	O
9	O
±	O
3	O
.	O
30	O
.	O
239	O
±	O
0	O
.	O
013Non	O
-	O
Caucasian16352	O
.	O
0	O
±	O
4	O
.	O
865	O
.	O
1	O
±	O
3	O
.	O
30	O
.	O
236	O
±	O
0	O
.	O
011	O
p	O
-	O
Value0	O
.	O
210	O
.	O
470	O
.	O
17Maternal	O
tobacco	O
use	O
during	O
pregnancyYes3652	O
.	O
9	O
±	O
4	O
.	O
766	O
.	O
2	O
±	O
2	O
.	O
30	O
.	O
240	O
±	O
0	O
.	O
011No34351	O
.	O
6	O
±	O
4	O
.	O
664	O
.	O
8	O
±	O
3	O
.	O
40	O
.	O
237	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
10	O
<	O
0	O
.	O
010	O
.	O
31Maternal	O
alcohol	O
use	O
during	O
pregnancyYes355	O
.	O
0	O
±	O
1	O
.	O
066	O
.	O
0	O
±	O
3	O
.	O
40	O
.	O
230	O
±	O
0	O
.	O
001No37751	O
.	O
7	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012	O
p	O
-	O
Value0	O
.	O
020	O
.	O
660	O
.	O
51Maternal	O
prenatal	O
vitamin	O
use	O
during	O
pregnancyYes31451	O
.	O
8	O
±	O
4	O
.	O
665	O
.	O
0	O
±	O
3	O
.	O
30	O
.	O
238	O
±	O
0	O
.	O
012No6651	O
.	O
3	O
±	O
4	O
.	O
764	O
.	O
6	O
±	O
3	O
.	O
40	O
.	O
238	O
±	O
0	O
.	O
014	O
p	O
-	O
Value0	O
.	O
500	O
.	O
290	O
.	O
80	O
p	O
-	O
Values	O
obtained	O
from	O
Kruskal	O
–	O
Wallis	O
tests	O
.	O

(	O
2014	O
)‡	O
Yang	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
6	O
month	O
infant	O
neurodevelopmental	O
outcomes	O
by	O
treatment	O
group	O
,	O
assessed	O
by	O
the	O
Ages	O
and	O
Stages	O
QuestionnaireOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueCommunication	O
domain51	O
.	O
30	O
(	O
9	O
.	O
03	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
63	O
)	O
0	O
.	O
35	O
(−	O
0	O
.	O
68	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
5010	O
.	O
36	O
(−	O
0	O
.	O
67	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
493Gross	O
motor	O
domain53	O
.	O
35	O
(	O
10	O
.	O
05	O
)	O
52	O
.	O
74	O
(	O
10	O
.	O
84	O
)	O
0	O
.	O
61	O
(−	O
0	O
.	O
54	O
,	O
1	O
.	O
75	O
)	O
0	O
.	O
2970	O
.	O
55	O
(−	O
0	O
.	O
59	O
,	O
1	O
.	O
69	O
)	O
0	O
.	O
344Fine	O
motor	O
domain52	O
.	O
25	O
(	O
10	O
.	O
52	O
)	O
51	O
.	O
20	O
(	O
10	O
.	O
74	O
)	O
1	O
.	O
05	O
(−	O
0	O
.	O
11	O
,	O
2	O
.	O
21	O
)	O
0	O
.	O
0751	O
.	O
00	O
(−	O
0	O
.	O
13	O
,	O
2	O
.	O
14	O
)	O
0	O
.	O
082Problem	O
solving	O
domain53	O
.	O
60	O
(	O
9	O
.	O
55	O
)	O
52	O
.	O
86	O
(	O
9	O
.	O
15	O
)	O
0	O
.	O
74	O
(−	O
0	O
.	O
29	O
,	O
1	O
.	O
76	O
)	O
0	O
.	O
1580	O
.	O
72	O
(−	O
0	O
.	O
31	O
,	O
1	O
.	O
74	O
)	O
0	O
.	O
170Social	O
domain51	O
.	O
71	O
(	O
9	O
.	O
52	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
74	O
)	O
0	O
.	O
77	O
(−	O
0	O
.	O
34	O
,	O
1	O
.	O
87	O
)	O
0	O
.	O
1730	O
.	O
69	O
(−	O
0	O
.	O
41	O
,	O
1	O
.	O
79	O
)	O
0	O
.	O
218Total	O
score262	O
.	O
47	O
(	O
34	O
.	O
92	O
)	O
258	O
.	O
72	O
(	O
36	O
.	O
54	O
)	O
3	O
.	O
75	O
(−	O
0	O
.	O
13	O
,	O
7	O
.	O
63	O
)	O
0	O
.	O
0583	O
.	O
53	O
(−	O
0	O
.	O
33	O
,	O
7	O
.	O
40	O
)	O
0	O
.	O
073More	O
than	O
1	O
score	O
below	O
cut	O
-	O
off	O
*	O
49	O
(	O
4	O
.	O
58	O
)	O
69	O
(	O
6	O
.	O
51	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
44	O
,	O
1	O
.	O
12	O
)	O
0	O
.	O
1370	O
.	O
69	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
126	O
Values	O
are	O
mean	O
and	O
standard	O
deviation	O
(	O
or	O
number	O
and	O
percentage	O
),	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
(	O
or	O
relative	O
risks	O
)	O
and	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

Neither	O
trial	O
utilised	O
a	O
placebo	O
-	O
controlled	O
design	O
,	O
limiting	O
the	O
interpretation	O
of	O
the	O
study	O
results	O
.	O

to	O
expand	O
the	O
delivery	O
of	O
services	O
in	O
selected	O
districts	O
of	O
some	O
of	O
the	O
states	O
of	O
the	O
country	O
)	O
(	O
1	O
).	O

Indeed	O
,	O
beta	O
actin	O
did	O
not	O
differ	O
between	O
the	O
SC	O
and	O
VitD	O
-	O
mice	O
(	O
data	O
not	O
shown	O
).	O

This	O
work	O
showed	O
that	O
women	O
with	O
signs	O
of	O
insulin	O
resistance	O
produced	O
about	O
half	O
as	O
much	O
milk	O
as	O
those	O
without	O
.	O
34It	O
is	O
important	O
to	O
note	O
,	O
she	O
says	O
,	O
that	O
all	O
the	O
women	O
in	O
this	O
study	O
had	O
concerns	O
about	O
their	O
milk	O
production	O
and	O
were	O
already	O
supplementing	O
with	O
formula	O
.	O

Pregnant	O
women	O
were	O
advised	O
to	O
use	O
the	O
daily	O
supplements	O
provided	O
through	O
Government	O
antenatal	O
clinics	O
,	O
or	O
if	O
these	O
were	O
not	O
available	O
,	O
to	O
use	O
a	O
double	O
dose	O
of	O
the	O
weekly	O
supplements	O
.	O

Elastic	O
Net	O
selected	O
the	O
same	O
variables	O
as	O
LASSO	O
,	O
as	O
well	O
as	O
an	O
additional	O
5	O
PCBs	O
and	O
1	O
PBDE	O
.	O

Interaction	O
between	O
diet	O
and	O
sex	O
was	O
found	O
in	O
the	O
plasma	O
levels	O
of	O
bilirubin	O
and	O
ALT	O
(	O
Table1	O
),	O
and	O
an	O
almost	O
significant	O
interaction	O
in	O
leptin	O
levels	O
[	O
F	O
(	O
1	O
,	O
18	O
)=	O
3	O
.	O
349	O
,	O
P	O
=	O
0	O
.	O
084	O
].	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
mothers	O
and	O
offspring	O
who	O
had	O
information	O
on	O
at	O
least	O
one	O
of	O
the	O
outcomes	O
of	O
interest	O
(	O
wheeze	O
,	O
asthma	O
,	O
atopy	O
,	O
eczema	O
,	O
hay	O
fever	O
,	O
total	O
IgE	O
and	O
lung	O
function	O
)	O
by	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
#	O
Free	O
sugar	O
intake	O
g	O
·	O
day	O
−	O
1p	O
-	O
valueQuintile	O
1	O
(	O
1	O
.	O
6	O
–	O
34	O
.	O
0	O
)	O
Quintile	O
2	O
(	O
34	O
.	O
0	O
–	O
46	O
.	O
6	O
)	O
Quintile	O
3	O
(	O
46	O
.	O
6	O
–	O
60	O
.	O
8	O
)	O
Quintile	O
4	O
(	O
60	O
.	O
8	O
–	O
82	O
.	O
4	O
)	O
Quintile	O
5	O
(	O
82	O
.	O
4	O
–	O
345	O
.	O
1	O
)	O
Mother	O
'	O
s	O
age	O
years	O
29	O
.	O
4	O
±	O
4	O
.	O
729	O
.	O
1	O
±	O
4	O
.	O
529	O
.	O
2	O
±	O
4	O
.	O
628	O
.	O
9	O
±	O
4	O
.	O
527	O
.	O
9	O
±	O
4	O
.	O
7	O
<	O
0	O
.	O
001	O
Parity	O
043	O
.	O
246	O
.	O
148	O
.	O
644	O
.	O
944	O
.	O
00	O
.	O
001	O
135	O
.	O
437	O
.	O
235	O
.	O
136	O
.	O
335	O
.	O
9	O
≥	O
221	O
.	O
416	O
.	O
716	O
.	O
318	O
.	O
820	O
.	O
0	O
Sex	O
of	O
child	O
Male51	O
.	O
252	O
.	O
350	O
.	O
552	O
.	O
349	O
.	O
50	O
.	O
39	O
Female48	O
.	O
847	O
.	O
749	O
.	O
547	O
.	O
750	O
.	O
5	O
Multiple	O
pregnancy	O
Singleton97	O
.	O
396	O
.	O
798	O
.	O
098	O
.	O
397	O
.	O
30	O
.	O
01	O
Twin2	O
.	O
73	O
.	O
32	O
.	O
01	O
.	O
72	O
.	O
7	O
Season	O
of	O
birth	O
Winter15	O
.	O
017	O
.	O
616	O
.	O
615	O
.	O
716	O
.	O
0	O
<	O
0	O
.	O
001	O
Spring23	O
.	O
625	O
.	O
326	O
.	O
829	O
.	O
130	O
.	O
7	O
Summer33	O
.	O
129	O
.	O
331	O
.	O
828	O
.	O
927	O
.	O
1	O
Autumn28	O
.	O
327	O
.	O
824	O
.	O
926	O
.	O
426	O
.	O
2	O
Breastfeeding	O
duration	O
months	O
Never21	O
.	O
318	O
.	O
917	O
.	O
522	O
.	O
127	O
.	O
1	O
<	O
0	O
.	O
001	O
<	O
334	O
.	O
030	O
.	O
030	O
.	O
129	O
.	O
234	O
.	O
2	O
3	O
–	O
613	O
.	O
114	O
.	O
914	O
.	O
613	O
.	O
312	O
.	O
8	O
≥	O
631	O
.	O
536	O
.	O
337	O
.	O
435	O
.	O
425	O
.	O
9	O
Mother	O
'	O
s	O
educational	O
level	O
Certificate	O
of	O
Secondary	O
Education16	O
.	O
712	O
.	O
913	O
.	O
414	O
.	O
520	O
.	O
4	O
<	O
0	O
.	O
001	O
Vocational8	O
.	O
69	O
.	O
28	O
.	O
18	O
.	O
510	O
.	O
8	O
Ordinary	O
level36	O
.	O
235	O
.	O
032	O
.	O
835	O
.	O
138	O
.	O
8	O
Advanced	O
level24	O
.	O
626	O
.	O
626	O
.	O
326	O
.	O
021	O
.	O
2	O
Degree14	O
.	O
016	O
.	O
219	O
.	O
415	O
.	O
98	O
.	O
9	O
Maternal	O
ethnicity	O
White97	O
.	O
897	O
.	O
298	O
.	O
598	O
.	O
498	O
.	O
80	O
.	O
003	O
Non	O
-	O
white2	O
.	O
22	O
.	O
81	O
.	O
51	O
.	O
61	O
.	O
2	O
Housing	O
tenure	O
Owned	O
/	O
mortgaged82	O
.	O
686	O
.	O
586	O
.	O
585	O
.	O
176	O
.	O
8	O
<	O
0	O
.	O
001	O
Council	O
rented9	O
.	O
97	O
.	O
26	O
.	O
68	O
.	O
815	O
.	O
8	O
Non	O
-	O
council	O
rented7	O
.	O
56	O
.	O
37	O
.	O
06	O
.	O
17	O
.	O
5	O
Financial	O
difficulties	O
No82	O
.	O
682	O
.	O
884	O
.	O
385	O
.	O
378	O
.	O
8	O
<	O
0	O
.	O
001	O
Yes17	O
.	O
417	O
.	O
215	O
.	O
714	O
.	O
721	O
.	O
2	O
Maternal	O
history	O
of	O
atopic	O
diseases	O
No32	O
.	O
232	O
.	O
033	O
.	O
731	O
.	O
428	O
.	O
90	O
.	O
05	O
Yes67	O
.	O
868	O
.	O
066	O
.	O
368	O
.	O
671	O
.	O
1	O
Maternal	O
anxiety	O
score	O
during	O
pregnancy	O
0	O
–	O
924	O
.	O
023	O
.	O
423	O
.	O
120	O
.	O
814	O
.	O
3	O
<	O
0	O
.	O
001	O
10	O
–	O
1425	O
.	O
127	O
.	O
525	O
.	O
726	O
.	O
124	O
.	O
3	O
15	O
–	O
2024	O
.	O
425	O
.	O
127	O
.	O
327	O
.	O
125	O
.	O
4	O
≥	O
2026	O
.	O
524	O
.	O
124	O
.	O
026	O
.	O
136	O
.	O
1	O
Maximum	O
maternal	O
tobacco	O
exposure	O
cigarettes	O
·	O
day	O
−	O
1	O
None27	O
.	O
827	O
.	O
628	O
.	O
928	O
.	O
219	O
.	O
2	O
<	O
0	O
.	O
001	O
Passive	O
only45	O
.	O
448	O
.	O
547	O
.	O
346	O
.	O
042	O
.	O
3	O
1	O
–	O
97	O
.	O
67	O
.	O
78	O
.	O
18	O
.	O
08	O
.	O
1	O
10	O
–	O
1912	O
.	O
510	O
.	O
19	O
.	O
410	O
.	O
115	O
.	O
2	O
≥	O
206	O
.	O
76	O
.	O
26	O
.	O
27	O
.	O
715	O
.	O
2	O
Maternal	O
paracetamol	O
use	O
during	O
pregnancy	O
No38	O
.	O
038	O
.	O
037	O
.	O
738	O
.	O
036	O
.	O
40	O
.	O
86	O
Yes62	O
.	O
062	O
.	O
062	O
.	O
362	O
.	O
063	O
.	O
6	O
Maternal	O
antibiotic	O
use	O
during	O
pregnancy	O
No83	O
.	O
785	O
.	O
484	O
.	O
083	O
.	O
782	O
.	O
90	O
.	O
34	O
Yes16	O
.	O
314	O
.	O
616	O
.	O
016	O
.	O
317	O
.	O
1	O
Maternal	O
supplement	O
use	O
during	O
pregnancy	O
No44	O
.	O
543	O
.	O
144	O
.	O
441	O
.	O
941	O
.	O
60	O
.	O
26	O
Yes55	O
.	O
556	O
.	O
955	O
.	O
658	O
.	O
158	O
.	O
4	O
Maternal	O
infections	O
during	O
pregnancy	O
No57	O
.	O
255	O
.	O
155	O
.	O
853	O
.	O
349	O
.	O
3	O
<	O
0	O
.	O
001	O
Yes42	O
.	O
844	O
.	O
944	O
.	O
246	O
.	O
750	O
.	O
7	O
Total	O
energy	O
intake	O
kJ	O
·	O
day	O
−	O
15567	O
±	O
13766499	O
±	O
13267166	O
±	O
13607931	O
±	O
14889317	O
±	O
1994	O
<	O
0	O
.	O
001	O
Maternal	O
pre	O
-	O
pregnancy	O
BMI	O
kg	O
·	O
m	O
−	O
2	O
<	O
18	O
.	O
502	O
.	O
72	O
.	O
84	O
.	O
44	O
.	O
08	O
.	O
1	O
<	O
0	O
.	O
001	O
18	O
.	O
50	O
–	O
24	O
.	O
9970	O
.	O
874	O
.	O
377	O
.	O
776	O
.	O
777	O
.	O
4	O
25	O
.	O
00	O
–	O
29	O
.	O
9917	O
.	O
717	O
.	O
113	O
.	O
514	O
.	O
811	O
.	O
6	O
≥	O
30	O
.	O
008	O
.	O
85	O
.	O
84	O
.	O
44	O
.	O
52	O
.	O
9	O
Birthweight	O
g	O
<	O
25004	O
.	O
24	O
.	O
03	O
.	O
64	O
.	O
35	O
.	O
60	O
.	O
02	O
2500	O
–	O
299914	O
.	O
213	O
.	O
213	O
.	O
912	O
.	O
815	O
.	O
2	O
3000	O
–	O
349934	O
.	O
834	O
.	O
935	O
.	O
136	O
.	O
735	O
.	O
6	O
3500	O
–	O
399932	O
.	O
233	O
.	O
633	O
.	O
533	O
.	O
633	O
.	O
0	O
≥	O
400014	O
.	O
714	O
.	O
413	O
.	O
812	O
.	O
611	O
.	O
0	O
Gestational	O
age	O
weeks	O
39	O
.	O
4	O
±	O
1	O
.	O
839	O
.	O
5	O
±	O
1	O
.	O
739	O
.	O
5	O
±	O
1	O
.	O
739	O
.	O
5	O
±	O
1	O
.	O
839	O
.	O
4	O
±	O
1	O
.	O
90	O
.	O
28	O
Child	O
'	O
s	O
BMI	O
at	O
age	O
7	O
years	O
kg	O
·	O
m	O
−	O
2	O
<	O
15	O
.	O
0025	O
.	O
826	O
.	O
330	O
.	O
327	O
.	O
730	O
.	O
7	O
<	O
0	O
.	O
001	O
15	O
.	O
00	O
–	O
17	O
.	O
4951	O
.	O
952	O
.	O
351	O
.	O
254	O
.	O
452	O
.	O
6	O
17	O
.	O
50	O
–	O
20	O
.	O
4917	O
.	O
216	O
.	O
614	O
.	O
214	O
.	O
313	O
.	O
6	O
≥	O
20	O
.	O
505	O
.	O
24	O
.	O
84	O
.	O
33	O
.	O
53	O
.	O
1	O
Maternal	O
weight	O
gain	O
during	O
pregnancy	O
Quartile	O
130	O
.	O
323	O
.	O
724	O
.	O
523	O
.	O
524	O
.	O
5	O
<	O
0	O
.	O
001	O
Quartile	O
224	O
.	O
325	O
.	O
025	O
.	O
124	O
.	O
725	O
.	O
0	O
Quartile	O
324	O
.	O
227	O
.	O
026	O
.	O
326	O
.	O
423	O
.	O
4	O
Quartile	O
421	O
.	O
324	O
.	O
324	O
.	O
125	O
.	O
427	O
.	O
1	O
Data	O
are	O
presented	O
as	O
mean	O
±	O
sdor	O
%,	O
unless	O
otherwise	O
stated	O
.	O

¶	O
Studies	O
in	O
which	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
epigenetic	O
change	O
(	O
s	O
)	O
were	O
reported	O
in	O
separate	O
publications	O
but	O
were	O
performed	O
within	O
the	O
same	O
experimental	O
animals	O
.	O

Weitz	O
et	O
al	O
.	O

Conclusion	O
Low	O
cord	O
25	O
(	O
OH	O
)	O
D	O
levels	O
are	O
seen	O
in	O
Hispanic	O
infants	O
,	O
but	O
their	O
functional	O
significance	O
is	O
uncertain	O
related	O
to	O
bone	O
health	O
in	O
a	O
southern	O
US	O
setting	O
.	O

1	O
Flow	O
chart	O
of	O
the	O
study	O
inclusion	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Characteristics	O
of	O
the	O
pregnant	O
women	O
and	O
their	O
infants	O
at	O
birthMeanSDBirth	O
weight	O
(	O
grams	O
)	O
a3542537	O
.	O
7Birth	O
length	O
(	O
cm	O
)	O
a502	O
.	O
3Gestational	O
age	O
at	O
delivery	O
(	O
days	O
)	O
28012	O
.	O
4Gestational	O
age	O
T1	O
(	O
days	O
)	O
7613	O
.	O
8Gestational	O
age	O
T3	O
(	O
days	O
)	O
23412	O
.	O
9Maternal	O
s	O
-	O
25OHD	O
T1	O
(	O
nmol	O
/	O
L	O
)	O
6424	O
.	O
4Maternal	O
s	O
-	O
25OHD	O
T3	O
(	O
nmol	O
/	O
L	O
)	O
7534	O
.	O
4N	O
(%)	O
Male	O
gender	O
of	O
infanta976	O
(	O
49	O
.	O
8	O
)	O
Small	O
for	O
gestational	O
age	O
(	O
weight	O
or	O
length	O
)	O
93	O
(	O
4	O
.	O
5	O
)	O
Low	O
birth	O
weight	O
(<	O
2500	O
g	O
)	O
58	O
(	O
2	O
.	O
8	O
)	O
Preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
78	O
(	O
3	O
.	O
8	O
)	O
Spontaneous	O
preterm	O
delivery	O
(<	O
37	O
weeks	O
)	O
55	O
(	O
2	O
.	O
7	O
)	O
Pregnancy	O
loss97	O
(	O
4	O
.	O
7	O
)	O
Intrauterine	O
fetal	O
death	O
(≥	O
22	O
weeks	O
)	O
9	O
(	O
0	O
.	O
5	O
)	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
aLive	O
born	O
infants	O
only	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
The	O
pregnant	O
women	O
’	O
s	O
vitamin	O
D	O
status	O
in	O
the	O
first	O
(	O
T1	O
)	O
and	O
third	O
(	O
T3	O
)	O
trimester	O
of	O
pregnancy	O
,	O
and	O
their	O
characteristics	O
(	O
mean	O
or	O
percent	O
)	O
grouped	O
by	O
25OHD	O
concentration	O
in	O
(	O
T1	O
)	O
T1	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N198291788565125	O
%	O
10	O
.	O
114	O
.	O
840	O
.	O
128	O
.	O
76	O
.	O
4BMI	O
T1	O
(	O
kg	O
/	O
m2	O
)	O
25	O
.	O
124	O
.	O
924	O
.	O
423	O
.	O
924	O
.	O
4Age	O
T1	O
(	O
years	O
)	O
29	O
.	O
430	O
.	O
931	O
.	O
632	O
.	O
032	O
.	O
4Born	O
in	O
Sweden	O
(%)	O
14	O
.	O
154	O
.	O
683	O
.	O
387	O
.	O
893	O
.	O
5Tobacco	O
use	O
T1	O
(%)	O
6	O
.	O
84	O
.	O
64	O
.	O
04	O
.	O
61	O
.	O
6Nulliparous	O
T1	O
(%)	O
34	O
.	O
842	O
.	O
042	O
.	O
643	O
.	O
142	O
.	O
7Vitamin	O
D	O
supplement	O
use	O
T1	O
(%)	O
10	O
.	O
628	O
.	O
245	O
.	O
256	O
.	O
662	O
.	O
9University	O
level	O
education	O
(%)	O
32	O
.	O
354	O
.	O
961	O
.	O
367	O
.	O
366	O
.	O
1Small	O
for	O
gestational	O
age	O
(%)	O
5	O
.	O
74	O
.	O
25	O
.	O
34	O
.	O
14	O
.	O
0Preterm	O
delivery	O
(%)	O
4	O
.	O
15	O
.	O
23	O
.	O
83	O
.	O
91	O
.	O
6Low	O
birth	O
weight	O
(%)	O
3	O
.	O
04	O
.	O
53	O
.	O
12	O
.	O
11	O
.	O
6Pregnancy	O
loss	O
(%)	O
6	O
.	O
35	O
.	O
64	O
.	O
55	O
.	O
10T3	O
25OHD	O
(	O
nmol	O
/	O
L	O
)<	O
3030	O
–	O
49	O
.	O
950	O
–	O
74	O
.	O
975	O
–	O
99	O
.	O
9	O
≥	O
100N163330473409443	O
%	O
9	O
.	O
018	O
.	O
226	O
.	O
022	O
.	O
524	O
.	O
4Small	O
for	O
gestational	O
age	O
(%)	O
7	O
.	O
55	O
.	O
54	O
.	O
74	O
.	O
62	O
.	O
3Preterm	O
delivery	O
(%)	O
4	O
.	O
31	O
.	O
23	O
.	O
62	O
.	O
21	O
.	O
6Low	O
birth	O
weight	O
(%)	O
4	O
.	O
30	O
.	O
32	O
.	O
71	O
.	O
21	O
.	O
4	O
T1	O
first	O
trimester	O
,	O
T3	O
third	O
trimester	O
,	O
25OHD	O
25	O
-	O
hydroxyvitamin	O
D	O
Birth	O
size	O
and	O
preterm	O
delivery	O
In	O
total	O
,	O
93	O
(	O
4	O
.	O
5	O
%)	O
infants	O
were	O
born	O
SGA	O
.	O

VD	O
serum	O
levels	O
are	O
inversely	O
proportional	O
to	O
blood	O
pressure	O
,	O
lipid	O
levels	O
,	O
insulin	O
resistance	O
and	O
metabolic	O
syndrome	O
symptoms	O
in	O
PCOS	O
patients	O
[	O
27	O
,	O
28	O
,	O
29	O
,	O
30	O
].	O
Figure	O
2shows	O
how	O
VD	O
deficiency	O
,	O
together	O
with	O
obesity	O
,	O
may	O
increase	O
insulin	O
resistance	O
and	O
deplete	O
glucose	O
transport	O
through	O
cellular	O
walls	O
—	O
VD	O
stimulates	O
insulin	O
receptor	O
expression	O
and	O
insulin	O
secretion	O
[	O
31	O
].	O

PubMed	O
Central	O
:	O

Multiple	O
national	O
cohort	O
studies	O
have	O
found	O
associations	O
between	O
maternal	O
obesity	O
and	O
shorter	O
duration	O
of	O
breastfeeding	O
,	O
29although	O
the	O
reasons	O
for	O
this	O
relationship	O
are	O
not	O
clear	O
.	O

Results	O
Descriptive	O
analysis	O
From	O
July	O
21st	O
through	O
December	O
4th	O
2014	O
,	O
we	O
interviewed	O
and	O
collected	O
surveys	O
on	O
4808	O
post	O
-	O
partum	O
women	O
.	O

Briefly	O
,	O
women	O
attending	O
one	O
of	O
three	O
UK	O
hospitals	O
[	O
University	O
Hospital	O
Southampton	O
National	O
Health	O
Service	O
(	O
NHS	O
)	O
Foundation	O
Trust	O
,	O
Southampton	O
,	O
UK	O
(	O
latitude	O
50	O
.	O
9	O
°	O
North	O
);	O
Oxford	O
University	O
Hospitals	O
NHS	O
Foundation	O
Trust	O
,	O
Oxford	O
,	O
UK	O
(	O
latitude	O
51	O
.	O
8	O
°	O
North	O
);	O
Sheffield	O
Hospitals	O
NHS	O
Trust	O
(	O
University	O
of	O
Sheffield	O
),	O
Sheffield	O
,	O
UK	O
(	O
latitude	O
53	O
.	O
4	O
°	O
North	O
)]	O
for	O
early	O
pregnancy	O
ultrasound	O
screening	O
(	O
11	O
to	O
14	O
weeks	O
of	O
gestation	O
)	O
between	O
6	O
October	O
2008	O
and	O
11	O
February	O
2014	O
were	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

[	O
34	O
]	O
It	O
is	O
now	O
recognized	O
that	O
everyone	O
is	O
at	O
risk	O
for	O
vitamin	O
D	O
deficiency	O
.	O

Care	O
of	O
premature	O
babies	O
is	O
primarily	O
an	O
action	O
gap	O
As	O
evidenced	O
by	O
the	O
large	O
survival	O
gap	O
between	O
babies	O
born	O
in	O
high	O
-	O
income	O
countries	O
and	O
those	O
born	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
effective	O
interventions	O
exist	O
to	O
reduce	O
death	O
and	O
disability	O
in	O
premature	O
babies	O
,	O
yet	O
this	O
care	O
does	O
not	O
reach	O
the	O
poor	O
and	O
most	O
disadvantaged	O
populations	O
where	O
the	O
burden	O
is	O
highest	O
[	O
6	O
].	O

GDM	O
increases	O
the	O
risk	O
of	O
adverse	O
pregnancy	O
and	O
neonatal	O
outcomes	O
,	O
and	O
the	O
risk	O
of	O
obesity	O
,	O
metabolic	O
syndrome	O
,	O
diabetes	O
,	O
and	O
cardiovascular	O
disease	O
in	O
later	O
life	O
both	O
of	O
the	O
mother	O
and	O
the	O
child	O
[	O
13	O
].	O

Methods	O
We	O
did	O
a	O
randomised	O
placebo	O
-	O
controlled	O
trial	O
to	O
compare	O
oral	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3with	O
placebo	O
given	O
to	O
children	O
aged	O
1	O
–	O
11	O
months	O
in	O
Kabul	O
,	O
Afghanistan	O
.	O

Infant	O
sex	O
and	O
maternal	O
ethnicity	O
were	O
also	O
significant	O
predictors	O
of	O
birth	O
weight	O
percentile	O
(	O
Table	O
1	O
);	O
all	O
other	O
covariates	O
were	O
not	O
significant	O
.	O

After	O
adjusting	O
for	O
obstetrical	O
factors	O
(	O
model	O
3	O
),	O
there	O
was	O
a	O
positive	O
significant	O
relationship	O
between	O
adherence	O
to	O
western	O
dietary	O
pattern	O
[	O
OR	O
5	O
.	O
51	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
1	O
.	O
82	O
-	O
16	O
.	O
66	O
),	O
P	O
=	O
0	O
.	O
001	O
]	O
with	O
having	O
low	O
birth	O
weight	O
infant	O
.	O

[	O
16	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
healthy	O
young	O
Thai	O
men	O
and	O
women	O
(	O
age	O
25	O
–	O
54	O
years	O
)	O
and	O
found	O
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
three	O
-	O
fold	O
higher	O
in	O
females	O
than	O
in	O
males	O
(	O
43	O
.	O
1	O
%	O
in	O
females	O
compared	O
to	O
13	O
.	O
9	O
%	O
in	O
males	O
).	O

Methods	O
Design	O
and	O
study	O
population	O
We	O
conducted	O
a	O
cross	O
-	O
sectional	O
study	O
during	O
August	O
and	O
September	O
2010	O
on	O
a	O
sample	O
of	O
400	O
consecutive	O
women	O
who	O
had	O
given	O
birth	O
in	O
a	O
regional	O
specialist	O
obstetric	O
centre	O
,	O
the	O
Cuza	O
-	O
Vodă	O
Clinical	O
Hospital	O
in	O
Iaşi	O
,	O
Romania	O
.	O

Materials	O
and	O
methods	O
Full	O
-	O
term	O
infants	O
without	O
any	O
chronic	O
diseases	O
or	O
major	O
anomalies	O
were	O
enrolled	O
in	O
the	O
Prediction	O
of	O
Allergies	O
in	O
Taiwanese	O
Children	O
cohort	O
study	O
.	O

Feeding	O
practices	O
have	O
also	O
been	O
looked	O
at	O
,	O
as	O
well	O
as	O
maternal	O
states	O
such	O
as	O
high	O
temperature	O
or	O
an	O
unhappy	O
maternal	O
emotional	O
state	O
[	O
17	O
–	O
19	O
,	O
58	O
].	O

Finally	O
,	O
to	O
determine	O
the	O
combined	O
effects	O
of	O
SNPs	O
,	O
a	O
genotype	O
risk	O
score	O
(	O
GRS	O
)	O
was	O
calculated	O
as	O
the	O
sum	O
of	O
the	O
number	O
of	O
risk	O
alleles	O
at	O
rs10741657	O
(	O
G	O
)	O
and	O
rs2282679	O
(	O
C	O
),	O
as	O
identified	O
in	O
the	O
previous	O
analysis	O
.	O

The	O
participants	O
who	O
had	O
depression	O
scores	O
of	O
>	O
13	O
were	O
exited	O
from	O
this	O
clinical	O
trial	O
and	O
referred	O
to	O
psychiatrist	O
for	O
further	O
assessment	O
and	O
treatment	O
,	O
because	O
,	O
the	O
nature	O
of	O
our	B
study	I
was	O
preventative	O
than	O
management	O
.	O

Inconsistencies	O
in	O
the	O
literature	O
may	O
also	O
reflect	O
other	O
causative	O
factors	O
in	O
which	O
vitamin	O
D	O
is	O
a	O
mediator	O
.	O

Birth	O
by	O
Cesarean	O
Delivery	O
The	O
delivery	O
of	O
a	O
baby	O
by	O
cesarean	O
delivery	O
has	O
been	O
suggested	O
to	O
be	O
associated	O
with	O
increased	O
risk	O
of	O
allergies	O
and	O
atopic	O
diseases	O
in	O
the	O
child	O
,	O
most	O
probably	O
because	O
of	O
a	O
lower	O
bacterial	O
exposure	O
for	O
the	O
child	O
.	O

There	O
is	O
sufficient	O
evidence	O
that	O
increased	O
PFAS	O
(	O
especially	O
PFOA	O
)	O
exposure	O
is	O
associated	O
with	O
low	O
birth	O
weight	O
[	O
18	O
–	O
20	O
],	O
but	O
mixed	O
results	O
are	O
reported	O
for	O
other	O
EDCs	O
and	O
birth	O
weight	O
[	O
18	O
,	O
21	O
].	O

Published	O
studies	O
have	O
differed	O
substantially	O
from	O
one	O
another	O
in	O
design	O
and	O
in	O
ability	O
to	O
account	O
for	O
variations	O
in	O
circulating	O
influenza	O
viruses	O
,	O
vaccine	O
components	O
,	O
target	O
population	O
,	O
and	O
place	O
of	O
study	O
,	O
making	O
cross	O
-	O
study	O
comparisons	O
difficult	O
[	O
31	O
].	O

We	O
defined	O
vitamin	O
D	O
deficiency	O
as	O
<	O
50	O
nmol	O
/	O
L	O
,	O
a	O
common	O
cut	O
-	O
point	O
in	O
the	O
literature	O
.	O
5	O
,	O
22	O
,	O
23	O
Statistical	O
analyses	O
First	O
,	O
we	O
analyzed	O
bivariate	O
associations	O
between	O
25	O
(	O
OH	O
)	O
D	O
category	O
and	O
PNV	O
use	O
as	O
well	O
as	O
covariates	O
including	O
maternal	O
age	O
,	O
race	O
/	O
ethnicity	O
,	O
smoking	O
,	O
education	O
and	O
BMI	O
.	O

However	O
,	O
by	O
weeks	O
28	O
to	O
36	O
,	O
women	O
taking	O
the	O
daily	O
supplement	O
had	O
a	O
significantly	O
higher	O
prevalence	O
of	O
hemoconcentration	O
,	O
a	O
condition	O
defined	O
as	O
hemoglobin	O
levels	O
above	O
145	O
g	O
/	O
L	O
.	O

African	O
American	O
women	O
accounted	O
for	O
a	O
majority	O
(	O
69	O
%)	O
of	O
the	O
non	O
-	O
white	O
births	O
and	O
had	O
a	O
19	O
%	O
PTB	O
rate	O
.	O

This	B
review	I
concludes	O
with	O
a	O
discussion	O
highlighting	O
some	O
of	O
the	O
methodological	O
issues	O
in	O
researching	O
associations	O
between	O
diet	O
and	O
infant	O
neurodevelopment	O
.	O

To	O
enable	O
de	O
-	O
differentiation	O
of	O
the	O
highly	O
specialized	O
mature	O
male	O
and	O
female	O
gametes	O
and	O
subsequent	O
generation	O
of	O
multiple	O
specialized	O
cell	O
types	O
capable	O
of	O
performing	O
a	O
wide	O
range	O
of	O
diverse	O
functions	O
,	O
these	O
genomes	O
require	O
differential	O
modifications	O
so	O
that	O
functionally	O
relevant	O
genes	O
can	O
be	O
switched	O
on	O
/	O
off	O
.	O

Several	O
studies	O
have	O
been	O
shown	O
that	O
,	O
with	O
cutoff	O
score	O
of	O
12	O
–	O
13	O
,	O
this	O
scale	O
develops	O
into	O
more	O
indicative	O
in	O
identifying	O
real	O
depression	O
in	O
women	O
[	O
36	O
,	O
37	O
,	O
42	O
].	O

The	O
contents	O
were	O
resuspended	O
in	O
100	O
µL	O
of	O
mobile	O
phase	O
(	O
80	O
%	O
methanol	O
and	O
20	O
%	O
water	O
)	O
and	O
transferred	O
into	O
high	O
performance	O
liquid	O
chromatography	O
(	O
HPLC	O
)	O
injector	O
vials	O
.	O

This	O
results	O
in	O
the	O
increase	O
of	O
calcium	O
absorption	O
from	O
the	O
intestine	O
.	O
27	O
Previous	O
studies	O
,	O
17	O
,	O
27of	O
intramuscular	O
injection	O
of	O
600	O
,	O
000	O
unit	O
of	O
vitamin	O
D	O
was	O
associated	O
with	O
significant	O
increases	O
of	O
serum	O
vitamin	O
D	O
at	O
1	O
.	O
5	O
,	O
3	O
,	O
and	O
6	O
months	O
,	O
but	O
not	O
significant	O
at	O
9	O
and	O
12	O
months	O
later	O
.	O

Intramuscular	O
or	O
intravenous	O
iron	O
is	O
thought	O
to	O
be	O
associated	O
with	O
allergic	O
reactions	O
and	O
anaphylactic	O
shock	O
;	O
furthermore	O
,	O
parenteral	O
iron	O
is	O
thought	O
to	O
predispose	O
to	O
venous	O
thrombosis	O
and	O
occasionally	O
cardiac	O
arrest	O
and	O
death	O
[	O
2	O
].	O

After	O
adjusting	O
for	O
Medicaid	O
status	O
,	O
BMI	O
at	O
delivery	O
and	O
prenatal	O
vitamin	O
use	O
,	O
black	O
infants	O
had	O
a	O
3	O
.	O
6	O
greater	O
odds	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
CI	O
):	O
2	O
.	O
4	O
,	O
5	O
.	O
6	O
)	O
of	O
having	O
vitamin	O
D	O
deficiency	O
compared	O
with	O
white	O
infants	O
(	O
Table	O
2	O
).	O

(	O
2007	O
),	O
and	O
/	O
orSquazzo	O
et	O
al	O
.	O

None	O
of	O
the	O
other	O
variables	O
listed	O
in	O
Table1were	O
found	O
to	O
be	O
confounders	O
.	O

Persons	O
being	O
observed	O
by	O
a	O
stranger	O
,	O
such	O
as	O
a	O
study	O
data	O
collector	O
,	O
may	O
alter	O
their	O
behavior	O
compared	O
to	O
usual	O
practice	O
,	O
potentially	O
increasing	O
their	O
handwashing	O
in	O
the	O
presence	O
of	O
the	O
observer	O
[	O
29	O
,	O
30	O
].	O

While	O
it	O
has	O
been	O
suggested	O
that	O
body	O
fat	O
and	O
therefore	O
childhood	O
nutrition	O
per	O
se	O
play	O
a	O
direct	O
role	O
in	O
determining	O
the	O
age	O
of	O
pubertal	O
onset	O
[	O
36	O
],[	O
37	O
],	O
the	O
effects	O
of	O
an	O
intrauterine	O
obesogenic	O
environment	O
have	O
not	O
been	O
considered	O
.	O

2	O
.	O
1	O
.	O

The	O
Field	O
Implementers	O
will	O
then	O
visit	O
the	O
pregnant	O
mother	O
along	O
with	O
the	O
SS	O
within	O
the	O
next	O
48	O
h	O
to	O
conduct	O
a	O
pregnancy	O
test	O
and	O
enquire	O
about	O
the	O
last	O
menstrual	O
period	O
.	O

Studies	O
of	O
EAH	O
among	O
girls	O
have	O
shown	O
positive	O
associations	O
with	O
mothers	O
'	O
but	O
not	O
fathers	O
'	O
disinhibited	O
eating	O
(	O
52	O
,	O
65	O
).	O

While	O
in	O
a	O
study	O
by	O
Cassidy	O
-	O
Bushrow	O
et	O
al	O
.,	O
in	O
African	O
-	O
American	O
women	O
,	O
an	O
inverse	O
relationship	O
was	O
observed	O
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
the	O
early	O
stages	O
of	O
pregnancy	O
and	O
antenatal	O
depression	O
.	O

Examples	O
include	O
the	O
occurrence	O
of	O
generalized	O
eczema	O
requiring	O
identification	O
of	O
the	O
cause	O
before	O
treatment	O
or	O
a	O
suspected	O
allergy	O
to	O
a	O
drug	O
needed	O
for	O
therapy	O
of	O
the	O
mother	O
(	O
eg	O
,	O
penicillin	O
for	O
treating	O
syphilis	O
)	O
[	O
50	O
].	O

2009	O
).	O

Public	O
health	O
interventions	O
have	O
included	O
reducing	O
maternal	O
disease	O
,	O
prenatal	O
care	O
of	O
mothers	O
,	O
reduction	O
of	O
exposure	O
to	O
teratogens	O
(	O
agent	O
that	O
can	O
disturb	O
the	O
development	O
of	O
an	O
embryo	O
or	O
fetus	O
),	O
and	O
nutritional	O
interventions	O
[	O
2	O
].	O

These	O
both	O
provide	O
evidence	O
that	O
DNA	O
methylation	O
can	O
be	O
stably	O
inherited	O
,	O
and	O
highlight	O
specific	O
loci	O
protected	O
from	O
global	O
epigenetic	O
erasure	O
that	O
could	O
be	O
involved	O
in	O
transmitting	O
epigenetic	O
information	O
across	O
generations	O
.	O

Our	O
case	O
report	O
highlights	O
the	O
early	O
,	O
successful	O
diagnosis	O
and	O
surgical	O
repair	O
of	O
a	O
healthy	O
41	O
-	O
year	O
-	O
old	O
female	O
who	O
presented	O
with	O
an	O
acute	O
type	O
A	O
aortic	O
dissection	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
.	O

Of	O
the	O
139	O
PTBs	O
,	O
approximately	O
half	O
were	O
spontaneous	O
(	O
47	O
%)	O
and	O
half	O
were	O
indicated	O
(	O
53	O
%),	O
of	O
the	O
latter	O
,	O
66	O
%	O
were	O
indicated	O
for	O
maternal	O
hypertensive	O
disorders	O
.	O

Because	O
of	O
substantial	O
antibody	O
levels	O
from	O
transplacental	O
transmission	O
,	O
infants	O
are	O
less	O
likely	O
to	O
get	O
respiratory	O
infection	O
before	O
6	O
months	O
of	O
age	O
.	O

The	O
experiment	O
comprises	O
a	O
valuable	O
model	O
especially	O
for	O
'	O
fetal	O
'	O
programming	O
,	O
because	O
cross	O
-	O
fostering	O
enabled	O
assessment	O
of	O
solely	O
the	O
nutritional	O
effects	O
during	O
gestation	O
.	O

The	O
20	O
µl	O
reactions	O
were	O
incubated	O
for	O
1	O
h	O
at	O
37	O
°	O
C	O
and	O
held	O
at	O
4	O
°	O
C	O
.	O

In	O
the	O
preterm	O
group	O
,	O
the	O
dynamics	O
of	O
GR	O
splicing	O
were	O
altered	O
,	O
since	O
GR	O
α	O
correlated	O
with	O
GR	O
-	O
P	O
(	O
r	O
=	O
0	O
.	O
710	O
,	O
P	O
=	O
0	O
.	O
021	O
)	O
and	O
GR	O
β	O
correlated	O
with	O
GAS5	O
(	O
r	O
=	O
0	O
.	O
792	O
,	O
P	O
=	O
0	O
.	O
011	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Arachnodactyly	O
and	O
kinked	O
tail	O
in	O
skeletal	O
morphology	O
mutant	O
1	O
(	O
Skm1	O
).	O

Results	O
The	O
present	O
study	O
was	O
conducted	O
on	O
100	O
children	O
(	O
63	O
boys	O
and	O
37	O
girls	O
)	O
with	O
a	O
mean	O
age	O
of	O
8	O
.	O
85	O
years	O
(	O
Range	O
:	O
6	O
–	O
14	O
;	O
SD	O
=	O
1	O
.	O
82	O
years	O
).	O

If	O
an	O
environmental	O
exposure	O
is	O
truly	O
transgenerational	O
,	O
then	O
:	O
(	O
1	O
)	O
following	O
an	O
in	O
utero	O
exposure	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	O
least	O
the	O
F3generation	O
(	O
great	O
-	O
great	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
mother	O
and	O
F3represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
;	O
or	O
(	O
2	O
)	O
following	O
an	O
ex	O
utero	O
exposure	O
in	O
childhood	O
/	O
adulthood	O
the	O
resulting	O
change	O
penetrates	O
to	O
at	O
least	O
the	O
F2generation	O
(	O
the	O
great	O
-	O
grandchildren	O
),	O
where	O
F0is	O
the	O
exposed	O
generation	O
and	O
F2represents	O
the	O
first	O
non	O
-	O
exposed	O
generation	O
.	O

Using	O
an	O
in	O
vitro	O
system	O
of	O
adipose	O
tissue	O
from	O
Angus	O
and	O
Wagyu	O
steers	O
,	O
Rhoades	O
et	O
al	O
[	O
91	O
]	O
reported	O
that	O
the	O
rate	O
of	O
glucose	O
incorporation	O
into	O
FA	O
was	O
over	O
two	O
times	O
higher	O
than	O
the	O
rate	O
of	O
acetate	O
incorporation	O
into	O
IMF	O
,	O
although	O
they	O
were	O
similar	O
in	O
subcutaneous	O
fat	O
.	O

Diet	O
of	O
the	O
Infants	O
As	O
mentioned	O
previously	O
,	O
for	O
breast	O
-	O
feeding	O
,	O
there	O
is	O
insufficient	O
evidence	O
to	O
determine	O
whether	O
it	O
is	O
more	O
protective	O
against	O
allergies	O
and	O
asthma	O
than	O
bottle	O
feeding	O
because	O
in	O
a	O
recent	O
study	O
,	O
prolonged	O
and	O
exclusive	O
breast	O
-	O
feeding	O
could	O
not	O
decrease	O
the	O
rate	O
of	O
allergies	O
or	O
asthma	O
in	O
children	O
[	O
88	O
].	O

(	O
2006	O
),	O
Lee	O
et	O
al	O
.	O

Complete	O
blood	O
count	O
showed	O
hemoglobin	O
of	O
13	O
.	O
7	O
g	O
/	O
dL	O
,	O
hematocrit	O
42	O
.	O
6	O
%,	O
white	O
blood	O
cell	O
count	O
15	O
,	O
200	O
/	O
mm3	O
,	O
and	O
platelet	O
count	O
of	O
76	O
,	O
000	O
/	O
mm3	O
.	O

Moreover	O
,	O
we	O
demonstrate	B
for	O
the	O
first	O
time	O
the	O
expression	O
of	O
GAS5	O
in	O
human	O
placentas	O
.	O

Male	O
piglets	O
were	O
castrated	O
at	O
d	O
4	O
of	O
age	O
.	O

Pearson	O
Chi	O
-	O
square	O
test	O
,	O
analysis	O
of	O
variance	O
,	O
Kruskal	O
-	O
Wallis	O
and	O
Bland	O
-	O
Altman	O
tests	O
were	O
employed	O
.	O

Similarly	O
,	O
animal	O
studies	O
documented	O
normoweight	O
at	O
birth	O
when	O
the	O
early	O
pregnancy	O
was	O
conducted	O
under	O
caloric	O
restriction	O
(	O
Cleal	O
et	O
al	O
.,	O
2007	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Poore	O
et	O
al	O
.,	O
2010	O
).	O

2007	O
).	O

(	O
A	O
)	O
female	O
offspring	O
whose	O
dams	O
received	O
50	O
%	O
of	O
normal	O
nutrition	O
and	O
who	O
were	O
fed	O
either	O
a	O
postnatal	O
standard	O
chow	O
diet	O
or	O
(	O
C	O
)	O
a	O
high	O
fat	O
postnatal	O
diet	O
,	O
and	O
(	O
B	O
)	O
offspring	O
of	O
dams	O
fed	O
a	O
high	O
fat	O
diet	O
who	O
were	O
fed	O
a	O
postnatal	O
standard	O
chow	O
diet	O
or	O
(	O
D	O
)	O
a	O
high	O
fat	O
postnatal	O
diet	O
.	O

The	O
first	O
national	O
micronutrients	O
status	O
survey	O
,	O
published	O
in	O
early	O
2013	O
,	O
reported	O
that	O
iron	O
deficiency	O
among	O
non	O
-	O
pregnant	O
non	O
-	O
lactating	O
women	O
was	O
7	O
.	O
1	O
%.	O

The	O
remaining	O
dietary	O
intake	O
of	O
different	O
food	O
items	O
and	O
specific	O
nutrients	O
were	O
similar	O
among	O
the	O
three	O
groups	O
of	O
women	O
with	O
different	O
levels	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Table1	O
).	O

To	O
expand	O
on	O
the	O
bioinformatically	O
informed	O
analysis	O
,	O
which	O
suggested	O
that	O
methylation	O
of	O
CpG	O
loci	O
proximal	O
to	O
a	O
TFBS	O
were	O
associated	O
with	O
AluYb8	O
methylation	O
,	O
we	O
performed	O
a	O
GSEA	O
using	O
specific	O
TFBS	O
,	O
obtained	O
from	O
the	O
UCSC	O
Genomes	O
Browser	O
.	O

Opposing	O
influences	O
of	O
prenatal	O
and	O
postnatal	O
growth	O
have	O
previously	O
been	O
described	O
for	O
adrenarche	O
[	O
14	O
],	O
central	O
fat	O
distribution	O
[	O
15	O
]	O
and	O
insulin	O
sensitivity	O
at	O
age	O
8	O
years	O
[	O
16	O
].	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
ml	O
),	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Studies	O
exposing	O
pregnant	O
rats	O
and	O
mice	O
to	O
valproate	O
demonstrated	O
increased	O
autistic	O
-	O
like	O
behaviors	O
in	O
the	O
offspring	O
.	O

We	O
therefore	O
limited	O
our	O
study	O
population	O
to	O
only	O
women	O
of	O
white	O
ethnicity	O
(	O
95	O
.	O
8	O
%	O
of	O
eligible	O
women	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Multiple	O
regression	O
for	O
mean	O
vitamin	O
D	O
levelVariableUnstandardized	O
regression	O
coefficient	O
(	O
b	O
)±	O
95	O
%	O
confidence	O
intervalP	O
value	O
Intercept71	O
.	O
01	O
//	O
S	O
-	O
ECC	O
(	O
Reference	O
=	O
Yes	O
)	O
5	O
.	O
331	O
.	O
24	O
,	O
9	O
.	O
420	O
.	O
01Regular	O
milk	O
drinker	O
(	O
Reference	O
=	O
Yes	O
)-	O
6	O
.	O
60	O
-	O
13	O
.	O
16	O
,	O
-	O
0	O
.	O
030	O
.	O
05Season	O
(	O
Reference	O
=	O
Winter	O
)	O
5	O
.	O
221	O
.	O
37	O
,	O
9	O
.	O
060	O
.	O
008Vitamin	O
D	O
drop	O
user	O
(	O
Reference	O
=	O
Yes	O
)-	O
2	O
.	O
172	O
.	O
01	O
,	O
-	O
6	O
.	O
130	O
.	O
28Yearly	O
income	O
(	O
Reference	O
=	O
<	O
28	O
k	O
)	O
2	O
.	O
732	O
.	O
06	O
,	O
-	O
1	O
.	O
320	O
.	O
19	O
S	O
-	O
ECC	O
=	O
Severe	O
Early	O
Childhood	O
Caries	O
.	O

Two	O
-	O
way	O
ANOVA	O
showed	O
a	O
main	O
effect	O
of	O
the	O
diet	O
on	O
the	O
gene	O
expression	O
of	O
Cnr1	O
in	O
hypothalamus	O
and	O
liver	O
,	O
Cnr2	O
in	O
hypothalamus	O
and	O
PAT	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
β	O
,	O
and	O
Mgll	O
in	O
liver	O
and	O
PAT	O
,	O
and	O
Dagl	O
α	O
in	O
PAT	O
(	O
see	O
TableS2for	O
statistical	O
values	O
).	O

Maternal	O
and	O
Infant	O
GR	O
Polymorphisms	O
,	O
Maternal	O
Attitudes	O
,	O
and	O
Fetal	O
Birth	O
Weight	O
Four	O
GR	O
polymorphisms	O
were	O
investigated	O
:	O
Bcl	O
I	O
,	O
N363S	O
,	O
Tth111	O
I	O
,	O
and	O
ER22	O
/	O
23EK	O
(	O
Table	O
3	O
).	O

F	O
.,	O
G	O
.,	O
and	O
S	O
.	O

As	O
S	O
-	O
ECC	O
is	O
influenced	O
by	O
the	O
social	O
determinants	O
of	O
health	O
,	O
there	O
were	O
differences	O
in	O
parental	O
education	O
levels	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
household	O
income	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
between	O
groups	O
,	O
with	O
lower	O
levels	O
of	O
both	O
education	O
and	O
household	O
income	O
in	O
the	O
S	O
-	O
ECC	O
group	O
.	O

The	O
association	O
between	O
fish	O
,	O
fatty	O
acids	O
or	O
vitamin	O
D	O
and	O
psychotic	O
-	O
like	O
symptoms	O
was	O
summarized	O
in	O
terms	O
of	O
relative	O
risk	O
ratios	O
(	O
RRRs	O
)	O
and	O
corresponding	O
95	O
%	O
confidence	O
intervals	O
,	O
and	O
it	O
was	O
evaluated	O
by	O
energy	O
-	O
adjusted	O
multinomial	O
logistic	O
regression	O
(	O
polytomous	O
logistic	O
regression	O
),	O
for	O
example	O
:	O
RRR	O
=	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
fish	O
intake	O
>	O
2	O
/	O
week	O
)/	O
P	O
(	O
y	O
=	O
high	O
level	O
group	O
;	O
no	O
fish	O
intake	O
)/	O
P	O
(	O
y	O
=	O
low	O
level	O
group	O
;	O
no	O
fish	O
intake	O
).	O

Thus	O
,	O
1	O
,	O
290	O
women	O
remained	O
for	O
analysis	O
.	O

We	O
recorded	O
GWG	O
at	O
first	O
measurement	O
,	O
at	O
approximately	O
the	O
12th	O
,	O
20th	O
and	O
30th	O
gestational	O
weeks	O
,	O
and	O
at	O
last	O
measurement	O
.	O

Within	O
this	O
window	O
the	O
peak	O
for	O
immune	O
system	O
priming	O
or	O
susceptibility	O
is	O
believed	O
to	O
vary	O
differentially	O
in	O
response	O
to	O
presenting	O
antigens	O
[	O
53	O
,	O
54	O
].	O

Low	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
during	O
pregnancy	O
is	O
reported	O
to	O
increase	O
the	O
risk	O
for	O
a	O
low	O
IQ	O
and	O
suboptimal	O
neuro	O
-	O
developmental	O
outcomes	O
in	O
childhood	O
[	O
10	O
],	O
factors	O
that	O
in	O
turn	O
are	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
adult	O
mental	O
disorders	O
like	O
schizophrenia	O
[	O
11	O
].	O

Another	O
positive	O
point	O
is	O
that	O
few	O
studies	O
have	O
collected	O
data	O
on	O
maternal	O
dietary	O
patterns	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Hence	O
,	O
the	O
effects	O
of	O
maternal	O
attitudes	O
on	O
fetal	O
weight	O
depend	O
on	O
the	O
mother	O
'	O
s	O
polymorphism	O
of	O
GR	O
gene	O
.	O

Homes	O
with	O
high	O
pet	O
activities	O
have	O
been	O
shown	O
to	O
have	O
greater	O
levels	O
of	O
pesticide	O
residues	O
in	O
sampled	O
carpet	O
dust	O
than	O
homes	O
with	O
low	O
pet	O
activities	O
[	O
31	O
,	O
32	O
].	O

Protein	O
Expression	O
in	O
the	O
Nucleus	O
Accumbens	O
of	O
Rats	O
Exposed	O
to	O
Developmental	O
Vitamin	O
D	O
Deficiency	O
Abstract	O
Introduction	O
Developmental	O
vitamin	O
D	O
(	O
DVD	O
)	O
deficiency	O
is	O
a	O
candidate	O
risk	O
factor	O
for	O
schizophrenia	O
.	O

Considering	O
this	O
and	O
the	O
physiological	O
changes	O
to	O
the	O
vitamin	O
D	O
pathway	O
in	O
pregnancy	O
,	O
it	O
is	O
therefore	O
possible	O
that	O
the	O
genetic	O
variants	O
associated	O
with	O
baseline	O
serum	O
25	O
(	O
OH	O
)	O
D	O
status	O
and	O
the	O
response	O
to	O
supplementation	O
also	O
differ	O
between	O
the	O
pregnant	O
and	O
nonpregnant	O
state	O
.	O

Maternal	O
and	O
cord	O
blood	O
were	O
collected	O
for	O
determining	O
the	O
25	O
(	O
OH	O
)	O
D	O
level	O
.	O

PubMed	O
Central	O
:	O

(	O
2014	O
)	O
Only	O
studies	O
that	O
measured	O
both	O
adverse	O
phenotypes	O
and	O
associated	O
epigenetic	O
changes	O
in	O
response	O
to	O
an	O
environmental	O
exposure	O
were	O
reviewed	O
.	O

Skilled	O
examiners	O
and	O
good	O
quality	O
images	O
with	O
grey	O
-	O
scale	O
and	O
power	O
Doppler	O
US	O
seem	O
more	O
reliable	O
than	O
other	O
techniques	O
in	O
detecting	O
and	O
differentiating	O
malignant	O
and	O
benign	O
solid	O
thyroid	O
nodules	O
,	O
especially	O
for	O
small	O
lesions	O
.	O

Crosstabs	O
of	O
these	O
same	O
variables	O
by	O
study	O
condition	O
and	O
survey	O
time	O
points	O
were	O
also	O
calculated	O
.	O

2008	O
).	O

(	O
A	O
)	O
Genomic	O
DNA	O
sequence	O
chromatograms	O
from	O
normal	O
(	O
upper	O
)	O
and	O
mutant	O
(	O
lower	O
)	O
Skm1	O
and	O
Skm2	O
mice	O
(	O
left	O
panel	O
and	O
right	O
panel	O
,	O
respectively	O
).	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	O
to	O
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

Treatment	O
of	O
reflux	O
during	O
pregnancy	O
should	O
focus	O
on	O
nonpharmacological	O
measures	O
,	O
such	O
as	O
avoiding	O
large	O
meals	O
shortly	O
before	O
bedtime	O
,	O
sleeping	O
with	O
the	O
upper	O
body	O
elevated	O
,	O
and	O
avoiding	O
extensive	O
consumption	O
of	O
coffee	O
,	O
sweets	O
,	O
and	O
fatty	O
foods	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
was	O
significantly	O
higher	O
for	O
less	O
educated	O
women	O
and	O
women	O
who	O
reported	O
not	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
.	O

Schizophrenia	O
in	O
adulthood	O
is	O
often	O
preceded	O
by	O
milder	O
symptoms	O
and	O
delusions	O
during	O
adolescence	O
.	O

Conclusions	O
The	O
results	O
suggest	O
that	O
BMI	O
is	O
predominantly	O
associated	O
with	O
the	O
maternal	O
line	O
,	O
possibly	O
either	O
with	O
intrauterine	O
development	O
,	O
or	O
inherited	O
through	O
the	O
X	O
chromosome	O
,	O
or	O
both	O
,	O
while	O
height	O
is	O
a	O
more	O
complex	O
trait	O
with	O
genetic	O
influences	O
of	O
the	O
parents	O
and	O
that	O
of	O
the	O
paternal	O
grandfather	O
predominating	O
.	O

At	O
baseline	O
,	O
23	O
%	O
of	O
control	O
(	O
29	O
/	O
124	O
)	O
and	O
20	O
%	O
of	O
intervention	O
(	O
25	O
/	O
125	O
)	O
participants	O
said	O
that	O
another	O
person	O
reminded	O
them	O
to	O
wash	O
hands	O
on	O
a	O
typical	O
day	O
.	O

Accordingly	O
,	O
population	O
studies	O
,	O
which	O
have	O
been	O
conducted	O
by	O
the	O
United	O
States	O
Centers	O
for	O
Disease	O
Control	O
and	O
Prevention	O
,	O
have	O
reported	O
a	O
prevalence	O
of	O
ASDs	O
of	O
1	O
of	O
68	O
children	O
at	O
risk	O
.	O

However	O
,	O
in	O
a	O
cross	O
-	O
sectional	O
setting	O
causal	O
relationships	O
cannot	O
be	O
determined	O
.	O

The	O
study	O
was	O
able	O
to	O
adjust	O
for	O
several	O
important	O
confounds	O
,	O
including	O
length	O
of	O
gestation	O
and	O
infant	O
sex	O
;	O
however	O
,	O
the	O
sample	O
size	O
was	O
moderate	O
,	O
and	O
only	O
69	O
%	O
of	O
the	O
offspring	O
(	O
mostly	O
non	O
-	O
Hispanic	O
White	O
)	O
had	O
data	O
available	O
at	O
6	O
months	O
.	O

Briefly	O
,	O
Japanese	O
Black	O
cattle	O
are	O
generally	O
fed	O
a	O
high	O
concentrate	O
diet	O
from	O
11	O
to	O
30	O
months	O
of	O
age	O
to	O
induce	O
deposition	O
of	O
IMF	O
.	O

This	O
evaluation	O
was	O
performed	O
after	O
5	O
minutes	O
of	O
rest	O
in	O
the	O
supine	O
position	O
,	O
and	O
the	O
electrodes	O
were	O
applied	O
to	O
the	O
hand	O
,	O
wrist	O
,	O
ankle	O
and	O
foot	O
of	O
the	O
right	O
-	O
hand	O
side	O
of	O
the	O
body	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
and	O
depression	O
scores	O
in	O
nulliparous	O
and	O
multiparous	O
subgroupsVariables	O
Mean	O
(	O
sd	O
)	O
NulliparousMultiparousVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
valueVitamin	O
D	O
groupControl	O
groupN	O
p	O
-	O
value	O
*	O
25	O
(	O
OH	O
)	O
D	O
at	O
baseline	O
(	O
ng	O
/	O
mL	O
)	O
13	O
.	O
13	O
(	O
6	O
.	O
91	O
)	O
13	O
.	O
25	O
(	O
6	O
.	O
55	O
)	O
41	O
/	O
510	O
.	O
9312	O
.	O
49	O
(	O
9	O
.	O
08	O
)	O
9	O
.	O
31	O
(	O
5	O
.	O
34	O
)	O
34	O
/	O
270	O
.	O
1525	O
(	O
OH	O
)	O
D	O
at	O
delivery	O
(	O
ng	O
/	O
mL	O
)	O
18	O
.	O
40	O
(	O
11	O
.	O
38	O
)	O
12	O
.	O
49	O
(	O
6	O
.	O
29	O
)	O
33	O
/	O
430	O
.	O
0116	O
.	O
58	O
(	O
8	O
.	O
54	O
)	O
11	O
.	O
36	O
(	O
5	O
.	O
47	O
)	O
28	O
/	O
250	O
.	O
02Depression	O
score	O
at	O
baseline8	O
.	O
41	O
(	O
3	O
.	O
52	O
)	O
8	O
.	O
73	O
(	O
3	O
.	O
57	O
)	O
41	O
/	O
510	O
.	O
678	O
.	O
47	O
(	O
4	O
.	O
35	O
)	O
8	O
.	O
48	O
(	O
4	O
.	O
30	O
)	O
34	O
/	O
270	O
.	O
99Depression	O
score	O
at	O
38	O
-	O
40w	O
gestation6	O
.	O
47	O
(	O
3	O
.	O
43	O
)	O
7	O
.	O
98	O
(	O
3	O
.	O
74	O
)	O
38	O
/	O
460	O
.	O
065	O
.	O
80	O
(	O
3	O
.	O
62	O
)	O
7	O
.	O
44	O
(	O
4	O
.	O
28	O
)	O
30	O
/	O
270	O
.	O
12Depression	O
score	O
at	O
postpartum	O
(	O
4w	O
)	O
4	O
.	O
59	O
(	O
3	O
.	O
24	O
)	O
7	O
.	O
27	O
(	O
4	O
.	O
04	O
)	O
34	O
/	O
450	O
.	O
0024	O
.	O
60	O
(	O
3	O
.	O
40	O
)	O
7	O
.	O
52	O
(	O
4	O
.	O
70	O
)	O
30	O
/	O
270	O
.	O
01Depression	O
score	O
at	O
postpartum	O
(	O
8w	O
)	O
4	O
.	O
18	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
24	O
(	O
3	O
.	O
79	O
)	O
34	O
/	O
450	O
.	O
0014	O
.	O
20	O
(	O
3	O
.	O
79	O
)	O
7	O
.	O
07	O
(	O
4	O
.	O
37	O
)	O
30	O
/	O
270	O
.	O
01	O
*	O
Mann	O
–	O
Whitney	O
U	O
test	O
We	O
examined	B
the	O
correlation	O
between	O
change	O
in	O
vitamin	O
D	O
concentrations	O
and	O
change	O
in	O
depression	O
scores	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
4	O
and	O
8	O
weeks	O
postpartum	O
.	O

Results	O
Descriptive	O
statistics	O
are	O
displayed	O
intable	O
2for	O
children	O
at	O
each	O
age	O
point	O
and	O
for	O
each	O
of	O
the	O
adult	O
lineage	O
groups	O
.	O

Introduction	O
Pregnancy	O
is	O
associated	O
with	O
major	O
physiological	O
and	O
future	O
psychosocial	O
changes	O
and	O
adaptation	O
to	O
these	O
changes	O
is	O
crucial	O
for	O
normal	O
fetal	O
development	O
and	O
for	O
healthy	O
infant	O
-	O
mother	O
relationships	O
.	O

§	O
N	O
(%)	O
of	O
live	O
births	O
.	O

We	O
made	O
initial	O
comparisons	O
of	O
time	O
-	O
to	O
-	O
an	O
-	O
episode	O
between	O
the	O
two	O
groups	O
with	O
log	O
-	O
rank	O
tests	O
and	O
Kaplan	O
–	O
Meier	O
plots	O
.	O

Previous	O
studies	O
have	O
shown	O
an	O
increased	O
blood	O
level	O
of	O
serotonin	O
in	O
individuals	O
affected	O
with	O
autism	O
spectrum	O
disorder	O
,	O
warranting	O
the	O
exploration	O
of	O
a	O
possible	O
association	O
[	O
65	O
].	O

Therefore	O
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
is	O
not	O
infrequent	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
the	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

Therefore	O
,	O
we	O
recommended	O
the	O
following	O
times	O
of	O
possible	O
pathogen	O
transmission	O
to	O
the	O
neonate	O
for	O
handwashing	O
with	O
soap	O
:	O
after	O
respiratory	O
secretion	O
contact	O
,	O
before	O
umbilical	O
cord	O
care	O
,	O
before	O
breastfeeding	O
,	O
and	O
after	O
fecal	O
contact	O
.	O

Funding	O
The	O
time	O
of	O
JEL	O
and	O
MVK	O
was	O
funded	O
by	O
a	O
grant	O
from	O
Bill	O
&	O
Melinda	O
Gates	O
Foundation	O
to	O
Save	O
the	O
Children	O
'	O
s	O
Saving	O
Newborn	O
Lives	O
programme	O
.	O

However	O
,	O
we	O
considered	O
it	O
unethical	O
to	O
withhold	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
deworming	O
from	O
women	O
of	O
reproductive	O
age	O
over	O
a	O
long	O
period	O
of	O
time	O
given	O
the	O
evidence	O
from	O
short	O
-	O
term	O
studies	O
on	O
the	O
efficacy	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
[	O
8	O
].	O

The	O
most	O
commonly	O
used	O
herbs	O
were	O
ginger	O
and	O
peppermint	O
.	O

The	O
PFAS	O
exhibited	O
a	O
minimum	O
GM	O
of	O
1	O
μg	O
/	O
L	O
(	O
PFNA	O
)	O
and	O
maximum	O
GM	O
of	O
13	O
.	O
6	O
μg	O
/	O
L	O
(	O
PFOS	O
).	O

Improved	O
human	O
exposure	O
data	O
could	O
be	O
collected	O
and	O
used	O
to	O
facilitate	O
the	O
use	O
of	O
more	O
relevant	O
doses	O
,	O
routes	O
of	O
administration	O
,	O
metabolites	O
and	O
mixtures	O
.	O

Studies	O
in	O
migrants	O
implicate	O
postnatal	O
environmental	O
exposures	O
,	O
but	O
do	O
not	O
exclude	O
prenatal	O
effects	O
.	O
1529Blood	O
concentrations	O
of	O
25	O
-	O
hydroxyvitamin	O
D	O
fluctuate	O
with	O
season	O
,	O
but	O
the	O
etiological	O
relevance	O
of	O
these	O
fluctuations	O
to	O
MS	O
risk	O
is	O
unknown	O
.	O

PubMed	O
Central	O
:	O

Full	O
coverage	O
of	O
antenatal	O
corticosteroids	O
alone	O
resulted	O
in	O
high	O
mortality	O
reductions	O
,	O
a	O
41	O
%	O
decrease	O
from	O
2010	O
[	O
20	O
].	O

These	O
alterations	O
are	O
primarily	O
the	O
result	O
of	O
hormonal	O
effects	O
.	O

While	O
DEP	O
was	O
associated	O
with	O
a	O
14	O
g	O
increase	O
in	O
birth	O
weight	O
in	O
the	O
combined	O
analysis	O
,	O
it	O
was	O
associated	O
with	O
a	O
51	O
g	O
increase	O
in	O
males	O
and	O
a	O
9	O
g	O
decrease	O
in	O
females	O
in	O
the	O
sex	O
stratified	O
analysis	O
.	O

Marbling	O
is	O
positively	O
correlated	O
with	O
juiciness	O
,	O
tenderness	O
,	O
and	O
palatability	O
of	O
beef	O
[	O
1	O
].	O

When	O
body	O
weight	O
at	O
three	O
months	O
was	O
included	O
as	O
a	O
covariate	O
in	O
this	O
analysis	O
,	O
changes	O
in	O
BMC	O
remained	O
significant	O
,	O
p	O
=	O
0	O
.	O
03	O
,	O
but	O
changes	O
in	O
BMD	O
were	O
not	O
(	O
p	O
=	O
0	O
.	O
06	O
).	O

It	O
is	O
worth	O
mentioning	O
that	O
their	O
tools	O
for	O
determining	O
depression	O
were	O
different	O
than	O
ours	O
.	O

There	O
are	O
very	O
few	O
human	O
studies	O
which	O
include	O
three	O
generations	O
of	O
family	O
members	O
and	O
which	O
also	O
collect	O
anthropometric	O
data	O
or	O
study	O
heritability	O
patterns	O
.	O

Primiparous	O
women	O
were	O
more	O
likely	O
to	O
use	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
(	O
aOR	O
,	O
2	O
.	O
0	O
;	O
95	O
%	O
CI	O
,	O
1	O
.	O
1	O
-	O
3	O
.	O
7	O
).	O

IMF	O
deposition	O
can	O
positively	O
affect	O
beef	O
taste	O
including	O
tenderness	O
and	O
flavor	O
,	O
favoring	O
highly	O
marbled	O
beef	O
.	O

To	B
study	I
the	O
Vitamin	O
D	O
nutritional	O
status	O
of	O
pregnant	O
women	O
with	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
)	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
and	O
analyze	B
the	O
different	O
sources	O
of	O
Vitamin	O
D	O
intake	O
.	O

Studies	O
found	O
that	O
about	O
70	O
%	O
of	O
pregnant	O
women	O
are	O
affected	O
by	O
these	O
symptoms	O
during	O
their	O
last	O
trimenon	O
,[	O
85	O
]	O
and	O
50	O
%	O
of	O
them	O
are	O
likely	O
to	O
take	O
acid	O
-	O
suppressing	O
medication	O
.	O

Further	O
evaluation	O
of	O
the	O
vitamin	O
D	O
testing	O
and	O
supplementation	O
protocol	O
is	O
planned	O
.	O

This	O
means	O
that	O
Nampt	O
promotes	O
osteocyte	O
differentiation	O
through	O
a	O
pathway	O
mediated	O
by	O
SIRT1	O
(	O
16	O
,	O
17	O
).	O

In	O
this	O
study	O
,	O
215	O
women	O
with	O
GDM	O
were	O
seen	O
at	O
sites	O
randomized	O
to	O
deliver	O
either	O
MNT	O
or	O
standard	O
care	O
.	O
27Fewer	O
subjects	O
in	O
the	O
MNT	O
group	O
required	O
insulin	O
(	O
24	O
.	O
6	O
%	O
vs	O
31	O
.	O
7	O
%,	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
there	O
was	O
a	O
trend	O
to	O
fewer	O
women	O
having	O
a	O
glycated	O
hemoglobin	O
(	O
HbA1c	O
)	O
>	O
6	O
%	O
(	O
8	O
.	O
1	O
%	O
vs	O
13	O
.	O
6	O
%,	O
p	O
=	O
0	O
.	O
25	O
).	O

Assessment	O
of	O
25	O
(	O
OH	O
)	O
D	O
On	O
the	O
day	O
that	O
the	O
study	O
medication	O
was	O
dispensed	O
and	O
at	O
34	O
weeks	O
of	O
gestation	O
,	O
a	O
nonfasted	O
venous	O
blood	O
sample	O
was	O
obtained	O
and	O
serum	O
stored	O
at	O
−	O
80	O
°	O
C	O
.	O

Mentioned	O
foods	O
as	O
an	O
unhealthy	O
food	O
might	O
have	O
been	O
given	O
an	O
adverse	O
score	O
in	O
the	O
healthy	O
and	O
traditional	O
dietary	O
patterns	O
in	O
the	B
current	I
study	I
.	O

(	O
2003	O
)	O
demonstrated	O
a	O
decrease	O
in	O
the	O
hypothalamic	O
levels	O
of	O
AEA	O
(	O
confirmed	O
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
)	O
and	O
an	O
absence	O
of	O
significant	O
changes	O
in	O
the	O
gene	O
expression	O
of	O
Cnr1	O
and	O
Faah	O
in	O
the	O
hypothalamus	O
of	O
weaned	O
pups	O
after	O
a	O
maternal	O
undernutrition	O
throughout	O
the	O
last	O
part	O
of	O
pregnancy	O
and	O
/	O
or	O
lactation	O
.	O

For	O
these	O
reasons	O
,	O
total	O
thyroidectomy	O
appears	O
to	O
be	O
the	O
appropriate	O
approach	O
to	O
MTC	O
.	O

Women	O
who	O
reported	O
a	O
preference	O
for	O
shadow	O
had	O
a	O
higher	O
risk	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
in	O
our	O
study	O
.	O

It	O
is	O
important	O
to	O
note	O
that	O
not	O
all	O
environmentally	O
induced	O
adverse	O
phenotypes	O
have	O
been	O
associated	O
with	O
epigenetic	O
changes	O
.	O

The	O
recall	O
is	O
done	O
chronologically	O
unless	O
the	O
participant	O
wishes	O
to	O
recall	O
randomly	O
.	O

Another	O
possible	O
explanation	O
may	O
be	O
that	O
the	O
frequent	O
intake	O
of	O
fish	O
and	O
PUFA	O
may	O
be	O
advantageous	O
in	O
lower	O
doses	O
but	O
disadvantageous	O
in	O
higher	O
doses	O
.	O

Health	O
care	O
workers	O
and	O
their	O
professional	O
organisations	O
:	O
Invest	O
•	O
Advocate	O
for	O
and	O
participate	O
in	O
evidence	O
-	O
based	O
training	O
,	O
deployment	O
and	O
retention	O
of	O
workers	O
with	O
the	O
necessary	O
skills	O
to	O
address	O
the	O
burden	O
of	O
preterm	O
birth	O
.	O

Methods	O
The	O
cross	O
sectional	O
study	O
was	O
carried	O
out	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
one	O
of	O
the	O
18	O
health	O
districts	O
in	O
the	O
South	O
West	O
Region	O
of	O
Cameroon	O
with	O
an	O
estimated	O
population	O
of	O
86	O
,	O
272	O
inhabitants	O
[	O
9	O
].	O

Mean	O
methylation	O
across	O
the	O
26	O
,	O
486	O
autosomal	O
CpG	O
loci	O
was	O
not	O
significantly	O
associated	O
with	O
the	O
birth	O
weight	O
groups	O
(	O
see	O
Supplemental	O
Material	O
,	O
Table	O
1	O
).	O

After	O
2	O
weeks	O
of	O
feeding	O
(	O
pregestational	O
period	O
),	O
adult	O
females	O
(	O
4	O
month	O
old	O
)	O
were	O
allowed	O
to	O
mate	O
with	O
male	O
rats	O
of	O
the	O
same	O
strain	O
weighting	O
484	O
.	O
5	O
±	O
7	O
.	O
96	O
(	O
Figure1	O
).	O

Postponing	O
surgery	O
to	O
at	O
least	O
6	O
-	O
7	O
months	O
after	O
diagnosis	O
of	O
DTC	O
in	O
the	O
first	O
trimester	O
does	O
not	O
adversely	O
affect	O
prognosis	O
;	O
on	O
the	O
other	O
hand	O
,	O
thyroidectomy	O
can	O
be	O
safely	O
performed	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
or	O
after	O
delivery15	O
.	O

Fatty	O
fish	O
is	O
a	O
rich	O
dietary	O
source	O
of	O
essential	O
fatty	O
acids	O
and	O
vitamin	O
D	O
,	O
both	O
of	O
which	O
could	O
be	O
implicated	O
in	O
the	O
development	O
of	O
schizophrenia	O
.	O

The	O
costing	O
reported	O
here	B
includes	O
distribution	O
of	O
supplements	O
,	O
health	O
staff	O
training	O
,	O
production	O
and	O
distribution	O
of	O
educational	O
materials	O
and	O
regular	O
monitoring	O
.	O

The	O
physiologically	O
elevated	O
position	O
of	O
the	O
diaphragm	O
and	O
hyperventilation	O
in	O
pregnancy	O
further	O
increase	O
the	O
risk	O
of	O
hypoxia	O
.	O

Even	O
more	O
importantly	O
,	O
the	O
body	O
grew	O
faster	O
than	O
the	O
head	O
for	O
those	O
with	O
ASD	O
by	O
the	O
end	O
of	O
the	O
first	O
year	O
of	O
life	O
,	O
suggesting	O
a	O
closer	O
following	O
of	O
length	O
to	O
circumference	O
during	O
development	O
.	O

Statistical	O
methods	O
.	O

Comparatively	O
,	O
maternal	O
high	O
fat	O
nutrition	O
led	O
to	O
a	O
small	O
but	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
birth	O
weight	O
compared	O
to	O
Cont	O
(	O
Figure	O
1B	O
).	O

Results	O
3	O
.	O
1	O
.	O

Whatever	O
their	O
developmental	O
origin	O
,	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
seem	O
to	O
greatly	O
differ	O
in	O
their	O
function	O
.	O

String	O
beans	O
and	O
peas	O
also	O
correlated	O
inversely	O
with	O
ALL	O
risk	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Summary	O
of	O
the	O
main	O
findings	O
for	O
the	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
childhood	O
outcomes	O
:	O
a	O
)	O
atopy	O
(	O
n	O
=	O
6117	O
)	O
and	O
b	O
)	O
atopic	O
asthma	O
(	O
n	O
=	O
5228	O
).	O

In	O
pregnancy	O
,	O
acute	O
type	O
A	O
aortic	O
dissection	O
has	O
an	O
overall	O
incidence	O
of	O
0	O
.	O
4	O
cases	O
per	O
100	O
,	O
000	O
person	O
years	O
[	O
2	O
].	O

While	O
this	O
may	O
reflect	O
evidence	O
of	O
a	O
true	O
lack	O
of	O
persisting	O
effect	O
of	O
maternal	O
dietary	O
modification	O
and	O
birth	O
weight	O
on	O
weight	O
at	O
6	O
-	O
months	O
of	O
age	O
,	O
it	O
may	O
also	O
be	O
indicative	O
that	O
other	O
factors	O
are	O
of	O
relatively	O
greater	O
importance	O
in	O
driving	O
early	O
,	O
ex	O
-	O
utero	O
,	O
infant	O
growth	O
and	O
development	O
.	O

A	O
post	O
-	O
weaning	O
HF	O
diet	O
in	O
offspring	O
exposed	O
to	O
a	O
prenatal	O
HF	O
diet	O
had	O
no	O
further	O
effect	O
(	O
Figure	O
3B	O
,	O
C	O
;	O
Table	O
1	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0006744	O
.	O
g003	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
Percentage	O
of	O
offspring	O
entering	O
puberty	O
over	O
time	O
in	O
animals	O
whose	O
dams	O
received	O
a	O
high	O
fat	O
diet	O
.	O

Because	O
of	O
notable	O
differences	O
in	O
vitamin	O
D	O
concentrations	O
between	O
African	O
Americans	O
and	O
Whites	O
,	O
analyses	O
were	O
stratified	O
by	O
race	O
.	O

PubMed	O
Central	O
:	O

RNA	O
was	O
quantified	O
by	O
spectrometry	O
with	O
a	O
NanoDrop	O
ND	O
-	O
1000	O
spectrophotometer	O
(	O
PEQLAB	O
,	O
Erlangen	O
,	O
Germany	O
).	O

In	O
low	O
birth	O
weight	O
males	O
there	O
was	O
no	O
significant	O
increased	O
risk	O
observed	O
for	O
autism	O
alone	O
.	O

Women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
received	O
a	O
comprehensive	O
intervention	O
over	O
the	O
course	O
of	O
their	O
pregnancy	O
that	O
included	O
a	O
combination	O
of	O
dietary	O
,	O
exercise	O
and	O
behavioural	O
strategies	O
,	O
delivered	O
by	O
a	O
research	O
dietician	O
and	O
trained	O
research	O
assistants	O
[	O
22	O
].	O

Although	O
some	O
studies	O
have	O
found	O
evidence	O
of	O
a	O
correlation	O
between	O
low	O
birth	O
weight	O
and	O
autonomic	O
dysfunction	O
,	O
the	O
results	O
remain	O
inconclusive	O
.	O

The	O
present	B
study	I
achieved	O
a	O
greater	O
improvement	O
in	O
haemoglobin	O
concentration	O
and	O
a	O
greater	O
decline	O
in	O
the	O
prevalence	O
of	O
anaemia	O
compared	O
to	O
these	O
previous	O
reports	O
.	O

Result	O
:	O
As	O
mentioned	O
above	O
,	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
month	O
is	O
proved	O
to	O
se	O
helpful	O
for	O
mother	O
&	O
fetus	O
.	O

In	O
an	O
analysis	O
of	O
questionnaire	O
data	O
from	O
8	O
,	O
765	O
children	O
aged	O
5	O
to	O
7	O
years	O
,	O
smoking	O
after	O
pregnancy	O
was	O
not	O
associated	O
with	O
childhood	O
obesity	O
but	O
intrauterine	O
exposure	O
was	O
(	O
20	O
).	O

Prior	O
to	O
cortisol	O
treatment	O
,	O
both	O
cell	O
lines	O
were	O
maintained	O
for	O
3	O
hours	O
in	O
phenol	O
red	O
-	O
free	O
media	O
containing	O
charcoal	O
stripped	O
FBS	O
.	O

Conclusion	O
Gestational	O
exposure	O
to	O
phthalates	O
,	O
PFAS	O
,	O
PCBs	O
,	O
PBDEs	O
,	O
OCPs	O
or	O
OPPs	O
had	O
null	O
or	O
small	O
associations	O
with	O
birth	O
weight	O
.	O

Implement	O
•	O
Build	O
capacity	O
at	O
research	O
institutions	O
,	O
especially	O
in	O
low	O
-	O
and	O
middle	O
-	O
income	O
countries	O
,	O
and	O
train	O
professionals	O
.	O

Phylogenetic	O
trees	O
were	O
constructed	O
using	O
the	O
FastTree	O
method	O
[	O
41	O
].	O

2	O
.	O
3	O
.	O

For	O
example	O
,	O
Michael	O
Kramer	O
,	O
a	O
perinatal	O
epidemiologist	O
at	O
McGill	O
University	O
in	O
Montreal	O
,	O
points	O
out	O
that	O
investigators	O
are	O
more	O
likely	O
to	O
submit	O
,	O
and	O
journal	O
editors	O
to	O
accept	O
,	O
papers	O
reporting	O
significant	O
associations	O
than	O
those	O
showing	O
no	O
such	O
association	O
—	O
a	O
phenomenon	O
known	O
as	O
publication	O
bias	O
,	O
which	O
can	O
affect	O
observational	O
studies	O
in	O
any	O
field	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	B
(	O
1	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
global	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
phenotype	O
(	O
s	O
);	O
(	O
2	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
size	O
and	O
nature	O
of	O
cohort	O
,	O
type	O
of	O
sample	O
analyzed	O
,	O
use	O
of	O
case	O
controls	O
,	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
,	O
validation	O
in	O
independent	O
cohorts	O
);	O
or	O
(	O
3	O
)	O
associations	O
between	O
environmental	O
exposure	O
(	O
s	O
),	O
specific	O
epigenetic	O
changes	O
(	O
s	O
)	O
and	O
adverse	O
phenotypes	O
(	O
s	O
)	O
that	O
were	O
confirmed	O
in	O
a	O
relevant	O
in	O
vivo	O
and	O
/	O
or	O
in	O
vitro	O
system	O
.	O

Although	O
we	O
report	O
that	O
the	O
combination	O
of	O
prenatal	O
caloric	O
restriction	O
and	O
postnatal	O
high	O
fat	O
nutrition	O
also	O
advanced	O
the	O
age	O
at	O
puberty	O
,	O
this	O
was	O
not	O
directly	O
linked	O
to	O
body	O
weight	O
at	O
puberty	O
.	O

However	O
,	O
our	O
data	O
indicated	O
a	O
lower	O
preference	O
for	O
a	O
novel	O
highly	O
-	O
palatable	O
food	O
(	O
chocolate	O
mixture	O
)	O
than	O
the	O
familiar	O
standard	O
diet	O
in	O
RC	O
females	O
when	O
they	O
were	O
exposed	O
for	O
4	O
days	O
.	O

Genotyping	O
,	O
which	O
was	O
not	O
practical	O
in	O
our	O
study	O
setting	O
,	O
might	O
have	O
aided	O
the	O
interpretation	O
of	O
our	O
findings	O
,	O
as	O
shown	O
in	O
a	O
vitamin	O
D	O
supplementation	O
trial	O
for	O
tuberculosis	O
.	O
20	O
We	O
accounted	O
for	O
nutritional	O
factors	O
through	O
a	O
diet	O
questionnaire	O
,	O
weight	O
at	O
recruitment	O
,	O
and	O
growth	O
comparison	O
at	O
the	O
end	O
of	O
our	O
study	O
—	O
any	O
nutritional	O
deficiencies	O
would	O
have	O
been	O
equally	O
balanced	O
between	O
the	O
two	O
groups	O
.	O

Restricted	O
fetal	O
growth	O
is	O
one	O
of	O
the	O
most	O
important	O
global	O
public	O
health	O
problems	O
which	O
provides	O
a	O
foundation	O
for	O
developing	O
chronic	O
diseases	O
throughout	O
their	O
life	O
[	O
2	O
].	O

The	O
overall	O
client	O
satisfaction	O
was	O
compared	O
with	O
the	O
different	O
socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
respondents	O
(	O
Table	O
4	O
).	O

Both	O
the	O
Diabetes	O
Prevention	O
Program86and	O
the	O
Finnish	O
Diabetes	O
Prevention	O
Study87demonstrated	O
this	O
,	O
with	O
an	O
intensive	O
intervention	O
including	O
lifestyle	O
coaches	O
,	O
strict	O
supervised	O
exercise	O
regimes	O
and	O
caloric	O
restriction	O
.	O

MTC	O
is	O
somewhat	O
more	O
aggressive	O
than	O
papillary	O
or	O
follicular	O
carcinoma	O
.	O

Survival	O
analysis	O
could	O
therefore	O
not	O
be	O
performed	O
,	O
as	O
time	O
to	O
event	O
data	O
were	O
missing	O
.	O

It	O
was	O
validated	O
for	O
the	O
population	O
in	O
the	O
Transition	O
and	O
Health	O
during	O
Urbanisation	O
of	O
South	O
Africans	O
(	O
THUSA	O
)	O
study	O
[	O
39	O
]	O
and	O
its	O
reproducibility	O
was	O
proven	O
[	O
40	O
,	O
41	O
].	O

For	O
these	O
patients	O
,	O
surgery	O
could	O
be	O
safely	O
performed	O
during	O
the	O
mid	O
-	O
trimester	O
or	O
delayed	O
until	O
delivery	O
without	O
worsening	O
prognosis3034	O
.	O

Our	O
findings	O
report	O
,	O
for	O
the	O
first	O
time	O
,	O
the	O
impact	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
for	O
women	O
who	O
are	O
overweight	O
or	O
obese	O
on	O
early	O
infant	O
neurodevelopment	O
.	O

The	O
RT2	O
reactions	O
including	O
the	O
entire	O
RT1	O
reactions	O
,	O
mixed	O
with	O
5	O
µl	O
moloney	O
murine	O
leukemia	O
virus	O
reverse	O
transcriptase	O
(	O
M	O
-	O
MLV	O
)	O
5	O
×	O
buffer	O
(	O
250	O
mM	O
,	O
pH	O
=	O
8	O
.	O
3	O
)	O
Tris	O
–	O
HCl	O
,	O
15	O
mM	O
MgCl2	O
,	O
50	O
mM	O
dithiothreitol	O
and	O
375	O
mM	O
KCl	O
,	O
1	O
.	O
25	O
µl	O
of	O
10	O
mM	O
-	O
deoxyribonucleotide	O
tripho	O
-	O
sphate	O
,	O
1	O
µl	O
M	O
-	O
MLV	O
RNase	O
(	O
200	O
U	O
/	O
µl	O
)	O
and	O
0	O
.	O
5	O
µl	O
RNase	O
inhibitor	O
(	O
40	O
U	O
/	O
µl	O
).	O

In	O
2006	O
,	O
following	O
a	O
baseline	O
study	O
of	O
the	O
prevalence	O
of	O
anaemia	O
,	O
iron	O
deficiency	O
and	O
soil	O
transmitted	O
helminth	O
infection	O
prevalences	O
[	O
12	O
],	O
we	O
introduced	O
an	O
anaemia	O
and	O
helminth	O
control	O
program	O
consisting	O
of	O
weekly	O
iron	O
-	O
folic	O
acid	O
supplementation	O
and	O
regular	O
deworming	O
for	O
women	O
of	O
reproductive	O
age	O
in	O
Yen	O
Bai	O
,	O
a	O
rural	O
province	O
in	O
the	O
northern	O
mountainous	O
region	O
of	O
Vietnam	O
.	O

The	O
inverse	O
probability	O
weighting	O
analysis	O
also	O
produced	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

Male	O
adult	O
offspring	O
(	O
n	O
=	O
8	O
)	O
were	O
compared	O
to	O
control	O
male	O
(	O
n	O
=	O
8	O
).	O

However	O
,	O
as	O
these	O
different	O
cells	O
are	O
often	O
mixed	O
,	O
such	O
as	O
occurs	O
for	O
classical	O
and	O
“	O
brite	O
”	O
adipocytes	O
in	O
some	O
human	O
depots	O
(	O
Wu	O
et	O
al	O
.,	O
2012	O
;	O
Cypess	O
et	O
al	O
.,	O
2013	O
;	O
Jespersen	O
et	O
al	O
.,	O
2013	O
),	O
only	O
the	O
use	O
of	O
specific	O
cell	O
surface	O
markers	O
(	O
i	O
.	O
e	O
.,	O
ASC	O
-	O
1	O
,	O
PAT2	O
,	O
and	O
P2RX5	O
for	O
white	O
,	O
“	O
brite	O
”	O
and	O
brown	O
adipocytes	O
,	O
respectively	O
)	O
will	O
allow	O
for	O
their	O
identification	O
,	O
as	O
well	O
as	O
for	O
the	O
precise	O
understanding	O
of	O
their	O
respective	O
therapeutic	O
properties	O
(	O
Ussar	O
et	O
al	O
.,	O
2014	O
).	O

A	O
number	O
of	O
specific	O
actions	O
,	O
pursued	O
by	O
all	O
partners	O
and	O
applied	O
across	O
the	O
RMNCH	O
continuum	O
of	O
care	O
,	O
will	O
help	O
prevent	O
preterm	O
birth	O
and	O
associated	O
mortality	O
,	O
and	O
have	O
an	O
immediate	O
,	O
profound	O
and	O
sustained	O
impact	O
on	O
human	O
capital	O
.	O

Conclusion	O
:	O
It	O
is	O
therefore	O
clear	O
that	O
the	O
diet	O
of	O
pregnant	O
woman	O
according	O
to	O
Ayurveda	O
will	O
prevent	O
many	O
complications	O
of	O
pregnancy	O
,	O
which	O
will	O
lead	O
to	O
healthy	O
pregnancy	O
&	O
healthy	O
fetus	O
&	O
finally	O
good	O
outcome	O
.	O

First	O
,	O
we	O
had	O
a	O
low	O
follow	O
-	O
up	O
rate	O
and	O
,	O
thus	O
,	O
used	O
imputation	O
techniques	O
to	O
support	O
the	O
analysis	O
.	O

2011	O
).	O

There	O
are	O
two	O
known	O
factors	O
which	O
contribute	O
to	O
development	O
of	O
iron	O
deficiency	O
anaemia	O
(	O
IDA	O
)	O
in	O
pregnancy	O
;	O
the	O
first	O
is	O
the	O
woman	O
'	O
s	O
iron	O
stores	O
at	O
the	O
time	O
of	O
conception	O
and	O
the	O
second	O
is	O
the	O
amount	O
of	O
iron	O
absorbed	O
during	O
gestation	O
.	O

Tobacco	O
smoke	O
exposure	O
also	O
predicted	O
lower	O
birth	O
weight	O
with	O
a	O
210	O
g	O
reduction	O
among	O
smoking	O
mothers	O
(>	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
)	O
compared	O
with	O
non	O
-	O
smoking	O
mothers	O
(<	O
3	O
ng	O
/	O
ml	O
serum	O
cotinine	O
).	O

Substantially	O
more	O
information	O
is	O
available	O
regarding	O
the	O
frequency	O
of	O
hand	O
cleansing	O
after	O
defecation	O
.	O

Most	O
pregnant	O
women	O
were	O
satisfied	O
with	O
the	O
level	O
of	O
care	O
received	O
during	O
ANC	O
in	O
public	O
health	O
centres	O
in	O
the	O
Buea	O
Health	O
District	O
.	O

(	O
2011	O
)*/†	O
Peng	O
et	O
al	O
.	O

The	O
association	O
between	O
GWG	O
and	O
offspring	O
overweight	O
may	O
decrease	O
as	O
children	O
grow	O
older	O
[	O
49	O
,	O
50	O
].	O

The	O
overall	O
characteristics	O
of	O
the	O
study	O
population	O
across	O
different	O
categories	O
of	O
dietary	O
patterns	O
are	O
presented	O
inTable	O
6	O
.	O

We	O
hypothesized	O
that	O
there	O
is	O
a	O
maternal	O
stress	O
-	O
GR	O
interaction	O
that	O
can	O
influence	O
fetal	O
birth	O
weight	O
.	O

In	O
this	B
paper	I
,	O
we	O
describe	O
the	O
protocol	O
of	O
a	O
community	O
-	O
based	O
cluster	O
randomised	O
controlled	O
trial	O
that	O
aims	B
to	B
evaluate	I
the	O
impact	O
of	O
maternal	O
antenatal	O
IFA	O
supplements	O
on	O
perinatal	O
outcomes	O
.	O

For	O
every	O
10	O
-	O
fold	O
increase	O
in	O
DEP	O
exposure	O
,	O
there	O
was	O
a	O
14	O
g	O
increase	O
in	O
birth	O
weight	O
95	O
%	O
CI	O
(-	O
51	O
,	O
79	O
).	O

